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Note to the Reader
This work is a survey of lymphoma which makes use of the
greatly increased knowledge of the physiology of the lymphocyte and
mononuclear phagocyte gained over the last two decades. The
approach to the problem of lymphoma has undergone a quiet revolution
in this period as techniques for the classification of lymphoid cells
have become available. Today the physiology of lymphoid cells is
well known, but this knowledge tends naturally to be restricted to
a relatively few individuals closely concerned with the problems of
experimental immunology. This was taken into account in writing
this thesis, and a comparatively large section of the work is
devoted to a summary of normal lymphoid cell physiology (Chapters
3-6). This forms the basis of the understanding of the lymphoma
in terms of lymphocyte function which forms the experimental section
of the work presented here. Chapters 7 to 10 contain a more
detailed analysis of the surface of the lymphocyte and show how this
contributes to our knowledge of B and T cell differentiation in the
immune response. Chapter 12 is a complete survey of the available
literature on surface markers in lymphoma and leukaemia published
to date. The experimental work is presented in chapters 13-23» and
the conclusions are discussed in Chapter 21*. For ease of reading,
the quoted references are included at the end of each chapter.
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INTRODUCTION
"Pathological physiology is the main fortress of Medicine, while
pathological anatomy and the clinic are outlying bastions"
Rudolf Virchow 181*7
"Uber die Standpunke in der vissenschaftlichen Kedicin"
Virchows Archive 1_, 3*
"Insofar as cellular pathology deals only with the changes of the
form and mixture of the living body it remains merely pathological
anatomy, i.e. not pathological physiology, and insofar as it seeks
to raise itself to the latter we must, in accordance with all that
has been said before, call it a decisive step backward to a past
stage of development"
Gustav Spiess 1855
"Die Cellular-Pathologie in Qegensatz zur Humoral und
Solidarpathologie"
Virchows Archive 8, 303-
"Until the cytologists can convincingly demonstrate just which
cells are plasma cells and which are not, which are lymphoid but
not lymphocytes, what the life cycle of the lymphocyte really is,
and what is the relationship of these cells to one another and to
macrophages, polymorphs and fixed reticuloendothelial cells we
shall remain confused"
McMaster 1953
In The Nature and Significance of the Antibody
Response. Editor Pappenhelmer, Columbia





lymphomas were probably first recognised by David Craigie,
and an account given of them as follows t-
"Either after repeated attacks of inflammation, alternating
with resolution, or with a slow and indistinct form of the disease,
a gland or cluster of glands gradually enlarges, and resisting all
forms of resolution becomes unusually hard." Craigie recognised
the malignant potential of such growths, and realised that they
were distinct from carcinoma by their unique anatomical
distribution (Craigie 1823).
In 1832 came the classical paper of Thomas Hodgkin "On
Some Morbid Appearance of the Absorbent Glands and Spleen" in
which the clinical histories and post-mortem findings in six cases
were described of the disease which now bears his name. Sections
prepared from tissue from Hodgkin♦3 original cases by Fox (1926),
showed that cases 2 and k as originally described were compatible
with the modern descriptions of that condition, and it lias been
subsequently argued (Kaplan, 1972) that probably U out of the
original 6 cases would be accepted as cases of Hodgkin's Disease.
Rudolph Virchow (1856) in his book "Cellular Pathology"
distinguished two forms of leukaemia, which he called the
"ordinary splenic form" (i.e. Myeloid leukaemia) and the "lymphatic
form" (i.e. lymphocytic leukaemia). He appreciated that the cells
in these two forms of leukaemia were different. "In the well
marked lymphatic font the cells are small, the nuclei large in
proportion and single, usually sharply defined with dark outlines
and somewhat granular, whilst the cell wall is frequently in such
apposition/.••
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apposition to them that an interval can hardly be demonstrated" •
He goes on to say that these facts "can hardly be interpreted in
any other manner than by supposing the spleen and lymphatic glands
are really intimately concerned in the development of the blood".
Virchow appreciated the normal histological appearances of
lymph nodes, and described the reactive changes of sinus
histiocytosis and reactive fibrosis. Following his description of
leukaemia or "white blood" (181i5) Virchow subsequently classified
the two forms of leukaemia into leukaemic and aleukaemic forms.
The aleukaemic forms probably included most of what would today be
regarded as lymphomas. Cchieim (1865) proposed the term
pseudoleukaemia for these conditions.
In 1893 Kundrat distinguished from the group of
pseudoleukaemia a number of cases in which disease remained
localised to the lymph nodes without apparent bone marrow
involvement. These he called "lymphosarcoma", and noted that this
group itself contained several variants which may have represented
other disease.
In 1916 Sternberg described eight cases of leukosarcoma and
"myeloblastic leukaemia" associated with enlargement of thymus
and mediastinal lymph nodes. This type of lymphoma is now
identified as "Sternberg Sarcoma".
Brill, Baehr and Rosenthal (1925) described "Generalised
Giant Follicular Hyperplasia of lymph Nodes and Spleen", as a
separate entity and three years later Gberling (1928) described
"Reticulo-endothelial sarcoma" distinguishing this entity from the
multiple myeloma of bone marrow. In 1930 Roulet further
distinguished/...
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distinguished the primary lieticulo-endothelial sarcomas of lymph
nodes from those in bone as "retothel sarkom
As pointed out by Kobb-Smith (1938) numerous accounts of
lymphoma reached the literature under the description of
reticulosis or reticulo-endotheliosi.-. According to Sternberg
(1936) lesions so described were so ill classified as to
contribute little more to the concept of lymphomatous disease
than Conheim's description "pseudoleukemia". Whilst retaining
the title "reticulosis" to describe these conditions itobb-smith
divided them into three broad classes on the basis of cell type
and anatomical arrangement into Follicular reticulosis, Sinus
reticuloses and Medullary reticuloses. In this classification
he attempted tc relate both benign and malignant neoplastic
conditions of lymph nodes in one histopathological classification,
far too cumbersome to use diagnostically.
In 191*2, Gall and Mallory adopted a straightforward
approach to pathological classification of these diseases, and
made no attempt to explore the histogenesis of the lesions, which
in previous years had led to great confusion. Their criteria
were primarily cytological and they required their classification
to show a reasonably close correlation with the clinical course
of the disease. They discerned seven categories of lymphoma using
these criteria.
The dost recent addition to the classes of lymphoma now
distinguished was the report of Burkitt (1958) on Multicentric
Sarcoma of the jaw in African children, now named Burkitt's
lymphoma.
The most extensively used modern classification of lymphoma
is probably that of ftappaport Winter a .d Hicks (1956) brought up
to/•••
to date by Kappaport (1966).
With the emphasis laid on the cytological appearances of
the cell types in lymphoma and the appreciation of their importance
in prognosis, further attempts to classify lymphoma by these means
have been made. The category of Reticulum Cell Sarcoma was
severely criticised by Gall (1958) who found no cytological
grounds for its diagnosis. Lukes and Collins (197U, 1975) and
Lukes (1568) have proposed several variants of a classification
scheme based on the cytology of the normal lymphocyte as it
develops, from the small resting lymphocyte to the large
reactive or transformed lymphocyte such as occurs in the
germinal centres.
The most recent view of lymphcmata is based on the
identification of the classes of lymphoid cells which compose
the lymphoma. This follows the discovery of at least two classes
of lymphocytes, and identification of the receptors thought to be
specific for the class of lymphocyte involved.
5.
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Definition of the Lymphoma
A lymphoma is a malignant neoplasm of lymphoid tissue
arising in either central (thymus bone marrow) or peripheral
(lymph nodes, spleen, gut) lymphoid tissue. Lymphomas are
characterised by a progressive increase in cell nass of one more
of the cell types normally present in such tissue.
Host lymphomas are tumours of lymphocytes. lymphocytes are
non cohesive cells which under normal conditions give rise to the
cellular and humoral immune functions of the body. lymphocytes
under normal circumstances exhibit some features which with other
tissue cells would be regarded as malignant behaviour. They have
considerable mitotic potential, they are invasive of other normal
tissues, and they exhibit a wide range of cellular changes
(transformation) including changes in nuclear morphology, and
none of these features necessarily ii iicates a malignant state,
lymphocytes recirculate from lymph to blood, and back to the lymph
through pathways in the lymph node cortex and the splenic white
pulp. They are able to rapidly accumulate within a reactive
lymph node - and hence produce lyrapadenopathy - without active
division. Under antigenic stimulation, emigration from the blood
and mitotic division within the node can soon produce an
enlargement of the node, with some disturbance of normal
architecture, and in extreme cases invasion of local fat, whilst
retaining the charact eristics of a benign lesion. Upon cessation
of the stimulus the reactive features abate and the architecture
regains its normal appearance. This pattern of reaction is
clearly/...
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clearly seen in some drug induced lymph&denopathies, and in
toxoplasmosis, conditions which in the past were, and occasionally
still are confused with lymphomatous neoplasms.
A second constant cell type encountered in lymphoid tissue
is the macrophage, present in the spleen and in the sinusoids,
compact cortex and paracortex of lymph nodes. The ubiquity of
this cell, and its protean features led in the past to
considerable controversy over its origins. Happily these
problems have recently been resolved. The macrophage originates
from a stem cell precursor in bone marrow, and enters the blood
as the monocyte. Circulating monocytes settle in tissues, where
they modulate to macrophages. In some tissues, lymph nodes,
spleen and lung in particular, a resident macrophage population
is built up which alters both in morphology and in cell chemistry
to adjust to the local environment. Such populations frequently
retain a limited capacity for in situ division. Specialised
macrophages are frequently distinguished by terms descriptive of
their site (e.g. sinusoidal, alveolar macrophage, histiocyte) or
by other eporymous terms (e.g. Kupffer Cell, Tingible body
macrophage). As with the lymphocyte, the normal monocyte shows
the capacity to infiltrate normal tissues, to accumulate from the
circulating pool at sites of injury or antigenic stimulation, and
to alter its morphology. Hone of these features are indicative
of malignant behaviour. An additional feature leading to some
confusion lies in the resemblance of early cells of the monocyte
series to the lymphocyte, when assessed by light microscopy.
Some non-neoplastic lesions characterised by large accumulations
of macrophages (sinus histiocytosis, Whippies disease) have in the
past/...
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past been classified as malignant neoplasms, but in general
reactive conditions involving macrophages are easily recognised.
A third component of lymphoid tissue - in this thesis
called the reticular cell system - has been recently defined. In
the past the cells of this system were called "reticulum cells"
and they were regarded as progenitors of either lymphocytes or
macrophages or both. It is now doubtful that this is so. The
reticular cell is a stable differentiated derivative of early
mesenchyme, particularly of the coeloroic epithelium. It is
readily isolated frcan spleen, lymph node, and peritoneal sac in
man and shows features in vitro which distinguish it from the
fibroblast and the macrophage. In lymphoid tissues it is
intimately associated with reticulin fibre, but does not
necessarily secrete it. Such cells can be found in and around
the periphery of germinal follicles where they may play a role
in antigen trapping. Tumours of this cell probably do occur,
and there may yet be a role for the term reticular cell sarcoma
in the classification of tumours of reticular cells.
Finally mention must be made of two other classes of cell
which, because of the influence they exert on lymphocyte
differentiation and recirculation, may yet prove important in the
study of lymphomas. The epithelial cell of the thymus gland,
present in the thymic medulla, Is essential to the differentiation
of the class of T lymphocytes. This effect is produced both
locally (induction) and through the effects of a trophic hormone
acting in peripheral lymphoid tissue. The endothelial cell of
the post capillary venule in the lymph node, and similar
structures in the spleen control the entry of lymphocytes into
lymph/...
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lymph nodes from the blood. This structure is undoubtedly
influenced by trophic factors from the thymus gland, and perhaps
by the lymphocytes themselves, but the mechanisms by which the
blood/lymph node filter operates are obscure, and little is known
about lymphocyte recirculation patterns in man. It is conceivable
that lesions of these two tissues could exert a significant
influence on the types of cell contributing to the neoplastic mass
in an affected lymph node.
One of the features of the normal biology of these cell types,
lymphocyte, macrophage and reticular cell, is their capacity to
co-operate or interact in producing an immune response to antigen.
Macrophages for example will interact with both B and T lymphocytes
in the inductive and effector phases of the humoral or cellular
immune response. T lymphocytes will co-operate with B lymphocytes
in the humoral immune response to many antigens. The reticular
cell may play an essential role in the transformation of B
lymphocytes in a germinal centre. In the normal physiological
reactions of these cells a pure response by only one cell type to
one antigen is never 3een. Changes in cell populations other than
the one which eventually produces the antibody, or the cell
mediated immune response are always detectable. Moreover the
presence of two reactive cell populations does not always produce
the same result. T lymphocytes may help B lymphocytes to
proliferate and secrete antibody, or may inhibit the B lymphocyte
response. The response of T lymphocytes to an antigen may be
abrogated by the antibody secreted by B lymphocytes (blocking or
enhancement effect), while the response of macrophages to the same
antigen/...
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antigen may be facilitated by either antibody (a B lymphocyte
product) or by lymphokines (7 lymphocyte product). It is
therefore difficult to account for the proliferation of B lymphocytes
in a lymphocytic lymphoma when such a proliferation may be the
consequence of T cell stimulation, lack of T cell suppression,
increased macrophage stimulation of B cells, or the presence of a
mitogenic substance for B lymphocytes to mention but a few of the
extrinsic factors known to result in B cell proliferation
experimentally.
In the lymphoma the histological features can vary from forms
confusingly like the patterns seen in the extreme forms of
reactive hyperplasia, to raonomorphic proliferations of one cell
type. In the past, attempts to classify these lesions have
resulted in the attachment of labels to each histological type
with scant regard paid to the functional significance of the
lesions. Recently, with improvements in our knowledge of the
lymphocyte and its habits, several important advances have been
made.
Firstly tumours of individual classes of lymphocytes have
been identified because of the secretion by the cells of a single
unique class of immunoglobulin. By these means Waldenstroms
disease, and multiple myelomatosis may be diagnosed without
recourse to the microscope. The extreme abnormality or
perversion of normal physiological behaviour, which lies behind
the progressive growth of secretory B lymphocytes (plasma cells)
stands in marked contrast to the normal controlled secretion by
the same cell types of a restricted but polyclonal antibody as a
consequence/...
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consequence of encounters with antigen. In fact a more or less
monoclonal immune response can be produced experimentally, but it
does not result in progressive expansion of the antibody secreting
cells as is the case in Waldenstroms disease or myeloma.
Secondly, the accumulation of a monomorphic class of
lymphocytes, frequently seen in lymphomas, is seldom if ever seen
in lymph node reactions. The explanation of this event, interpreted
as a "maturation block" in the normal progress of lymphocytes though
phases of immaturity and reactivity to Inactivity and final
oblivion, has much to recommend it. Even though there remain
difficulties in defining the stage at which this "block of
matitration" occurs, the concept is a dynamic one, in which lymphocytes
entering a proliferative phase for some reason fail to mature and
remain fixed in an attitude of proliferation, resulting in an
enlarging population of non-functioning cells at the same stage of
development and hence of uniform appearance.
Here again such gross perturbations of normal physiology can
scarcely fail to be recognised, when compared with the reactive
lymph node, particularly because of the presence of cells in all
stages of development in the reactive node, and in the tendency of
normal reactions to pass through the reactive, hyperplastic phase to
a phase of resolution accompanied by functional maturation of the
participating cells.
Thirdly, with a better appreciation of the co-operation of
lymphocytes with other cell types the pathologist has to some
extent discarded the reluctance with which he classified lesions of
mixed cellularlty. Once the concept that lymphoma must be a tumour
of/...
12.
of lymphocytes alone was shown to have no factual basis since
normal responses invariably involve other cell types the lesion
containing mature and immature lymphocytes and macrophages can
clearly be called "mixed". Such an interpretation is more than
descriptive, and leads to the consequence of expecting co-operative
neoplasms in which the proliferation of the neoplastic cells is
dependent upon the mutual interaction of diverse cell types within
a single lesion (Horror Pathologicus).
By far the most important advance has recently been the
discovery and application of methods which allow identification of
living cells within lymphoid tumours. The lymphoma is a
proliferation of the cells composing lymphoid tissues. This
proliferation differs from the physiological proliferative state -
defined as an immune response - in that no inductive agent or
antigen can be demonstrated, and the proliferation fails to
terminate in the production of a state of immunity.
The immune response is unique in that an encounter with an
antigen leads physiologically to two effectst- division of cells
specifically reactive to that antigen, and the secretion of
molecules which either react with the antigen specifically or which
influence the local reaction of other cell types with that antigen.
It can thus be seen as a reaction in two phases, one the
inductive phase in which antigen is detected and encountered by
cells, and the other the effective phase in which the consequences
of the inductive process are expressed, by ultimately the
elimination of the antigen or neutralisation of its effects.
The cells which either react with antigen or induce or
control/*••
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control the reactions of other cells as a consequence of the
presence of antigen have been substantially and accurately defined.
The means of their definition have been the experimental
manipulation of cell populations in whole animals, and the
recognition of cell surface antigens constantly associated with
one cell class. In addition other techniques used involve the
reaction of these surface components with detectable particulates,
with other cells, or with chemical agents which produce or inhibit
proliferation or otherwise cause changes in the population under
study. These reactions in or on the cell surface are intimately
involved in the immune response. The reaction of a cell with any
particle or molecule in its vicinity takes place at the cell
surface. bince the surface and membrane of the cell is so
complex that physical interpretations of particle-cell
interactions become for practical purposes meaningless, the
concept of the "surface receptor" has been widely used to explain
the kinetics of such reactions. According to this hypothesis,
the surface of each and every cell possesses families of molecules
which can react by weak bonding to complementary regions on
paz^icles or other cells) that is possess "receptors" which
"bind" the "ligand" or particle. These receptors are determined
by genes expressed during the differentiation of the cell. For
some of the molecular families on the cell membrane, no "ligand"
is identified, but the molecules themselves can be identified by
their iiratunogemicity - these are the cell surface antigens - and
they have proved of great significance in understanding the
physiology of the immune response. The ability to identify the
cell surface antigens has led to the mapping or description of the
genes/...
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genes responsible for their expression.
The importance of the cell surface is two-fold. Firstly it
is the "eyes and ears" of the cell, and dictates the response of
that cell to its environment. Secondly it is accessible and can
be used to define both the cell class and its functional state.
The essence of this thesis is to relate the abnormal
proliferation of lymphoid cells in lymphoma to the normal knoxm
reactions of lymphoid tissue to antigens. This involves a
comparison of the known surface structures such as surface
receptors for immunologically reactive intermediates, on the
surface of the neoplastic lymphoid cell with the same structure
on the noxmal or reactive lymphoid cell.
In this thesis the data obtained by examining the surface
of lymphoma cells for the presence of surface markers is
presented. The markers employed detect differences in lymphoid
cell populations, and by this means quantitation of different
subclasses of lymphoid cells in a lesion can be achieved.
The examination of receptors on the cell surface goes
beyond this point. There is evidence that lymphocytes, during
their complex differentiation and interaction in immune responses,
express receptors which they would otherwise not in the "resting"
or inactive phase. There are morphological equivalents of these
alterations in receptor expression, notably in those cell
interactions which lead to the formation of reactive nodules or
germinal centres in the normal lymph node, or perhaps in the
nodular variants of the lymphomas. From the receptor patterns
otserved in the lymphomas examined it is suggested that in the
majority/...
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majority of cases the lymphoma can be interpreted in terms of
lymphoid differentiation reflecting the normal differentiation
seen in an immune response* It is not possible to determine
whether this is an abnormal response by normal lymphoid cells due
to some peculiarity of the antigen responsible for its initiation
(e*g. a virus) or whether abnormal lymphoid cells react in a
manner reminiscent of their normal counterparts but fail to bring
an immune response to a useful conclusion*
The lymphoma is thus interpreted as:-
AM ABNORMAL IMMUNE RESPONSE IN WHICH THE PARTICIPATING CELLS
BECOME FIXED IN AN ATTITUDE OF PSOUFEBATION BY FAILING TO
TERMINATE THE RESPONSE IN A NORMAL WAX.
This interpretation may not be factually correct, but it is
the contention of the author that since virtually all that is
known about lymphoid cell proliferation is determined from
experir mtal manipulation of the immune response any responsible
viewpoint must correspond to this interpretation to make most use
of the available facts. Since all data on lymphocyte
proliferation concern the response to antigens, so the neoplasm
can be usefully regarded as an abnormal immune response.
lymphomas occur principally and primarily in lymph nodes.
These are not merely aggregates of lymphocytes, but contain
important phagocytic, structural and endothelial elements. In
an enlarged lymph node of reactive type there is no difficulty in
grasping the concept of co-operation - that is the concerted
activity of phagocytic, endothelial, structural and lymphoid cells
in producing the resultant immune response. The difficulty in
grasping/...
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grasping this concept in respect of lymphomas is greater. In a
neoplastic lymph node, a minority of the cells present may be
objectively "neoplastic" (that is have chromosomal or antigenic
variations which can be demonstrated as e property of neoplastic
cells - for example monoclonal immunoglobulin secretion). The
remaining cells, according to at least one modem viewpoint, are
not part of the neoplasm. However, it could be argued that the
non-neoplastic lymphocytes are as essential to the continued
proliferation of the neoplastic lymphocytes in a lymphoma, as are
the macrophages and the T lymphocytes to the few B lymphocytes
proliferating and secreting antibody in a reactive lymph node.
As will be shown the study of surface receptors in lymphomas
does give seme factual support to these arguments.
«
CHAPTER 3
PHYLOGENY OF THE LYKPHORETICUIAR TISSUES
An account of the phylogeny of this system
demonstrates some important features of
immune responses are older than the phyla in
which they are now studied. Of the three
most important classes of immune reaction,
non-specific cellular immunity, specific cell
mediated immunity and humoral immunity, two
were present before vertebrate phyla evolved.
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SECTION III
The phylogeny of the Xymphoreticular Tissues
Fhylogeny is the tracing of a common cell, or cellular
function back, as it were, in time by examining that function in
coexistent phyla which have undergone diverse evolutions. By
this means the macrophage or the lymphocyte, and their functions
can be examined in invertebrates, in fishes, in cold blooded
animals, marsupials and maranals. As a general rule it is found
that physiological functions which are important to a species,
are never lost once gained during the course of evolution. On
the other hand they may undergo changes in which the ancestral
characteristic becomes barely recognisable when expressed in more
recent phyla.
The immune response exhibits such characteristics. In
invertebrates there are two types of response described. One -
the response of phagocytosis of invading bacteria or particulate
matter-evolved from the primitive feeding mechanism of protozoa,
and is expressed in all triploblastic invertebrate phyla so far
studied (see review by Stuart, 1970). An additional type of
immunity, that is the capacity to interact with competing
equivalent organisms, is well devloped in the colonial hydroids
Gorgonians (Theodore, 1970). These simple animals do not
coalesce with "foreign" species - rejecting them by inducing
cell necrosis at points of contact - a mechanism developed by
the ectoderm. Another noteable feature of invertebrate iraminity
is the dependence of the phagocytic reaction upon "opsonins" in the
body/...
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body fluids (Stuart, 1968; McKay at al., 1969; Hostetter and
Cooper, 1972) and of the latter reaction on call contact (Theodore,
1970 ) • Thus at such a primitive level of animal evolution the
main features of the mammalian immune reaction are observed1-
1) Phagocytosis dependent upon opsonins in body fluids
2) The ability of ectodermaly derived cells to cause
contact necrosis in foreign tissues.
In the terminology of mammalian immunity it could be said
that 1 ) is an example of phagocytlc-immunity initiated by opsonins
and 2) is cell mediated immunity, in the vertebrate dependent upon
the thymus gland.
In the absence of lymphocytes, invertebrate organisms exhibit
a kind of humoral immunity in which the phagocyte is the effector
cell and a kind of cellular issnunity in which the effector cell is
ectodermal. The further development of the immune system is
characterised by modifications of the phagocyte (with the
development of blood forming tissue) of the "opsonins" (with the
development of circulating antibodies) and of the Cell contact/
necrosis reaction involving ectodeim (development of the thymus
and thymic dependent lymphocyte system).
The phylogeny of the immune system in cold blooded
vertebrates has been extensively reviewed (Du Pasquier, 1973)*
There is a continued development and modification of the
phagocytic tissues (the primitive reticulo-endothelial system,
Stuart, 1968) of the invertebrate with the formation of an organ
the "Iymphomyeloid complex" which contributes lymphocytes,
nucleated red cells, and granulocytes to the circulation. Such
tissue/...
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tissue has now been identified in many primitive vertebrates, such
as agnathes, save for a few transitional forms (e.g. Arephioxus).
The appearance of the lymphomyeloid complex in primitive
vertebrates is associated with a very marked increase in the
susceptibility of the organism to irradiation and cytotoxic drugs
(Finstadt, et al.f 1969) in comparison with the invertebrate
(Sparks, 1972). In addition to the haematopoetic organ of the gut
wall the agnathes show a primitive thymus which develops on the
paryngeal aspect of the gill bars (Fitchtelius, 1969).
In the 3 awed fishes, the thymus, although primitive, has
already acquired some of the physiological characteristics
associated with mammalian thymus, noteably it shows involution
with age. In the larval tadpole the thymus is located behind the
eye, which is also the site of the monocyto-poetic organ of the
octopus - the "corps blanc" (Stuart, 1968). In fishes, and larval
amphibians, lyrapho- and haematopoesis occurs in the spleen, kidneys,
gut, liver and bone marrow, a situation which differs from the
agnathes where it is found only in gut wall. Antibodies of IgM
type are produced in fish (Marchalonis and Edelman, 1965).
In amphibians, both thymic and extrathymic lymphopoesis
can be identified, the extrathyraic tissues contributing lymphocytes
with identifiable surface immunoglobulin of IgM type. Antibodies
aire formed and secreted by cells morphologically like the IgG
producing plasma cells of mammals, and two classes of antibody are
produced. Both however are susceptible to cleavage with
mercaptoethanol and resemble IgM rather than IgG (Yaraaguchi et al.,
1973)* Antibody production in toads and in fish is dependent on
environmental temperature (Lin and Rowlands, 1973)# Thymectomy
in/...
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in the amphibian has little or no effect cm antibod; production
but will prevent graft rejection. The phenomena of second set
graft rejection and immunological enhancement (both Thymic
dependent phenomena) have been shown in the leopard frog (Vulpe
and Gebhardt, 1965).
The reptilia have no lymph nodes - these are found only in
marsupials and mammals, but they are noteable for two features -
the presence of pharyngeal tonsillar tissue is noted in the
alligator, and in some species the presence of a cloacal bursa.
Evolution at this stage present a divergence between the Immune
system of the bird, with the cloacal bursa of Fabricius, and the
mammal which subsequently develops true lymph nodes.
Xh terms of function, the cells which characterise the
lymphocyte system (Thymus dependent, T, and thymus independent,
B, lymphocytes) and the phagocytic and structural calls are all
present in the free swimming jawed fishes. Subsequent vertebrate
evolution has added the pharyngeal lymphoid tissue, bursal lymphoid
tissue, and lymph nodes, and with them the capacity to secrete low
molecular weight antibodies. In tho mammal five classes of
antibody are identified compared with two in the chicken (igM and
IgX) and only one in amphibians (Igh, both pentameric 19s and
monomeric 7s) and one in fish. It is obvious that increased
capacity to secrete immunoglobulin is the most marked
characteristic feature of the later evolution of the immune system.
There is also the implied genetic instability of antibody formation
which the rapid evolutionary modifications of this system demonstrate.
This brief summary serves to illustrate five major points
1) The/...
1 ) The extraordinarily primitive character of the mechanism
of phagocytosis and ectoderm-mediated cell necrosis
reactions.
2) A positive correlation between the evolution of
haeraopcotic and lymphopoetic tissue and increased
susceptibility to irradiation and cytotoxic drugs.
3) The capacity to reject grafts in vertebrate phyla
invariably depends upon the presence of an epithelial
thymus of ectodermal derivation with its associated
lymphocyte population.
it) That phylogenetically, normal lympho- and haematopoesis
can occur in spleen, liver, kidney, gill and gut wall.
5) The development of the major lymphoreticular organs of
mammals, pharyngeal lymphoid tissue, lymph nodes, and
the gut-associated lymphoid tissue, is a recent event
in evolutionary terms and is accompanied by an increase
in quantity and in number of subclasses of immunoglobulin
secreted.
22.
Biology and i-foysioiogy of the lymphocyte bystam
The lymphocyte is derived from a stem cell population in
bone znar 'ow. Ford and Mieklem (1963) showed that suspensions of
bone marrow cells will repopulate the irradiation depleted thymus
with lymphocytes. The bone marrow cells in these experiments bore
a marker chromosome, which, following proliferation in the thymus
of the irradiated host, could subsequently be identified in
secondary lymphoid organs, thoracic duct and blood. Cells from
the thymus, lymph nodes, thoracic duct and blood were much less
potent than bone marrow in repopulating thymus in irradiated
hosts (Ford et al., 19£6j Micklem et al., 1966). These facts
suggested that lymphocytes originated from a stem cell precursor
in bone marrow - and not from lymphoid tissue primarily.
The marrow itself contains a population of lymphocytes
diffusely admixed with myeloid and erythroid cells (Toffey and
Courtice, 1970) but in man follicular or nodular aggregates of
lymphocytes can normally be found (Bywlin, 197ki 1975). In the
guinea-pig the bone marrow lymphoid population is manufactured at
the rate of 1 x 10^ lymphocytes a day; the half life of the
marrow lymphocyte is estimated at 2h hours. (Everett and Tyler,
1967). The lymphocyte population of marrow itself cannot be
regarded as a true "stem cell pool" although it is the progenitor
of a class of antibody forming lymphocytes. Miller and Mitchell
(1969) using purified populations of thymic lymphocytes, and bone
marrow lymphocytes carrying marker chromosomes transferred to
irradiated animals, showed that the progeny of bone marrow
lymphocytes/..•
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CHAPTER k
PHYSIOLOGY OF THE LYMPHOCYTE
More Is known about the lymphocyte than about
any other cell type (with the possible
exception of the neurone). The overwhelming
nature of lymphocyte associated literature tends
to depress rather than elate those not intimately
acquainted with this cell. Nonetheless it is
important, particularly in a study of this kind,
to indicate a few of the basic facts about its
origins and functions. Without this knowledge
attempts to investigate tumours of lymphocytes
become confusing.
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lymphocytes - but not thymocytes - became antibody forming cells.
The stem cell of the lymphoid series has been studied by
Tyler and Everett (1966) and Edwards, Miller and Phillips (1970).
The former authors used a system in which one of a pair of
parabiotic animals was lethally irradiated, and cells in the other
3
labelled with H Thymidine while the connection between the two was
occluded. When circulation was re-established, the repopulation
3
of marrow, lymph nodes, and spleen by H thymidine labelled cells
could be studied. The cell responsible for this repopulation was
"Monocytoid" rather than lymphoid. Edwards, Miller and Phillips
(1970) using a chromosome aberration induced by irradiation in
myeloid cells, found that bone marrow "marked" by this method could
be used to reconstitute x-irradiated congenitally anaemic mice.
Myeloid colonies bearing the marker chromosome were recovered from
the spleens of recipient mice. On transfer of these colonies into
recipients concurrently injected with sheep erythrocytes, B and T
antigen-reactive cells of lymphoid origin were found to possess
marker chromosomes.
The bone marrow stem cell will form colonies of granulocytes
or monocytes upon cultures in soft agar. These "colony forming
units" (CFU) are regarded as the putative stem cell, but no
evidence of the direct generation of lymnhoid colonies from bone
marrow stem cells exists. The proliferation of the CPU isolated
from marrow requires the presence of additional factors, colony
stimulating factors, for colony growth. In the mouse, one source
of colony stimulating factor appears to be the activated T lymphocyte,
and administration of antigens to mice changes the frequency and
distribution/...
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distribution of haematopoetic cells in blood and in spleen due to
release of this factor (Cemy, 19710* It Is apparent that the
lymphocyte progeny of the bone marrow rtem cell cannot be directly
produced by culture of bone marrow, only monocytes and granulocytes
result from this procedure. However, lymphoid nodules will
develop in vitro from fragments of lymph node and spleen in
irradiated mice reconstituted with bone marrow (Metcalf, et al.,
1975). In vivo experiments also clearly show the ability of bone
marrow cells to restore the depleted lymphoid population of the
irradiated thymus or thymus graft. Treatment of bone marrow cell
suspensions with antisera designed to remove the thymic dependent
lymphocyte produces an increase in the numbers of in vitro colonies
formed by stem cells (Hookerjee and Poulter, 197b). The number of
colonies is also increased during early infection of mice with
ectromelia virus (McNeill and Killen, 1971a) and there is evidence
of secretion of a suppressor substance probably from the lymphoid
system later in the disease (McNeill and Killen, 1971b).
The stem cell is normally confined to the bone marrow, but
there is evidence in CRA mice, reconstituted with blood from CBA./T6
marked animals that a poorly proliferating peripheral blood lymphoid
stem cell exists. (Micklem, Anderson and Hoss, 1975). This has
been regarded as a stem cell "eliminated" from the bone marrow pool.
In man cells isolated from the peripheral blood have also
been shown to possess colony forming potential. The various
subpopulations of human peripheral blood mononuclears can be
separated and substantially purified by "rosetting" with appropriate
test particles and differential centrifugation of the resulting
rosetted/.. •
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rosetted and non-rosetted cells. When all T (thymic dependent)
lymphocytes were removed, a monocyte enriched fraction could be
prepared from which colony forming units making macrophages,
granulocytes, megakaryocytes, and even occasional monoblasts were
clearly present. From this fraction, further removal of cells
expressing Complement receptors, left a population of "stem cells",
which were neither T lymphocytes, B lymphocytes, or monocytes
(Barr, Whang-Peng and Perry, 1975)* B and T lymphocytes form
8*6% (T) and (B) of the mononuclear cells in human marrow.
7h% of cells have no B or T lymphocyte characteristics (Fauci, 1975).
In summary, the lymphoid stem cell is present in bone marrow,
but is not a bone marrow lymphocyte. lymphocytes can only develop
from this stern cell in the appropriate inductive environment of
thymus, bone marrow itself, or peripheral lymphoid tissues. It is
this exposure which determines the subsequent life history of the
lymphocyte, as it becomes committed at this stage to develop as
either an antibody forming cell (B cell) or as one of several
further categories of thymic dependent (T) lymphocyte. The
experimental evidence which has led to the interpretation of the
lymphocyte population in terms of their bone marrow (or Bursal)
dependence, and their thymic dependence, i.e. as "B" or "T"
lymphocytes forms the bulk of the cellular immunology of the last
decade. This evidence has led to slightly different viewpoints
on the nature of the B and T lymphocyte development. Strictly
speaking, in mammals, only the thymic dependent class of
lymphocytes is present, as no "Bursal equivalent" (that is tissue
performing the inductive role of the Bursa of Fabricius) has been
identified/.••
26.
identified in the mammal. However, in birds, the Bursa produces
lymphocytes which become antibody foiming cells on antigen
stimulation, and the presence of these cells is independent of
the thymus gland - i.e. are thymic independent. The terms thymic
dependent and thymic independent lymphocytes are possibly more
academically acceptable than the tsrms more popularly used T
lymphocyte (or T cell) and B lymphocyte (or B cell).
The lymphoid star, cell enters peripheral blood, and may seed
to the thymus gland, lymph node, gut associated lymphoid tissue or
spleen. There is some evidence that the fate of such lymphocytes
depends upon the inductive influence of the "primary" lymphoid
organs - the thymus, bone marrow, gut associated lymphoid tissue
and spleen. It has been shown in the rabbit that if lymphoid
suspensions are prepared from thymus, gut associated lymphoid
tissue, bone marrow or spleen, significant antigenic differences
between the populations can be shown, following immunisation of
horses with the lymphoid suspensions (Richter, Colas de la Noue and
Hardy, 1975). This implies that, from the stem cell in marrow,
lymphocytes differentiate and acquire different functional capacities
dependent upon the peripheral site in which they develop.
This finding is of some relevanc3 to the substance of this
thesis. The finding that lymphocytes of the spleen contain a
population which carries spleen specific antigens indicates that
(a) the bone marrow and thymus may not be the only primary
lymphoid organs, gut associated lymphoid tissue and
spleen must also be so classified.
(b) that all lymphoid organs except lymph node and blood are
capable of inducing differentiation of stem cells
resulting/...
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resulting in a unique organ associated lymphocyte
population, distinguishable by surface antigenic
characteristics.
The Thymus and thymic dependent lymphoid population
Removal of the thymus in the neonatal period is associated
with four effects.
1 ) Wasting of the thymectomised animal, due to failure of
cell mediated immune reactions resulting in infection.
This can be corrected with broad spectrum antibiotics.
2) Decrease in lymphocyte population of blood, lymph nodes
and spleen.
3) Diminished capacity to produce antibody following
injection of certain antigens.
h) A permanent failure to reject skin grafts from
incompatible donors.
Thymectomy in adult animals is not associated with
significant immune defects. If adult thymectomy is followed by
irradiation and reconstitution with bone marrow there is failure to
develop immunity against grafts, or to fully restore the
circulating lymphocyte population. If the animal is merely
irradiated, and protected with bone marrow from a syngeneic donor
without thymectomy, full immunocorapetence can be restored (Miller
and 08 >ba, 1963).
The thymic dependent lymphocyte is the major population of
thoracic duct lymph. Gowans (1962) and Gowans and Khight (196k)
showed that by cannulation of the thoracic duct, and removal of the
lymphocytes/...
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lymphocytes with thoracic duct lymph the lymphocyte population of
peripheral blood was greatly reduced. Similar observations were
made on the depletion of lymphocytes in spleen, lymph nodes, bone
marrow and thymic cortex in rats subjected to prolonged thoracic
duct drainage (Yoffey et al., 196U). Such depleted animals can
sill mount normal primary and secondary humoral immune responses
(Gowans and McGregor, 196$). The small lymphocyte population
drained from the thoracic duct lymph could terminate the state of
tolerance in neonatally grafted animals, and was thus shown to
contain immunologically competent cells (Gowans et al., 1963).
Since this circulating TDL (Thoracic Duct lymphocyte) population
was the one most severely depleted by thymectomy it was established
that the small lymphocyte of thoracic duct lymph was "thymic
dependent". The cells of the thoracic duct lymph will migrate
to the periarteriolar lymphocyte sheaths in the spleen and to the
paracortical areas of lymph nodes, but not into bone marrow (except
for a small subpopulation) or into germinal centres of lymph nodes
or spleen (Ford, 1969J Ford and Gowans, 1969). The recirculating
lymphocyte pool, most of which consists of long-lived, slowly
dividing lymphocytes, is largely, but not completely, derived from
thymic dependent lymphocytes. Thymectomy depletes the circulating
pool, as well as reducing the rate of entry of bone marrow derived
lymphocytes into this recirculating pool (Ford and Marchesi, 1971).
Thymectomy reduces the lymphocyte population in the paracortical
areas of lymph nodes, and also the periarteriolar lymphocytic
sheath of the spleen (Parrott, de Soussa and East, 1966). The T
lymphocyte population is not exclusively dependent upon the presence
of/,..
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of an Intact thymus, since in congenitally thymuslees (NU/NXJ)
mice a small number of theta antigen positive T lymphocytes can
be detected (Loor et al., 1975)*
The thymus gland
As previously mentioned the thymus gland develops as an
epithelial tissue derived from foregut structures. During the
second in-utero months, the epithelium of the primordiura becomes
lobulated and a cortex develops by rapid accumulation of lymphocytes
so that the organ is largely lymphoid by the 9th week of
intrauterine life. lymphocytes were originally thought to develop
from the epithelium of the thymus itself (Auerbach, 1961) but it
is now certain that they migrate from yolk sac or bone marrow into
the thymic rudiment and proliferate in the specialised environment
of the thymic epithelial cell (Moore and Owen, 1967} Micklem et al.,
1968). Repopulation studies have shown that thymus grafts of
epithelium become repopulated with cells originally derived from
bone marrow (Ford et al., 1965). The rate of proliferation of
the lymphocyte population is determined by the thymic epithelial
component (Miller and Osoba, 1967} Metcalf et al., 1961} El-Arini
and Osoba, 1973). The bulk of the lymphocytes produced in the
thymus gland probably die in situ. The lymphocyte rich cortex
is particularly vulnerable to so called "stress involution". In
some species, notably the oppossum, very marked thymic involution
occurs at birth (Block, 19CU). Thymic lymphocytes leave the
cortex to enter the spleen, and after following a rather
complicated circulatory pathway within the periarteriolar
lymphocyte/...
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lymphocyte sheath (Ford, 1969) re-enter the blood and lymphatic
circulation as part of the recirculating lymphocyte pool. As
previously indicated the great majority of thymic lymphocytes are
probably destroyed within the thymus, and the cortical lymphocytes
are particularly susceptible to irradiation and lysis by steroids.
A residual medullary population of thymic lymphocytes is steroid
and radiation resistant, and it has recently been shown that these
cells can persist in thymus grafts (Elliot, 1973) and are able to
transfer G.V.H. reactivity (i.e. are Immunocompetent) in contrast
to the labile cortical lymphoid component which is incompetent.
The concept of hetergoeneity among thymic, and thymus-derived
lymphocyte populations is recent. It is further complicated by
the known ability of thymic epithelium, but not thymic lymphocytes
or thymus-derived lymphocytes alone to restore the ability of a
thymectomised bone marrow reconstituted animal to mount a humoral
immune response to thymic dependent antigens (Dukor et al., 1965).
Not only is the thymus a major "factory" far the reproduction of
circulating lymphocytes (at least up to early adult life) it also
exerts a humoral influence on lymphocyte differentiation in the
periphery (Yoffey and Courtice, 1970).
The thymic lymphocyte (thymocyte) and the thymic dependent
lymphocyte (T lymphocyte) do not secrete immunoglobulin, although
they can both bind certain immunoglobulin classes passively to
their surface (e.g. IgM)(Webb and Cooper, 1973) and have surface
receptors which are immunoglobulin-like (Cone et al., 197U). The
thymic dependent lymphocyte is the primary reactive cell in graft
versus host disease (although it influences the activity of the
macrophage/...
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macrophage In the effector phase of graft versus host disease). The
specifically reactive T lymphocyte populations can be depleted of
graft versus host reactive lymphocytes by adherence to cells bearing
the sensitising antigens. This implies that in GVH a population of
T lymphocytes carry surface receptors for histocompatibility antigens
from "foreign" tissues, and that this population alone is responsible
for the production of graft versus host disease on transfer to
irradiated recipients (Bonavida and Xedar, 197k)» The nature of
the receptor for histocompatibility, and other antigens, on the
surface of the thymus dependent lymphocyte is dealt with in a later
section.
Among the population of thymus derived lymphocytes are found
several subpopulations with different functions. In graft versus
host disease, there is a population of T lymphocytes which are
cytotoxic to cells carrying the sensitising antigens. This
population can be inhibited by pretreatment with anti-thymocyte
serum and complement, indicating that the cytotoxic T cells carry
surface antigens similar to those expressed on thymic lymphocytes
(Sanderson and Franks, 197U). The cytotoxic T lymphocyte can also
be inhibited by antibody prepared to its surface antigen receptors
(Kimura, 197b) showing that such receptors are required for both
sensitisation and subsequent T cell-target cell interaction leading
to cytotoxicity.
A second important class of thymic dependent lymphocyte is
the carrier specific helper cell, defined by its ability to react
\
with the carrier protein of a haptene carrier complex, and
subsequently to stimulate B lymphocytes to divide and form
antibodies/...
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antibodies to the haptene. Such cells can be induced in vitro by
appropriate expsoure to carrier determinants (Kontianen and Feldman,
1973).
The third class of T lymphocytes defined by their function in
immune responses is the suppressor T cell. These cells act to
suppress or prevent antibody formation by B lymphocytes in vitro
and in vivo. If a transferred reactive cell population, in an
adoptive humoral immune response is treated by antisera gainst
thymocytes greater humoral response on subsequent immunisation
occurs. This is reminiscent of the enhancement by anti-T-cell
serum of the proliferation of bone marrow CFU in hasmatopoetic
colony assay. In a recent survey of subpopulations of T
lymphocytes it was shown that the separate functional groups of T
cells showed different surface antigenicity involving the ly surface
antigen system (Kisielow et al., 1975).
In addition to helping B cells in the immune response, T cell
helper populations have also been defined in T cell cytotoxicity
towards incompatible cells. Both helper functions, and GVH
cytotoxicity are specific in their induction and expression. T
cell mediated suppression of antibody formation is a non specific
function of thymic dependent lymphocytes (Janeway et al., 1975).
In addition to cytotoxic T lymphocytes induced by contact with
target cell antigens, cytotoxic T cell populations can be generated
by IgM antibody to target cells, using thymocytes not previously
exposed to target cell antigens. These are cells normally
immunologically incompetent but they are rendered specifically
cytotoxic for target cells coated with IgM (Lamon et al., 1975).
The/...
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The B lymphocyte system
The term B lymphocyte implies a differentiation from the
manmalian equivalent of the Bursa of Fabricius. This is probably
the bone marrow, and it ha3 been shown that the bone marrow
lymphocyte population contains the precursors of antibody forming
cells (Miller and Mitchell, 1969* Benner et al., 197U). In
addition to bone marrow derived lymphocytes there is also evidence,
at least for the rabbit, that B cells are supplemented by gut-derived
(appendix and sacculus rotundus) and possibly spleen-derived
antibody synthesising populations (Richter et al., 1975). The
term B cells, embraces the entire population of antibody
synthesising cells and their precursors whether strictly of bone
marrow derivation of not. The stem cell of the B lymphocyte
system matures in both bone marrow and in gut associated lymphoid
tissue in some species (Nieuwenhuis, 197ha). The development of
antibody synthesising cells is probably controlled by the "antigen
drive", i.e. the rate of entry into the body of bacterial and other
antigens. The presence of an association between the gut and the
differentiation of large numbers of antibody forming cell
precursors could be accounted for by the antigen load in the gut -
and hence the antigen drive to cells associated with it, without
the need to invoke a special role for the gut in the differentiation
of B lymphocytes (NJeurenhuis et al., 197Ua,b.). The end cell of the
B lymphocyte system is the plasma cell, which secretes antibodies
(Fegreus, 19U8) • Removal of B lymphocytes from bone marrow or
spleen of immunised animals, by techniques which eliminate cells
expressing surface immunoglobulin, abolish the ability of
irradiated/...
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irradiated animals reconstituted with this depleted population to
make antibodies, but leaves cellular immune responses more or less
intact (Campbell and Grey, 1972). The ability to inhibit the
uptake of antigen by B lymphocytes with the use of anti-light chain
antisera (Basten et al., 1971) in antigen binding reactions (Ada,
1970) shows that the antigen receptor on this class of cell is
surface immunoglobulin (Wigzell et al., 1969, 1970, 1971). This
constant feature of the B lymphocyte, the presence of surface
immunoglobulin, can be used to define the B cell population.
Mouse bone marrow lymphocytes are capable of synthesising antibody
in vitro after challenge with antigen in vivo. Subsequent
detection of antibody by the placque forming cell (PFC) assay
demonstrates this capability (Benner et al., 197U). Bone marrow
B lymphocytes may selectively migrate to the germinal centre
(Nieuwenhuis, 1971) where they differentiate into "memory" B cells.
B lymphocytes of the mouse, in addition to carrying immunoglobulin
also express sub-class specific receptors for immunoglobulin
IgG (the Fc receptor), receptors for complement components C3b,
C3d, and receptors (in man) for Ebstein Barr virus particles.
Using these criteria B lymphocytes are readily identified. B
lymphocytes, after production from bone marrow stem cell lie in
peripheral lymphoid tissues where they occupy two anatomical zones,
the diffuse lymph node cortex and the cortical follicles. In the
mammal, the gut associated lymphoid tissue is well endowed with
prominent secondary follicles, which show a "cap" on the luminal
surface, composed of small B lymphocytes. Flash labelling with H
thymidine in tonsil demonstrates very rapid labelling of this
lymphocyte/...
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lymphocyte cap, the labelling rate exceeding that even of the
thymus (Koburg, 1967J Mitrou et al., 1969). This speed of labelling
was also shown for the rabbit appendix (Nieuwenhuis, 197ha,b.).
In the spleen, B cells are localised to the peripheral areas
of the Malpighian body, around the marginal sinus. This area, the
peripheral white pulp (IWP), is not depleted by thymectomy (Parrott
and de Soussa, 1967), shows presence of specific antibody forming
cells after immunisation, and accumulates labelled B cells from
appendix or bone marrow (Nieuwenhuis, 197i|b).
Nossal and Pike, (1973)* demonstrated that B cells originate
from a non-B stem cell in the haemopoetic organs of the foetal
mouse about 3 days before birth. B cells do not arise in lymph
nodes but reach and populate them 5 days tfter birth. Recovery of
B cell populations after irradiation is rather slow, and the B cell
is more susceptible to irradiation than the T lymphocyte.
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CHAPTER $
THE MONONUCLEAR PHAGOCYTE SYSTEM
The macrophage can lay claim to the longest
experimental history of any cell type. Its
vigorous phagocytic response was noted by the
early biologists. In the last two decades
it has experienced an experimental renaissance.
It is now no longer regarded as a ubiquitous
dustbin, but as a subtle and important member
of an intricately organised cellular community.
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The Macrophage System (Mononuclear phagocyte system)
The cells which compose this system have certain defined
characteristics. These are:-
(a) Avid phagocytosis.
(b) strong adhesion to glass or plastic surfaces.
(c) Surface receptors for Fc portion of IgG molecule,
fragments C3b, C3d or complement, IgM molecules, and
altered fibrinogen.
(d) Receptors for cytophilic homocytotropic antibodies.
(e) Response to factors, such as the chemctactic factors
released from complement activation, and M.I.F. (migration
inhibition factor).
(f) Cytotoxicity towards cultured cells if "armed" with
antibody, or M.A.F. ("macrophage aiming factor").
In addition, there are certain cytological characteristics
seen by electron microscopy. These include the presence of
phagolysosomes, presence of leashes of microfilaments in the cytoplasm,
and evidence of pinocytosis and macropinocytosis. They have no
endoplasmic sacs, and no rough endoplasmic reticulum. The plasma
membrane is highly convoluted with broad cytoplasmic veils. Few
mitochondria are present in unstimulated cells. The nucleus is
unremarkable, and a small single nucleolus is usually present in
human cells.
The macrophage was one of the earliest tissue cells for which
a function was clearly demonstrated. Metchnikoff showed the role
of the phagocyte in defence against bacteria (1905) as a scavenging
cell in necrobiosis (1899) and in inflammation (1892) and as a
constituent/...
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constituent of the granuloma of tuberculosis (1888). The source
of macrophages in mammalIan tissues remained a mystery. Various
authorities argued an origin from the local tissue fibroblasts
and reticulum cells (Aschoff, 1921*) and from the blood monocyte
(Bloom, «92o), or, more controversially, from the lymphocyte.
This view, now considered erroneous, stemmed from the initial
observations of Metchnikoff (1888) on the formation of the cells
of tuberculous granulomas. He observed blood cells (i.e.
lymphocytes) metamorphosing to first macrophages, then to
epithelioid cells, and finally to giant cells. The ultimate
disciples of this origin of the macrophage from the peripheral
blood lymphocyte were hebuck (19kl) and Downey (1955).
The origin of the macrophage, the blood monocyte and
promonocyte, from the bone marrow stem cell was revived only
recently, although this correct view of its origins was shown
many years ago.
Murray, Webb and Jwann (1926) studying Bacterium Monocytogenes
infection in rabbits, found only a few cells not readily
distinguishable from lymphocytes among the monocyte population of
peripheral blood. As they pointeu out although the output of
small lymphocytes from the thoracic duct was increased by
infection, no increase in the macrophage population was seen.
If lymphocytes turned into macrophages or monocytes in lymph nodes
and reached the blood by way of the tho .'aoic duct then an
increased thoracic duct monocyte population Mould have been
detected. The increased monocyte population of peripheral blood
could only therefore have occurred by release of monocytes from
spleen/*••
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spleen or bone marrow. Witts and Webb (1927) confirmed these
findings, and emphasised the importance of supravital staining in
recognising forms of monocytes difficult to distinguish from
lymphocytes morphologically.
Spector, Walters and Willoughby (196$) showed by a dual
phagocytic and radioactive labelling technique that mononuclear
phagocytes in an inflammatory exudate were almost entirely
derived from the monocyte population if the peripheral blood.
They concluded that lymphocytes and "lymphoid monocytes" could be
excluded as a major population contributin g macrophages to an
inflammatory exudate. In the same year Vollcmann and Gowans
(1965) demonstrated that following labelling of thoracic duct
lymphocytes, few or no labelled cells accumulated on coverslips
in a "skin window" technique. The only labelled tissue which
consistently gave rise to monocytes wa3 bone marrow, although
the spleen did contain some monocyte precursors.
Van Furth and Cohn (1968) showed conclusively that the
mononuclear phagocyte took origin from a rapidly dividing
precursor cell, the promonocyte, in bone marrow. There was no
evidence of the origin of macrophages from lymphocytes. Local
macrophages, e.g. those in lung, show a limited capacity for
proliferation under normal conditions (Golde, Byers and Finley,
197U).
Spector and Willoughby (1968) investigating the histogenesis
of the macrophage in chronic inflammation and tuberculin reactions
in the rat showed that lymph node or thymus cells alone could not
reproduce the features of chronic specific inflammation. They
clearly/...
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clearly showed the monocyte or macrophage to be the "effector
cell" in such inflammation and established its ability to proliferate
locally under the influence of the sensitised small lymphocyte.
The kinetics of the bone marrow phagocyte (the monocyte and
its precursor the promonocyte) were established by Van Furth and
Dieseloff-Den-Dulk (1970) and by Van Furth (1970). They showed
that promonocytes are proliferating cells, and 70% enter division
every 2i; hours. The S (synthetic) phase of the cell cycle in
monocytes occupies 13.6 hours, and the mean generation time was
19.5 hours.
Bell and Shand (1972) re-examined the problem of the origin
of macrophages in graft versus host disease by using transferred
thoracic duct cells labelled by chromosome markers, and detected
by an immunofluorescence test based on antigen differences between
the donor and xenogeneic recipient. They could find no evidence
that macrophages of donor origin were preaent, or had originated
from the transferred thoracic duct population. A further study
(Shand and Bell, 1972) demonstrated in their xenogeneic (rat versus
mouse ) G.V.H. disease model, that bone marrow cells gave rise to
macrophages of donor karyotype and antigenicity in recipients.
These macrophages were found in all tissues and included the Kupffer
cell population of the liver. The conclusion was that bone
marrow contains a stem cell for the free and fixed macrophage
population, which is non-phagocytic, and non-glass adherent.
Despite clear evidence of the bone marrow origin, and the
demonstration that the monocyte population was not derived from
the lymphocyte population, occasional reports of the origin of
macrophages/...
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macrophages from lymphocytes in man (Berman and Pollack, 1967)
and in the rat (Elves, 1970) still continue to appear. The
reasons for this conflict of fact are worthy of examination.
The first reason is that of misinterpretation of morphology.
On looking at human peripheral blood, cells which are cytologically
"lymphoid" can be seen to alter their function and become
macrophages. The literature contains many such accounts (see
review by Rebuck, 191*7J Maximov, 1921*). De Bruyn (191*5) showed
by study of locomotion of peripheral blood cells that cells with
the cytology and characteristic locomotion of lymphocytes changed
into cells with the characteristics of macrophages. In man, the
peripheral blood contains cells with lymphoid morphology which
are either stem cells (Barr, Whang-Peng and Perry, 1975) or which
can functionally modulate to monocytes (i.e. are promonocytes).
Filially what defines a macrophage or monocyte? If the
phagocytosis of par icles is taken as proof of the monocyte or
macrophage then the mononuclear phagocyte system contains many
cells of different lineages corresponding to the Reticulo-endothelial
system of Aschoff. An extreme view of this mode of classifying
cells is taken by Chevremont (191*2) in which he defined the
phagocytic cell as a functional state (the histiocytary state)
which was completely independent of the histogenetic commitment
of the cell.
At the beginning of this section, the functional criteria by
which the macrophage can be defined are set out, and these are
now discussed. Reviews of the mononuclear phagocyte and
macrophage system are to be found in Nelson (1969), Carr (1973)
and Spector (1971*). The basis for the older views on the origins
of/...
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of macrophages can be found in Maximov (192U) and Aschoff (192l|).
Macrophages are glass adherent. Their facility in adhering
to glass, plastic, and even siliconised surfaces is a feature of
cells of this type. Lamvik (1966) showed that the majority of
macrophages derived from cultures of peripheral blood, were
adherent to glass and not present in suspension. Gough et al
(196$)f Elve3 et al (1966) and Jones (1966) had reported that
macrophages were formed from blood lymphocytes in suspension
cultures, especially when polymorphonuclear leukocytes were
present. The basis of proof was the presence of large amounts
of acid phosphatase in the suspension culture, and not on the
basis of functional tests (Gough and Elves, 1967). It is
noteable that on morphological grounds alone, pure lymphocytes
stimulated with P.H.A. are not glass adherent, and are non-
phagocytic (Robbins, 196I4). The requirement for polymorphs is
now felt to be a requirement for, in fact, monocytes which
contaminate polymorphonuclear suspensions (Lamvik, 1967). The
necessity of determining which cells stick to glass is an
essential point in the study of macrophage surface receptors, and
of phagocytic function, as the requirements for opsonins,
complement and antibody, and the ability to phagocytose itself is
dependent upon the type of culture and the environment of the
phagocytic cell (Habeshaw, 1970). There is a strong tendency to
regard all glass adherent cells from peripheral blood, lymph node,
or spleen suspensions as potential macrophages, even though not
all glass adherent cells exhibit the features of macrophages
derived from the mononuclear phagocyte system (e.g. the Reticular
Cell/...
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Cell of Stuart and Davidson (1571).
Nonetheless investigation of macrophage surface receptors
and other functions is still, strictly speaking, the investigation
of surface receptors and functions of glass adherent cells. The
difficulties of preparing such populations free of contaminants
3uch as fibroblasts or "serosal1* (endothelial) cells has been
demonstrated by Ross and Lilly white (1965) who showed that the
act of cardiac puncture can lead to significant contamination of
cult tares by fibroblasts.
The identification of macrophages by their ability to
phagocytose iron powder (Sanderson et al., 1975) carbon particles
or natural red dye (De Halleux Taper and Deckers, 1973) or
polystyrene or latex beads is used in studies of receptors on
mononuclear cells in man or animals. Garbony1 iron powder can
be used as an effective method of removing phagocytically active
cells from peripheral blood, since the iron powder and the
offending cells can be removed with a magnet.
The removal of phagocytes with iron powder is a complex
phenomenon. If uncoated iron particles are added to the cell
suspension, a greater proportion of cells are removed than if
iron pre-incubated in serum is added. In the latter case
functional phagocytes are removed, in the former case adherent
cells whether phagocytic or not are removed (Sanderson et al,
1975).
Mononuclear phagocytes have receptors for IgG, which can be
detected by the use of IgG coated test red cells. Adherence or
phagocytosis of these particles can be inhibited competitively
by/...
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by free IgG, aggregated IgG, or by the Fc fragment of the IgG
molecule (Lo Buglio Contran and Jandl, 1967? Gelfand et al.,
1971? Schmidt and Douglas, 1972? Mantovani, Rabinovitch and
Nussenzweig, 1972? Nelson, 1969).
IJhr showed that complexes of salmonella and antibody would
attach to the surface of the mouse macrophage when either 7S IgG
or 19S Igk antibody was used to complex with the antigen. Neither
cytophilic antibody nor complement was required for this attachment
reaction (Uhr, 196$).
The receptor for Fc IgG is demonstrated by treating the
washed macrophage with aggregated IgG (MacLennan, 1972? Huber
and Fudenberg, 1965) or with red cells coated with immune IgG.
Mouse macrophages will bind such particles, (Berken, Benaeerraf,
1966) and will also bind human red cells sensitised with iso-
haemagglutinins (Stuart and Cumming, 1967). The receptor for
IgG is lost during phagocytosis, but reappears 6-8 hours after
the phagocytic event (Schmidt and Douglas, 1972). The classes
of antibody bound by human monocytes are restricted in that no
binding of IgGii occurs, although IgG1 and l"gG3 subclasses of
immunoglobulin are bound (Huber and Holm, 197$). In the mouse,
macrophages will bind antibodies of 7S 2 immunoglobulin class
without prior interaction with antigen. They will also bind cells
sensitised with heterologous IgG or IgM, but homologous ? globulin
with cytophilic properties has also been described (Nelson, 1969).
There is no evidence that macrophage receptors for cytophilic antibody




The sensitivity of the IgG receptor on the human macrophage
can be measured. Less than 1,000 molecules of antibody on a
target red cell can be easily detected by a rosette test (Arend
and Mannik, 1975). The Fc receptor appears to be specific for
IgG, since cells coated with IgM, IgA, IgE or IgD were not bound
by human monocytes (Huber et al., 1971a). The subclass specificity
of the macrophage receptor for IgG was limited to IgGl and IgG3,
whereas that on lymphocytes is active towards IgGl, 2 and 3#
although this may be related to the method by which the receptors
are evaluated, different results being obtained with aggregated
IgG (MacLennan, 1972) than with particles coated nonspecifically
with IgG subclasses (Huber and Holm, 1975# Hay, Torrigiani and
Roitt, 1972i Huber et al., 1971b).
The actual number of receptor sites on the rabbit alveolar
macrophage has been estimated at 2 - 2.35 million molecules per
cell (Phillips-Quagliata et al., 1971). There is an interesting
report of the expression of an Fc/IgG receptor by heterokaryons
formed between mouse macrophages and melanoma cells in culture.
When the heterokaryon was first formed the Fc receptor was
present, but was lost by two days in culture. It could readily
be detected again by gentle trypsinisation of the cells. The
loss of Fc receptor was due to production of a masking protein by
the fused cell, which could be inhibited by cycloheximide
(Gordon, 1975). If fused with a chick fibroblast the Fc
receptor decayed more slowly (five days) but was not recoverable
following trypsinisation. These experiments show that the
receptor for IgG antibody on the macrophage is a secretion
product/...
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product of that cell, and is not merely acquired from the serum
or culture medium.
The IgM receptor
The presence of IgM receptors on macrophages is
controversial and the evidence for their existence conflicting.
Huber and Holm (1975) could find no IgM receptor on human
monocytes, using RBC coated with cold agglutinins of IgM class.
In mouse systems, cultured peritoneal exudate cells react with
mouse 19S IgM coated red cells in the presence of Ca++ion (Lay
and Nussenzweig, 1969)# Stuart and Cummings (1969) found that
the mouse peritoneal macrophage would bind human red cells
coated with isohaemagglutinins (which are IgM antibodies).
Rhodes (1973) showed that guinea pig spleen macrophages possessed
a receptor for 7S IgM, but not for 19S IgM, using the sheep RBC
as the test particle. Free IgM antibody in the medium is
ineffective in inhibiting binding of IgG coated red cells to
macrophages (Arend and Mannik, 1975)• There are no reports
extant of IgM antibody binding receptors on the monocytes of man.
Anti-Macrophage Serum
Antisera which react specifically with macrophages have been
prepared (lowed!et al., 196 Feldman et al., 1972). These
antisera will inhibit phagocytosis, macrophage processing of
antigen, and macrophage mediated cytotoxicity. Anti-mouse
macrophage serum reacts with the mouse peritoneal macrophage but
not with bone marrow or peripheral blood monocytes (Feldmann et
al., 1972). Maintainance of bone marrow or peripheral blood
monocytes/...
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monocytes in vitro for some days allows the development of
macrophage specific antigens (Virolainen et al., 1971). Macrophage
antisera are specifically cytotoxic when incubated with complement,
or can "arm" macrophages untreated with the antiserum for cytotoxic
reactions with antiserum sensitised macrophages. Sensitised
macrophages release chemotactic factors (Leibovich and Ross, 1975).
U7.
TABLE 2
MONOCYTES AND THEIR SUBCLASSES
CLA.SS FEATURES
Stem Cell No E receptor (man)











Monocyte Fc, Clj., C3d receptors








Makes C„ and C,2 h
Has IgM receptors
(for isohaemagglutinin)
Expresses SB and LD
Alloantigens (mouse)
Expresses la antigens
Expresses H-2 antigen (mouse)
Note only "species specific" antigens detected. Other
differentiation antigens not known. All classes are cytotoxic
for antibody coated cells.
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CHAPTER 6
THE RETICULAR TISSUES
Not all the cells in lymph nodes are as well
known or as well characterised as the
lymphocyte and macrophage. In this chapter
the misfits of the lympho reticular system
will be considered. The reticular, dendritic
and endothelial cells are poorly understood
despite the importance attributed to them in
the historical fantasies of an earlier era.
U8.
The Reticular Tissues
The terra reticular tissues is here used to include the
structural components of primary and secondary lymphoid tissues.
In normal terminology the reticular tissues are descriptive of
several classes of cell, Including the reticular cell, and the
dendritic cell of the germinal centre.
The dendritic cell (Steinraann and Cohn, 1973) was isolated
from peripheral lymphoid tissues of mice. Spleen was teased
into a single cell suspension and an adherent population of cells
was obtained. Typical phagocytic forms were rare, and the
major cell type was morphologically dendritic, forming long thin
cell processes. Motion was not typically that of the
macrophage, and the cell showed features which differed from
conventional macrophages. These cells lacked phagolysosomes,
surface ruffles and pinocytotic vesicles. The dendritic cells
lack membrane associated ATP'ase, and contain little acid
phosphatase, while macrophages possess both these enzymes. When
spleen was tiypsiniaed (Steinmann and Cohn, 1973 ) more macrophages
than dendritic cells were recovered. Dendritic cells were
unresponsive to IgG coated red cells, lacking Fc receptors.
Some of the qualities Steinmann and Cohn ascribed to the
dendritic cell of mouse spleen were reported previously by Stuart
and Davidson (1971a,b,c)for the "reticular cell" present in
culture of peritoneal exudate, tonsil, lymph nodes and human
spleen. This cell also lacked receptors for IgG, and showed
slightly different cytochemistry from the macrophage, but was
phagocytic for yeast and for injured nucleated lymphoid cells.
The/...
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The cells contained leashes of microfilaments, as do the cells of
endothelial or macrophage lineage. In prolonged culture the
human peritoneal "reticular cell" produced an extracellular
"coat" or secretion which Henry (1975) described as a "feltwork"
or "felting" which identifies the reticulin fibre forming cell.
The dendritic cell of the germinal centre supposedly differs
from the "dendritic cell" of Steinmann and Gohn, the "Reticular
cell" of Stuart and Davidson or the Reticulin fibre forming
"Reticular cell" of Kirsten Henry. The difference between the
"dendritic" cell of Steinmann and Cohn, and the dendritic cell
of the germinal centre lies in the capacity of the latter to
take up immune complexes in vivo whereas there is no evidence of
this occurring with isolated dendritic cells in vitro (Steinmann
and Cohn, 1975).
The "reticular cell" or Stuart and Davidson has been
isolated from human spleen and from tonsillar germinal centres.
It lacks Fc receptors but is phagocytic towards injured
lymphocytes. (Compare "clustering" of lymphocytes around
dendritic cells described by Steinmann and Cohn, 19750 In
cytochemistry it resembles the macrophage, but differs from the
fibroblast, even though bearing a superficial morphologic
resemblance to fibroblasts in early cultures.
The controversy about the terminology of these cell types,
and of the structural matrix of the fibre network in lymph node
and spleen has been reviewed by Stuart (1975), who distinguishes
two types of cell within this group. One, the fibrocytic
"reticulum" cell forms the structural fibres, and the other, the
reticular/...
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reticular cell forms an anastomosing framework of living
protoplasmic fibres, which are separate from the structural
component. These cells are present in germinal centres, and in
the marginal zone of the Malpighian corpuscle (Streefkerk and
Veerman, 1971) and differ from the conventional mononuclear
phagocyte.
The 'endritic cell of the germinal centre was identified by
studies on the uptake of ^125 or fluorescent labelled antigen by
germinal centres (Hanna and Szakal, 1968)(Nossal et al, 1968)
(McDevitt et al., 1966)(Korngold and Mellors, 1963)(Ortega and
Mellors, 1957). In germinal centres antibody was found in
cells which had "elongated and seemingly continuous cell
processes which appeared as though attached to reticulin fibres".
(Mellors and Torngold, 1963). These experiments which purported
to show antibody formation, accidentally demonstrated the
dendritic antigen retaining cell. McDevitt et al (1966) in the
125
first of a series of papers on the distribution of 1 labelled
T-G-A-L (a synthetic polypeptide) showed that all the follicular
labelling was due to antigen complexed with antibody, and that
the intensity of such labelling was dependent upon the amount of
antibody present. No antigen was retained by lymphocytes, but
was retained in a lacy pattern relating to the cell processes
between the lymphocytes rather than to the limphocytes themselves.
Nossal Abbot and Mitchell (1968) showed that antigen
localised to the follicles faster in immunised than in virgin
rats. It remained extracellular attached to dendritic processes
of "follicular reticular" cells. A second type of reticular cell
associated with the follicle is illustrated (Pig. 6. Nossal
Abbot and Mitchell, 1968) which corresponds to the cell described
in/...
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in the periphery of the rat Malpighian body by Streefkerk and
Veerman (1971).
The "reticular dendritic" cell of the germinal centre was
shown by Maruyama and Masuda (1y6U) to show "desmosomes" or tight
junctions between processes at points of contact. Schwartzendruber
and Hanna (1965) described these cells with H3 thymidine
autoradiography, and showed the "dendritic cell" of the germinal
centre to be a relatively stable slowly dividing component. By
comparison with the epithelial component of the thymic medullary
cell, the epithelial cell of the bursa of Fabrlcius, and of the
thymus of the emhrysnic chick, all of which show the presence of
demosomal junctions, Schwartzendruber maintained that the
dendritic cell of the germinal centre was epithelial in nature.
(Schwartzendruber, 1965). The syncytium formed by these cells
would therefore represent an epithelial component similar to the
thymic medullary epithelium, exerting a trophic function on the
bone marrow derived lymphocytes in their passage through this area.
There are two problems in attempting to understand the nature
of the "structural" cells of lymphoid tissue. The first is
historical, the second is technical.
Historically the structural component of lymphoid tissue was
regarded as the stem cell source for lymphocytes and monocytes and
was called the "Toptipotential, or stem cell reticulum". The
lymphocyte, produced in lymph nodes entered the bone i arrow to
differentiate into haematopoetic cells (Jordan and Speidel, 1923J
Alden and Dawson, 1927). In an investigation of agyrophillic
cells in the spleen and lymph nodes, Marshall described four types
of metalophil and non-metalophil cell, which he also subdivided into
those/..•
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those with phagocytic capacities, and those which had not. All
the cells he described were more or less constantly associated with
the structural reticulin (reticulum)(Marshall, 1556). The four
cell types described (macrophage, sinus lining cell, irregular and
coarse branching cell, and white pulp metalophil cell) were further
investigated by Marshall and White (1950) during an antibody
response. Their findings were interpreted as differentiation of
the non-metalophil "stem-cell" of the reticulum into lymphoblast
forms. It is only relatively recently, with the advent of
electron microscopy and autoradiography, that study of the microscopic
and functional differentiation of the structural cells has been
possible. Can such information be obtained from tissue culture
of "reticular" and "dendritic" cells (Stuart and Davidson, 1971a,
b,c) (Steinmann and Cohn, 197l4-> 1975)? As pointed out by Bloom
(1937) it is extremely difficult in tissue culture to distinguish
genetically programmed cell differentiatioi from cellular
"modulation" caused by changes in environmental conditions.
Richter (1958) after extensive cultural investigations of the
mesenchymal cell could come to no definite conclusions about
"genetically programmed" differentiation of the mesenchyme, but
showed that the coelomic epithelium was a separate, definitive
structure which yielded dendritic cells in culture, but which did
not differentiate into either macrophages or lymphoid cells. It
is quite possible that the different functions and morphologies
defined in different systems for the "dendritic cell" and the
"reticular" cell can be the effect of different approaches to
isflation and culture of sue i cells.
In/«..
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In the author's opinion the structural component of lymph
node consists, from the available evidence, of possibly four cell
types, these are
(1) endothelial cell of capillary and minor blood vessels.
(2) reticulin fibre forming cell.
(3) reticular cell - non fibre forming and selectively
phagocytic.
(U) dendritic cell of the germinal centre.
The most simple approach would be to consider that types 3
and 1| are derived from mononuclear phagocytes - there is some
evidence that the "resident" macrophage in lymph nodes can divide
and is somewhat different from the classical mononuclear phagocyte
(Carr, 1975). The dendritic cell of the germinal centre has
receptors on its surface for IgG immune complexes which distinguishes
it from the cell isolated by Stuart and Davidson or the cell of
Steinmann and Cohn. The presence of desmosomes and/or tight
junctions is an interesting observation but not really helpful, as
similar structures are found in the endothelium of spleen, between
epithelioid cells of granulomata, and in the synovial membrane.
The dendritic and reticular cells described by Cohn and by Stuart
are now accepted as being the same cell type (Steinmann, Adams and
Cohn, 1975).
It should be pointed out that the isolation of the same cell
type from a variety of tissues in which it is constantly
associated with reticulin fibre (e.g. peritoneum, lymph node, tonsil,
spleen) and which shows consistant features (phagocytosis of yeast,
lymphocytes, unique cytochemistry and morphology, lack of IgG
receptors/...
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receptors) is as far as our understanding goes of the structural
components of lymphoid tissue.
55.
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Has desmosomes, is present
in germinal centres.
Has Fc but not C3 receptors.
Marshall and White (19*56)
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CHAPTER 7
surface characteristics OF lymphoid cells
surface antigens
From the suudy of the normal physiology and the
characteristics of the lymphocytes, macrophages
and structural cells of the lymph node, the theme
now transfers to the more detailed analysis of
these cells, in particular the lymphocyte.
In this chapter the surface antigens of the lymphocyte
are considered. These are known to be functionally
important in three instances, firstly in histo-
incompatibility reactions which are determined by the
HLA gene complexes, secondly in genetically det rmined
immune responses related to the expression of the Ir
genes, and thirdly in the relationship between the




These are substances which can be identified either
serologically (SD antigens) by the preparation of a specific
antiserum or immunologically by the demonstration of graft
rejection, graft versus host disease, or stimulation of lymphocytes
in a rixed lymphocyte reaction (LD antigens). The two classes of
antigens are therefore either serologically defined or lymphocyte
defined. The former are SD, and latter LD antigens. The LD
antigens are tmigenic, and determined by the non H-2 M Locus.
In the mouse, many surface antigen characteristics are
determined by the H-2 gene complex, a linked series of genes
present on a small segment of the 15th chromosome. The H prefix
stands for histocompatibility and these genes control the ability
of tissues to exist in mutual harmony, providing identity at major
histocompatibility loci is present.
Within the H-2 complex is a cluster of genes which determine
(1) the antibody response to a variety of antigens, (2) the
susceptibility of lymphoid cells to lymphoma induction by tumour
virus, (3) the ability of cells to react to differences in
antigenicity in the mixed leukocyte culture and graft versus host
disease reactions, and (1*) determine a number of lymphocyte
alloantigens and transplantation antigens of minor type. The
region controlling this multiplicity of immune functions is called
the I or It gene (Ir standing for immune response).
Closely related to the H-2 gene complex is a further gene TL,
which although not part of the complex is probably linked to the
H-2 gene. The mechanisms or defining these antigens are highly
involved/...
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involved, necessitating the use of congenic mouse strains (i.e.
strains genetically identical to a standard inbred strain of mice:
e.g. BIO). Different "haplotypes" (i.e. different sequential
arrangements of alleles within the gene) can be introduced into
this standard highly inbred strain, and their effects measured by
sophisticated techniques for demonstrating the resulting antigens
or immune reactivity (Shreffler and David, 1975)*
In the mouse the H-2 and TL complex genes have the regions:
K, I, S, D and TL, each region being responsible for a subset of
phenomena traceable to the H-2 TL complex.
The major histocompatibility antigens are determined by
alleles in the K and D regions of the H-2 complex, minor alleles
determining histocompatibility differences are also found in the TL
region (HTLa) and the I region (H-2I). The S region determines
the quantity (Ss) and the alloantigen on 2 globulin molecules
(SsLp) which is also male sex limited (SL). The I region controls
some surface lymphocyte antigens (la) certain aspects of the
humoral immune response (Ir-1A,Ir-1 B), and the mixed leukocyte and
GVH reaction with sections of K and D regions (lymphocyte activating
determinants - L.A.D.) The TL region controls the expression of
the TL antigens (thymus leukaemia cellular alloantigens). The K
and I regions also control two important functions: the
susceptibility of mice to tumour virus (MIJLV) and the interaction of
T lymphocytes and B lymphocytes in the immune response.
Stimulation in mixed lymphocyte cultures can occur with
blast transformation and proliferation of co-cultured cells, even
when histocompatibility antigens of the major histocompatibility
system (H-2) do not differ. Apart from minor histocompatibility
differences/...
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differences traceable to other regions of the H-2 complex, another
locus called the M locus in mice appears to be a major factor
determining reactivity in mixed leukocyte reactions. Histo¬
compatibility antigens expressed by genes of the H-2 major
histocompatibility system are present on both B and T lymphocytes
and are called lymphocyte activating determinants (IAD's). IADs
of the minor histocompatibility system (M locus IADs) are expressed
only by B lymphocytes, and in the M locus assay system in vitro
B lymphocytes are required as stimulator cells, and T lymphocytes
as responder cells. (Van Boehmer and Sprent, 197h). Recently
it has been shown that both H-2 determined lymphocyte activating
determinants and M locus determined IADs are present on macrophages
(Schirrmacher, Pena-Martinez and Festenstein, 1975), which may
account for the ability of macrophages to stimulate T lymphocytes,
and B lymphocytes, particularly since an integrated immune response
by lymphocytes to macrophage processed antigen is determined by
genetic compatibility at the I region of the H-2 complex. M locus
antigens may also be responsible for stimulation in xenogeneic
(e.g. rat vs mouse) systems. There is evidence that human
lymphocytes can recognise mouse H-2 SD antigens (Lindhal and Bach,
1975).
The I region genes are the most important from the point of
view of lymphocyte activation, co-operation, and the immune
response. These genes form a part of the H-2 complex in mice.
They determine immune responses to individual synthetic
polypeptide antigens (McDevitt et al., 1972). In this group are
geres which control synthesis of IgG (Ir-IgG) and IgA (Ir-IgA)
antibodies/...
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antibodies (IAeberraan et aJ.,, 1972). The ability of cells to
respond in mixed lymphocyte reactions are also determined by this
gene group (Bach et al., 1972), which controls the expre 3ion of
lymphocyte defined (LD) alloantigens. These genes also control
the presence on lymphoid cells of serologically defined antigens,
known as the la antigens (Hauptfeld, Klein and Klein, 1973)•
Indeed a whole new category of lymphocyte associated antigens has
been uncovered in studies of the I region of the H-2 complex.
These include the so called new lymphocyte antigen system (Lna)
(David, Schreffler and Frelinger, 1973) and a B lymphocyte antigen,
specific for peripheral B lymphocytes called Beta antigen (Sachs
and Cone, 1973). Similar genes control interactions between
macrophages and T cells, and T cell and B cells, in both guinea
pig (Shevach and Rosenthal, 1973) and in mice (Katz et al., 1973).
In the rhesus monkey, Ir genes have been described, and are shown
to be related to the major histocompatibility genes RhL-A (Dorf,
Balmer and Benacerraf, 1975)* la like antigens have been
described on the Daudi cell line, and on normal human B lymphocytes
from which HLA antigens have been "stripped" using anti-B^-micro-
globulin antiserum (Jones et al., 1975)•
The la subregion of the H-2 complex also controls the
expression of an antigen specific factor secreted by T cells, which
co-operates with B cells to produce an humoral immune response
(Taussig et al., 1975)* la antigens themselves are preferentially
expressed on B cells, but have been isolated from thymocytes
(Goding, White and Marchalonis, 1975)* There is a close
association between the receptor for immunoglobulin G. (IgG/Fc
receptor/...
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receptor discussed in the next section) and the expression of la
surface antigen (Dickler and Sachs, 197i+)»a However, isolated Fc
receptors do not appear identic 1 to the la antigen (Rask et al.,
1975) and more recent evidence suggests that the Fc receptor is
associated with a further class of antigens which are not part of
the H-2 complex (Dickler et al., 1975)* H-2 linked genes,
probably of the la region determine the specific B lymphocyte
antigens in mice (Sachs and Cone, 1973) and also appear to control
the rate of expression of the complement receptor (CRL-1 gene) in
mice (Gelfand et al., 197Ua). The relationship between the la
antigen, detected serologically, and the Fc receptor which is
inhibited by anti-la alloantisera, has recently been shown to be
spurious, since any antisera (e.g. anti MBIA, anti IyB.2) which
are directed against B cells can inhibit the Fc receptor
(Schirrmacher, Halloran and David, 1975)*
There are, in addition to antigens determined by the H-2
gene complex in the mouse, a variety of other alloantigea not
determined by tie H-2 or TL complex. These are the theta antigen,
the Iy antigens Lyl, Iy2, Ly3, LyB and antigen, and the
antigen PC.
Species specific antigens are also present, MSLA (Mouse
specific lymphocyte antigen), MBIA (Mouse B lymphocyte antigen),
M3PCA (Mouse specific plasma cell antigen) and the Hy antigens.
Some viral antigens are expressed by murine lymphocytes infected
with C type virus particles, a good example being the Gj antigen
expressed on virus infected lymphocytes in negative strains but
also on normal thymocytes in some strains. (Old and Boyse, 1973).
The/...
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The group of MSLA, MBLA and MCPCA antigens are all defined by the
use of hetero-antisera (i.e. from a rabbit) and are therefore called
"species* antigens. Human surface antigens (other than HL-A)
correspond to the species antigens rather more closely than to the
alloantigens in the mouse.
The theta antigen, now called thyl was first associated with the
thymocyte, but wa3 later shown to occur on all peripheral T
lymphocytes, skin and brain (Reiff and Allen, 1963). Recent
analysis of this antigen shows that it is glycoprotein in nature, and
is superficially located in the membrane. It is not related
genetically or structurally to the H-2 antigen group, and there is
clear evidence that it is not an antigen receptor for the T cell
since anti-thyl antisera do not prevent antigen recognition by T
cells (Vitetta et al., 1973; Vitetta et al., 197ii loelants et al.,
1973). Theta CH3 antigen is now termed thyl.1, and theta AKR
antigen thyl .2.
The originally proposed glycolipid nature of the tbyl antigen
has recently bean challenged, as a cell surface glycoprotein (T2S)
has been isolated from T cells and reacts strongly with anti-thyl
sera (Trowbridge, Weissman and Bevan, 1975).
The antigens Ly-A, ly-B were first described on thymocytes and
peripheral lymphocytes by the use of cytotoxic antisera. These
alloantigens are controlled by two genetic loci, Iy-A, Ly-B and
there were initially shown to be two alleles of these loci, giving
four antigens in all, LyA-1, LyA-2, LyB-1 and LyB-2. A third
locus LyC has also been described (Boyse et al., 1968; Boyse et al.,
1971).
The Ly antigen loci h.ve now been renamed Ly1 and Iy2 and Ly3.
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Iy antigens have not been detected on cells other than lymphoid
cells, and do not occur to any great extent in thymectomised mice.
They appear to be specific for lymphocytes undergoing thymus
dependent differentiation. Each Iy antigen system comprises a
genetic locus, Ly-1 on chromosome 19, Iy-2 and Iy-3 on chromosome
6. Each locus determined 2 alleles, which specify one of two
alloantigens 1 or 2, thus the Iy antigens are described as Lyl.1,
Iy1.2, Iy2.1, Ly2.2, Iy3.1 and Iy3.2. All inbred mice specify
one allele from each genetic locus on their thymic dependent
lymphocytes (e.g. Iy1.2, Iy2.2, Iy3.1 ) as their phenotype. In
contrast thy antigen expression is limited to only thyl .1 or thyl .2
positive cells (theta positive cells).
The expression of Iy antigen correlates with the
differentiation and maturation of thymic dependent lymphoid cells.
In the neonate nearly all Iy + cells were Iy1,2,3 positive, but
during ageing the pattern changed with Iy1 + and Iy23+ cells foiming
a substantial spleen population (Cantor and Boyse, 1975a). Iyl ♦
cells appear to co-operate with B cells in antibody formation. Ly2+
or Ly3+ cells appear to generate cytotoxicity. The cytotoxic T
cell has the phenotype Iy2 or Ly3, and this is stable and distinguishes
the class of cytotoxic as opposed to helper T cell which has the
phenotype Iy1. It also shows that helper and cytotoxic T cells
are committed to their roles before antigen stimulation. Both
categories, Iy1+ cells and Iy23+ cells can recognise alloantigens
and respond by proliferation (Cantor and Boyse, 1975b). Tukahashi
(1972) showed that in mouse T lymphoraa/leukaemia K36, the T cells
were negative for theta and IyA antigens (Iy1), but expressed Iy2
(IyB) while another leukaemia E G2 expressed theta (thyl) and Iy1
(IyA) antigens, but not Ly2 (IyB). This finding suggests that
leukaemia/...
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leukaemias of functional groups of differentiated T cells (T
helper and T cytotoxic) can occur, whilst retaining their
differentiation.
A further Iy group antigen, Lylj. has been described on B
lymphocytes, for which it appears specific (McKenzie and Plate,
197U).
In man the lymphocyte surface antigens are less well defined,
particularly since alloantisera are avail able only through foetal-
maternal immunisation by foetal cells in pregnancies (Winchester
et al., 1975). Nonetheless, the histocompatibility antigens, in
this case denoted by the letters HL, have been well characterised
by a mixture of serological and mixed leukocyte culture tests. In
addition la-like antigens which, in the mouse, are B cell associated
and his toeompaitibility linked, have been defined on B cells in
man (Jones et al., 197$)$ but little is known of them (Winchester
et al., 1975).
The HL-A alloantigens have been isolated from human lymphocyte
membranes (Mann et al., 1969). This group of antigens is now
serologically defined, as pure HL-A antigen does not stimulate in
mixed lymphocyte reactions (ling et al., 197U). It is said that
HL-A antigens alter rapidly with the establishment of cell lines in
culture. This event was proposed to account for the observed
ability of isologous cultured lymphocytes to stimulate in mixed
lymphocyte reactions (MLR). Indeed, lymphoid, cell lines are among
the strongest stimulators in mixed lymphocyte reactions, possibly




Apart from the histocompatibility antigens on human
lymphocytes, it has proved possible to raise antisera against human
T lymphocytes (Wortis et al., 1973) and against human B cells
(Greaves and Brown, 1973). Antigenicity of cells tends to vary
with the cell cycle, and recently antisera raised against human
thymocytes, and Burkitt lymphoma cells, reacted with thymocytes, B
lymphoblaats, T lymphoblasts, and lymphoid cell lines. These
antigens, one of which resembles the i antigen on red cells, are
expressed only on neoplastic cells, (both lymphoid and non lymphoid)
or on dividing cells (Thomas and Phillips, 1973? Thomas, 197k).
As in mouse systems, specific antigens have been defined on
leukaemic cells (Monahanakumar et al., 197k? Baker, 1975)* these
are probably analogous with the G antigen system in mice but have
* A
not. been as well defined.
Most studies of surface antigenicity have involved murine
T lymphocytes, but there are B cell specific antigens in the mouse
on both B cells and plasma cells. In man B cell specific antigens
have been described (Greaves and Brown, 1973).
The mouse B lymphocyte antigen (MBLA.) was described on
circulating B cells and lymph node cells using a hetdoantiserum
rendered specific by adsorption (Raff et al., 1971). An antigen
on B cells, PC1, was described by Takahasi et al. (1970). This
antigen is an alloantigen, determined by a gene, PCa, which
segregates as a Mendelian dominant, and is not histocompatibility
linked. This alloantigen, specific to mature mouse B cells, is
not present on thymocytes, leukaemia cells, or T cells but is found
on liver, kidney, brain, lymph node and myeloma cells, and is
present/...
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present on Immune haemolytic placque forming cells* A second B
cell/plasma cell antigen has also been described (Tutoku et al.,
197U) which, unlike PC1, is also represented on about half of the
thymocytes, and is not present on liver, kidney or brain cells.
The G^ antigen system in the mouse is of interest in that it
is related to the Murine lymphoma virus (MuLV) (Gross virus)*
Infection of mice with this virus is ubiquitous, spontaneous
leukaemia strains (AKR, C58) are overt carriers. Other strains
show no overt infection but they develop MuLV virus and MuLV induced
antigens on induced tumours, or in tissue cultures. MuLV antigen
is detectable in embryo mice of virtually all tested strains during
gestation. Normal mice (i.e. those shewing no lymphomas) show a
virus related antigen, called G (for Gross) and 11 (chromosome
linkage groupH). This antigen differs from the directly virus
induced cell surface antigens GCSA, and GSA (Gross cell surface antigen,
and Gross soluble antigen). Because of its ubiquity, antisera
against were first raised in rats to which Gross Virus
leukaemia was transplanted. The resulting antiserum showed strong
cecity for the thymocyte. of >o«e moue. etrein. (0,x poeftiv.)
but little or none for others (G^ negative). The same antigen
Q1X can be Induced on ret thymocyte* temporary by the MuLT viru.
showing that its expression is virus linked (Stockert, Old and
Boyse, 1971).
TL antigens in TL+ mouse strains are demonstrated only on
thymocytes and leukaemia cells. Leukaemia induced in a TL negative
strain, results in the expression of TL antigens on circulating
leukaemic cells. Even though the antigen is not demonstrable on
peripheral/ ••.
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peripheral lymphoid cells (spleen and lymph node lymphocytes) in TL
positive mice, injection of these cells into a TL negative mouse
strain will produce the appropriate anti-TL alloantiserum (Komuro,
Boyse and Old, 1973)* The thymus is necessary for the maturation
of Tl- to T1+ cells in TL-recipients of spleen or lymph node cells.
Further experiments reveal that thymic hormone induces in vitro
differentiation of spleen and bone marrow lymphoid cells from adult
animals. These cells also acquire both thyl (theta) antigen and
the Ly antigen. Similar antigen induction occurs with cells from
congenitally thymusless mice and cells from embryo mouse liver
(Komuro and Boyse, 1973)• These findings emphasise the role
played by the thymic epithelium in inducing maturation of the
surface phenotype of the T lymphocyte. If thymus lymphoid cells
are co-cultured in vitro with thymic epithelium, there is an
increase in H-2 antigen expression and a gradual decrease in thyl
antigen expression, features which characterise the peripheral T
lymphocyte. This process of "maturation" was proceeded by cell
division as a necessary step (Mosier and Pierce, 1972).
The presence of the subclass and differentiation specific
surface markers on the murine T lymphocyte has proved valuable
in defining subpopulations of mouse thymocytes and their
functional characteristics. For example the TL negative thymocyte
population in TL positive mice is effective in causing GVH disease,
is steroid resistent, and has helper cell activity. These cells
also have increased amounts of H-2 antigen on their surface, and can
recirculate to spleen and lymph nodes. Indeed the steroid
resistent thymocyte population is virtually identical, both
antigenically/...
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antigenically and functionally with the splenic T lymphocyte
population (Stobo, Rosenthal and Paul, 1973J Konda, Stockert and
Smith, 1973) Schlesinger, Korzash and Israel, 1973).
The study of cell surface antigens of similar type in human
lymphoid populations is by no means as advanced technically as in
the murine system. Some antigens have been defined in man, as
for example the membrane antigens expressed by thymocytes, and
infectious mononucleosis cells (Thomas, 1972). One antigen on
human lymphoid cells which reacts with anti-brain sera, and is
therefore analogous to thyl, has been described (Brown and Greaves,
197U) as have antigens specific for CLL cells and normal B
lymphocytes (Greaves and Brown, 1973)* Antisera prepared against
human thymocytes in rabbits will react with a subpopulation of
human peripheral lymphocytes, and will Inhibit rosette formation
with sheep erythrocytes (T rosettes) but not with complement
coated red cells (B rosettes)(Wortis, Cooper and Brown, 1973).
Treatment of peripheral blood by such antisera in the presence of
complement removes all surface Ig negative cells (Smith et al«,
1973).
Attempts have been made, using specific human thymus
lymphocyte antisera in conjunction with "lectinsH such as
coneanavalin A, phytohaemagglutinin, or pokeweed mitogen, to
define subclasses among human thymocytes, similar to those described
for the mouse. Anti-human thymic lymphocyte sera can inhibit
mixed lymphocyte reactions by preventing proliferation of
responder cells, but quite failed to prevent a proliferative
response to either phytohaemagglutinin or to concanavalin A. It
did interfere with the proliferative response to P.P.D. of
tuberculin/...
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tuberculin, and had no effect on lymphokine release. The
Interpretation offered is that the cells responding to stimulation
by lectins are a subpopulation of human T lymphocytes (Woody et al.,
1975)* In fact from the evidence presented it appears that B cell
proliferative responses in man are inhibited as strongly as T cell
responses by anti-T cell sera. For example, the mltogenic effect
of PPD is primarily on B rather than T lymphocytes (Sultzer and
Nilsson, 1972) yet it is inhibited, whilst response to
phytohaemagglutinin is not inhibited, although it is primarily a
T cell response (Greaves, Janossy and Loenhoff, 197U).
The use of heteroantisera to define human lymphocyte
subpopulations is in its earliest stages, but providing that antisera
of sufficient specificity to define differentiation, and subclass
specific antigens can be prepared, free of anti-HIA and other
activities, these techniques offer a quick and reliable guide to
cellular differentiation. Antisera to B^-microglobnlin seem
relatively B cell specific in human systems (Ringdan and Moller,
1975).
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TABLE h t Antigens Expressed on Lymphoid Cells in the Mouses
Histocompatibility, Differentiation, Species and
Subclass Specific Antigens.
Antigen Cells on which Expressed Antigen Class
H-2 SS Thymocytes weak + all
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References:
(Old and Boyse, 19735 Stockert et al., 1971; Schlesinger et al.,
1973} Konda et al., 1973} Klsielow et al., 1975} Boyse et al.,
1968} Takahashi et al., 1970} Eaff et al., 1971} Vitteta et al.,
1973} Vitetta et al., 197k} Schreffler and David, 1975).
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TABLE 5













Theta (thy 1) weak
H-2 positive
Peripheral T cells Theta (thy 1) weak
TL negative
H-2 positive




T cell Helper (antibody formation)






Theta (thy 1) positive




Theta (thy 1) positive
All T lymphocytes express Sd alioantigens, none express LD
alloantigens. They express la antigens weakly. A few T
cells react with isologous HBC. Note that differentiation
of T cell subclasses is independent of antigen.
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CHAPTER 8
SURFACE CHARACTERISTICS OF LYMPHOID CELLS
AUTISM RECOGNITION UNITS AND SURFACE RECEPTORS
The prime function of the lymphocyte, is to
interact with and respond to antigens. This
account is concerned with the surface receptors
by which lymphocytes trap antigen, and with
surface receptors concerned with the subsequent
cellular response to antigen.
72.
Surface Receptors for combination with Antigen
Lymphoid cells react to the presence of antigen in their
environment by binding that antigen to the cell surface. Such
binding can be recognised by labelling the antigen radioactively,
and the physiology of the antigen binding cells studied by their
elimination (so called antigen suicide technique) or by separation
(antigen binding cell depletion or enrichment procedures). The
receptor for antigen has two characteristics, firstly it is specific
for the antigen, and secondly it is present on only a small
population of lymphoid cells.
Direct proof that antigen binding lymphocytes were
responsible for the immune reaction to the bound antigen stemmed
from the experiments of Ada and Byrt (reviewed by Ada, 1970) vising
the antigen suicide technique. In this technique an antigen is
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heavily labelled with I with very high specific activity. The
labelled antigen is mixed with lymphoid cells, which are then
washed, and injected into an irradiated syngeneic recipient
reconstituted with bone marrow or foetal liver cells. Both B and
T cells binding more than say 10,000 molecules of antigen are
killed by the radiation dose they receive and on subsequent
immunisation no antibody is formed (Basten et al., 1971).
Techniques using red cells coated with specific antigen have also
been employed (Bach, 1971). In this test, antigen coated
erythrocytes are reacted with lymphocytes, and antigen binding
cells give rise to rosettes or clusters of bound RBC surrounding
the binding lymphocyte. These clusters can be removed by
centrifugation and the residual cells tested for their capacity to
respond/...
73.
respond to the test antlgen« lymphoid populations so treated
fail to respond to subsequent antigen challenge as in the antigen
suicide technique.
The binding site for antigen on the B lymphocytes is surface
immunoglobulin. This can be shown by the capacity of anti-Ig,
anti-u chain or anti-L chain sera to inhibit antigen binding
(Roelants et al., 1973) or antigen suicide (Ada, 1970). The
number of specific antigen reactive B cells is characteristically
small, but rises quite steeply following immunisation with that
antigen but not with unrelated ones (Wilson, Munro and Coombs,
1969). There is abundant evidence that the antigen receptor on
the B lymphocyte is immunoglobulin, and that its combining site is
of equal affinity to the antibody the progeny of that B cell will
eventually produce (Makela, 1970).
T lymphocytes also respond to immunisation by proliferation,
showing immunological memory and being susceptible to tolerance
induction (Greaves, Owen and Raff, 1973)* The receptor for antigen
on T cells is not usually demonstrable by mechanisms which suceed
with B lymphocytes. Conflicting views of the presence of
immunoglobulin as the receptor on T cells has been long a subject
of controversy. One problem is demonstrating antigen binding by
T lymphocytes. It has been shown that substantial numbers of
antigen binding cells can be eliminated by treatment with theta
(thy 1) anti-serum and complement (Greaves and Moller, 1970j
Roelants, 1972). Cells in the mouse which are theta antigen
positive will bind SRBC to their surface, and can be shown to "cap"
this antigen in the same manner as B cells. This does not prove that
the T cell receptor is immunoglobulin (Ashman and Raff, 1973).
Binding/...
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Binding of antigen can be inhibited by anti-imraunoglobulin, but
not with anti-theta sera, and the "capping" of antigen did not
alter the distribution of theta antigen, showing that the alloantigen
is not the antigen receptor on T cells. Antigen receptors on both
B and T lymphocytes, 1-2 months after antigen priming were found to
be "capped" by anti-iirgnunoglobulin antisera. Binding of antigen
to both B and T cells was inhibited by anti-u and anti-L chain
antisera, but not by anti thy 1 antisera, suggesting that IgM is
the T cell receptor (Roelants, Forni and Pernis, 1973). Other
evidence is less conclusive.
The genes controlling the immune responsiveness of T
lymphocytes, and the co-operation of these cells with B lymphocytes
are linked to the major histocompatibility gene complex. In the
mouse these immune response (Ir) genes map to the I region of -the
H-2 complex. The Ir genes determine antigenic molecules (la
antigens) which are expressed largely on the B lymphocyte. There
is definite evidence that la antigens are expressed also on murine
T lymphocytes (Goding, White and Marchalonis, 1975). Recent
trends have thus been directed towards the identification of T
cell antigen receptors by using closely related strains in which,
by appropriate immunisation, antibodies can be prepared to the
antigen combining sites (Ir gene products) on both B and T
lymphocytes (Mitsuda, 197U). In one model, alloantibodies
directed against the SD (serologically determined) alloantigens are
raised by injecting spleen cells from one parent (P 1 ) into the
other parent (P 2). The alloantibodies so produced are isolated
and then used to immunise the P1 x P2 hybrid recipient. Such
antial l.oantisera/...
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anti-alloantisera produced by the F1 hybrid will react
preferentially with the antibody combining site of the parental
P2 alloantiserum, since the F1 hybrid is congenitally tolerant
both of parental alloantlgens (expressed on cells) and of parental
allotypic determinants on the antibody molecules. The only "new"
antigenic structure presented to the F1 hybrid is the antigen
combining site of the alloantibody formed in the P2 parent. Such
anti-alloantisera will react with B cells only, because the
antigens are SD antigens, and T cells are unreactive to these
antigens and lack receptors for them (Binz, Lindenmann and Wigzell,
19710.
This model has been further refined by the above authors
in an attempt to identify the antigen combining site on the T
lymphocyte for the LD (lymphocyte determined) alloantigens. These
LD antigens cannot be serologically detected but can be reacted
against by T lymphocytes, and can also be used to separate, by
immune adsorption, reactive T lymphocytes from a lymphocyte
population (Wekerle, Eshhar and Feldman, 197h). T lymphocytes
express SD alloantigens but not LD alloantigens, while B cells
express both SD and LD alloantigens. B cells will respond to
SD alloantigens and will stimulate T lymphocytes by the LD
alloantigen (Simpson, 1975). Preparations containing B cells
cannot be used for immunisation of the F1 (P1 x P2) hybrid since anti-
allotype antibodies occur against SD alloantigen binding sites on
the B cell surface and could confuse the issue. If, however,
pure T cell populations from parent P2, immunised with spleen cells
from parent P1, are injected into the F1 hybrid, the T cells
reactive/...
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reactive against PI, LD alloantigens, which are not present in P2
T lymphocyte populations, will express antigen binding sites which
are antigenic in the P1/P2 F1 hybrid. The anti-T cell receptor
antibody so produced exhibits a capacity to react with a
proportion of P2 T lymphocytes - these T cells can be removed on
anti-idiotypic-antibody coated bead column which leads to a
specific depletion of P2 T lymphocytes capable of reacting against
PI ED alloantigens. This work shows that the B and T lymphocyte
share the same set of genes which determine the specificity of the
antigen receptor site, since anti-idiotypic antibody so produced
will react both with purified IgG alloantibody combining site and
with the normal parental T lymphocytes (Binz and Wigzell, 1975]
Binz, 1975).
Evidence supporting the close linkage of T cell antigen-
receptor sites and the H-2 gene complex has been obtained by
studying the requirement for histocompatibility in the effector
phase of T cell mediated cytotoxicity (Doherty and Zinkernagel,
19750, between the stimulator cells and reactive T lymphocytes,
and for histocompatibility between T cells and macrophages in the
generation of helper cells (Erb and Feldman, 1975). It appears
from studies of hybrid animals that the antigen receptor mechanism
of the T cell is better at detecting "self" or "altered self"
antigens than at reacting with foreign antigens. This accounts
for relatively high numbers of self reactive T lymphocytes (Cohen
and Werkerle, 1972), or T lymphocytes reactive with closely
related strains (Ford, Simmonds and Atkins, 1975)* the better
immune surveillance of hybrid as against inbred animals with LCM
infection/...
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infection (Doherty and Zinkernagel, 1975b) and the high levels of
spontaneous T lymphocyte/red cell reactions observed in mice
(Micklem, Asfi and Anderson, 1970) and man (Baxley et al., 1973 )•
The receptors for antigen on T cells were originally
demonstrated to be of IgM antibody (Dwyer, Warner and Mackay, 1972)
but the recent demonstration of IgM receptors on T cells, all owing
the binding of environmental antibody and hence conferring antibody-
like specificity on T cell reactions, has clarified the picture
considerably (Maietta et al., 1975j Cooper and We3t, 197li).
The demonstration that anti-idiotypic antibodies, passively
administered can sensitise mice for a secondary response to the
antigen recognised by the immunoglobulin idiotype used for
preparation of the anti-idiotype antibody. Such sensitisation
can occur in both B and T cell systems (T helper, B precursor
lymphocytes) and lends support to the theory of antigenic identity
of the T cell receptor with B cell surface Ig idiotype. Reaction
with anti-idiotypic antibody is, then, equivalent to interaction
with antigen (Black et al., 1976). Further investigations show
that the idiotypic markers of the T cell receptor (T helper cell)
in this system are not connected with the H-2 haplotype (i.e. are
not produced by the Ir gene) but are probably produced by the Ig-1
gene complex, the "heavy-chain linkage group" which determined
immunoglobulin expression in the mouse (Hammerling et al., 1976).
This is further evidence that the T cell receptor - even if not
conventional Ig, is certainly controlled by those genes controlling
Ig expression.
In summary it is not now believed that the T lymphocyte
antigen/...
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antigen receptor is determined by genes closely associated with
the major histocompatibility gene complex as proposed by Shevach,
Paul and Green (1972 ) (H&iroierling et al., 1976). It i3 not a
conventional immunoglobulin molecule, but it is a T lymphocyte
specific antigenic structure (Wekerle, Eshhar and Feldman, 19710*
The receptor for antigen on the B lymphocyte is antibody, but
both B and T lymphocyte receptors for a single alloantigen show
the same antigenic structure, as determined fcy the reaction of
anti-alloantisera prepared against both antibody and T cell
receptors.
Anti-idiotypic antibodies can act to promote rensitisation
of B cells for Ig production, and T cells for the heloer effect,
and both classes of receptor appear to be determined by heavy
chain linkage group (Igl) genes rather than Ir genes in the mouse.
The cells secreting an antibody bearing a specific idiotpyic
marker can be suppressed by the administration of anti-Idiotypic
antibody. This was shown when rabbits were treated with anti-
idiotypic antibody, and failed to secrete antibody expressing that
idiotype upon subsequent antigen challenge (Cosenza and KOhler,
1972).
Investigations of this kind point to the possibility of
selective elimination of cells expressing single idiotype
determinants, a possible method for eliminating clones of
neoplastic cells.
Surface Receptors for Immunologically active Intermediates
1)/...
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1) The Fc receptor.
A subclass of B lymphocytes expresses a surface receptor for
the Fc fragment of immunoglobulin IgG in both mouse and man
(Dickler and Kunkel, 1972$ Paraskevas et al., 1972} Basten et
al., 1972a, b). This is conventionally detected by rosetting
tests in which antibody coated red cells are incubated with
lymphocyte suspensions. Lymphocytes binding with the complex of
red cells and antibody express the Fc receptor. In the human
system, the Fc rosetting lymphoid population can also be
identified using heat-aggregated immunoglobulin (Dickler, 197li).
Free immunoglobulin is not bound and the reaction appears to be
specific for B lymphocytes (Dickler and Kunkel, 1972). The
studies of Dickler (197U) also show that the receptor is specific
for the Fc portion of IgG, F(ab) fragments which retain the antigen
combining site do not sensitise red cells for adherence to
lymphocytes in this test. The surface Ig of the B lymphocyte is
not involved in this reaction, as mild trypsin!sation which
removes surface Ig does not prevent binding of an IgG antigen
complex. The receptor for IgG Fc is important in that it mediates
the cytotoxic reactions attributed to a subiopulation of lymphoid
cells, K cells, which are able to kill tumour cells sensitised
with IgG antibody. The evidence that IgG Fc receptors are
expressed only on B lymphocytes (among the lymphocyte population -
macrophages also express receptors for IgG Fc) lies in the
conjunction of stainable surface immunoglobulin and Fc receptors
on the same population (Dickler, 19710# In normal human blood,
16-21# of the lymphocyte population express IgG Fc receptors, and
the/...
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the bulk of these are surface Ig positive cells. About 3-k%
of normal T lymphocytes (surface Ig negative) also egress Fc
receptors. The marker Fc receptor is better regarded as being
expressed on a population of lymphocytes which overlaps
extensively with that population expressing surface Ig, but is
not a specific marker only of B lymphocytes. In the mouse, a
population of cytotoxic (K) cells showing IgG Fc receptors, but
lacking any conventional B cell (surface Ig) or T cell (thy 1.2)
surface markers has been described (Greenberg et al., 1975)* 3n
man lymphocytes, monocytes and neutrophil polymorphs all express
receptors for Fc IgG. There is however some subclass specificity
of the Fc receptor on these cells. lymphocytes will bind
unaggregatea IgG of IgG1 or IgG^ subclasses, but not IgGg, IgG^,
Igfi., IgD or IgM. Monocytes will bind IgG^ or IgG^, but bind
IgG^ poorly if at all. Neutrophils bind IgG^, IgGy IgA^,
IgA? secretory IgAS and also IgG^. The Fc portion of the
immunoglobulin molecule appears to confer cytophillia for certain
cell surfaces (Lawrence et al., 1975). Not only lymphoid cells
express receptors for Fc IgG, these have also been described on
mouse placenta, and yolk sac cells of the mouse embryo (Elson
et al., 1975).
Apart from the circulating lymphocyte of B lineage further
studies have revealed similar receptors on lymph node cells
(Siegal, 1972) and on cultured plasmacytoma cells (Cline et al.,
1972). Ramasamy and Co-workers (197k) put forward the interesting
proposition that expression of the Fc receptor was related to
activation of B lymphocytes, in that it acted as a reservoir on
the/...
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the B cell membrane for immunoglobulin secreted by that cell.
Thus in a pro-secretory B cell, the bulk of the Ig Fc receptor
sites would be unoccupied, and the passive binding of antibody
coated red cells would be strong. As secretion of immunoglobulin
by the B cell increased, fewer Fc receptor sites would be
available, and the increase in surface fluorescence would be
paralleled by a decrease in antibody coated red cell binding.
Finally, the plasma cell would fall to express Fc receptor at
all, as it is totally committed to IgG production, and all its
receptor sites are occupied by secreted IgG. There is evidence
that lymphokine secretion by the B lymphocyte can be triggered
through not only the Fc receptor but also the surface Ig itself
and the receptor for complement (Wahl, Iverson and Oppenheim,
197U).
In the reports on Fc receptor distribution on subclasses of
lymphoid cells it is frequently difficult to reconcile individual
observations because of the widely divergent techniques of assay,
cell separation and experimental manipulation. As an example
cytotoxic activity towards antibody coated cells expressed by
spleen cells from the mouse, reveals a null receptor cell
(Greenberg et al., 1972) which is largely represented in the
glass adherent cell population (Greenberg, Shen and Roitt, 1973)
and is almost certainly a macrophage (Goldstein et al., 1973).
"Null receptor" cells have had a variety of origins postulated
for them, for example immature "stem" cells (Barr, Whang-Peng and
Perry, 197£) antibody forming cell precursors (Basten, Warner and
Handel, 1972) or plasma cells (Ramasamy et al., 197k). However,
other classes of non adherent mouse spleen cell are also cytotoxic
to/...
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to antibody coated cells (Greenberg et al., 1975)> and there are
null cells, characterised only by their receptor for IgG^ subclass
in the mouse. Thus at least two classes of spleen cell exhibit
as a common characteristic the ability to kill antibody coated
target cells. This property is also shared by neutrophil
polymorphs and macrophages. The other property all share is the
receptor for IgG. The "class" of antibody depndent cytotoxic
cell (K cell) is therefore to a very large extent an artefact of
experimental method rather than a "nosological entity". This
work is noteworthy since it illuminates the difficulties in
defining subclasses of lymphoid cell on the basis of their
receptors, as distinct from their surface antigenic
characteristics.
There is evidence to show that, under some circumstances, T
lymphocytes in both mouse (Yoshida and Anders son, 1972 j Andersson
and Grey, 197h$ Stout and Herzenberg, 197$) and man (Ferrarini
et al., 1975) can express receptors for Fc IgG. T cells in the
Guinea pig also appear to express Fc receptors (Van Boxel and
Rosenstreich, 197U). In the papers of Yoshida and Andersson,
and Stout and Herzenberg, IgG antibody complexed with erythrocytes
or with IgG anti-IgG were used as the test particles. Resting,
i.e. inactive, T lymphocytes did not express Fc receptors, but
tranfformed reactive T lymphocytes did express this receptor (Yoshida
and Andersson, 1972). It was further shown that Fc receptor
positive T lymphocytes were not helper cells (Stout and Herzenberg),
a finding which implies that expression of Fc receptors may be a
property of transformed responding (i.e. "effector")
T/...
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T lymphocytes. In the studies of Andersson and Grey (19710
aggregated IgG in a mouse system was used in an attempt to
quantitate the Fc receptors on B and T lymphocytes. Fc receptors
were found on 20-1x5% of thymus cells, and on 70-85% of spleen
cells. A very senstive radiolabelling assay technique was
employed. Both "null cells" (thy-1 negative SIg negative) and
thy-1 positive SIg negative thymus derived lymphocytes could bind
substantial amounts of aggregated immunoglobulin.
Fc receptors have been described on human lymphocytes which
form rosettes with sheep erythrocytes (Ferrarini et al., 19710
and which are presumptive T cells. The same group has also
described a receptor for IgM antibody on human T cells, although
this is distinctive and does not show inhibition with free IgG,
arguing that the receptor for IgM antibody on T cells is not an
Fc receptor (Morietta et al., 1975)* In the mouse, it has been
shown that IgM receptors present on normal thymocytes can mediate
T cell cytotoxicity against LCM virus infected cells (Lamon et al.,
1975).
The biochemical nature of the Fc receptor, and the genes
determining its expression have recently come under scrutiny.
Since the Ir gene products are involved in cany of the reactions
which might also involve Fc receptors, the relationship of the
Fc receptor to the H-2, and Ir gene products was an obvious
starting point for such studies. The relationship of the Fc
receptor to the H-2 complex, and the antigen binding sites
on T and B lymphocytes (which are Ir gene products) was studied
by Basten, Miller and Abraham (1975). These authors concluded
that/...
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that one group of H-2 determined alloantigen3 was in close
proximity to the gene determining the Fc receptor. Anti-H2
antibody, administered to cell suspensions as the Fab fragment,
could block the Fc receptor on B cells. This antiserum reacted
predominantly with the H-2 alloantigens not coded for by H-2K
or H-2D segments, thus lying in the region of the Ir gene complex.
The Ir determinant for Fc receptor seems to be expressed only on
the B cell, but appropriate anti H-2 antisera prevented T cells
binding to antigen present on B cells - implying that one of the
Ir gene products of the B cell may be an Fc receptor, while in
the T cell it may be the antigen receptor site.
Schirnnacher, Halloran and David (1975) re-examined the
data of Dickler and Sachs (197k) which claimed to show close
association of I region determined alloantigens, and the Fc
receptor on B cells, by the use of I antigen alloantisera prepared
in H-2 compatible animals. They showed that not only would
anti-la antisera inhibit the Fc receptor, but anti-Iy k.2, rabbit
anti-mouse B cell antiserum (MBLA.) and rabbit anti-mouse
immunoglobulin would also effectively inhibit Fc receptors.
On the other hand, antisera against thy 1 or xenogeneic anti-
thymocyte antisera failed to inhibit Fc receptors. Fab fragments
of inhibitory antisera were also inhibitory, and appropriate
inhibition of the K cell by Fc receptor was obtained by whole Ig
molecules, but not by Fab fragments. It was therefore concluded
that the Fc receptor was not, antigenically at least, part of the
la molecule. Further attempts to relate the Fc receptor to la
antigens biochemically also have failed to demonstrate identity
of these two components (Hask et al., 1975)*
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The Complement Receptor
The phenomenon of "immune adherence" described by Nelson
(1953) between normal human erythrocytes and T pallidum sensitised
with antibody in the presence of complement, stimulated further
research into the mechanisms of adherence, and of the cells with
which immune adherence takes place. In his original description
Nelson regarded such adherence as a method of increasing the
efficiency of phagocytosis. It was therefore natural to examine
the neutrophil and macrophage for immune adherence reactions.
Receptors for complement were described on blood leukocytes,
including lymphocytes by Lay and Nussenzweig (1968), and
receptors for complement on macrophages by Huber et al (1968).
It was shown that the human monocyte expressed a receptor for
the third component of complement (activated C3), that this
receptor required large amounts of bound complement to function,
and was separate from the receptor for IgG (IgG Fc) on the same
cell.
The first definitive account of complement receptors on
,vi*
human peripheral blood lymphocytes was by Michlmayr and Huber
(1970). The test particle was the sheep erythrocyte , coated
with IgM antibody and human complement. Both monocytes and
lymphocytes bound these cells, but monocyte binding was reported
to be inhibited by EDTA. A mean of 20%, with a range of 12% to
29% of lymphocytes had complement receptors by this test. These
findings were confirmed by Bianco, Patrick and Nussenzweig (1970)
who also used EDTA to inhibit binding to monocytes and poly¬
morphonuclear leukocytes. Bianco and Nussenzweig (1970) later
showed/...
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showed, in the mouse, that lymphocytes which bound complement
sensitised red cells lacked theta (thy 1) antigen, and that CRL
(complement rosetting lymphocytes) were B cells. This was
confirmed by demonstrating that complement sensitised red cells
reacted preferentially with lymphocytes contained in the B
lymphoid areas of spleen, and lymph node, but not in thymus
(Dukor, Bianco and Kussenzweig, 1970j Silveira, Mendes and
Tolnai, 1972). The latter authors showed preferential binding
of complement sensitised erythrocytes to the germinal centre in
lymph nodes in man, but failed to show binding to thymus using
Frozen sections. Apart from the presence of complement
receptors on normal human lymphocytes and monocytes, they were
also demonstrated on leukaemic lymphocytes and on cells from
lymphoid cell lines (Shevach et al., 1972a) in man and in the
mouse (Shevach et al., 1972b).
The specificity of the binding in complement receptor
studies involves two variables:- firstly the class of cell to
which the complement sensitised particle is presented, and
secondly the complement components expressed on the surface of the
particle. .Extensive studies have been undertaken to exactly
determine which classes of cell bind to which complement
component.
Briefly complement consists of eleven components, of which
C.j, C^» are relevant. C1 (composed of three subunits
Clq, C1r, C1s) is bound by IgM antibody (and IgG if present in
sufficient concentration) and subsequently interacts with Ch, C2
and 03 in that sequence. Each interaction involves the
splitting/...
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splitting of a fragment from the native free complement
component, the major portion being bound, and the minor
component entering the fluid phase. For example Ch is split by
C1s into Clta and Cltb. Cltb is bound to C1 to give Clltb. This
complex fixes C2 to form C1ltb2a, a complex called C3 convertase
which splits C3 into C3a and C3b. C3b is fixed to the cell
surface, and there is acted on by C3 inactivator which converts
bound C3b to C3d by way of an intermediate C3c component.
Erythrocytes expressing CI, ClUb, Clltb2a, Cl!t,2,3(b or d), Cit,3b,
Clt,3d, can be prepared and these are used to test the specificity
of the receptors on the cells studiedj e.g. human red cells
express receptors for C3b component but not for the C3d component.
C3b cells are "immune adherence positive" with human red cells,
C3d cells are "immune adherence negative". Using such techniques
it has been shown that the C3 component was the major one
influencing the binding to lymphocytes, as complement coated red
cell binding could be inhibited with split products of C3 (Eden
et al., 1973)- Human lymphocytes were in fact shown to possess
two receptors: for C3b, or for the inactive product C3d (C3b
inactivator cleaved C3b). Human neutrophils expressed
receptors for C3b and Git but not for C3d. (Ross et al., 1973J
Ross, Polley and Grey, 1973j Eden, Miller and Nussenzweig,
1973).
Studies of CRL in human blood or tissue preparations also
have to take into account the class of erythrocyte (e.g. sheep,
ox, human) used, and the source of complement (mouse, rabbit,
guinea pig, human) in preparing the test particle. Sheep
erythrocytes/. *.
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erythrocytes, sensitised with rabbit antibody and mouse
complement, will react with human T cells as well as B cells,
under the conditions cited by Boss et al. (1973 )• This was
not the experience of the author of this thesis, using a similar
system but with great attention paid to standardisation of the
initial eensitisation by IgM antibody, and not of some other
laboratories (Gatien et al., 1975a, 1975b), using essentially
similar techniques.
More careful study paid to the lymphoid cells expressing
the complement receptor, particularly when these were combined
with tests for responsiveness to phytomitogens, and for the Fb
receptor, revealed that not all cells possessed both Fc and C3
receptors together, although there was considerable overlap
between these populations. 70% of Fc receptor cells had C3
receptors as well and no cells expressed the C3 receptor only.
This work, in the mouse, revealed that rapidly dividing lympho-
blastoid B cells responding to bacterial lipopolysaccharide
(a B cell mintogen) retained their Fc receptor, but lost the
receptor for C3 (Holler, 197U).
The re have also been further reports showing that the
receptor specificities attributed to C3b in previous reports,
may well have been due to the expression on human lymphocytes
at least, of a receptor for GU. This CU receptor will cross
react with C3b:- the second lymphocyte receptor, for
inactivated complement (C3d) reacts only with C3d, and not with
Gh or 03b (Ross and Polley, 1975)* The Cii receptor (BokLsch
and Sobel, 197b) but was first described, again on the human
erythrocyte, by Cooper (1969).
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The role of the receptors for complement and IgG Fc in the
development of the immune response, and in the regulation of B
lymphocyte proliferation and differentiation is currently being
explored. It has been shown that immune complexes containing
complement bind to the complement receptor in preference to binding
to the receptor for Fc IgG (Theofillopoulos, Dixon and Bokisch, 197U)•
These authors also managed to show that receptor for Fc and
complement on human lymphoid cell lines did not universally occur
together, and did not always occur only on SIg positive cells.
The complement and Fc receptors seem to appear rather later
than the surface immunoglobulin on the B lymphocyte surface.
Although the numbers of SIg positive B lymphocytes in the neonatal
mouse spleen achieve adult or near adult proportions by the end of
the first two weeks of life, the numbers of Fc or complement
receptor expressing lymphocytes do not reach adult levels until at
least 6 weeks of age (Gelfand et al., 197l;a). If, as seems probable,
the major immunoglobulin expressed is IgM, then the Fc receptor will
not be occupied by IgK molecules, and consequently its rate of
expression is not simply due to masking by immunoglobulin molecules,
but due to actual synthesis by the cell. It is reasonable to believe
that the expression of complement receptors is tinder genetic control
since the rate of appearance of a complement rosetting lymphoid
population depends upon a gene located with the H-2 complex
(Gelfand et al., 197lib).
The presence of the complement receptor is of great importance
in the activation of B lymphocytes. Cobra venom factor (which
destroys C3) prevented the development of humoral antibody formation
to thymic dependent antigens (Pepys, 1972). The* addition Qf quite
small/...
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small quantities of C3b to cultures of mouse lymphocytes in vitro,
is sufficient to cause transformation of B lymphocytes with
O
incorporation of H thymidine into DNA. (Hartmann and Bokisch, 1975).
C3> C3a and C3c were much less stimulatory, or failed to stimulate
cultures at all. A role for the complement receptor has been
proposed by adherents of the "two signal" hypothesis of B
lymphocyte activation (Reviewed by Dutton, 1975) and some others
regard the C3 receptor as a major mitotic stimulator of the B
lymphocyte (Hartmann, 1975)(Moller, 1975). These concepts of B
lymphocyte activation will be discussed later.
The complement receptor has been generally regarded as a
superior marker of B cells than the Fc receptor, since the Fc
receptor is also expressed on activated T lymphocytes. T
lymphocytes do not express complement receptors, although
neoplastic cells, as in some lymphoid cell lines from the mouse
(Greenberg and Zatz, 1975) chicken and man (Powel et al., 197k>
Stuart and Habeshaw, 1975) show characteristics of T lymphocytes
and also express the complement receptor.
The complement receptor has been used to deplete lymphocyte
populations of "K" lymphoid cells, indicating that in addition to
possessing the Fc receptor through which it mediates the cytotoxic
reaction, the K cell has a receptor for complement. However, the
addition of complement to target cell monolayers pretreated by IgG
antibody, did not increase target cell lysis by lymphocytes,
showing that this receptor is not important to cytotoxic K cell
reactions (Perlmann et al., 1975). The classes of lymphocyte
expressing Fc and complement receptors were transformed by B cell
mitogens/...
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mitogens. It was shown that more 3 cells had Fc receptors than C3
receptors. After activation by mitogens (LPS) and transformation
into blast cells, the C3 receptor is lost. Mitogens such as P.P.D.,
stimulate B cells to transform. C3 receptors are quickly lost,
but Fc receptors are retained (Moller, 197k). There is also
evidence that B cell mitogens themselves will activate B cells much
more efficiently in the presence of complement than in its absence
(Moller and Coutinho, 1975)*
In addition to the presence of receptors for the clearly
defined immunologically reactive intermediate such as the IgG Fc
receptor, receptors for IgM, and the receptor for C3 and Cli components
of complement, lymphocytes show other characteristics by which they
can be identified. The receptor for the sheep erythrocyte is
claimed as a specific marker for human T lymphocytes, receptors
for EB virus are B lymphocyte markers, and receptors for Cholera
endotoxin, also mark B lymphocytes • Receptors for measles virus
have been detected on human T lymphocytes.
The phenomenon of positive binding of sheep erythrocytes to a
subpopulation of human blood lymphocytes was first reported by
Brain, Gordon and Willetts,(197C) (Brain and Gordon, 1971J Brain
and Marston, 1973). The finding was confirmed by a number of
separate laboratories (Lay et al., 19711 Wybran Fundenberg and
Gchle inger, 1971* Jondal, Holm and Wigzell, 1972 j Froland, 1972j
Coombs et al., 1970). Before the technology was standardised,
results obtained tended to be rather variable, and accurate
determination of the class of reactive cell was not possible
(Bentwich et al., 1973)• The blocking of the sheep erythrocyte
receptor/...
92.
receptor (E receptor) was studied by Wernet and Kunkel (1973) and
immunoglobulins were ineffective in inhibiting E rosetting.
It was shown that antisera prepared against human thymocytes
or brain could inhibit E rosetting (Wortis, Cooper and Brown, 1973)
suggesting that the cell responsible was the thymic dependent T
lymphocyte. Most of the E rosetting cells are not found to have
Fc IgG or complement receptors, although a subpopulation (2% or so)
do express dual receptors (Steel, Evans and Smith, 1975) (Diclcler,
Adkinson and Terry, 1971;). The most substantial early evidence for
identifying the E rosetting cell as a T lymphocyte stemmed from the
high levels of E rosetting obtained with thymus (Jondal et al.,
1972j Silviera et al., 1972) and observations with aati-T cell sera
(Yata et al., 1973} Auiti and Wigzell, 1973). E rosettes are
occasionally encountered on EB virus infected B lymphoid cell lines,
and occasional co-existence of E rosettes and complement receptors
on the same cell do occur, but have hitherto been described only on
cell lines, or in lymphoid neoplasms (Smith et al., 1975} Stuart
and Habeshaw, 1975). The levels of E receptor lymphocytes, Fc IgG,
complement receptor lymphocytes and B lymphocytes have been
quantitated accurately in human peripheral blood (Holm et al.,
1975} Habeshaw and Young, 1975)(Bobrove et al., 1 97il) and in
spleen (Visakorpi and Eepo, 1973} Stuart and Habeshaw, 197it).
Proteolysis appears to enhance E rosetting and T cell function
in malignant disease (Holland, Brown and Thornes, 1975). Protease I
from Aspergillus oryzae (Brinase) and streptokinase both were
effective in increasing levels of E rosetting cells. Chapel (1973)
described/...
93.
described enhancing of S rosetting by papain and trypsin, providing
treatment of the lymphocytes was mild and no loss of viability
occurred. This effect was attributed to "unveiling" of E
receptors by proteolysis. Fhospholipase A inhibited E rosetting.
E rosettes can be stabilised by the addition of glutaraldehyde
after rosetting, but when this is done substantial numbers of B
cells do bind sheep erythrocytes (Evans, Smith and Steel, 1975).
Enhanced E rosette formation is also observed following treatment
of erythrocytes with 0.1 U3m 2 aminoethyisothiouronium bromide
(Kaplan and Clark, 197k) and substantial numbers of surface Ig+
(B lymphocytes) forming E rosettes are seen, with virtually all
peripheral blood lymphocytes (67%) rosetting. Similar, but not so
pronounced E rosetting by B cells occurs with sheep cells pretreated
with neuraminidase (Bentwick et al., 1973)(Weiner, Bianco and
Nussenzweig, 1973).
In the mouse, treatment <£ lymphocytes with phytomitogens
(plant agglutinins) agglutinates and stimulates subclasses of B or
T lymphocytes (Schnebli and Dukor, 1972). Both Dhytohaemagglutinin
and concanavalin A will enhance E rosetting when cultured with human
lymphocytes (Gergely et al., 1973). Phytohaeaagglutlnin is recognised
as a T cell specific mitogen, while CON-A stimulates both B and T
cells. Stimulation of human lymphocytes with PHA does increase
both E rosetting cells, and spontaneous rosette formation with
homologous human erythrocytes (gpOrh-) both functions of T cells
(Sheldon and Holborow, 1975).
The effect of dextran on E rosette formation was studied by
Brown, Mpern and Wortis (1975) who fouuad enhancement. A similar
effect/...
9k.
effect has been noted on human lymphocytes separated over Ficoll
triosil gradients (BlacJriLe, 1973) and on some samples of human
polymorphonuclear leukocytes separated by dextran sedimentation
(Hsu and Fell, 197U).
The rather strange biological phenomenon of human T cells
binding sheep erythrocytes does have a species parallel in that
papain treated rabbit erythrocytes are bound by guinea pig
thymocytes and peripheral T cells (Wilson and Gurner, 1975).
Other receptors on human lymphocytes include the measles
virus receptor on human T lymphocytes which is not a consequence
of prior immunisation (Valdimarsson, Agnarsdottir, Lachman, 1975)•
Human B lymphocytes have a receptor for the EB virus (Jondal and
Klein, 1973), which overlaps with the receptor for complement, i.e.
is on the same population. Some E rosetting, thymus derived
lymphoid cell lines have been described (MInowada, Ohnuma and
Moore, 1972) and more recently, proof that these cell lines lack
EB virus particles (which only affect B lymphocytes) has been
provided (Kaplan, Shope and Peterson, 197h)•
Thus in man there is good evidence that the E receptor
overlaps substantially with the T lymphocyte population as defined
by antisera and mitogens, and overlaps little if at all with the
population expressing complement receptors. If lymphocytes are
treated with proteases, or sheep erythrocytes with neuraminidase,
E rosetting populations then overlap substantially with Surface Ig,
or complement receptor lymphocytes.
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Having examined how lymphocytes trap
antigen, and having described surface
characteristics related to determination
of cell class and immune responsiveness,
this chapter describes the principal types
of interactions between cells which occur
in the response to antigen.
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2) Co-operation between thymic dependent (T) and thymus independent
(B) lymphocytes in humoral immune responses
Lethally irradiated mice can be saved from death by an
injection of syngeneic bone marrow cells. If thymectomy is carried
out before irradiation, the reconstituted animals can be shown to lack
cells capable of causing graft versus host disease, and such animals
will also accept skin grafts from unrelated mouse strains. They
have no thymic dependent lymphocytes. In investigating the
response to such animals to antigens, Claman, Chaperon and Triplett
(1966) injected mice reconstituted with either bone marrow cells or
thymus cells, or both, with sheep red blood cells as antigens. They
found a greater antibody response in bone marrow and thymus
reconstituted animals than in recipients of thymus or bone marrow
alone. This synergism of bone marrow derived and thymus derived
cells was subsequently confirmed by Miller and Mitchell (1968) for
other classes of erythrocyte as antigen, and by Taylor (1969) and
Miller and Svoboda (1971) for serum proteins. Hot all proteins
require the presence of both T and B cells for an adequate immune
response - some require only B lymphocytes; these are called
thymic independent antigens, the thymic dependent antigens require
both B and T lymphocytes for an adequate humoral immune response
(Miller, 1971). On* class of antigens, the haptene-protein
conjugate, shows unusual behaviour when used to immunise animals
(Rajewsky, 1969). Haptenes will only elicit an immune response
when coupled to a carrier protein. If a secondary challenge with
the same haptene coupled to the same carrier is given, then a good
anti-haptene/...
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anti-haptene antibody response is seen. If the second challenge
is made with a different carrier, but the same haptene, then a poor
anti-haptene response occurs. The effect is due to carrier
specific thymic derived cells (T cells) and all haptene-carrier
responses are thymic dependent. This was shown by Mitchison (1971)
using NIP-ovalbumin, (NIP 11 5 iodo 3 nitrophenyl acetyl - ovalbumin).
When animals were immunised with NIP-ovalbumin and then challenged
with NIP-BSA. (BSA ■ Bovine Serum Albumin), no secondary response to
NIP occurred. This was shown to be due to the generation of cells
with anti-ovalbumin binding capacity during the primary immunisation.
Since the subsequent challenge was with NIP-BSA and as no BSA
binding cells were present the response to the haptene NIP was
reduced. Raff (1970) showed that the cells which bound the
carrier had the characteristics of thymus derived lymphocytes. As
a rule it is now established for several haptene-protein conjugate
systems that thymus derived cells "see" the protein carrier and that
the antibody forming B lymphocytes "see" the haptene. For an
efficient secondary response both cell types must be present. This
role of the T lymphocyte is described as "the helper effect".
Such experiments have now clearly established that in the
normal humoral immune response both B and T lymphocyte co-operate
in antibody formation. The effects of T cells on antibody
formation by B cells are more involved than enabling B lymphocytes
to "see" antigen. As demonstrated by Mitchison (1968) the uncommitted
"virgin" B lymphocyte can be "primed" by antigen in concentrations
«»8
of 10 molar. If 10 times less (10 molar) antigen is present
the lymphocyte binds it, but fails to respond to subsequent
challenge/...
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challenge, i.e. it is paralysed. If a "primed'1 lymphocyte is
exposed to 10~^ molar concentration of antigen it will convert to
an antibody secreting plasma cell. If exposed to 10 ^ molar, i.e.
100,000 times that concentration of antigen, it will fail to secrete
antibody, i.e. will become paralysed by antigen excess. Therefore
a humoral immune response will occur only if antigen is present in
concentrations which will "prime" or convert primed antigen reactive
B cells. Where antigen is scarce, some mechanism of concentration
is required, where antigen is in excess some mechanism of
elimination of that excess is required or no immune response will
ensue (Mitchell, Humphrey and Williamson, 1972). It has been
suggested that antigen activated T cells, by binding antigen,
reduce its availability for B cells in such a way as to decrease
the tolerogenicity (paralysing capacity) of that antigen for B
lymphocytes of high antigen binding capacity, and at the same time
to prevent other B cells forming clones due to the "antigen drive"
by a direct T lymphocyte mediated suppressor effect. The former
activity can be interpreted as a T cell helper effect, and the
latter as a T cell suppressor effect (Mitchell, 1975). Such
effects can undoubtedly be shown, but requirement for another cell
type - the macrophage can be demonstrated.
3) The role of the macrophage in antigen handling
During an immune response, injected antigen is trapped in
lymph nodes by cells which do not themselves secrete antibody. Two
types of cell are involved, the macrophage, and the dendritic cell
of the germinal centre. Macrophages, unlike B lymphocyte^ can
bind/...
98.
bind many antigens. The extent to which they bind antigen depends
upon the degree of polymerisation of the antigen (i.e. its size) and
upon the presence of specific antibody. Macrophages do not appear
in any way to influence the specificity of antibody formation
subsequent to antigen binding, but binding is important as it is
impossible to induce tolerance by macrophage bound antigen in
distinction to soluble or native antigen (Unanue, 1972). By contrast,
immunisation of mice with antigen bound to macrophages invariably
increases the subsequent immune response in comparison with free
antigen (Unanue and Askonas, 1968). Some antigens administered in
a soluble form are very poor immunogens, but are highly immunogenic
wheri administered with macrophages (Mitchison, 1969). According to
one view, macrophages act as a "focusing" devie for antigen,
concentrating antigen on its surface in a form where B and T
lymphocytes can interact together to initiate an immune response.
Feldman et al. (1975) believes that the macrophage acts as a
receptacle for the T cell surface receptor. In this model the T cell
interacting with antigen by virtue of its surface antigen receptor
sheds the complexed receptor (consisting of 7S IgM bound to antigen)
which is abstracted from the intercellular fluid by the macrophage.
The macrophage possibly has receptors for IgM antibody-antigen
complexes (e.g. isohaemagglutinins)(Stuart and Cumraing, 19671
Lay and Kussenzweig, 1969) but this is controversial (Huber and
Holm, 1975)# This has been discussed. The macrophage + T cell
receptor + antigen stimulates the B lymphocyte which then forms
antibody, in this model. Macrophages are also ideally suited to
the destruction of excess antigen, after an antigen injection less
than 0.5£ of the antigen remains associated with the macrophage
surface/...
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surface. The bulk of antigen is destroyed. Macrophages may also
co-operate directly with B lymphocytes through the medium of surface
fixed antigen, either directly or in the form of antigen antibody
complexes.
The question of co-operation between macrophages and T
lymphocytes in the initiation of graft rejection has not been
settled. T lymphocytes from unsensitised rats when cultured on
monolayers of fibroblasts from unrelated rats can undergo
transformation and generate cytotoxic lymphocytes (Ginsberg, 1969).
Evidence supporting the role of the macrophage as an antigen
processing cell for T lymphocyte responses stems from the in vitro
mixed lymphocyte reaction, in which leucocytes from two unrelnt-d
donors are mixed and cultured in vitro. Transformation of T
lymphocytes occurs if macrophages are present. Highly purified
lymphocyte preparations are said to be inactive (Bain et al, 1965).
The importance of the macrophage may relate to its ability to "fix"
antigen in an immunogenic form.
U) Role of the reticular cell in antigen handling in the developing
germinal centre.
There are frequently observed close anatomical relationships
between antigen containing macrophages and lymphoid cells, especially
in homograft reactions (Sharp and Burwell, 1960j Haheln, 1971)*
and in the germinal centre. Macrophages preserve the immunogenic
portion of an antigen (Cohn, 1962), but the bulk of ingested antigen
is destroyed. The remaining immunogenic component is capable of
activating B cells, either directly or through interaction with
the/...
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the T lymphocyte. A direct role for the macrophage in activating
B cells was shown by Gallily and Feldman (1967) using shigella
organisms transferred to irradiated mice. Macrophages are required
for the interaction between particulate antigens and B lymphocytes
(Mosier, 1967). In studying the response of the lymph node to
antigen it is found that cells other than the macrophage retain
antigen. Marshall and White (19$0) describes these cells as
irregular with finely branched processes, surrounding the follicle.
They stained with silver. Similar cells within the germinal centre
did not stain with silver.
At this point some explanation is required. The fact that
Marshall and 'White failed to stain the intrafollicular cell with
silver but could stain the perifollicular cell is of some interest.
Both cell types were at that time regarded as forming a pert of the
"reticulum" of the lymph node. The smaller, dark, and silver
staining cells were regarded as structural cells which had
differentiated from the larger, pale, non-silver staining totipotent
"reticulum" cell which gave rise to fibre-forming, lymphoid and
histiocytic elements. (Marshall, 1956j Maximow, 1 92h). It was
therefore quite natural to suppose that since the germinal centres
produced lymphocytes, no fibres should be present within them, as
the reticulum cell was differentiating in a "lymphoid" rather than
a "fibrogenic" direction.
This observation of the "reticulum" cell of the germinal centre
acquired greater importance when it was demonstrated (White, 1963) that
an antigen retaining "reticular net" was present in the germinal
centres of lymph nodes and spleen, and that these antigen retaining
cells/...
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cells belonged to the same group as the cells described by Marshall
and White. Several other authors have described the antigen
retaining dendritic or reticular cell of the germinal centre. The
localisation of antigen within the germinal follicle was studied by
radio-iodinated proteins and synthetic polypeptides, injected into
animals with and without preformed antibody (McDevitt et al, 1966).
Such studies indicated that follicular localisation of antigen was
a function of preformed antibody, and that the amount localised in
germinal follicles was dependent upon the amount of antibody given
with the antigen or naturally present. It was later shown that
the immune complexes formed between antigen ana antibody in the
germinal centre failed to bind complement (Perais et al., 1969).
Antigen localised in the perifollicular area penetrates the germinal
centre rather slowly on the reticular cell processes. The movement
of antigen into the germinal centre is radio-sensitive but its
retention therein is not (Hunter et al., 1969). The ultrastructural
features of antigen uptake by germinal centre dendritic cells show
that localisation is extracellular, and is in the form of small
aggregates of antigen and immunoglobulin diffusely localised to the
fine dendritic processes of these cells which run between the
lymphocytes and lymphoblaats (Nossal et al., 1968). These dendritic
cells have "desmosomes" at points of contact and appear to contain
fibrils (Maruyama and i-iasuda, 19&U).
In summary, antigen is handled by macrophages which destroy most
of it. Any they retain is immunogenic both to T and B lymphocyte
populations. If pre-existing antibody is present in an animal, the
antigen (or a very minor part of it) localises to the dendritic
reticular cell of the germinal centre as an antigen/antibody complex.
Such/...
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Such antigen stimulates germinal centre development and
enlargement and is unusual in that when so localised the complexed
material falls to bind complement.
5) Macrophage lymphocyte interaction in the immune response
Heactivity of thymus dependent lymphocytes can be induced by
contact in vitro with allogeneic cultured fibroblasts (Ginsberg,
1969). In antigen induced proliferation of immune T lymphocytes
in the guinea pig complete removal of adherent cells, including
macrophages, prevents the proliferative response of T cells to
antigen (Waldron et al., 1973)* Exposure of macrophages to antigen
for 1 hr. at 3l7°G, washing, and subsequently mixing with immune
lymphocytes produced a proliferative response. Although in the
first case sansitisation of T cells directly to allogeneic fibro¬
blasts in long term culture can occur, it appears that, upon
sensitisation, macrophages are necessaiy to enable an immediate
proliferative response to ensue. One morphological marker of
macrophage induced lymphocyte proliferation may be physical
adherence reactions between macrophages and lymphocytes such as
those described in lymph nodes by Miller and Avrameas (1971). Hosier
and Pierce (1972) have suggested that macrophages in thymus may play
a part in the functional maturation and differentiation of thymocytes.
Lipsky and Rosenthal (1973) have investigated the binding of guinea
pig lymphoid cells to tissue cultures of macrophages. This binding
of lymphocytes was independent of serum and antigen and not
dependent upon the presence of surface antibody and both B and T
lymphocytes were bound. Bound cells exchanged readily for free
lymphocytes/...
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lymphocytes in the surrounding medium. The receptor for
lymphocytes on the macrophage surface can be shown to differ from
the Fc IgG receptor, in its requirement for Calcium (Ca++) ion and
susceptibility to sodium azide.
Macrophages and lymphocytes can be physically observed to
interact in immune responses. In immune reactions in the guinea
pig, there is evidence that for antigen recognition by the thymic
dependent lymphocyte, macrophages sire required. Where the
macrophage and T lymphocytes are from different strains of guinea
pig, there is no antigen recognition by the T lymphocyte, but when
both macrophage and lymphocyte are histocompatible, sensitisation of
the T lymphocyte by antigen can occur (Rosenthal and Shevach, 1973).
In responses to thymic dependent antigens, or haptene-carrier
complexes, contact between the antigen csirrying macrophage and the
antibody forming lymphocyte was essential. The first step in such
reactions - the binding of antigen by T cells and its release as an
immunogenic complex (IgT/antigen) produces tolerance in a B cell
population unless macrophages are present (Feldman, Schrader and
Boylston, 1975).
Other important features of macrophage/lymphocyte interaction
include a) the maintenance of lymphocyte viability in tissue culture,
b) functional maturation and differentiation of thymocyte populations,
c) the enhancement of non specific resistance by macrophages following
contact with sensitised lymphocytes (Krahenbuhl and Remington, 1971 ),
d) induction of a primary response to particulate antigens, though
not to B cell mitogens, e) induction of a secondary response to
haptene-carrier complexes in presence of T lymphocytes, f) the
ability/...
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ability for lymphocytes to proliferate in a secondary response to
a particulate antigen is dependent upon macrophages (Lipslcy and
Rosenthal, 1975).
Equally important classes of interactions between
sensitised lymphocytes and macrophages occur in which the macrophage
acts as the effector cell under the influence of the sensitised
lymphocyte via the lymphokLnes. This kind of interaction does
not require direct lymphocyte macrophage contact.
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CHAPTER 10
THE PROBLEM OF B CELL DIFFERENTIATION
This chapter is concerned with the
definition of differentiation* and
explains on what basis the term is used
in describing differentiation in the B
lymphocyte system.
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B Cell Activation in the Normal Response to an Antigen
The reaction to an antigen involves the ultimate production of
a specific protein, the antibody, which reacts with the stimulatory
antigen. In order to produce this antibody the B lymphocyte must
be stimulated to proliferate expanding the population of cells
capable of synthesising that antibody, and must differentiate from
an inactive cell to a cell capable of manufacturing and exporting
2-3 x 106 molecules of antibody per minute.
The necessity of expanding the reactive B lymphocyte pool by
mitosis is seen when the genetic control over antibody synthesis is
considered. Normally, only 1 in 1,000 to 1 in 10,000 B lymphocytes
express antigen binding sites which will react with a given antigenic
determinant. The antigen binding sites are found in the variable
portion of the immunoglobulin molecules, and the amino acid sequence
in this region is determined by a set of genes (estimated at about
1,500) called V genes (Hilschmann et al., 1969). A principle,
called V gene restriction, appears to operate which states that a
cell can express only one of the several million possible V gene
sequences. In general terms this principle require that one B
lymphocyte can express only one kind of variable chain determined by
its own unique V gene sequence (one cell one antibody rule). This
rule does not affect the class of antibody secreted (IgM, IgG etc.)
since this is determined by the constant or C region of the heavy
chain of the immunoglobulin molecule. Thus it is possible for a
B lymphocyte to "switch" from IgM antibody production, to IgG
production, with the same V gene sequence, and hence antibody
specificity being shared by both IgG and IgM molecules (Bell, 1975).
Factors/...
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Factors which trigger an expansion of the B lymphocyte pool,
by inducing mitosis in the B lymphocyte population, may not be
directly related to either reaction with antigen, or subsequent
antibody synthesis. It is better to regard factors producing cell
division as their principal effect as producing "activation" of the
B lymphocyte, and those influencing immunoglobulin production as
producing "differentiation" of the B lymphocyte. Thus it is found
that substances such as bacterial lipopolysaccharide will produce
a great mitogenic response by B lymphocytes (Gery, Kruger and
Spiesel, 1972) but this nifco genie response does not result in
production of a single class of antibody directed against the
stimulating substance. Those cells not expressing high affinity
receptors for lipopolysaccharide proliferate in the early response,
as well as those producing specific anti-lipopolysaccharide
antibodies. Such a response is called a polyclonal response, and
the mitogens producing it are called polyclonal B cell activators
(PBA). These substances show two features of interest
1) They are all activators of complement and may function
by interaction with the complement receptor on the B
lymphocytes (Dukor et al., 197k)
2) In the response to such substances T lymphocytes are
not required (Coutinho, 1975)* These are sometimes
called T independent antigens.
However, polyclonal B cell activators are a highly heterogenous
group, including lipopolysaccharides, proteins, synthetic
polypeptides, polymers of inosine and cytosine, (Poly 10), and
products of activated T cells and macrophages. They produce
proliferation/...
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proliferation, rather than differentiation and specific antibody
secretion.
The modulation of the proliferating B cell into a specific
antibody secreting cell has been regarded as a co-operative function
of helper cells and antigen itself, adsorbed to the specific
receptors on the cell surface. This, has resulted in the "two
signal" hypothesis of B cell activation, one non-specific signal
from T cells or macrophages activating the cell to secrete antibody,
and the second specific signal by antigen inducing commitment to anti¬
body secretion. The experimental evidence supporting this view is
given by Button (1975), who shows that in the response to donkey red
cells, antigen alone will not stimulate the B cell to synthesise
antibody (as assessed by counting the number of lytic placques made
by B cells exposed to antigen alone). The addition of T cells h0
hours after exposure to antigen increases the numbers of placque
forming and hence actively secreting B cells. However, exposure to
antigen alone does initiate, or prime B cells to proliferate, and
the subsequent addition of T cells stimulates both proliferation and
antibody secretion. In this model the "switch on" signal comes
from antigen, and the "secrete" signal comes from T cells.
Proliferative responses (usually measured by the incorporation
3of H thymidine) by B cells exposed to antigen can occur where no T
helper cells are present. In experiments with synthetic antigens
(e.g. (T,G)-A -L), it was shown that IgM to IgG switching, and
limited proliferation of B cells occurred in the absence of T cell
help. The switching from IgM to IgG production is taken as
representing/,..
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representing a differentiation step. Yet the actual secretion of
antibody did not occur (Hammerling et al., 1973)• IgM secreting
cells are able to proliferate in the absence of T cell help, but
IgG secreting cells were produced only following the addition of
syngeneic T cells (Davie and Paul, 197U). The differentiation
step from IgM to IgG surface immunoglobulin expression was shown to
be thymus independent.
The use of the term differentiation
Differentiation is the irreversible commitment of a cell to
a particular pattern of development. Cells which secrete IgG
cannot revert to IgM production, and hence are fully differentiated.
They become, after development of the cytoplasmic machinery for IgG
manufacture, end cells:- plasma cells. On the other hand IgM
producing cells may become IgM manufacturing plasma cells (and hence
fully differentiated) or may switch to IgG production. The IgM
carrying B cell, which is not secreting IgM or IgG may differentiate
into an IgM secreting end cell, or into an IgG carrying (but not
secreting) cell, or into an IgG producing fully differentiated plasma
cell. Differentiation is said to occur at the point at which
commitment of the cell occurs. This is independent of cell
proliferation in B cell systems, and independent of antigen
exposure in T cell systems (Cantor and Boyse, 197i>a and 197£b).
Whether or not a committed cell synthesises its product is dependent
on "activation" "modulation" or "stimulation" and is usually
proceeded by mitotic division. It appears that the sequence of
events in the B cell system involves 1) differentiation followed
by division and 2) activation followed by synthesis of antibody.
Unlike/...
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Unlike the T cell system, in which cellular differentiation
is either autonomous or under thymic humoral control and is largely
independent of antigen, the steps of B cell differentiation are not
marked by the sequential appearance or loss of easily detected
surface antigens. Differentiation steps can be inferred from the
behaviour of the complement and Fc receptors on immature B cells as
they mature into antibody producing cells (Hamasamay et al., 19724■}
Gelfand et al., 197ka.} Gelfand et al., 197l|b), or as they develop
from lymphoid stem cells in spleen and lymph node explants (Metcalf
et al., 1975). B lymphocytes stimulated to proliferation by
mitogens appear to lose their receptor for complement at the blast
cell stage, but retain their receptor for Fc IgG (Moller, 197k).
In a study of immature B cells in the neonatal mouse it has been
shown that they lack C3 receptors, but possess Fc receptors, and
although they express surface Ig, fail to cap and hence shed this
immunoglobulin after treatment with anti-Ig sera (Sidman and Unanue,
1975a). Further investigation showed that failure to clear anti-
mouse Ig immune complexes from the membrane correlated with a
failure of the immature B cell to restore its surface Ig following
treatment with anti Ig sera. The mature B cell capped readily,
and shed this material quickly, and equally quickly restored "clean"
surface Ig. If surface Ig was removed by pronase, both mature and
immature B cells resynthesised surface Ig at equal rates (Sidmar.
and Unanue, 1975h)»
Early in embryology and in their development from stem cells,
B lymphocytes develop certain surface features which are retained
throughout their life span. These include surface immunoglobulin
(Sidman and Unanue, 1975a,bj Metcalf et al., 1975) and the species
specific/...
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specific antigens MBLA in the mouse (Raff &Ckntor, 1971 ) HBIA in man
(Greaves and Brown, 1973)» together with alioantigens PC1
(Takahashi et al., 1971) B cell antigen (Tutoku et al., 197U) and
Iyii in the mouse (McKenzie and Plate, 197U) and HL-B alloantigens
on B cells in man (Winchester et al., 1975a,b; Mann et al., 1975)*
Apart from the HL-B alloantigens in man which are also present on
monocytes, these antigens are more or less specific for all B cells
at whatever stage of their differentiation. Plaji&a calls are
reported to possess antigens not expressed on the bulk of B cells
(Yotoku et al., 197h).
It was believed, by analogy with the thymus gland, that these
antigens were acquired by a process of induction from the epithelial
tissues of the bursa in the case of B cells. As previously
mentioned, there is some evidence that congenitally thymusless mice
do possess small numbers of cells expressing theta (thy 1 ) antigen
(Raff, 1973J Loor and Roelants, 1971*) and the "precursor" or stem
cells of T cell lineage are actually increased in numbers.
Similar findings have now been reported in Bursectomised birds
(Jankovlc et al., 1975) in which IgM bearing cells of B lineage
were found in numbers equivalent to those in sham Bursectomised
birds, the only difference being in the density of surface IgM
which was greatest in the sham Bursectomised controls.
These findings must cast doubt on the process of induction -
which is held responsible for the appearance of class specific
differentiation antigens on B and T cells, although as Boyse and
Cantor point out the thymus is necessary for the induction of TLA
and Ly antigens in the mouse. As these authors have shown, the
surface/...
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surface antigen characteristics of T helper and. T cytotoxic cells
are determined intrinsically before exposure to antigen occurs
(Cantor and Boyse, 1975b).
Unlike the T cell system, the B cell system has not such well
characterised surface antigens, although it is possible that Ir
gene determined la antigens in the mouse (Hauptfeld, Klein and
Klein, 1973), monkey (Dorf, Balner and Benacerraf, 1975) and man
(Jones et al., 1975) may yet prove able to identify functional
subclasses of B lymphocytes.
There is good evidence that the differentiation of the B
lymphocyte from the immature, non-capping, and weakly responsive
B cell to the rapidly capping, receptor rich and, finally,
secreting B cell is not brought about by intrinsic regulatory
mechanisms as proposed for the T lymphocyte. The B lymphocyte in
its response to antigen shows that antigen is the inductive agent,
bringing about subsequent differentiation as expressed by changes
in reactive cells in recirculation (Strober, 1972) and by the fact
that most in vitro proliferative responses to antigen involve
proliferation of T cells, rather than B cells (Aim and Peterson,
1969). The fact that antigen alone induces a change from a sessile
(fixed) pro-secretory B cell to a circulating B cell in the first
case, and antigen alone fails to proliferate B cells in the second
case illustrates that changes in B cell behaviour and function can
be influenced directly by antigen but only in certain respects.
Antigen alone can change the recirculatory patterns of B cells (a
surface phenomenon) or can trigger a switch in the class of surface
immunoglobulin secreted (Hamraerling et al., 1973), but of itself
fail3 to trigger either proliferation or secretion of antibody by
B/...
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B cells. Since in antigen responses B cell differentiation is not
overtly accompanied by alterations in surface antigen expression, it
is debateable whether changes triggered by antigen amount to a
differentiation step. However, the subsequent behaviour of B cells
reactive with that antigen is permanently altered, and since such
alterations are by definition differentiation steps it can be
concluded that
a) B cell differentiation is antigen driven
b) Antibody secretion is independent of the presence
of antigen.
As has been shown, there is good evidence to support the
theory that proliferation of B cells, suppression of B cells, and
secretion of antibody in the secondary (IgG) response are all T
cell dependent, although the differentiation of the B cell prior to
engaging T cells is antigen driven and independent of proliferation.
Recent evidence in support of B cell differentiation by
antigen has been shown by Zauderer and Askonas (1976). In
lipopolysaccharide (LPS) stimulated spleen cell cultures precursors
of IgM, IgG and IgA secreting cells can be produced by the raitogenic
stimulus of LPS. These "secondary" secreting B cells differentiate
over a 1 7 day period following LP'S stimulation. In high density
cultures inhibitory cells are also found. The LPS stimulation,
and the development of secretory B cells in independent of T cells
in the culture medium. Thus an antigenic and mitogenic stimulus
in vitro is quite adequate to produce differentiation from IgM
bearing cells of IgM secreting and IgG secreting cells. IgA
secreting cells also are derived from surface IgM expressing cells.
In/...
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In this system proliferation could be inhibited without effect on
the development of IgG secreting cells by 6-8 days) indeed owing
to the inhibition of suppressor cells IgO levels were actually
higher in B(JDR treated than in untreated cultures.
11U.
TABLE 6
EXPRESSION OF DIFFERENTIATION ANTIGENS AND SURFACE RECEPTORS AS A
CORRELATE OF THE FUNCTIONAL STATE OF THE LYMPHOID CELL
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TABLE 7








Express receptor for CU, C3d.
Express M Locus LAD's
Express SD and LD alloantigens
B antigen (la antigen)
INa (la antigen)
EB virus receptors (man)
microglobulin (man)
Surface IgM








Surface IgM or IgG










All B cells express SD and LD alloantigens, and la antigens
strongly. Note expression of Fc and C receptors is variable, and
the paucity of differentiation alloantigens on B cells compared
with T cells. B cell differentiation is antigen dependent (antigen
drive).
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CHAPTER 11
SUMMARY OF PHYSIOLOGY OF
LYMPHOID TISSUE: (CHAPTERS U-10)
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The physiology of the lymphocyte and the cells associated
with it in lymphoid tissue has been reviewed in some detail, and
the following conclusions have been drawn.
The lymphocyte, and the macrophage are derived from stem
cells originating in bone marrow, and these stem cells are probably
of different classes. The lymphocyte develops initially in either
the thymic cortex or the bursal equivalent tissue of the mammal,
and depending upon the inductive influences of thymic epithelium or
bursal equivalent tissue develops as either a non-immunoglobulin
secreting cell responsible for cell mediated immunity (the T
lymphocyte) or as an antibody secreting precursor of the plasma
cell (B lymphocyte). These two cell classes can be distinguished
on the basis of their tissue localisation, their function, their
surface antigenic structure, the expression of receptors for
immunological intermediates, and the secretion of surface
immunoglobulin. The receptors which interact with antigen on B
and T lymphocytes are antigenically similar sharing idiotypic
determinants that of the B lymphocyte is immunoglobulin, the nature
of the T lymphocyte antigen receptor is unknown. From the classes
of B and T lymphocyte is is possible to describe subpopulivbions of
B and T cells which differ, in the case of B cells in their
expression of surface and intracytoplasmic immunoglobulin, and in
T cells in the expression of subsidiary surface antigenic structure.
T lymphocytes of three classes exist, the immature T cell, the
cytotoxic T cell and the helper T cell. B lymphocytes of several
classes exist, as defined by surface antigenicity they are either
pro-secretory B cells or plasma cells, by surface Ig expression
they/...
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they are pro-secretory B cells of XgCi, IgjW, XgD, IgA, IgE classes,
or plasma cells of these classes, and by functional studies they
are defined as precursor 3 lymphocytes (virgin B calls), activated
B lymphocytes (responder B cells), or memory B lymphocytes.
Macrophages in tissue, and in blood develop from a precursor
cell, the monocyte, which circulates in man. The precursor of
this cell is the colony forming unit, which can differentiate along
either granulocytic or monocytic pathways. As far as is known it
does not differentiate into lymphocytes. Macrophages exist as
several subclasses determined by their tissue localisation (blood,
lung, liver, etc.) but really three different types are important,
the colony forming unit (series stem cell) the tissue macrophage
and the monocyte (the exudate macrophage precursor). The monocyte
is probably one of the cytotoxic lymphoid cells (so called K cells)
responsible for antibody mediated cytotoxicity.
Macrophages can interact with T lymphocytes and with B
lymphocytes in both inductive and effector phases of the immune
response. T lymphocytes can act S3 s ppressor., of B cell function
or as helpers. In either role they determine the capacity of the
committed B lymphocyte to secrete antibody, they do not prevent
commitment of the B lymphocyte by antigen. Antigen retention in
lymph nodes also involves a third cell type, the dendritic
macrophage, which bears an uncertain relationship to the stromal
reticulin fibre associated reticular cell.
The nature of such reactions is to produce an immune response,
a permanent adaptive change in the reactivity of the animal
concerned, to the antigen which evoked the change.
lymphomas/...
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lymphomas are proliferations of lymphocytes, macrophages
and possibly of cells derived from the stromal component of the
lymph node (reticular tumours). It has been hypothesised that
such tumours can be interpreted as AN ABNORMAL IMMUNE RESPONSE IN
WHICH THE RESPONDING CELLS BECOME FIXED IN AN ATTITUDE OF
PROLIFERATION BY FAILING TO TERMINATE THE RESPONSE IN THE NORMAL
WAY.
In the next section, the facts discovered about the
lymphocytes of man in health and in neoplastic disease will be
surveyed.
CHAPTER 12
T LYMPHOCYTE, B LYMPHOCYTE
SURFACE CHARACTERISTICS IN DISEASE
120.
T Lymphocyte, B Lymphocyte and Macrophage surface Characteristics
in Man.
The concept of a dual system of immunity, mediated by two
separate classes of lymphocyte has received wide acceptance, and
has stimulated the extension of investigations performed on
experimental animals into the field of human physiology and
pathology.
Initially sutdies of the function of the T lymphocyte in man
were limited to the assessment of PHA response (a function of T
lymphocytes)(Heilman, Gambrill and Leichner, 1973) or testing
indirectly for T lymphocyte function by skin testing (Aisenberg,
1966) or the use of lyraphokine assay in, for example, the migration
inhibition test (Dumonde, 1975). Copying the mouse work, several
attempts have been made to identify specific antigens, analogous to
the theta (thy 1) antigen on mouse lymphocytes, by immunising
rabbits or guinea pigs with human foetal thymus (Aisenberg et al.,
1973)(Ishii et al., 1975) human brain tissue (Greaves and Brown,
197h)(Takada et al., 197U) or with T cells from patients with
agammaglobulinaemia (Auiti and Wigzell, 1973). Tests of these
sera, employing cytotoxicity, detect the T lymphoid population with
a high degree of accuracy, but may fail to achieve the same
specificity when employed in the immunofluorescence technique
(Habeshaw - personal observations). Similarly some workers have
found that antisera against T cells give anomalous results when
compared with surface receptor evaluation, either in immunodeficiency
states (Tata et al., 19731 Smith et al., 197U) or with lymphoid
cell lines. The discovery of the spontaneous sheep cell rosette,
and/...
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and correlation of this finding with the presence of E receptors
on thymocytes, gave an easily adaptable technique widely used for
the quantitation of T lymphocytes in man. For example, Incefy,
L'Esperence and Good (1975) and Bach (1973) have used the technique
to investigate the role of thymic humoral factors in the functional
maturation of the human T lymphocyte, and others have used the E
rosette test to distinguish "active" rosetting, i.e. to demonstrate
a subpopulation of strongly rosetting "activated" T lymphocytes
(Wybran, Carr and Fudenberg, 1973)* The E rosette test has
largely replaced the functional PHA transformation studies in the
evaluation and enumeration of T lymphocytes and has lately come to
be though of as an absolute marker of T lymphocytes. This has
occurred despite the findings of considerable overlap between B
and T lymphocyte markers when E rosettes are made following
neuraminidase treatment, or other treatments which enhance E
rosetting (Kaplan and Clark, 197U)• It also ignores the potential
confusion of "immune" B cell rosettes and E rosettes made by T
cells, especially since at least one B lymphoid cell line, PEN2,
can be shown to secrete IgM antibody with anti-sheep red cell
activity (Steel, et al., 19710 and also contains substantial
numbers of E rosetting cells (Habeshaw - personal observations).
Such objections to the absolute equation of E rosetting cells « T
lymphocytes are valid, and it is preferable not to call E rosetting
cells T lymphocytes (Habeshaw and Young, 1975)* It is also known
that under some conditions both polymorphonuclear leukocytes (Hsu
et al., 1973) and hepatocytes will form spontaneous sheep cell
rosettes. Other easily identifiable surface characteristics
are // • • •
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are much less well documented, and depend more on the absence of
other markers, such as surface Ig and C3 receptors, than on the
presence of specific markers for T cells. The surface morphology
of T cells by scanning electron microscopy was thought a specific
feature, since the B lymphocyte is "hairy", while the T cell is
smooth (Poliack et al., 197U) but this is now no longer thought to
be a foolproof method of distinguishing B and T lymphocytes (Kay,
1975)» Other features of the E rosetting phenomenon, not so well
known, are the blocking of the E receptor by very high
concentrations of non-immune IgG, IgA and IgM antibody globulin
(at levels of 1 mg/ml), and the complete failure to inhibit E
rosette formation with anti-human IgG, or IgM antisera (Blackie,
1973)• This demonstrates that the E receptor is not an immuno¬
globulin molecule, yet can be competitively inhibited by very high
concentrations of non-immune globulin. It is also possible to
inhibit or mask the ligand on the sheep cell surface with which
the lymphocyte receptor interacts. Sheep red cells coated either
specifically or non-specifically (e.g. tanned RBC) with immuno¬
globulin in high concentrations will fail to form E rosettes with
T cells, but will react with the Fc receptor on B lymphocytes and
macrophages (Fraser, 197U) • Similar findings have been reported
with human thymocytes (Gatien et al., 1975)* In addition to the
formation of E rosettes, there is some evidence that a subpopulation
of human T lymphocytes can form spontaneous rosettes with human red
cells, particularly if treated with PHA or neuraminidase (Sheldon
and Holborow, 1975)(Baxley et al., 1973)(Sandilands et al., 1975).
These observations have been extended by Tak Ian Tu (1975) who
showed/...
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showed that human red cell rosettes were more resistant than
SRBC rosettes to inhibition with proteolytic agents, and anti-
thymocyte antiserum, but that the capacity for spontaneous
rosette formation with human KBC was not regenerated after
trypsinisation. Using stringent rosetting criteria, including
the use of 5$ BSA as a supporting medium, levels of human RBC
rosetting comparable to E rosetting were achieved, and most E
rosetting cells bound human red cells also. The E rosette and
anti-human thymocyte antisera may detect different populations
of cells, since E rosettes are consistently lower than the numbers
of T cells detected by anti-thymocyte antisera. Thymic extracts
appear to induce the formation of both the E rosette, and human
T cell surface antigen. Protein synthesis by the cell is
necessary for both E rosetting and antigen expression (Incefy,
L'Esperence and Good, 1975). It has also been suggested that T
cells in peripheral blood have less T cell antigen on their
surface than thymocytes, a situation similar to that found in the
mouse (Ishii et al., 1975).
In addition to the markers for the T lymphocyte already
described, there is some evidence that additional receptors on the
T cell for complement, for Fc IgG, and for IgM do occur. A small
percentage (2-3$) of human T lymphocytes in peripheral blood do
have receptors for both sheep red cells, and for complement coated
chicken red cells (Chiao, Pantic and Good, 197U). This finding
has also been reported for surface immunoglobulin carrying cells
and E rosetting cells (Diekler, et al., 197U) and for E rosetting
cells with Fc receptors. In a murine lymphoma, cells in culture
showed/...
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3howed the presence of surface IgG, Fc receptor and reaction with
anti-theta antiserum (Grey, Kubo and Cerottini, 1972).
In the mouse such mixed receptors are frequently found, in
particularly the Fc receptor, frequently described as being on
"activated" T lymphocytes. The expression of these receptors
has been extensively studied, in particular by Gyongyossy et al.
(1975)» Human T cells appear to express also a receptor for
IgM and this receptor is not inhibited by free IgG, which
distinguishes it from the Fc receptor (Moretta et al., 1975).
Human T cells can be shown to have Fc receptors (Ferrarini et al.,
1975).
In summary, the distinguishing surface markers for the human
T cell are surface antigen, ability to rosette with sheep, or
human erythrocytes under controlled conditions, and the
occasional occurrence of Fc, C3 and Igtt receptors among the T
lymphoid population.
The surface characteristics of the human B lymphocyte are
well documented; the B lymphocyte is defined as a lymphoid cell
expressing surface immunoglobulin easily detectable by staining
with immunofluorescence technique. This immunoglobulin is a
cell product, and is not merely adsorbed to the cell surface.
There is an enormous literature relating to this surface
immunoglobulin, since it was one of the first class specific
lymphocyte markers detected, and also one of the most easily
studied. The original description of surface immunoglobulin on
lymphocytes is attributed to Moller (1961) in a study of histo¬
compatibility antigens on mouse lymphocytes. It was established
by/...
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by the work of Raff (1970), Pernis et al. (1971), Unanue et al. (1971),
that cells expressing easily detectable surface Ig by direct
immunofluorescence were B lymphocytes. In studies of surfsice Ig,
it was shown that the light chains were more easily detected than
the heavy chain determinants which tend to remain "buried" in the
cell membrane (Froland and Natvig, 1972). This is important,
particularly if good results are to be obtained with anti-heavy
chain antisera these should preferably be directed agsdnst both
the Fc and Fd portions of the immunoglobulin heavy chain (Seligmann,
Preud'homme and Brouet, 1973). These authors also established
two important technical variations in surface immunoglobulin
determination, that of demonstrating two sets of Ig molecules
on the lymphocyte surface, and secondly the demonstration of Ig
synthesis by the lymphocyte following trypsinisation. When the
lymphocyte is stained by fluorescent coupled anti-immunoglobulin
in the cold, and then warmed to 37°C within 10 to 15 minutes
most of the immunoglobulin has "capped" to one pole of the cell
(Taylor et al., 1971). If the cells are first capped with a
monospecific anti-heavy chain antiserum and then restained in
the cold with a second antiserum, the presence of two different
surface Ig molecules can be confirmed (Preud'homme et al., 1972).
This "co-capping" technique has also been used to describe the
relationship between microglobulin and HLA. antigen. The
numbers (as percentage) of surface Ig bearing cells in peripheral
blood are well documented, and range from 12$-23$ (Seligmann,
Preud'homme and Brouet, 1973) to between 10 and 16$ (Murphy, 1975)
of purified (monocyte depleted) lymphocytes. These figures are
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lower than those of Habeshaw and Young (1975) of 0.5 x 10^/ml
(500 cu nan), but in the latter case no loss of B cells was
allowed and the technique probably slightly overestimates B cell
numbers in whole blood. The more recent data for unseparated
blood (Greaves and Brcwn, 1971*) and for whole blood corrected
for cell loss (Holm et al., 1975) are all compatible with these
findings. In their paper, Habeshaw and Young drew attention
to the fact that a small population (0.3 x 10^/ml) of peripheral
blood cells undoubtedly stained for surface Ig, but failed to
cap, even when treated under conditions which capped a very high
proportion of peripheral blood B cells. At the time the nature
of this cell was unclear, although it was thought unlikely to be
a monocyte or macrophage. Subsequent published work from studies
of the mouse B lymphocyte (Sidroan and Unanue, 1975) identify this
fluorescent non-capping cell as being an immature B lymphocyte.
Apart from this, other studies have indicated a clear
"maturation" of peripheral blood lymphocytes on the basis of
expressed surface immunoglobulin. Murphy (1975) showed that in
the first two decades of life, cells expressing IgH surface Ig
were much more numerous than those with IgG. After the second
decade IgG expressing lymphocytes become more common than IgH
lymphocytes. Earlier work on the lymphoid cell antigen receptor
immunoglobulin (Pernis, Forai and Amante, 1971) clearly showed
that cells secreting IgG antibody can express on their surfaces
IgH antibody of the same light chain type, and the same allotypic
specificity as the secreted IgG. Geligmann, Proud'homme and
Brouet (1973) showed that in multiple myeloma they could detect
on/...
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on the cell surface both kappa and lambda light chain
determinants, and sometimes more than one class of heavy chain,
and similar findings have been described in CLL by Papamichael
et al.(1971) and Piessens et al. (1973)* The explanation of
these findings is still not clear, indeed Piessens suggests that
CLL may be a disease characterised by a polyclonal increase of
B lymphocytes, not a monoclonal expansion of these cells. The
most commonly accepted explanation of the finding in normal
blood, of two classes of heavy chain (usually IgM, IgG but
sometimes IgD, IgM) on the lymphocyte surface, with a common
single light chain determinant is that of "immunoglobulin
switching" as a consequence of cell maturation (Froland and
Natvig, 1973)(howe et al., 1973)* In cases where different
classes of light chain occur together on the same cell, it is
probable that spurious interaction of Ig aggregates with an Fc
receptor may have occurred, or that the cell concerned is
secreting a rheumatoid factor with anti-IgG specificity. In
the latter case, co-capping experiments will show the IgG class
to co-cap with an anti IgM antiserum (Seligmann, Proud'homme and
Brouet, 1973)* An additional possibility, encountered in some
connective tissue diseases such as SLE, is that anti-lymphocyte
(anti-leukocyte )globulin is actually present, and capable of
inducing a spurious staining reaction (Bentwich and Kunkel,
1973).
Chronic lymphocytic Leukaemia
The most widely studied phenomena in human lymphoid
neoplasia/...
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neoplasia have been the synthesis, distribution, and class of
immunoglobulin on the surface of lymphocytes in CLL (Aisenberg
and Bloch, 1972} Aisenberg, Bloch and Long, 1973} Grey,
fiabellino and Pirofsky, 1971} Piessens et al., 1973} Preud'homme
and Seligmann, 1972} Flad et al., 1973} Moxpz, Shalmon and
Hahn, 1973} Murphy, 1975). In the series of Grey, Rabellino
and Pirofsky, most CLL cells expressed IgM, and a smaller number
membrane associated light chains with no detectable heavy chain,
suggesting that CLL was a monoclonal expansion of B lymphocytes.
Aisenberg, Bloch and Long showed that both IgM and IgG could be
demonstrated on the surface of some individual lymphocytes in
CLL, and found two cases of CLL with no surface immunoglobulin
present upon the neoplastic cells. A tendency for cells to
become surface Ig negative with either chemotherapy or disease
relapse was noted. As previously remarked, Piessens group
holds the view that a proportion of cases of CLL are of lymphocytes
showing a polyclonal immunoglobulin coat, and suggesting that at
least a proportion of CLL cases are of T rather than B lymphocyte
origin. Recent data from Seligmann's group bases on immuno¬
globulin resyntnesis following trypsinisation suggests that this
view might be correct (Brouet et al., 1975)* Murphy (1975)
in common with Preud'homme and Seligmann (1972) classifies most
CLL as B cell tumours with monoclonal expression of IgM. Some
cases express surface IgG, and occasional cases exhibit a mixed
IgG/IgM pattern. Flad et al. (1973) find that in CLL there is
good evidence of two abnormalities of behaviour of the CLL cell,
firstly a large proportion of CLL cells fail to cap their surface
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Ig, and secondly the lymphocytes of CLL fall to recirculate in
a normal fashion. An additional abnormality expressed by the
membrane of the CLL lymphocytes is the susceptibility of the Ig
synthetic mechanism to blocking with anti-Ig antiserum (Munoz,
Shalmon and Hahn, 1973 )> recalling the mouse experiments of
Sidman and Unanue (1975) who showed that this is a feature of
the immature B lymphocyte. A similar kind of abnormality is
the observation that in alpha chain disease, despite the presence
of intracytoplasmic immunoglobulin there was no surface Ig,
leading to the conclusion that in the absence of a light chain,
there is loss of the ability to express surface Ig (Seligmann,
Freud*horame and Brouet, 1973)* Such features of the CLL cell
compare with those described for the cell of immunodeficiency
disease patients, where three classes of abnormality can be
described (Wu, Lawton and Cooper, 1973)J a failure of the B
lymphocyte to develop the capacity to secrete Ig at all (which
corresponds to the loss of surface Ig expression in CLL), the
arrest of B lymphocyte development, (with failure to secrete
intracytoplasmic Ig) and disordered maturation of the B lymphocyte
with secretion of defective Ig or with defective Ig secretion.
In one case of CLL Bentwich and Kunkel (1973) found that
the neoplastic cells bound aggregates of immunoglobulin but
failed to show surface immunoglobulin. On culture, the
reappearance of surface Ig was noted, and it was found that a
factor in the patient*s serum necessary to cause synthesis of
surface Ig was lacking in this case.
In a study of 10 patients with CLL, Wilson and Hurdle
(1973)/...
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(1973) found 8 to be B cell in type, with 2 cases showing T cell
markers. In this paper assessment of surface immunoglobulin
was made by a sensitive radiolabelllng assay of immunoglobulin
synthesis by the neoplastic cells. In a similar study of one
patient with CLL, Moras, bhalmon and Hahn (1973) showed that
surface Ig on the CLL cells was Ig£4 in type, and free light
chain was synthesised. The synthesis of both u chain and of
light chain could be blocked with anti u and anti kappa or anti
lambda antisera (antigenic modulation) a feature thought to
represent an immature form of B lymphocyte (compare the case
with that described by Bentwich and Kunkel, 1973)•
In the cases described by Mellstedt and Pettersson (197U)
it was noted that the Ig bearing cells lacked C3 receptors in
most cases, but C3 receptor bearing cells were active in cell
mediated cytotoxicity. In most oases of CLL, the circulating
cells show the presence of surface Ig detectable by immuno¬
fluorescence, and these cells frequently also express complement
receptors (Eoss et al., 1973) and receptor for aggregated
immunoglobulin, or the Fc receptor (Ferrarini et al., 1975b).
In some instances surface Ig may not be present, as in the case
described in a patient with thymoma (Siegal et al., 1973) but
Fc receptors may in such cases be present. Serum factors may
suppress the expret sion of surface Ig, not only in CLL but also
in immune deficiency states (Cooper, Lawton and Bockman, 1971 j
Wernet et al., 1973)- The nature of the suppressive factor
is unknown, but it is noteworthy that B cells left in contact
with anti immunoglobulin antisera fail to synthesise Ig. When
well/...
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well washed, the bulk of B cells shed the surface bound immune
complex and can recommence Ig synthesis (Loor, Forni and Pernis,
1972). Pre-incubation of cells from lymphoid cell lines in
acetate buffer converted a high percentage from a non synthetic
resting state to an actively synthesising state. Most of 10
cell lines expressed Kappa chain and u chain determinants, but
two synthesised only light chain (Hutterworth, Iitwin and Cleve,
1972). Simil;ir findings of mainly u chain and Kappa chain
synthesis by neoplastic cells in a variety of lymphoproliferative
disorders were noted by Piessens et al. (1973)» and by Grey,
liabellino and Pirofsky (1971).
Not all chronic lymphocytic leukaemias are of B cell
origin, as previously remarked there are accounts of T cell
leukaemias. In the case described by Wetter, ileis and Weert,
(1973) plasma cells in peripheral blood showed E rosetting, and
failed to transform when treated with anti-Ig antisera. These
cells also failed to transform when exposed to pokeweed mitogen,
but expressed surface Kappa chain and had the electron
microscopic appearances of plasma cells. The most complete
account of T cell chronic lymphocytic leukaemia (Brouet et al.,
1975) showed a clear correlation of certain clinical features
with the presence of a population of E rosetting cells in
peripheral blood. The clinical features were those of
splenomegaly, skin lesions, and neutropenia. Cells from the
bone marrow (2 patients) and in the skin nodules (1 patient)
rosetted with sheep erythrocytes and stained with anti T antisera
prepared from brain (2 cases) and from the circulating T cells
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of a child with Bruton-type agammaglobulinaemia. These authors
suggest that T cell CLL may be more common than supposed, since
spurious B cell appearances can be given by in vivo coating of T
cells with iirmunoglobulin and since in the absence of E
rosetting the diagnosis of a T cell lymphoma required an absence
of surface Ig staining and negativity of B cell markers, such as
Fc or EAC receptors on the lymphoma calls. Further details of
T cell CLL wore given by an account of a female patient with
lymphadenopathy and erythrodermia, with a high proportion of E
rosetting cells in the peripheral blood and negative staining
of leukaemic cells for surface Ig (Sumiya et al., 1973)*
The nature of the T cell in chronic lymphocytic leukaemia
is not entirely settled, since at least one section of the
available literature considers the population to be reactive
rather than neoplastic: for example in Infectious Mononucleosis,
where it is well established that the causative EB virus infects
the B lymphocyte, the morphologically abnormal infectious
mononucleosis cell shows the surface features of a T lymphocyte
(Sheldon et al., 1973)• Circulating B lymphocytes are
apparently present in normal numbers in this condition. Among
those convinced that a morphological T call equivalent of the
plasma cell exists - as could be presumed from some descriptions
of "T cell lymphoma" - are Lennert, Kaiserling and Muller -
Hemerlink (197£) who describe by Light and EM morphology a cell
equivalent to the plasma cell occurring associated with T
lymphoblast in the paracortex of lymph nodes. This cell is
stated not to form E rosettes. Whether or not the T lymphocyte
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is implicated in the chronic lymphocytic leukaemias, there are
several theories about the role of the £ rosetting cells found
in some CLL peripheral blood samples. In a study of chronic
lymphocytic leukaemia, Wybran, Chantler and Fudenberg (1973)
isolated normal T cells by applying the criteria of £ rosetting,
negative staining for surface immunoglobulin, and responsiveness
to PHA. These authors consider that the depressed PHA
responsiveness of peripheral lymphocytes in chronic lymphocytic
leukaemia is not due to any intrinsic defect of the T lymphocyte,
but rather that it is due to "dilution" of normal responsive T
cells by the neoplastic peripheral blood population. In other
accounts, however, there is evidence presented which shows an
apparent change in the neoplastic population from a predominantly
B lymphocyte pattern, to a T lymphocyte pattern for example during
a psuedomonas infection in the patient described (Nowell et al.,
1975)• The data relevant to the behaviour of GLL cells in vitro
when stimulated with raitogenic substances is reviewed by Perera
and Pegrum (1975)* An interesting conclusion, drawn from over
fifty reports in the literature, concerns the fact that the
CLL lymphocyte will continue to proliferate in vitro by virtue
of some surface property which can be eliminated by prior
trypsinisation. The other surface abnormalities which CLL
lymphocytes readily show are the rosetting with mouse
erythrocytes (Stathopoulos and Elliott, 197k) and a failure to
respond as do normal B lymphocytes when incubated with anti¬
immunoglobulin antisera (Daguillard, Fontaine and Tardleu, 197U).
Refractoriness to stimulation by anti-immunoglobulin antisera
is not generally found to extend to agents such as pokeweed
mitogen/...
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mitogen or phytohaemagglutinin (Schweitzer, Melief and Eijsvoogel,
1973). The CLL cells do, however, fail to either stimulate
or respond to stimulation in the mixed lymphocyte reaction. The
proliferative response to phytohaemagglutinin could certainly be
due to contamination of the cell cultures with small numbers of
normal blood lymphocytes, particularly T cells. This is
certainly the opinion of Cohnen, Konig, Augener, Brittinger
and Douglas (1973) who found in normal blood plasma cells caused
by stimulation of B lymphocytes by pokeweed mitogen. These
were considerably less frequent in CLL, showing the relative
unresponsiveness of CLL lymphocytes.
The effect of treatment on CLL has been considered by
several authors. Smith and Ez.dinU (197U) showed that in the
normal course of the disease the numbers of B cells, with
complement receptors rose, and the numbers of T lymphocytes
(E rosetting cells) fell. If a single course of irradiation
was given to the spleen, the numbers of circulating B cells
rapidly fell, suggesting that a selective trapping of neoplastic
B lymphocytes (expressing monoclonal immunoglobulin) was
operating, and that the beneficial effects of splenic irradiation
could be due to enhancement of this trapping mechanism (Astaldi
et al., 1975).
lymphoid Cell Lines
Lymphoid cell lines have been the chosen objects of study
by many investigators, and there are sane points of similarity
between the findings here, and in some lymphomas. For example
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lymphoma cell lines bearing both B and T lymphocyte surface
markers have been described in the mouse (AKR strain)(Greenberg
and Zatz, 1975) although on prolonged culture the cells appeared
to revert to a B cell clone. This has also been observed with
the cell line PEN(2) (Habeshaw - personal observations) but in
this case much of the E rosetting activity shown by these
immunoglobulin secreting cells may be due to the production of
antibody against the sheep erythrocyte (Steel et al., 197U).
In normal blood, cells bearing both B and T surface markers
have been described (Bickler, Adkinson and Terry, 197U) and dual
receptor neoplasms of similar type occur in man (Habeshaw and
Stuart, 1975J Murphy, 1975? Haegert et al., 1'97ii).
In one account of a T lymphoid cell line from man (Huang et
al., 197li) cultures of peripheral blood lymphocytes showed that
initially they possessed either T cell, or a mixture of B and T
cell markers. Subsequently, $ lines lost their T cell
characteristics, and showed reversion from an abnormal (psuedo-
diploid) mode of Karytotype to the normal diploid mode. However,
one cell line retained its psuedodiploid mode, and retained its
T lymphoid characteristics over an extended (1U month) period in
culture. Minowada, Ohnuma and Moore (1972) established their
criteria for evaluation of lymphoid cell lines on the basis of
rosette formation, and it was later shown (Kaplan, Shope and
Peterson, 19710 that T lymphoid cell lines in man were all derived
from children with leukaemia secondary to lymphosarcoma, and none
contained the EB virus genome which is ubiquitous in B lymphoid
call lines. Hutteroth, Idtvin and Cleve (1972) showed that at
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this date B lymphoid cell lines, whether from normal or neoplastic
tissue, all contained the EB virus genome.
A recent, and intriguing, observation of lymphoid cell lines,
by Jondal, Klein and Yefenof (1975) shows that virtually all
normal human peripheral blood T lymphocytes will readily form
rosettes between themselves and EB virus carrying B lymphoid cell
lines. Blast transformed T cells never showed this phenomenon,
but normal blast transformed B cells could rosette normal T cells,
but ra her weakly. The T cell receptor for the lymphoid cell
lines was not blocked by sheep red cell membranes, and was not
therefore the E receptor, was not blocked by staphylococcal
protein A - which reacts with IgG present on the B lymphocytes,
and was not blocked by IgG, anti-immunoglobulin antisera, anti-B^
microglobulin antisera or anti T cell antiserum. These
observations are relevant and may be crucial to the phenomena
later described in Hogkin's Disease.
Macrophage cell lines have been described only once by
Ralph and Nakoinz (1975) who showed a capacity of the cultured
cells to phagocytose, and to be cytolytic in an antibody mediated
cytotoxicity reaction.
Acute Leukaemias
In cases of leukaemia of acute lymphoblastic type most of
the cell types found are receptor silent (18 out of 22). Four
cases were found to have T surface markers. In chronic
lymphocytic leukaemia, only 1 out of 11 cases was receptor silent,
one case showed T cell markers and the other nine were of B
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lymphocytes (Brown et al., 197U). An antiserum prepared against
human thymus gland and adsorbed with cells from B lymphoid cell
lines reacted with both normal T lymphocytes and with acute
lymphocytic leukaemia cells (Smith et al., 1973) implying an
origin from T lymphocytes even in the absence of other T surface
markers (E rosettes).
A novel clinical syndrome in acute lymphocytic leukaemia
has been described (Bitter et al., 1975) in which three patients
showed both acid phosphatase positivity and E rosette formation.
This interesting observation may need caution in interpretation
since cells of the granulocytic series have on occasions been
found to exhibit E rosetting (Hsu et al., 197ii). Acute
leukaemias of macrophages (monoblastic leukaemia) have been
described which are positive cytochemically for peroxidase and
strongly positive for non specific esterase. The syndrome is
characterised by a high incidence of spontaneous disseminated
introvascular coagulation (DOG) and response with heparin and
Daunorubicin was obtained. (McKenna et al., 1975). The studies
of Borella, Ben and Green (197U) showed that acute lymphocytic
leukaemia of cells having convoluted nuclei were E rosette
positive in three cases of acute lymphoblastic leukaemia and in
one case of childhood lymphosarcoma. These authors conclude
that there are two types of ALL in children, one of
undifferentiated stem cells, and the other showing the features
of lymphoblasts with cell markers of normal thymocytes, and
extensive disease at presentation with mediastinal enlargement.
Other authors report cases of acute lymphoblastic leukaemia in
which/...
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which the lymphoblasts bound sheep cells, or reacted with anti
thymocyte antisera. These lymphoblasts were negative when
examined for surface immunoglobulin by immunofluorescence (Kersey
et al., 1973i 197U). There is a recent publication describing
specific acute leukaemia associated antigens which are disease
rather than cell class specific (Baker, Kamachandar and Taub,
1975)• These can be confused with membrane antigens specific for
human lymphoid cells in the dividing phase (Thomas and Phillips,
1973J Thomas, 197U)-
A recent report by Chechik and Gelfand (1976) shows that
the antigens common to thymocytes, and found in acute lymphoblastic
leukaemia of T cell type, (called H Thy-L, Human Thymus 9
Leukaemia antigen) can also be found in acute myelogenous leukaemia -
in one case. Patients with £ rosette negative acute myelogenous
leukaemia (7 cases) failed to show the presence of H Thy-L
antigen.
Solid Lymphomas
Eleven non-Hodgkin lymphomas were studied by Peter et al.
(197b). These included h diffuse lymphocytic lymphomas, U
nodular lymphocytic lymphomas, 2 histiocytic lymphomas and 1
epithelial thymoma. These authors judged 6 of the lymphomas to
be B cell in type, 2 were T cell, 1 was a "null cell" lymphoma
and 2 were of indeterminate status. One small cleaved and one
small non-cleaved follicular centre cell lymphoma were judged
to be of T cell type, with 72, and 77 per cent of the cells
bearing T markers. Of the others, h0-$$% of cells bore IgM
antibody/...
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antibody, 1-90$ bore IgG antibody, 16-81$ had kappa chain, and
k-9Q% had lambda chain immunoglobulins. Of the B cell lymphomas,
3 out of U studied had receptors for aggregated immunoglobulin
(Fc receptors). Seven normal lymph nodes did not contain more
than $0% of T cells or more than of B cells of a single
immunoglobulin class, these being the criteria for diagnosis of
lymphoma. The receptor silent tumours were twoj one was a
diffuse lymphoma of poor differentiation, and the other an
epithelial tumour of the thymus gland. Of particular interest
was the discovery that only 2 IgM bearing lymphomas were monoclonal.
One tumour had two classes of heavy chain (u and^ ) and two
classes of light chain (Kappa and Lambda). One had two light
chains (Kappa and Lambda) and one heavy chain. In two patients
Ig secreting cells clearly had no Fc receptor.
One problem in classifying lymphomas by markers presumed
specific for T and B cells lies in the possibility of a single
class of neoplastic cell expressing both B and T cell markers.
Such a case has been reported by Sandilands et al. (1 97U),
where pancytopenia and hepatomegaly with abnormal, dual receptor
cells in the peripheral blood was followed by a leukaemic blood
picture and death from hepatic failure. Cells with dual
receptors also occur in small numbers in normal peripheral blood
(Dickler, Adkinson and Terry, 197U).
In a limited number of cases reported by Murphy (1975)
mixed receptors for T cells (E) and EA.C figure prominently. In
three cases of thymoma examined, two cases of lymphosarcoma with
leukaemia and one case of chronic lymphocytic leukaemia mixed E
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and EAC receptors were found on four occasions. The single
patient with Sezary Cell syndrome had normal blood differential,
and it is remarked that in most patients with solid lymphoid
tumours no monoclonal Ig secreting lymphoid population is detected
in the blood.
A much broader selection of patients has been studied by
the group comprising, Green, Jaffe, Shevach, Edelson, Frank and
Berard (1975) who adhere to the conventional but restricted
frozen section technique for demonstrating the localisation of
areas of lymphoid tissue binding receptor particles, developed
by Bilviera, Mendes and Tonali (1972).
Jaffe et al. (1975) showed that in frozen sections of
control lymph nodes, which are reacted with complement or
antibody coated red cells, the follicular lymphocytes bound 03
coated red cells, but did not bind antibody coated red cells.
Macrophages in the sinusoids bind both EAC and IgG coated red
cells. This data indicates that in the normal lymph node
follicle EAC receptors are present, but Fc receptors are absent
from the follicular B lymphocyte. In their studies of six
patients with nodular lymphoma the neoplastic cells expressed
receptors for complement, but not for Fc portion of IgG, and
were presumed to be B lymphoid in origin. In 2 cases of
reticuloendotheliosis, and one case of histiocytic lymphoma ,
the tumour cells bound Igu-£A (i.e., had Fc receptors) but failed
to express complement receptors, and were classified as neoplastic
histiocytes. In three cases of diffuse lymphocytic lymphoma,
only sheep erythrocyte binding cells were found, and these
neoplasms/...
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neoplasms were classified as T cell lymphomas.
Brouet, Labaume and Seligmann (1975) report that in 25
cases of lymphoma, especially well differentiated lymphocytic
lymphoma, and acute lymphosarcoma cell leukaemia, the neoplastic
cells were predominantly of B cell type. Most poorly
differentiated lymphocytic lymphomas were also monoclonal
proliferations of B lymphocytes. These authors did however report
that in I4. cases of histiocytic lymphoma, the cells lacked
receptors and other surface characteristics of either B or T cell
type, and were receptor silent tumours. Mot all B lymphoid
malignancies expressed monoclonal surface Ig, in at least one
case the surface immunoglobulin was polyclonal. In the one
nodular lymphoma examined UO% of E rosetting lymphocytes were
also present in addition to the neoplastic B lymphocytes, which
expressed u chain and Kappa chain (i.e. were IgM bearing cells).
In a further case the malignant cells expressed both B and T cell
surface markers.
Hansen et al. (1?7U) evaluated lymphocytic subclasses and
lymphocyte function in twenty eight patients with lymphoma, 10
with Hodgkin,s Disease and 18 with non-Hodgkin lymphoma. Most
(80$) of Hodgkln,s Disease patients showed impaired cell
mediated immunity, or defective leukocyte response to PHA, and
there were indications of changes in the ratio of B and T
lymphocytes. In non-Hodgkin lymphoma, six patients showed
monoclonal expansion of the peripheral blood B cell population.
In one patient with a pleural effusion, the abnormal circulating
B cells did not appear in the pleural effusion. This paper
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concentrates exclusively on the peripheral blood mononuclears
and does not report on the cellularity of the lymphoid neoplasm
itself. The monoclonal B lymphocytes expressed IgM with Kappa
chain.
In a similar paper, Smith et al. (197b) report on the
susceptibility of abnormal circulating lymphocytes to anti-
thymocyte (HTLA.) and anti-bone marrow lymphocyte (HBLA) antisera
directed against the HTLA. and HBLA surface antigens. Many
inconsistencies were noted when these antisera were used to
classify lymphoma cells, or cells from patients with primary
immunodeficiencies. T cells in Wiscott-Aldrich syndrome, in
acute lymphocytic leukaemia, and T cell lymphocytic lymphoma,
failed to form E rosettes but were classifiable as T cells on
the basis of their reaction with anti-HTLA sera. In Lurkitt' s
lymphoma, B lymphocyte lymphoma and some B cell lines, there was
a spurious elevation of E rosetting cells which reacted with
anti-HBLA antisera. This implies that in B lymphocyte lymphomas,
especially those carrying EB virus, E rosetting by B lymphocytes
can occur.
In a limited series, studied by methods similar to those
used by Shevach et al. (1975) and Green et al. (1975) Dorfmann
(1975) finds that the nodules of nodular lymphomas will bind EAC,
but do not bind EA reagents - in other words they are B cells with
C3 but not Fc receptors. He also observed that in no case of
histiocytic lymphoma were receptors expressed for either Fc or C3
on the lymphoma cells. He concludes that nodular lymphomas
are tumours of B lymphocytes, while the histiocytic lymphomas
&!*©/ 0 0 9
1U3-
are of debatable origin.
Green, and co-workers (197^)> using adherence of antibody
or complement coated red cells to frozen sections of lymph node
or spleen show that preferential binding by complement receptors
occurs in the follicles of spleen and lymph node. The preparation
used for the detection of the Fc receptor does not apparently bind
to the B lymphocyte, but will bind with the tissue histiocyte.
Histiocytes around the splenic follicle, in the marginal sinus,
bound complement coated red cells, but those in the cords of
Bilbroth did not. In their cases they find that "histiocytic
medullary reticulosis" showed a predominance of histiocytes in
the single spleen examined, and in "hairy cell" leukaemia they
conclude that the neoplastic cells in two cases were also
histiocytic. Nodular lymphocytic lymphomata (six cases) were
tumours of B lymphocytes. In three cases of diffuse lymphocytic
lymphoma the tumours were T cell in type. In four cases of
chronic leukaemia and erythrodermia, three of whom had the
Senary syndrome, and three patients with mycosis fundoides, most
showed elevations of T lymphocytes. In one case mixed E and
EAC rosettes were detected in blood. In tissue sections the
bulk of the cells detected were found to be T cell in type. There
is some indication that the small lymphocytic form of Sezary
Syndrome might be confused with CLL. The T cell "solid lymphomas"
are of interest, particularly since the case described by Smith
et al. (1973) of a malignant thymic tumour in a boy, associated
with a lymphosarcoma cell leukaemia, in which both the circulating
and the tumour cells expressed E receptors (were T lymphocytes).
The/...
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The two varieties (small cell and large cell) of Sezary syndrome
were described by Lutzner, Edelson and Smith (1973) who showed
that circulating neoplastic cells of T lymphocytic class were
a feature of both diseases. Additional cases were described
by Broome et al. (1973) with confirmatory evidence of T cell
origin of the Sezary cell, and by Kalden et al. (1971;), who
showed that the neoplastic cells failed to respond to
stimulation with PHA.
The "Leukaemic £eticuloendotheliosisn cell has attracted
attention; with Green et al., describing it as histiocytic.
On the other hand Stein and Keiserling (197k) clearly show this
interesting cell to have the properties of a B lymphocyte, in
particular it is peroxidase and esterase negative, non glass
adherent and non phagocytic. The surface Ig expressed is Igh
in type. This view was supported by studies of an additional
five cases of leukaemic reticuloendotheliosis (Catovsky et al.,
197U).
More recent accounts of receptors in solid lymphoid tumours
attempt some degree of classification of the lesions by the
surface characteristics of the constituent cells. In the paper
of Cooper et al. (1975) four groups of lesions are identified,
six patients had B cell tumours with strong surface Ig expression,
eight patients had CLL with weak expression of surface Ig, five
patients had lymphomas composed predominantly of T cells, and
three patients had unclassifiable lesions. In no case of T
cell lymphoma were there circulating neoplastic cells, and in




Gajl-Peczalska, Bloomfield and Sosin (1975) in their series
showed that 20% of nodular lymphocytic lymphoma patients, and 11% of
diffuse lymphoma patients had abnormal B cells in the peripheral blood
at diagnosis. The lymph nodes in their series of nodular lesions
showed 62% to be of B cell origin, and all of their poorly
differentiated diffuse lymphomas were of B cell type. The patients
with abnormal circulating cells of B or T type had a worse prognosis
than the others. In an earlier paper in which the peripheral blood
only was examined in 37 patients, abnormal B cells identified by
monoclonal surface Ig were found in about 20% of cases (Gajl-
Peczalska et al., 1973).
In a study of seven cases of diffuse histiocytic malignant
lymphoma Habeshaw and Stuart (1975) showed that only in one case
were the cells of histiocytic (macrophagic) derivation. One case
showed a definite overlap of E and EA.C receptors, and one a possible
overlap. One case was a "receptor silent" tumour showing an absence
of all surface markers. The other cases were of B cell origin. In
a further paper (Stuart and Habeshaw, 1976) in which nineteen cases
of diffuse and nodular lymphocytic lymphomas were examined, it was
shown that most lesions were of B lymphocyte class. One diffuse
lymphocytic lymphoma was of T lymphocyte type, and one was receptor
silent. The nodular lymphomas all exhibited some T cells as well as
B cells, and in one case the nodule cells showed overlap between F,
rosetting and surface immunoglobulin positive cells. The surface Ig
positive cells expressed some C3 receptors, but failed to express
receptors for Fc IgG.
BurkLtt's/...
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Burkitt•s lymphomas have also been examined, and are found
to be B cell in type. Jondal, Svedmyr, Klein and Singh (1975)
showed that in Burkitt's lesions about 1$ of T cells contaminated
the predominantly B lymphoid populations. When EAC rosetting
cells (B cells) were removed the residual T lymphocytes exhibited
cytotoxicity towards EB virus carrying Burkitt cell lines. The
Burkitt B cell failed to kill a normal cell line, K-562, in the
presence of antibody, while normal B cells could kill this cell
line. T cells from patients with infectious mononucleosis were
also weakly cytotoxic for EB virus carrying cell lines. The clonal
origin of the Burkitt cell was neatly demonstrated by making use
of the G-6-PD isoenzyme pattern, by Fialkow, Klein, Gartler and
Clifford (1970). The tumours in one patient expressed only one
of the two isoenzymes present in the normal tissue of that patient.
Some work on the surface characteristics of animal lymphomas
has reached the literature. In an analysis of the gonadal tumours
in Marek's disease in the fowl, Hudson and Payne (1973) found most
to be T cell in type. In the blood of chickens with T cell gonadal
tumours, the circulating T cell population was reduced, while the
B cell numbers showed an absolute, not relative, increase. In some
cases a mixture of both B and T cells was found in the tumours, and
in these cases the proportions of circulating T cells were increased.
These studies made use of anti-T and anti-B antisera.
In Marek's disease, the T cells from gonadal tumours form
T lyraphoblast cell lines in tissue culture (Powell et al., 1971;).
In Bovine lymphosarcoma it has been demonstrated that the
neoplastic cells are B cell, with surface expression of gamma or mu
heavy/...
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heavy chain. Thymic cells from these animals failed to bind
antibodies to surface Ig determinants. It was noted, however,
that tumour cells expressed gamma heavy chain while blood
lymphosarcoma cells expressed mu heavy chain. The neoplastic cells
were also found to bind IgM non specifically, and retained it after
multiple washes.(Tsuyuguchi, Ming-Ming and Karusch, 1973)• The
similarity of the bovine lesion to human lymphosarcoma is obvious,
but the lesion of Marek's disease has no obvious counterpart in
man.
Receptor studies are of some value in examining tumours
other than those of the lymphoid system, and recent investigations have
explored the role of macrophage content in experimental tumours of
mice, and its relationship to prognosis (Eccles and Alexander, 197U).
In this paper the macrophage content of the lesions is related to the
T lymphocyte, since removal of T lymphocytes resulted in a decrease
in the macrophage content of the tumour. BOG, which has some
suppressive effect in this system raised macrophage numbers within
tumours. There is also a connection between immunodeficiency states,
and the incidence of lymphomas (Gatti and Good, 1971) and it is now
established that the incidence, particularly of poorly differentiated
lymphomas is much higher (possibly by a factor of 7) in immuno-
deficient as against normal persons. The reason for this may be
failure of immune surveillance, which could account for the increased
incidence of many kinds of tumour in immunosuppressed patients
(Gershwin and Steinberg, 1973), lymphomata in particular. Since
suppressor cells regulate lymphoid hyperplasia, loss of the suppressor
T cell function could lead to continual stimulation of antigen
reactive/...
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reactive cells - with the consequence of unrestricted and hence
neoplastic proliferation. Another exciting possibility lies in
the identification of blocking factors which prevent lymphocyte
differentiation, such as that demonstrated in a patient with
thymoma (Seigel et al., 1973) or that present in thoracic duct
lymph in a patient with myasthenia gravis (Hanroerstrom et al., 1975)*
Another factor which may operate in the biogenesis of
lymphomas is that of macrophage stimulation of the growth of
lymphoma cells. Nathan and Terry (1975) have clearly shown that
normal mouse macrophages profoundly stimulate the growth of
experimental murine tumours, especially lymphomas. BCG infected
macrophages appear to stimulate much less than normal macrophages.
This observation is rendered more important by demonstrating that
other factors, e.g. 2 mercaptoethanol, which dissociate surface
immunoglobulin also have a stimulatory effect on murine lymphomas.
These observations illustrate that blocking factors, and macrophage
content of human lymphomas may be crucial factors in predicting
their biological behaviour.
Hodgkjnts Disease
Hodgkin's Disease is usually regarded as an entity quite
distinct from the other classes of lymphomatous disease. The
epdeaniology of the condition contrasts with that of other lymphomas
in terms of bimodal age and sex distribution, and in seasonal
incidence (Levine, 197i*j Smithers, 197Uj Kaplan, 197U). Some
(Levine, 197U) argue strongly that it is of infective (virus)
aetiology/...
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aetiology, like infectious mononucleosis or Marek's disease in the
chicken, while others (Kaplan) regard it as a true neoplasm of
lymphoid tissue. The latter view is to some extent supported by
the finding of monoclonal B cell expansion in the blood of some
cases of Hodgkin,s Disease (Hansen et al., 197U) but the absolute
numbers of B cells are usually normal or low (Faletta et al., 1973)•
After treatment, the levels of B cells rise, and the levels of B
lymphocytes are thought to correlate with the presence of active
disease. Material for the study of Hodgkin's disease is readily
available from laparotomy, and includes spleen and abdominal lymph
nodes removed for staging purposes (Rosenberg, 1972J Ferrer-Brown,
et al., 1971). The disease exhibits the presence of a morphologically
abnormal cell, the Reed Sternberg cell, and much of the receptor data
concerns the exploration of the nature of this entity. Three views
as to its origin are given} Kadin et al. (197ii) regard it as B
lymphocyte in type by virtue of the presence of surface and intra-
cytoplasmic (Dutton, 197k)(Taylor, 191b) immunoglobulin. The cell
is frequently found to be rosetted by T lymphocytes, and all
authors agree on this point. Biniamov and Ramot (197U) discount
the feeble surface Ig expression on the Reed Sternberg cell, and
suggest an origin from the T lyraphoblast, while Brylan, Jaffe and
Berard (197li) on the basis of Scanning EM morphology would favour
a histiocytic (not B cell not T cell) origin. In the involved
spleen, and in involved lymph nodes (Kaur et al., 197hi Joseph and
Belpomme, 1975) the numbers of T lymphocytes are found to be much
higher than in uninvolved tissue. Joseph and Belpomme (1975)
showed a decrease in splenic B lymphocytes but did not regard this
as/...
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as statistically significant. In a survey of 22 spleens from
patients with HodgkLn's Disease (Habeshaw, Stuart, Young and Gore,
1976) it was shown that in male patients the total concentration
of splenic lymphocytes fell, while in female patients it rose,
during Hodgkin's disease. There was also evidence from male
patients of a significant decrease in splenic B lymphocytes. In
involved tissue, B lymphocytes are low in number, and at many
different stages of differentiation, while T lymphocytes are raised
in number. IgM receptors are occasionally found on cells from
Hodgkin's lesions, implying T cell or macrophage involvement
(Habeshaw, et al., 1976). The Reed Sternberg cell is a protean
entity, which appears to exhibit both macrophage like features
(esterase positivity) and expresses some surface immunoglobulin
(Stuart and Habeshaw, 1976). The increase in T cells in the spleen
in Hodgkin's Disease described by Kaur et al. (197h) has also been
shown in the spleen of treated (Kaur et al., 197Ub) and untreated
patients with chronic granulocytic leukaemia (Kaur, Spiers and
Galton, 1975), and may therefore not be specific to Hodgkin's Disease.
However, the lesion in involved spleens involves the Malpighian
follicle, leaving the periarteriolar lymphocytic sheath intact, and
this would give some support for both B and T cell abnormalities
in the Hodgkin's Disease spleen (Halie et al., 197U). It has also
been shown that IgG antibodies directed against T lymphocytes can
be found in Hodgkin's Disease tissue, and immunoglobulin synthesis
is high in uninvolved spleen (Grifoni et al., 1975J Longmlre et al.,
1971). Recent studies (Payne et al., 1976) show that T cell
increase does occur in uninvolved Hodgkin's Disease lymph node and
spleen/...
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spleen, with corresponding decrease in B cells. In this study,
in 6 cases out of 2U, an overlap between SIg bearing cells and T
cells is noted. In a study on IgM receptors in Hodgkin's Disease,
it was noted that in 5 out of 32 cases, cells bearing IgM receptors
were present on spleen lymph node or blood cells (Habeshaw, Young
and Stuart, 1976).
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INTERPRETATION OF RECEPTOR DATA FROM LYMPHOMAS
The previous survey of crude receptor data in lymphomas
brings out several important new facts. Firstly tumours of lymph
nodes are predominantly tumours of B lymphocytes. In this group
of tumours there are several descriptions of abnormal surface Ig,
both in the class of immunoglobulin expressed and its location on
the cell surface. Secondly not all neoplasms of B lymphocytes
express the Fc and 03 receptors normally expressed by B lymphocytes
in lymph node or peripheral blood. These receptors are concerned
with activation of B lymphocytes in the normal immune response,
and such findings lend weight to the postulate that neoplasms
could represent an abnormal or perverted immune response.
Thirdly it has been shown that in several classes of
lymphoma, and in lymphocytic leukaemia, that cells thought not to
be neoplastic are altered numerically or functionally in a
constant manner. Increased numbers of T cells occur in some B
cell neoplasms, or non neoplastic conditions. Macrophages are
important in the development of and resistance to experimental
lymphomas in mice.
These observations point to the possibility of cell to cell
interactions in lymphomas similar to those described in the normal
immune response. In this section, the data relating to abnormal
Ig expression in lymphoma, changes in Fc and C receptor expression,





There are consistant abnormalities of surface Ig expression
associated with lymphoma. The chief of these is the failure of
the cell to secrete immunoglobulin at all: a process which can be
reversed by trypsinisation (Habesbaw - personal observations}
Aisenberg, Bloch and Long, 1973)• The ability of the B cell to
express surface Ig may depend upon its capacity to synthesise light
chain, since in heavy chain disease, the neoplastic cells fail
to express surface Ig (Seligmann, Preud'homme and Brouet, 1973).
Bentwich and Kunkel (1973) showed that surface Ig negative cells
from a patient with CLL, became positive after culture in the
patient's serum. The potential abnormalities of Ig secretion by
neoplastic or immunodeficient lymphocytes have been reviewed by
Wu, Lawton and Cooper (1973). Serum inhibition of surface Ig
secretion has been described by Cooper, Lavton and Bockmann (1971),
and Loor, Forni and Pernis (1972) showed how antisera against
surface Ig could block new surface Ig synthesis. In lymphoid
cell lines the capacity to secrete surface Ig can be restored by
washing the cells in acetate buffer (Hutterworth, Litwin and Cleve,
1972). Recently, in experimental immune responses in mice, a
factor secreted by T lymphocytes effectively blocks surface Ig
synthesis in the responding population (Lee and Paraskevas, 1976).
Milton and Mowbray (1972) have shown that Bovine c<2 glycoprotein
will reversibly inhibit Ig synthesis by rat lymphocytes. Apart
from failure of the B cell to secrete immunoglobulin in tie neoplasm,
it is now known that in many cases the immunoglobulin secreted is
structurally/...
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structurally abnormal (Piassens et al., 19735 Grey, Rabellino and
Pirofsky, 1971). In most cases monoclonal IgM antibody with Kappa
chain (u k) is secreted, but cases secreting K chain only have been
described. These primary abnormalities in surface immunoglobulin
secretion have also been shown in acute lymphoblastic leukaemia,
and chronic granulocytic leukaemia (Metzger, Mohanakumar and Miller,
1975). The neoplastic cells in these conditions could be killed
by anti-Kappa and anti-Lambda and anti-heavy chain antisera and
complement. Following trypsinisation of the cells reactivity of
K-light chain antiserum was detected after 2 hours (in the case of
GCL) and 8 hours (ALL). All heavy chain activity was abolished
following trypsinisation, and did not regenerate.
The expression of surface Ig, and secretory Ig, and the
switches from IgD lgM, and IgM IgG during the maturation of the
B lymphocyte into the plasma cell have been used to formulate a
classification of neoplasms of the B cell, by an assessment of its
degree of maturation or "differentiation" (Salmon and Seligmann,
197U).
Salmon and Seligmann (19710 proposed that B cell lymphomas
could be classified on the basis of 5 classes of B lymphocyte:-
these are BO (B stem cells), B1 lymphocyte (virgin B lymphocyte),
B2 (Immunoblast), B3 (Memory B lymphocyte), BU (Plasmacytoid
lymphocyte) and B5 (Plasma cell).
The basis of this classification are the extensive studies
carried out by the authors on myeloma cells. The central feature
is the triggering of a clone of cells and its subsequent monoclonal
expansion, by an antigen. A second or oncogenic stimulus then
loads/...
1#.
leads to irreversible proliferation. B cells in a lymphoma are
regarded as B cells which have become "frozen" at a point on the
pathway of normal B lymphocyte differentiation. The neoplastic
B lymphocyte virtually always exhibits monoclonality of the
expressed surface immunoglobulin. Monoclonal immunoglobulins are
found in diseases such as CLL, some - but not all lymphomas, heavy
chain disease, macroglobulinaemia, and multiple myeloma. On the
other hand, if the BO stage had undergone malignant transformation,
polyclonal neoplasms of B cells might be expected - such lesions
are rare. Salmon and Seligmann believe that the B1 lymphocyte
tumours are represented most commonly by the CLL and well
differentiated lymphocytic lymphoma group. In CLL the lymphocytes
are usually non-secretory and fail to show further maturation,
e.g. by development of intracytoplasmic Ig. In a few CLL patients
the cells are more mature, showing serum M secretory components.
The B2 cell is regarded as a derivative, by division, from
the B1 cell. The B2 cell is the principal cell type of poorly
differentiated lymphomas, Burkitt's lymphoma, and some cases of
Histiocytic lymphoma. These tumours may or may not express the
same class of heavy chain as the precursor B1 cell.
The B3 or memory cell has no identifiable equivalent in
lymphomas to date.
From the B3 memory cell is derived the lymphocytoid plasma
cell (Bli) which has both surface and intracytoplasmic IgM and
secretes IgM in the body fluids, the malignant equivalent is
Waldenstroms Disease.
The final stage, the secretory plasma cell secretes IgG,
IgA,/•..
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IgA, IgD, IgM or IgE.
Because the neoplastic process is continuous, in Bl;
neoplasms division of B3 cells is necessary to maintain memory cells.
Thus in Waldenstroms Disease pleomorphism of the B cell series is
seen. Although the bulk of the cells are secretory Blj. cells, all
stages from B1 to B3 are seen with some B5 plasma cells.
In addition, it is suspected that niyeloma cells secrete a
substance which inhibits the proliferation of normal B2 cells.
These two features - the wide involvement of B cells at several
stages of differentiation and the blocking of B2 proliferation
render the classification of lymphomas by these means very complex.
In support of the hypothesis is the discovery of myeloma
proteins with antibody-like activity in both mouse and man
indicating the importance of antigen in triggering B cell
proliferation initially, and this is the most important finding
relating the neoplasm and responsiveness to antigen (Eisen et al.,
1970).
It has also been shown that cell lines can secrete antibodies
which react with sheep or ox red cell determinants (Steele et al.,
197U).
Apart from the expression of abnormal or monoclonal immuno¬
globulin on the cell surface, the distribution of immunoglobulin
can also be abnormal. "Hie reaction of any ligand with the surface
glycoprotein of the lymphocyte is followed by movement of the
crosslinked surface protein to one pole of the cell, and this
movement is dependent upon an intact cell metabolism. Incubation
in the cold (Loor and Hagg, 1975) or in the presence of sodium
azide/...
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azide prevents capping. This penomenon, first described by-
Taylor, Dufus, Raff and I)e Petris (1971), is also dependent upon
the degree of cross linkage of membrane immunoglobulin, or membrane
glycoprotein. Using anti-lmmunoglobulin antibodies, De Petris and
Raff (1973) showed that "patching" occurred at 0°C with whole
antibody, and capping at 37°C. When Fab fragments of antibody
were used the labelling on the surface was diffuse at all temperatures.
Loor, Forni and Pernis (1972) showed that aggregation of diffuse
surface Ig into spots or dots of fluorescent complex when treated
with anti-Ig-antisera, was not inhibited by sodium azide or
incubation in the cold. Formation of caps following washing or
warming at 37°C was followed by disappearance of Ig anti-Ig complex
from the membrane by interiorisation or shedding. If surface Ig
bearing cells are left in contact with anti-immunoglobulin antisera
surface Ig synthesis is inhibited. The pehnomenon of dot
formation on the cell surface is thus NOT DEPENDENT UPON THE
INTEGRITY OF THE METABLIC PROCESSES OF THE CELL. The formation of
caps can be prevented by inhibition of cellular respiration (azide)
or by cytochalasin which interferes with spindle formation and
intracellular microfilaments. This suggests that the ability to
cap surface Ig-anti-Ig immune complexes is a phenomenon of normal
and metabolically intact cells, while failure to cap implies
abnormality of either the intracellular microfilaments or
respiratory metabolism. Cells vary in their ability to cap
surface Ig. In CLL cells often fail to cap surface Ig (Flad et al.,
1973), and in mouse myeloma cells very prolonged incubation, e.g.
more than 5 hours, is required for capping to occur (Bevan, 1973)*
Patching/...
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Patching and capping are general phenomena, not restricted solely
to the B lymphocyte - for example basophils and macrophages patch
and cap cytophilic antibody bound by the Fc receptor on the surface
of these cells (Ferrarini, Munro and Wilson, 1973)* In Hodgkin's
Disease some of the surface Ig bearing cells show failure to cap,
but in addition antibodies reacting with T cells may be present,
implying that non capping cells might be T lymphocytes (Grifoni
et al., 1975). In normal peripheral blood most of the B
lymphocytes cap readily a small number, however, do not. These
cells are not monocytes, since monocytic leukaemia cells show no
surface Ig (Habeshaw and Young, 1975). The comparative ease with
which normal lymphocytes cap, and the failure of some lymphoma B
cells to cap can be used to classify B cell lymphomas (Habeshaw,
Macaulay and Stuart, in press).
Expression of Fc and Complement Receptors
The work of Gorte, Kisso, Ferrarini and Bargellesi (1976)
clearly establishes a correlation between Fc receptor expression
and immunoglobulin secretion by MFC 11 myeloma cells. Only Ig
secreting cells expressed the Fc receptor, or cell which had
surface Ig. Gycloheximide treatment abolished both SIg expression
and Fc receptor. The complement receptor is thought to be
important in stimulating proliferation and secretory responses by
B lymphocytes (Hartmann, 1975). The complement receptor and the
Fc receptor are both important in cellular interaction, both
between normal lymphocytes and between lymphocytes and tumour
cells (Kerbel and Davies, 197k). In antibody mediated cytotoxic
reactions/.••
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reactions the Fc receptor only is involved in cell killing, the
complement receptor is not (Perlmann, Perlmann and Muller-Sberhard,
1975).
Cell interactions
Although there is little direct evidence implicating Fc
and complement receptors in interactions between lymphocytes, or
between lymphocytes and macrophages such interactions clearly do
occur. In a review of macrophage/lymphocyte interaction Lipsky
and Rosenthal (1975) list six classes of such interactions. These
are (1) the promotion of lymphocyte viability by feeder layers
of macrophages in vitro (2) functional maturation of T lymphocytes
from immature thymocytes in vitro (3) enhancement, of the
bactericidul function of macrophages by lymphocyte products (U)
induction of primary response in B lymphocytes by macrophages (5)
induction of secondary response (6) antigen initiated lymphocyte
proliferation. Normal macrophages can bind thymocytes and B and
T lymphocytes by a trypsin sensitive cation dependent mechanism.
In the presence of antigen, such macrophage lymphocyte interactions
become more stable, and binding of lymphocytes proceeds lymphocyte
transformation and proliferation. If antibody is present linkage
between macrophages and Fc receptor bearing cells can occur through
the Fc receptor. Similar spontaneous interaction between human
peritoneal cells and autologous lymphocytes occurs in vitro, and
is independent of serum antibody (Stuart, 1970).
T lymphocytes bind to B lymphoblastoid cell lines, and
weakly to normal blast transformed B lymphocytes (Jondal, n
and/...
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and Yefenof, 1975). Similar interactions between Reed Sternberg
cells and T lymphocytes occur in Hodgkin*s Disease (Stuait and
Habeshaw). Such binding is probably independent of the Fc
receptor. These morphological interactions have been regarded
as providing an alternative "second signal" to the activation of
B lymphocytes, in circumstances where the complement receptor is
either not present or not occupied by activated complement. In
normal lymphoid cultures the complement receptor probably supplies
the signal for B cell proliferation (Schumann et al., 197U). It
is evident that the role of the Fc receptor on B lymphocytes is not
concerned with B lymphocyte activation directly, but it may well
provide for close interaction between B cell and macrophage or B
cell and Fc receptor bearing T lymphocytes in the immune response
(Moller, Coutinho and Persson, 1975). In this review the authors
show that B cell activation is complex and multifactorial, Serum
inhibitors of B cell activation can be shown. Some antigens by
themselves activate B lymphocytes in a non specific manner.
Synergystic responses to incomplete (haptene) antigens require the
co-operation of T cells or macrophages, and antigen itself can
amplify the non specific proliferative response induced by B cell
mitogens.
These effects are difficult to relate to lymphomas.
Habeshaw end Stuart (1976) introduced the concept of co-operative
neoplasms for those tumours containing both B and T lymphocytes.
In untreated CLL, a predominantly B cell neoplasm, T cells are
frequently increased, although these cells are not neoplastic




cell in raising the T lymphocyte population is also seen in chronic
granulocytic leukaemia, and in involved nodes in Hodgkin's Disease.
So far little evidence of T cell abnormality - other than
the occurrence of morphologically bizarre T cells in Sezary
syndrome - has been found in lymphoma in man. Some heterogeneity
of the T cell population undoubtedly exists in normal peripheral
blood T lymphocytes (Woody et al., 1975)*
Changes in surface antigenicity associated with lymphoma
Most of the reported variations in surface antigens of
lymphoid cells concern the leukaemias rather than lymphomas. Cell
membrane marker glycoproteins specific for some human leukaemias
and lymphomas have been described (Billing, Rafizadah and TerasakL,
1975)* Using purified glycoproteins as immunising agents, antisera
cytotoxic to leukaemia and lymphoma cells but not to normal cells
could be prepared. The antigen concerned was detected in 70% of
leukaemic patients, and also in Hodgkin's Disease, Burkitt's
lymphoma, and histiocytic lymphoma. In some cases free antigen
was present in serum. Antisera to acute myeloid leukaemia cells
have also been prepared (Pendergrass et al., 197$) and used in
epidemiological investigation. In one family of seven sisters,
3 died of acute myeloid leukaemia, a fourth sister died from an
undetermined cause, and a fifth presented with acute myeloid
leukaemia. Antisera reacting against this sister's cells, also
reacted with myeloid cells of a disease free sibling. The surface
antigens of EB virus are frequently expressed in Burkitt's lymphoma,
infectious mononucleosis, and also in acute lymphoblastic leukaemia
(Zorbala-Mallios/.•.
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(Zorbala-Mallios and Sutton, 197U). The recent discovery of
naturally occurring allotypic markers for the human B lymphocyte
(Mann et al., 1975) has not yet been exploited in the study of B
lymphoid lymphomas. Antigens analogous to the p.27 and p.30 viral
proteins of murine C type viruses have been isolated from human
tissues, especially in systemic lupus erythematous, but such
antigens have not so far been related to any form of lymphoid
malignancy.
Conclusions
lymphomas are tumours of the cells of lymph nodes - and can
be tumours of B or T lymphocytes, of macrophages, or of the stromal
reticular or endothelial components of the lymph node. The
physiology of each of these cell classes has been reviewed,
lymphocytes are subclassified on the basis of their surface
characteristics, the presence of specific surface antigens,
expression of surface immunoglobulin, and receptors for Fc and
complement or the sheep red cell. The function of B lymphocytes
and T lymphocytes is to produce an immune response and in this
co-operation between the lymphocyte and other cell classes occurs.
The study of the surface characteristics of lymphoma cells reveals
that solid tumours are predominantly of B cell class, while T
cell lymphomas are rare. Lymphoma cells can express mixtures of
receptors of both B and T class, and receptor silent tumours
occur. Abnormalities of surface Ig expression, and distribution
have been noted in lymphomas, together with anamalous expression
of/...
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of Fc or deletion of Fc or C3 receptor. From this data it is
possible to suggest new features of lymphoma cells which might
indicate defects in cellular metabolism (Failure to cap surface
Ig) or co-operative (synergistic) tendencies in some neoplasms.
The data reviewed clearly indicates that previous views of the
pathogenesis of lymphoma grossly underestimate the complexity of
the subject facing the investigator in this field. The remainder
of this thesis illustrates the findings from two years
investigation of the biology of lymphoma using the comparatively
new and powerful techniques for investigating the cell surface.
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a) Sheep red cells
b) Ox red cells
c) Rabbit anti-sheep and rabbit anti-ox IgM antibody
d) Rabbit anti-sheep and rabbit anti-ox IgG antibody
e) Hunan red cells












Sheep red cells were obtained from a single animal. From
a flock of control sheep (through the courtesy of Dr.'s Cockburn
Forrester and David Mellors) six red cell samples were tested for
ability to form SRBC, IgG and SAG rosettes. Cells from one
animal were selected, and formed the basis of most of the results
obtained in this series, as well as those reported by Blackie
(1973) and Fraser (197U). Antisera were prepared in rabbits
(against sheep stroma prepared from slaughterhouse blood) and both
IgM and IgG antibody titres standardised with reference to this
animal (H88). After using these red calls weekly for nearly 2
years the animal was slaughtered. A new sheep cell donor was
selected (W77) and these cells standarieed against the antisera
already prepared. Quite marked differences in agglutinating and
complement fixing antibody titres were noted with these new cells,
but when correctly sensitised results with normal blood lymphocytes
for E, EAC and EAIgG rosettes were comparable with the previous
red cells. A third sheep was also used for a short time, prior
to the introduction of Ox red cells as the vehicle for complement
and IgG. Since then several sheep have acted as red cell donors
for E rosette formation 1 Anti-sheep red cell antisera are no
longer used and the singularity of the donor is not important
as virtually all samples of sheep red cell tested have equivalent
ability/...
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ability to rosette with human blood T lymphocytes.
bheep red cells were collected in Alsevers solution,
containing benzyl-penicillin (200 units/ml) and streptomycin (50ug/ml)
o
and stored under plasma at U C. Red cells preserve their rosetting
characteristics for at least k weeks under these conditions, but
were never stored for more than two weeks.
Ox red cells
Bovine red cells were obtained from a single animal
(No. 01171) kept at the District Cattle Blood Typing Field
Station (Roslyn). Recently a second single animal has acted as
the donor of the red cells (No. 01657). Dr. J.G. Hall kindly
supplied these blood samples. The ox blood is taken directly
into ACD as anticoagulant and the cells stored under plasma in
sealed "Vacutainer" tubes until required. Storage for up to
two weeks is possible without affecting reactivity with IgM or
IgG antisera. Both animals acting as red cell donors have "low
agglutinating" red cells.
Rabbit anti-sheep, and Rabbit art1-ox IgH antibody
Both antisera were prepared in a similar manner. Washed,
haemoglobin free stroma were standardised to a concentration of
1rag protein nitrogen per ml of solution (Protein determinations
by micro-Keljahl analysis) and used to immunise rabbits intra¬
venously according to the schedule described by Rabat and Mayer
(1961). After bleeding out, the separated serum was fractionated
on/...
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on dephadex G200 gel, in glycine buffer at pH8.0 - 8.2. On testing,
the bulk of the C fixing and lytic antibody activity was found in
the first peak eluted from the gel. It proved more easy to
prepare and separate anti-sheep-red-cell IgM than to prepare anti-
ox-red-cell IgM. Indeed with some immunisations, virtually all
antibody against sheep red cells was IgM, and such anti-sera were
used diluted but unfractionated. Rabbit anti-ox-red-cell IgM
was never found free of demonstrable 7S IgG antibody activity in
the same sera (mercapto-ethanol resistant agglutination) and rabbit
anti-ox-red-cell IgM antisera were always separated by gel
filtration before use. Antisera were absorbed with human AB rh+
red cells before fractionation.
The separated and titred IgM antibody was dialysed against
0.1 ^ lactose solution (it litres of 0.1% lactose per itO ml first
peak column effluent), freeze dried in 2 ml aliquots, and stored
in sealed ampoules under vacuum at -20°C. When required, these
IgM preparations were reconstituted with 1 ml of sterile 2% human
serum albumin solution (Salt poor HSA provided by courtesy of
Dr. J. Gash, South East Regional Blood Transfusion Service). Such
standardised preparations showed reproduceable activity upon
reconstitution, and titration of activity in both the column
effluent, and each batch of freeze dried product ensured maximum
control over the sensitisation process.
Rabbit anti-sheep, rabbit anti-ox IgJ antibody
Rabbits were immunised intraperitoneally with 2 ml of a
suspension of ox or sheep red cell stroma, followed by a single
1.M./...
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I.M. injection of 0.1 ml of stroma in complete Treund adjuvant.
Intraperitoneal injections were repeated at three weekly intervals,
and .antibody titre monitored by agglutination and complement lysis
tray tests. Rabbits were bled out at the appropriate intervals,
and the IgG separated by ammonium sulphate fractionation. The
precipitate was redi330lved and this was followed by prolonged
dialysis against tap water, and distilled water, to remove ammonium
sulphates, euglobulin, and reduce ionic concentration. Pure IgG
was then recovered by elution from a column of DEAE or QEAE
Sephadex in 0.01 ml Molar phosphate buffer containing 0.01 Molar
NaGl. The anti RBC IgG was titrated, and stored in 0.1 ml
quantities in elution buffer, at -20°C in sealed glass ampoules.
Antibody was absorbed with packed human AB red cells before
fractionation, to remove rabbit anti-human activity.
Human Bed Cells
Human red cells were obtained from ABO typed laboratory
personal. These cells were used for the formation of mixed
rosettes after sensitisation with rabbit anti human IgG to form
Hu-Fc reagent. Under certain circumstances human red cells will
form spontaneous rosettes with human lymphocytes. Red cells of
gpQrh- were used for these tests. Human gpOrh* red cells were
used to detect the absence of C3b fixed to ox or sheep red cells.
These human cells contain receptors for 03b, and absence of co-
rosetting between C3 sensitised cells and human red cells was
taken to indicate absence of C3b on complement sensitised sheep
or ox red cells. The absence of immune adherence on C3
sensitised/* * *
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sensitised cells indicated that the exposed determinant was C3d
(C3 inactivator cleaved G3b).
Habbit anti-human red-cell IgQ
Human cells were injected lntraperitoneally as 1 ml of
washed 9% suspension in physiological saline weekly for six weeks*
The serum was fractionated by ammonium sulphate precipitation and
the fractions stored at -20°C*
Buffer Solutions
Flcoll friosil Mixture for separation of leukocytes from samples
of peripheral blood and spleen
This was prepared by mixing 10 parts of a 22.9% solution
of Triosil 350 (Nyegaard and Co., Oslo) were mixed with 2h parts
of a 9% solution of Ficoll (Pharmacia), sterilised by membrane
filtration (Pore diameter 0.22 microns) and stored at room
temperature in 10 ml quantities in siliconised universal
containers. The specific gravity was 1.076.
Veronal Buffered - Gelatin - Saline with EDTA (VBS-Q-EDTA)
Stock solutions of veronal buffered saline^ (VBS), 0.10
molar trisodium ethylenediaminetetraacetate (EDTA) and 10%
Gelatin solution (G) were prepared. The gelatin was acid ossein
(Credo Food Products Ltd.) of p17.1 and was devoid of anti¬
complementary/ ...
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anti-complementary activity. The solution was prepared by mixing
100 ml of stock VBS with 395 ml of glass distilled water, and 5 ml
of warmed stock gelatin solution to give a final gelatin
concentration of 0.1%, This was then mixed in the ratio of U50 ml
of VBS-gelatin with $0 ml of stock EDTA solution to give VBS-G-EDTA.
The solution was prepared fresh each week, sterilised by filtration
and stored at
Veronal buffered Saline gelatin with Calcium and Magnesium ions
. ♦+
(VBS-G-Ca Kg ).
Stock solution of 1.0 molar MgCl2 with 0.15 molar CaCl2
was added to 20 ml of stock veronal buffered saline, and 1 ml of
warmed "\0% gelatin solution added. The volume was adjusted to
100 ml with glass distilled water. This solution was prepared
fresh daily.
Additional buffers used were phosphate buffered saline (PBS)
and physiological saline (8.Jg litre NaCl solution). These were
stored after sterilisation by autoclaving, in sterile bottles.
Tissue culture medium 199 with antibiotics was used for the
conveyance of lymph nodes and preparation of cell suspensions.
Complement
Several complement preparations were used, including Guinea
Pig complement (Wellcome freeze dried guinea pig serum) and
Human complement. Human complement was prepared from fresh
human serum (group AB), adsorbed with sheep or ox red cells, and
stored/...
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stored in 1 ml. quantities in liquid nitrogen.
Yeagt iuspension
least suspension was used for adsorbing guinea pig or human
complement to prepare guinea pig Rli, or human R3 reagent. Auto-
claved bakers yeast (200 gm) was washed in PBS until the supernatant
was clear. The yeast was then suspended in 250 ml of PBS, and
1.7 ml of mercaptoethanol added with stirring, and incubated at
37°C for 2 hours (in a fume cupboard). The yeast wa3 then washed
until the supernatant was free of mercaptoethanol (determined by
smell). Washed reduced yeast suspension in 500 ml of 0.35?
daGl was then treated with iodoacetamide (0.02 molar)(addition of
17.8 mg per 100 ml) with stirring. pd was adjusted by addition
of hM% sodium bicarbonate to pH 7. After 2 hours incubation
with stirring at room temperature the yeast was washed 3 times in
500 ml of PBS, and made up to 1 litre with VBS. 1 mg sodium
aside was added as preservative and the reagent stored at U°C.
Antlsera
The following antisera to rabbit and human immunoglobulins
and antisera to complement C3 and Cii were used:
Polyvalent rabbit anti-human Igt This preparation contains
antibodies against the major heavy chain classes of human immuno¬
globulin, e.g. IgG, IgA, IgM (Sera Services Ltd.).
Rabbit/.••
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Rabbit anti-huraan Kappa, anti-hunan Lambda Light chains: Anti-
Xappa and anti-Lambda antisera from rabbits (Dakopats s Copenhagen),
and FITC coupled rabbit anti-human Kappa and rabbit anti-human
Lambda (Sera Services Ltd.) were used.
FITC Coupled goat anti-Rabbit-Igt This antiserum was used as a
tracer of rabbit immunoglobulin in the sandwich technique (supplied
by Meloy Ltd.).
Rabbit anti-human C3, Rabbit anti-human Cii, Rabbit anti-Guinea
iig 03, and Rabbit anti-Guinea Pig Olit (Meloy Ltd.)(Cordis Ltd.)
These antisera were used to test the specificity of the reactions
for coating red cells with appropriate complement components, either
by a Coombs test on a C sensitised cells, or by sandwich immuno¬
fluorescence technique.
jjggunoperoxidase Reagents (Dakopats)
Peroxidase-ant .^.-peroxidase (rabbit )i This reagent consists of
horseradish peroxidase enzyme, coupled with a rabbit antiserum
against horseradish peroxidase.
dwine anti-rabbit IgGt This reagent is a potent swine antiserum
against heavy and light chains of rabbit 7S immunoglobulin.
Rabbit antisera to heavy chains (u, , ) and Kappa and Lambda
light/...
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light chainsi Dakopats antisera to Kappa and Lambda chains,
were used at titres of 1 in 100 to 1 in 200. Nordic rabbit anti-
human heavy chain antisera, particularly anti-alpha chain, were
more effective in this test than the Dakopats equivalent (Sera
Services Ltd.), and were substituted.
Normal Swine Serum; This was obtained through the kindness of
Professor Campbell, Poultry liesearch Institute, from a normal
breeding herd of Landrace pigs.
Specificity;
The specificity of most antisera were tested, either by
gel-diffusion or Immunoelectrophoresis. Anti-complement
antisera (Meloy) were tested by reaction with purified human or
guinea pig complement components (Cordis reagents).
Miscellaneous Materials
Acridine Oranget This consisted of 0.025? w/v aqueous solution
of acridine orange dye in distilled water (Brostoff, 197lt).
Neutral Ned Dyei A solution of 1# w/v of neutral red in
distilled water was used as stock. This was diluted 1 in 10 with




Stock TOS Bufferi This buffer (5 x concentrate) was prepared
by dissolving 83.0 gm fcaCl and 10.19 gm of sodium diethyl
barbiturate in 1.5 litres of distilled water. The pH was
adjusted to 7.35 - 0.Q5 by the addition of 1 N HC1, and made up
to 2 litres with distilled water. It was stored at U°C, for
up to 2 months.
2% Solution Human Serum Albumin: This was prepared by dissolving
2 gms salt poor freeze dried human serum albumin in 100 ml glass
distilled water. The solution was sterilised by filtration
(0.22 u filter).
White Cell diluting fluid: A mixture of physiological saline
containing 2.0 v/v glacial acetic acid and 0.1 £ gentian violet
was used in making white cell counts.
Stock Phosphate Buffered Saline 1 Stock solutions of 9.08 gns
of notassium dihydrogen phosphate (KH^PO^) per litre, and 11.88 gms
of disodium hydrogen orthophosphate (NagHPOj^HgO) were prepared
and mixed in approximate ratios of 20 mis to 80 mis to give a
pH of 7.1*. 10 ml of this stock solution was mixed with 90 ml
of sodium chloride solution (9g litre) to rive phosphate
buffered saline.
Human Gamma Globulin Preparations: These were used in (a)
assessing specificity of antisera, (b) to coat red cells non-
specifically in investigating subclass specificity of the Fc
receptor/...
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receptor, and (c) in rosette iniuhition experiments. All
fractions were prepared from myeloma or Waldenstrom Disease sera
in which the class and subclass of the major iramunoglobilin
fraction was known. These sera were supplied by Departments of
Therapeutics, and Haematology, Royal Infirmary of Edinburgh,
Fractionation of IgG subclass myeloma sera was performed on DEAE
cellulose (el ition with 0,01 - 0.1 H phosphate saline buffer
gradient). IgM containing Waldenstrom Disease sera were
fractionated on Sephadex G 200 gel, followed by dilution
precipitation of euglobulin, redissolving and refractdonation.
Fairly pure 101 samples were obtained by these means. Antisera
to subclasses of human IgG were used to classify the product
obtained by these means (Nordic reagents). The reagents so
prepared were freeze dried and stored at -20°C.
Tissue Cultire
Siliconised Washerman tubes, sterile heighton tubes and
tissue culture flasks (Falcon Plastics) were used to hold and
culture cells. Washing of cells was generally achieved in
polypropylene centrifuge tubes, to which platelets readily
adhere, but to which lymphocytes or macrophages adhere weakly.
Macrophages stick well to tissue culture grade plastic. Tissue
culture medium used was almost always medium 1993 supplemented






1 ) E Rosettes
2) Enumeration of Fc receptor with EAIgG and Ox Fc
reagents*
3) IgM receptors.
k) Preparation of Conplement rosettes.
5) Neutral Red Ingestion.
6) Detection of Surface Immunoglobulin bearing cells.
7) Detection of Intracellular Immunoglobulin.
8) Preparation of Cell suspension (from blood) and glass
adherent cells.
9) Separation of cells from spleen.




Preparation of Sheep Erythrocyte itosettes (E Rosettes)
The following variables have been assessed in relation to
the formation of rosettes between sheep red blood cells and human
blood lymphocytes
a) The optimal number ratio of sheep erythrocytes to
human lymphocytes for efficient rosettes formation.
b) The role of temperature.
c) The time of incubation.
d) Methods of lymphocytes preparation.
e) Presence or absence of serum in the incubation
medium.
f) The use of different sheep as donors.
g) Effect of glutaraldehyde fixation upon rosette
formation.
This work formed a large part of the thesis of R.AvS.
ELackie (1973) performed under the supervision of the author.
The conclusions reached in this study were as followsi-
a) Optimum practical ratio of sheep red cells to human
leukocytes was U0t1*
b) Preincubation of suspension for 5-10 minutes at 37°C,
followed by centrifugation and 2 hours Incubation at
U°C gave optimum numbers of rosettes.




d) There was enhancement of S rosette formation by
lymphocytes separated over Ficoll and iradequately washed.
Washing three times abolished these co-agglutinates which
were in part due to red cell clumping induced by Ficoll.
Dextran sedimentation did not appear to enhance E
rosetting.
e) Providing all other conditions were optimal, the presence
of serum did not enhance the numbers of rosettes detected.
However, serum, or serum albumin did appear to stabilise
rosettes making them more resistant to mechanical
disruption. Balanced salt solutions were all virtually
equivalent in supporting E rosetting, providing stable
pH conditions and high cell viability could be achieved.
f) Most sheep tested were equivalent in the ability of their
red cells to rosette with human peripheral blood
lymphocytes.
g) Glutaraldehyde fixation (0.5-6?) after resuspension
prevented mechanical disruption of rosettes. If applied
to the red cell/white cell pellet, spurious rosettes were
often found formed between the red cells and leukocytes.
Increasing inhibition of E rosetting in -ftiis system was shown
by IgG or IgA concentrations in excess of 10 mg/100 mlj- at levels
of 1 mg/ml rosette formation was almost totally inhibited.
From/...
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From this information an optimal method for the preparation
of sheep red cell rosettes was devised, and has been employed to
date with little modification. The method summarised is as
follows I
Preparation of E Rosettes
6
1) Washed leukocytes, 1x10 in 0.1 ml medium 199 are mixed with
1x0 x 1Q6 sheep red cells in 0.1 ml phosphate buffered saline.
The volume adjusted to 1 ml by addition of 0.8 ml medium 199.
2) Suspension warmed to 37°G, and incubated at 37°C for $
minutes.
3) Centrif ged for 5 minutes at I30g, and the >ellet incubated
for 2 hours at li°C.
h) Cells were resuspended for counting, after aspiration of 0.5 ml
overlying fluid, by rotation of the long axis of the tube
until resuspension is complete. Counting is assisted by the
addition of 0.1 ml of 0.02$ solution of acridine orange and
viewing immediately under mixed phase contrast and U.V.
illumination. Cells binding 3 or more sheep cells are
counted as rosettes.
178.
Figure 1i Rpgette by Scanning Electron Microscopy
The central small lymphocyte, In this case a smooth
surfaced T cell shows binding of 3 sheep erythrocytes,
and thus fulfills the criteria for an £ rosette.
Scanning X.M. x 12,500
(Illustration from a preparation by Dr. A.C. Parker)
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Preparation of EAIgG or Ox Fc reagents, and enumeration of Fc
receptors on lymphoid cells
In the initial series, use was made of the ability of high
concentrations of rabbit anti-sheep RBC antibody to block £ rosetting
while at the same time allowing detection of the Fc receptors. The
work which elucidated and standardised these techniques was reported
by Fraser (197U). This work established that "coating" sheep red
cells with IgG or IgM antibodies, or non specifically attaching IgG
or IgM to the red cell surface with Chromium effectively occluded
rosetting sites on the sheep red cell, and prevented them from
engaging the E receptors on T lymphocytes. This difficult work in
the standardisation of Fc receptors using the sheep red cell as the
test particle also showed two other important features, listed
below:
1) Optimal numbers of Fc receptor cells are detected only by
high concentrations of IgG Fc receptor on the surface of the test
red cell. Low concentrations of antibody on the red cell surface
detect only macrophages or monocytes and fail to react with B
lymphocytes. This is shown by the fact that Hu red cells ooated
with rh antisera form rosettes only with monocytes.
2) The reaction with the Fc receptor is subclass specific;
only some subclasses of human IgG will react with the Fc receptor
on the macrophage or lymphocyte surface.
It was previously shown that a concentration of 100 mg per
100/...
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100 ml of IgO or IgA immunoglobulin was required to block E
resetting when such immunoglobulin was present in the incubation
medium, but not upon the red cell surface. Titres of anti-sheep
IgO of 1 in 201*8, were found to inhibit E rosetting when reacting
with cells from sheep H88. litres below this, i.e. 1 in h0$6 were
rather less effective, and litres above this, i.e. 1 in 1021*
caused agglutination of the sheep cells. If it is assumed that
this titre is equivalent to 1ml/ml of surface red cell bound IgG
and assuming M.W. of 150,000 Daltons, the udniBrja number of
molecules per red cell for inhibition of E rosetting or for
optimal sensitisation for Fc detection is 1.25 x 10^ molecules
per HBC. Concentrations of 0.625 x 10^ molecules per red cell
are inadequate for inhibition of E rosette formation (with sheep
cells) and concentration greater than 2.50 z 10^ molecules/ red
cell cause agglutination. It must be stressed that such
calculations apply only to the individual antibody/sheep red
cell combination used, and to no other, but it serves as a useful
guide to adequate sensitisation of the red cell whether sheep or
ox red cells are used as the antibody carrier.
In terms of the subclass specificity of the rosetting
reaction, if red cells are passively sensitised with Gr coupled
IgG of known subclass, It is found that Ig il, and IgG3 will bind
to equivalent numbers of cells, but that IgOJ* subclass is not bound
by a substantial number of Fc rosetting cells. Note that this
effect is not due to variations in numbers of bound IgG molecules,




Peripheral Blood Lymphocyte iiosetting by IgG bound specifically
or non specifically to the sheep erythrocyte surface. (Partially

















1 in 201*8 S 28
1 in 1*056 S 31
1 in 800 S Agglutination




The absolute numbers of Fc receptor expressing cells in
normal human blood is 0.75 x 10^ per ml, but if cells coated
with IgGL subclass are used, only 0.L5 x 10^ per ml are found to
have Fc receptor. Furthermore if human 0rh+ red cells are
sensitised with immune IgG anti-rh antibody from pregnant patients
with/...
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with rheui us sensitisationj the numbers of Pc receptor bearing
cells are found to correspond only to these cells which are
phagocytic, i.e. to monocytes. Ho B cell receptors for Fc are
detected in this system (rh anti-rh).
From this data, optimum methods for the sensitisation of
sheep cells and rosette formation were developed, those given
here apply to sheep H88 and rabbit 7S antibody.
1) Washed sheep red cells were sensitised by incubation in
1 in 20U8 dilution of rabbit anti-sheep RBC IgG in PBS for 1 hour
at 37°C.
2) The cells were washed twice and mixed with 1x10^
leukocytes in a ratio of U0 red cells to 1 leukocyte . The
mixture was incubated for 10 minutes at room temperature in
siliconized Wassermen tubes, in a total volume of 1 ml.
3) The red and white cells were pelleted by centrifugation
at 180 x g and incubated for 2 hours at 1|°C.
U) Resuspension was by vigorous end over end inversion of
the Wasserman tube (x 5). The rosettes were either counted
directly, using a cell counting chamber (Improved Nebaur), followed
by an accurate white cell count, or the percentage of cells
binding 3 or more sensitised sheep red cell determined directly
after the addition of 0.1 ml of 0.01? acridine orange solution,
by mixed U.Y. and phase contrast microscopy.
In evaluating the Fc receptor a number of experiments were
performed using incubation for 2 hours at 37°C, and overnight




Owing to the difficulties in standardisation of sensitisation
of sheep cells, especially if different donor animals were used,
the ox red blood cell, and rabbit anti-ox-red cell 7S antibody
system were used in later experiments. At present the most stable
Fc receptor is obtained with the use of Formalised ox red cells
(Rax)(washed ox red cells which are stored in 0,$% solution of
buffered faritalin) and rabbit antibody. Using either formalised
ox rbc or washed ox rbc the technique employed is as follows
1) Washed ox (or formalised ox) red cells were sensitised
by the addition of rabbit-anti-ox-rbc IgO in nredetermined
optimal titre. They were incubated for 30 minutes at
37°C.
2) After washing twice in PBS cells were adjusted to a
6 6
concentration of 1*00 x 10 /ml and mixed with 1x10
leukocytes in a total volume of 1 ml.
3) Cells were incubated together for 10 minutes at 37°C
and centrifuged at 180 g for 5 minutes. They were
incubated at U°C for 2 hours.
U) Kosettes were resuspended by end over end inversion of
the incubation tube, stained by the addition of 0.1 ml
of 0.02^ solution of acridine orange, and counted using
incident U.V. and transmitted phase contrast illumination.
Comparison of rosettes made with sheep, ox, or formalised
ox red cells sensitised with rabbit antibody showed no significant




An essential precursor to the development of complement
sensitised sheep or ox red cells was the preparation of good IgM
antibodies for the sensitisation of red cells. If IgG
containing antisera are used for complement sensitisation the
criticism that IgG Fc rather than C3 receptors are detected is
valid. The use of IgM has other advantagesi in the sheep red
cell system, cells coated with IgM antibody to the exclusion
of E rosettin;; determinants show little or no background
rosette formation when tested with normal human leukocytes, as
shown in the accompanying table.
TABLE
Percentage of IgM rosettes farmed between Rabbit IgM-coated










Mean Value 1.17 (Range 0.17-1.9%)
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IgM antibodies are also very efficient at complement
fixation, an important point in producing maximum possible
concentrations of complement on the red cell surface. The
production of rabbit IgM antibody to sheep red cells was easily
achieved, and sheep red cells sensitised with anti-sheep IgM did
not form rosettes with normal human peripheral blood leukocytes.
Preparation of ox red cells sensitised with rabbit anti-ox IgM
antibody was more difficult, and IgM sensitised ox red cells
gave somewhat higher background counts than IgM sensitised sheep
cells, as shown in the accompanying table.
IgM receptors on human peripheral blood mononuclear cells











Mean Value 2.82 range 0.1 % to 82
IgM coated ox red
complement rosetting,
occasionally/...
cells were used as control particles for
since IgM receptors are detected
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occasionally and can be mistaken for complement receptors unless
IgM controls are included.
IgM receptor bearing cells were enumerated as follows
1) Sheep or ox red cells used sensitised by incubation in
o
the appropriate antibody for 1 hour at 37 C, and were then
washed twice.
2) Sensitised cells, at a concentration of U00 x 10° ml,
6
were mixed with white cells in ratio of U0 x 10 red cells to
6
1 x 10 white cells, and the volume of suspension adjusted to
o
1 ml. Cells were incubated for 5 minutes at 37 C, centrifuged
at I80g for 5> minutes and incubated at h°C for 2 hours.
3) Rosettes were counted in the resuspended material (end
over end inversion) following the addition of acrldine orange,
or more commonly by direct rosette counts followed by white cell




Preparation of complement rosettes
The preparation of test particles for complement rosetting
gave considerable difficulty, resulting in the adoption of dual
sensitisation technique for sheep red cells in the production of
EAC reagent. This technique was found essential to (a) detect
optimum numbers of complement rosetting cells and (b) to eliminate
cross reactivity between E and EAC receptors. The principal way
of avoiding the second (b) drawback was by the manufacture of
an adequate IgH antibody. Sheep red cells were sensitised in
different dilutions of IgM antibody, and optimal sensitisation
















In this case the titre chosen for IgM sensitisation was 1 in
201*8. The agglutination resulting at titres of 1 in $12 and 1 in
1021* illustrates the potentiation of sheep cell agglutination by
IgM antibody in the presence of leukocytes, and this is a major





The sensitised sheep cells were then washed in VBS-G-Ca Mg ,
cooled to 0°C and mixed with ice cold human or guinea pig complement
diluted 1 in 10 in VBS-G-Ca++Mg++ and held over ice for 30 minutes,
lysis occurs if the cells are warmed above 0°C. This step allows
slow fixation of C1U, and C2. Following a wash in ice cold VBS-G-
EDTA, the cells were warmed to 37°C in a 1 in 10 dilution of human or
guinea pig complement in VBS-G-EDTA and incubated for 30 minutes at
37°C. Often a trace of haemolysis is observed. This step allows
fixation of C3, and inactivation of fixed C3b to C3d by C3
inactivator. Some C1, C2 and possibly IgM antibody may elute at
this stage. The cells were then washed once in VBS-G-EDTA, and
subsequently resuspended in phosphate buffered saline. This
reagent is the EAC reagent used in most of the experiments
described.
EAC receptors were quantitated by reacting U0 x 10^ EAC cells
with 1 x 10^ leukocytes in siliconised Wasserman tubes in a volume
of 1 ml in PBS or tissue culture medium 199. The tubes were
incubated for 10 minutes at 37°C, centrifuged for 5 minutes at 180g
and incubated for 2 hours at li°C. Rosettes were resuspended by end
over end inversion of the tube, and counted in a white cell counting
chamber. White cell counts, performed in a standard manner, enable
calculation of the percentage of rosetting cells.
Checks were made on the influence of incubation temperature
on the numbers of EAC rosettes, E rosettes, and Igii rosettes as













Despite the care taken to ensure reproduceable sensitlsation
of sheep cell with complement, the technique has inherent
difficulties. The principal drawback is the agglutination of red
and white cells together, resulting in suspensions which cannot
yield accurate rosette counts. This is due to the enhancement of
agglutination of sensitised sheep cells by human leukocytes already
referred to. Complement coated cells can be prepared only with
great care, to avoid agglutination of suspension or lysis of red
cells during sensitisation. Complement coated cells must be
prepared fresh each day. These difficulties resulted in the
adoption of the ox red cell as a vehicle for complement, and a
sensitisation procedure based on the use of R reagents prepared
from guinea pig or human serum. Not only is the technique more
straightforward, but there is less variability in the results
obtained.
Preparation of C3 reagent using Ox Red Cells
Ox red cells were sensitised by 30 minutes incubation in 2 ml
of rabbit anti-ox red cell IgM reagent (rabbit anti-ox red cell
IgM in 2 ml of human serum albumin solution). Half these cells
were/.••
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were washed and were used to make IgM control rosettes. The
remainder were treated with human S3 reagent to form C3d sensitised
cells, or with guinea pig RI4 reagent to form C1U cells. R3
reagent was prepared from fresh or liquid nitrogen stored human
serum, Rh reagent (rarely used) from guinea pig serum. The human
♦♦
serum was diluted 1 in 10 (1 ml ♦ 9 ml VBS-G-Ca Mg ) and to this
was added 2 ml of reduced acetylated yeast suspension. The mixture
o
was incubated for 30 minutes at 37 C and the yeast removed by high
speed centrifugation. IgM sensitised red cells were added to the
R3 (or RU) reagent and incubated for 30 minutes at 37°C. The red
cells were washed once, and U0 x 10^ red cells incubated with
6 o
1 x 10 leukocytes in 1 ml for 10 minutes at 37 C. The mixture
was then centrifugeti at I80g and incubated for 2 hours at h°C in
a siliconised Wassorman tube. Rosettes were resuspended by the
end over end inversion of the tube and counted following the
addition of 0.1 ml of 0,2% acridine orange by mixed phase contrast
and 0.7. microscopy.
Normalised ox red cells can be used to make F(ox)C3* The
numbers of C3d rosetting cells found are quivaleaat with the three
reagents EAC, GxC3, and F(ox)C3, under the same conditions.
Reagents using formalised ox red cells are considerably more
stable than with fresh ox red cells, and keep for 3-U days with
no detectable deterioration.




The phagocytic cells were quantitated as cells concentrating
neutral red dye in a coarse granular form from a dilute solution
in physiological saline. Preliminary studies showed that of
several "phagocytic" markers investigated (colloidal carbon, Pelikan
Werke, Hanover, trypan blue, opsonised polystyrene, or starch
particles) neutral red dye was the most reliable and the simplest
marker to employ.
Cells (1 x 10^) were incubated for 30 minutes in a mixture
of 0.1 ml of a 0.1 % w/v solution of neutral red and 0.9 ml of
medium 199 or balanced salt solution, in siliconised Wasserraan tabes.
The cells were then washed in medium 199 or balanced plysiological
salt solution, reauspended in 0.1 ml volume, and sealed under a
coverslip. Neutral red ingesting cells were quantitated as cells
showing large vacuoles of neutral red dye in the cytoplasm.
Minimal small vacuolar uptake, often in the uropod, is found in
some lymphocytes, and myeloid cells can show quite marked diffuse
uptake into small vacuoles. In practice mononuclear phagocytes
are easily distinguished from lymphocytes (Fig. 2 )•
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Figure 2i Neutral Red Dye Teet
Tha preparation shows a monocyte and two lymphocytes
supravital!? stained with neutral red dye. The coarse
vacuolar uptake of dye by the central monocyte centres
with the single vacuole containing dye seen in the
cytoalasa of one of the lymphocytes (lower left of
centre). In practice this Method of identifying
mononuclear phagocytes proved simple and accurate.





The Detection of Surface Immunoglobulin Bearing Cells
The method used was developed from the simple detection of
cells with surface Ig, into a test which determines the behaviour of
the cell surface following the complexing of anti-Ig antiserum with
the surface Ig. Initial studies involved the reaction of cells
with FITC coupled anti-IgG, IgM or IgA antisera, by direct staining
for 10 minutes at 37°C. It was noted that both capping and non-
capping cells were present, and a spectrum of complete, partial,
and non-capped cells was detected. It was decided to investigate
the conditions of reaction leading to the capping phenomena. It
was shown that some cells did not cap despite prolonged incubation,
that caps were shed with prolonged incubation times, and that
incubation for 10-15 minutes at 37°C detected optimal numbers of
capping cells. It was also found that aggregates in the immuno¬
globulin antisera would produce spurious reactions with Fc
receptors producing a capping reaction due to aggregates of Ig.
These could be shown to react even with some thymus cells.
Method of detection of surface Ig
6,
Washed leukocytes (2 x 10 ) in 0.2 ml of PBS were reacted
with a 1 in 10 dilution of polyvalent rabbit anti-human immuno¬
globulin (anti-G,M,A chain), for 10-1$ minutes at 37°G. Cells
were then washed three times in PBS, cooled in ice, and then
stained for 30 minutes with 1 in 10 or 1 in 20 dilution of Goat
anti-r^bit Ig. The caps are formed during the incubation at
37 C, and small patches (non-capping surface Ig) are formed
mostly/...
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mostly during incubation at Q°C. Even prolonged (2 hr) incubation
o
at 37 C does not induce significant capping in the non-capping
population, but some aggregation of surface dots of Ig anti-Ig
o o
complex occurs, and this can be shown both at 37 C and at 0 C,
and in the presence of sodium azide which inhibits capping. Caps
are also shed by prolonged incubation, and can be observed to
reform on the capping population if it is subsequently washed and
reincubated in anti-Ig antiserum. Different forms of surface
staining are illustrated (Pig. ).
Specific Antisera
Antisera to human kappa and lambda light chain, and anti-
IgG, IgA, IgM and IgD coupled to PITC or Khodamine were used to
determine the class of antibody expressed on the cell surface.
These antisera were used at dilutions from 1 in 20 to 1 in UO,
reacted with white cells for 15 minutes at 37°C, followed by
washing twice in PBS. These reactions were not employed upon
every occasion] as a result cells expressing light chains only
on the surface might not have been detected in every case.
Synthesis of Immunoglobulin
The absence of stainable immunoglobulin does not necessarily
mean that the cell concerned cannot manufacture Ig. It has been
found that trypsinisation can restore the capacity of some cells
to react with anti-Ig antisera. The fact that a positive
staining reaction for surface Ig occurs on a cell does not
necessarily/...
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yi»?ure 3: Patterns of Distribution of Surface Ig by
Immunofluorescence.
Top right diffuse fluorescence, top left non-
capping fluorescence, centre right confluent
ring fluorescence, centre and lower left early
and late capoing fluorescence. Bottom right the
appearance of intraoytopl&snic fluorescence, in
ethanol fixed smear, of a plasma cell. The
diagram was prepared from ink sketches of
fluorescent patterns made at the microscope, and
printed from a reversal transparency to produce
a more realistic effect.
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necessarily imply a capacity for Ig synthesis. Mast cells,
polymorphonuclear leukocytes, platelets, and monocytes can all be
shown to react with anti-Ig antisera, but no resynthesis of surface
Ig occurs following trypsin!sation. Cells from carcinomata likewise
show non-specific staining for surface Ig in many cases, but do not
resynthesise Ig following trypsinisation. The technique used to
6
trypsinise cells was to treat 1*0 x 10 cells in 1 ml of medium 199
with 1 ml of 0.25$ solution of pancreatic trypsin of bovine origin
for 30 minutes at 37°C. The reaction was stopped by rapid
dilution and washing of cells in a large excess of prewarraed medium
199. Viability was assessed and the cells then cultured overnight
in medium 199 ♦ 10$ foetal bovine serum. Before culture the
absence of surface Ig was shown by staining with anti-Ig antisera.
Resynthesis is present by 6 hours, and is fully developed by 2h
hours, in normal control samples.
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Figure In Patterns of Surface Ig distribution
Non-Capping Cells
The typical appearance by immunofluorescence of
non-capping immunofluorescence. The tiny dots
of surface fluorescence snap In and out of focus
while under view, giving rise to a glittering
effect. Hote the absence of any capping In the
cells Illustrated. This appearance characterises
lymphomas of B1 or 32 subclasses.
lEsaunofluorescence of living cells, incident
UV.(Floea) illumination, FITC conjugated goat anti-
rabbit following polyvalent rabbit anti-human





Initially, intracellular immunoglobulin was detected by
reacting ethanol-fixed, air-dried lymph-node dabs, or cell
suspension-smears, with the appropriate specific antiserum coupled
to FITC. Background staining was troublesome, and was removed
only by prolonged washing and by staining with specific rabbit
antisera in a large excess of normal rabbit serum. In general
the iramunoperoxid&se technique is now preferred, since it can be
performed on formalin fixed lymph node which preserves the
anatomical relationships of the cytoplasmic Ig secreting cells.
The technique is described below: (the author is indebted to
Mr. R. Hogg for refining the technique and for the excellence of
his preparations).
Immnnoperoxidase Technique (Peroxidase anti-Peroxidase: PAP)
In essence this technique reacts an unlabelled rabbit
antibody to human immunoglobulin with the tissue section, followed
by a reaction with excess swine anti-rabbit serum. This reaction
leaves an excess of swine anti-rabbit immunoglobulin sites free to
interact with a tracer complex of rabbit anti-peroxidase antibody
and horseradish peroxidase presented as an immune complex. Sites
of binding of peroxidase are revealed by a di-amino-benzidine
reaction (MB) whioh gives a brown precipitate at the site of
peroxidase binding. A number of extremely important precautions
must be taken to procure a controlled and specific result, and
these are indicated below:
1)/...
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Fixation is achieved in 10# formal saline (not buffered).
Lymph node slices must be thin (2 ram) and fixation should
not be unduly prolonged (36-1*8 hours).
Embedding: throughout the tissue processing the temperature
must not be allowed to exceed 60°C. The wax used for
impregnation should have a melting point below 60°C, and
sections must be dried in an oven thermostatically controlled
to f>6°C.
inactivation of endogenous peroxidase. This is achieved
by treating de-paraffinised sections with 1 % of fresh
30 vol. solution of hydrogen peroxide. Controls incubated
directly with DAB are essential to prove inactivation of
endogenous peroxidase.
Blocking of non-specific (background) reactions with normal
swine serum is absolutely essential. It has been found
necessary to carry out the reactions with the various
antisera in a 1 in 20 dilution of normal swine serum to
svoid background.
The optimum dilutions of antisera must be deduoed by trial
and error. Too high concentrations result in heavy
background, are wasteful of expensive antisera, and do not
increase the sensitivity of the reaction. Titres of 1 in
1*0 to 1 in 200 or more are usual in this staining reaation.
The hydrogen peroxide and the DAB reagents must be of high
activity and good quality. Development times MUST BE
FIXED (2-3 minutes are adequate for moat tissues).




a) In&ctiv&tion of endogenous peroxidase must be proven.
b) Slides treated without addition of specific rabbit
anti-human immunoglobulin seraj normal rabbit serum
is substituted.
c) Slides treated with MB, but with omniass ion of the
peroxidase anti-peroxldase reagent.
In addition to these negative controls, each batch
of antiserum must be treated for a positive reaction
with a myeloma section secreting immunoglobulin of
known subclass.
d) In some sections the presence of iron containing
phagocytes can lead to the mis-identification of
immunoglobulin containing cells: a PBH stain on such
sections is helpful.
e) Hast cells in tissue section often stain by these
methods, and must be distinguished from Ig containing
plasma cells.
The method adopted is outlined below:
Step 1) Tissue is fixed in 10$ formaldehyde solution in saline.
Step 2) Conventional dehydration and embedding at temperatures
below 60°C.
Step 3) Sections are cut at optimum of it microns.
Step it) Bring sections to ethanol.
Step 5) Treat sections with 1$ hydrogen peroxide (30 vol) in




Step 6) Wash the section in Tris buffered saline, three times
for 5 minutes each.
Step 7) Treat with normal swine serum (1 in 20 dilution in Tris
Saline).
Step 3) Introduce specific immunoglobulin; rabbit anti-human
Kappa, or anti-human Lambda at dilutions of 1 in 100,
anti-human IgG, IgA or IgK at 1 in 50. These
dilutions are made in Tris buffer, or in 1 in 20
normal swine serum.
Step 9) Wash well in three changes of Tris saline, for 5 minutes
each wash.
Step 10) Treat sections with a 1 in 20 dilution of swine anti-
rabbit IgG, diluted in 1 in 20 normal swine serum.
Incubate at room temperature for 30 minutes.
Step 11) Wash sections in three changes of Tris saline, 5 minutes
each.
Step 12) React the sections with peroxidase anti-peroxidaae
immune complex at a 1 in 100 dilution, either in Tris
saline or in 1 in 20 normal swine serum.
Step 13) Wash sections in three changes of Tris saline, 5 minutes
each.
Step 11*) Stain sections in Di-amino-benzidine reagent (MB) in
concentration of 6 mg/10 ml Tris Saline (This solution
is made up fresh, is colourless and must be used
immediately) with the addition of 2 drops of 10 vol.
solution of hydrogen peroxide. Incubate for a
constant/...
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constant time (3-li minutes). btaining for longer
in the hope of increasing sensitivity will only
increase background staining to unacceptable levels.
Step 15) Wash sections well in distilled water, oounterstain
with naematoxylin, blue up in STWS (differentiating
if required).
dtep 16) dehydrate, clear in xylol and mount in i)PX.
By this technique, sites of immunoglobulin productions are
coloured an intense golden brown. The background should be
colourless. Plasma cells show uniform or reticular cytoplasmic
staining, proplasma cells (Mature BU lymphocytes) show localisation
of Ig to the BhofB, the clear perinuclear region occupied by the
Golgi apparatus. Most lymphocytes do not stain at ail in tissue
sections, and there is no correlation between pyroninophillia and
presence of intracytoplasmic ig in germinal centre cells.
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ngm Si Detection of Intracellular immunoglobulin by
the Immunoperoxidase (P.A.P.) technique
The illustration shove the typical appearances of
plasma cells in a lymph node from a patient with
Hodgkin1 s disease stained by the PJUP. technique
for gamma heavy chain (IgCi). Hote the localisation
of staining to the Golgi area in tvo cells, and
the absence of staining in surrounding cells,
including one plasma cell, which is not secreting
gamma heavy chain.
P.A.P. (rabbit anti-human gamma
chain, swine anti-rabbit serum, and rabbit anti-
peroxidase/peroxidase immune complex) formalin
fixed tissue, counterstained haematoxylin.
x 1,000
Preparation of Cell Suspensions
20b.
Preparation of Cells
The aim in producing cell suspension from several sources is
to recover lymphoid cells from lymph node, spleen, blood and
thymus whilst removing contaminating red cells and polymorphonuclear
leukocytes. All methods of removing contaminants result in some
loss of lymphoid cells, and it is important to ensure that such
loss does not favour the selection of one class of cell over
another. Once a cell suspension is obtained it is necessary to
prove that no selective cell loss has occurred. For this reason
it is essential to measure the loss of cells, and to examine
smears of cell suspensions before, and after separation to prove
the presence of all the initial types of lymphoid cells in the
suspension. In the following section the methods of separating
cells from blood, spleen, thymus, tonsil and lymph node are
described.
The following table shows the recovery of white cells from


























As can be seen, mononuclear cell recoveries are roughly the
same order for normal and pathological samples. With a few
exceptions, differential cell loss is acceptable, but occasional
pathological samples can lose most of the abnormal cells and
recoveries must be calculated for each.
Separation of Mononuclear cells from venous blood
Blood was taken into ACD, 3DTA, or lithium heparin as anti¬
coagulant. EDTA is the preferred anticoagulant since it prevents
platelet clumping and gives cleaner call suspensions. A white
blood cell count was performed., and smears made for differential
counting. The blood was then diluted with an equal volume of
physiological saline, and layered on Ficoll/Triosi1 mixture
(density 1.076). The bottles were cooled to ii°C, and centrifuged
at 1,800 g for 30 minutes at h°C. The red cells, and nearly all
the polymorphonuclear cells clump, and collect at the bottom of
the tube. The white cell layer was removed in toto, and washed
in medium 199, with care being taken to recover all the white
cells. These were finally resuspended in 1-2 ml of medium 199*
and counted. Smears were also made for differential counts.
The WBC in original volume divided into WBC in recovered
mononuclears/x 100 gives the percentage recovery of white cells.
The differential count of polymorphsAymphocytes/monocytes in
whole blood, and in the separated cells, indicates which classes
of cell aire lost, and also enables the mononuclear cell recovery
to be calculated:-
„ i ,, Recovered mononuclears x 100Mononuclear cell recovery »
Total mononuclears in blood sample
Average/...
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Average figures for peripheral blood are 3Q-U0$, with a
range of 17-70$.
The separated cells were washed 3 times in medium 199, and
6
finally resuspended in a concentration of 1 x 10 cells/ml.
Viability was determined by trypan blue dye exclusion technique.
Using such techniques it is possible to calculate not merely the
percentages of cells having a particular receptor, but their
absolute numbers in normal and pathological blood. An example
is given below
MA Id R. Atypical blood, diagnosed as A.L.L. two years ago: no
treatment.
WBC count 2.3 x 10^/ml. Differential: neutrophils 10$, Eosinophils
U$, Myelocytes 1$, Monocytes 1.$$, Lymphocytes 11$, atypical
lymphocytes U6$. Mononuclear cell count 2.78 x 10^/ml.
Recovery from Ficoll Triosil UU.6$, differential - all mononuclears
present.
Rosettes Percentage Absolute numbers/ml Normal Values/ml
E Rosettes 99 1.63 x 106 1.01 + 0.23 x 106
Fc Rosettes 9 0.25 x 106 0.7h * 0.23 x 106
C3 Rosettes 9 0.25 x 106 0.55 ♦ 0.26 x 106
IgK Rosettes Nil Nil 0.03 x 106
Neutral Red
Phagocytes h 0.1 x 106 0.38 ♦ 0.12 x 106
Capping Cells 30 0.82 x 106 0.55 ♦ 0.26 x 106
Non Capping
Cells Nil Nil 0.31 +0.11 x 106
Comment: There is some increase in T cell numbers, and decreased Fc
and C3 receptor bearing cells. Ron-capping cells are absent, this
is/...
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Is unusual, but B lymphocyte numbers are normal.
Method of Study of Glass dherent Cell Receptor Pro-file
Human peripheral blood mononuclear cells from 25-30 ml of
venous blood were separated on Ficoll/triosil and absolute
mononuclear cell counts determined (nos. of cells per ml). These
cells were washed three times, counted, and mixed with 20$ human
AB serum or 10$ lactalbus&n supplement (Habeshaw, 1971) in medium
199* Each batch divided into two equal samples:
Sample 1 was incubated for 6 hours at 37°C in siliconised
tubes, gently agitated. It was then washed and receptor profile
determined on these cells. This was the profile of normal
mononuclear cells.
Sample II was incubated at 37°C for 2 hours in contact with
glass, and the non-adherent cells eluted by washing in warmed
medium 199. The non-adherent cells were quantitatively recovered
from the washings and counted. Since the size of the original
innoculum was known, the proportions and numbers of adherent cells
could be calculated. Receptors were then quantitated in a
standard manner in the normal cells, the non-adherent population,
and the adherent cells.
Separation of Cells from
Spleen
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Methods of Separation of cells from Spleen
The suspension made by teasing spleen tissue contains
numerous red cells. In normal spleen up to 1% of cells recovered
are polymorphonuclear, and in Hodgkin's Disease, these proportions
can be exceeded. Ficoll/triosil density gradient eentrifugation
was the method chosen to remove non-lymphoid contaminants from
spleen cell suspensions, although frequently recoveries of
mononuclear cells were of a low order ( mv 21%). Because of its
variable cellular nature, and consistency, preparing cell
suspensions by mechanical rather than enzymic means proved the
most successful. The method was to tease out small fragments
with a scalpel blade, followed by repeated washing with pipetted
tissue culture medium. Stromal cells (fibroblasts, and
endothelium) are probably not represented in the spleen cell
suspensions so prepared.
In order to compare diseased spleens with normal spleens,
gone parameter was required which would accurately reflect
alterations found in disease. It was therefore decided to
measure accurately the spleen weight and total spleen cell count,
and from these values to derive the quantity "spleen cell
concentration" (number of cells per gm of wet spleen weight).
In establishing the methods of spleen cell concentration measurement
some control determinations were required, and these are now
presented.
'When a spleen is removed at operation, the organ contains
a variable amount of blood, as a consequence of the surgical
techniques employed. The blood removed with spleen can be
estimated/...
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estimated by (1) weighing the spleen in toto, (2) slicing the
spleen finely into 2ram thick sections and allowing the slices to
drain, (3) collecting the blood end weighing again. Subtraction
of the weight of blood from the total weight of the spleen gives
true spleen weight, which is the value used in these estimations.
The average normal spleen in this series yielded between 25 and 60
6
grams of blood, which contains about 2-3 x 10 white cells per
mlj i.e. 50 x 106 to 180 x 106 white cells, for a raean 3pleen
weight of about 150 grams. Since the spleen contains about
500 x 10^ recoverable white cells per gram of spleen weight, the
blood contained in the spleen does not significantly affect the
figures for normal total spleen cell count (which are of the order
of U-8 x 101° cells).
The determination of the total spleen cell count ideally
requires that the whole spleen should be reduced to a single cell
suspension after weighing, and representative counts made from
the resultant suspension. This is impractical for the routine
determination of cell counts on pathological spleeas where some
tissue may be required for other purposes. To investigate
alternative methods of quantitation the following experiment was
performed;
The spleen was weighed and sliced. .From the organ about
1 gra of tissue was removed, at random, avoiding areas containing
much vascular or connective tissue. The remaining spleen was
placed in an homogeniser and reduced to a single cell suspension,
the volume carefully measured, and cell counts done on the
suspension. The cell count per ml multiplied by the total
volume then gave the total recoverable white cell count.
The/...
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The 1 gin of tissue removed before homogenisation was very
accurately weighed in a covered Petrie dish to avoid evaporation
and then rendered into a single cell suspension in a loose fitting
all glass tissue grinder. The residue was washed carefully to
recover all white cells quantitatively and the cell count and
total volume accurately measured. The total cell count was
obtained by multiplying the spleen weight (in grains) by the cell
count per go of spleen tissue. Comparison of the values so
obtained on 5 spleens showed them to agree with + 10%, which is
of the same order as the "counting error" inherent in the white
cell counting technique (♦ 6%), It was thus shown that the
total spleen cell count can be reliably determined from as little
as 1 gm of spleen tissue. This method was subsequently adopted
as standard technique.
Comparison of total cell counts obtained by total or
subtotal spleen homogenisation, with counts estimated from small
amounts of splenic tissue. Material consisted of it P.M. spleens,
and one (3) Therapeutic Splenectomy.
ho. Spleen cell count Spleen cell count + Difference %
(Homogenised) (Estimated Total) ~
1 U.1U x 1010 U.70 x 1010 +11,9%
2 6.59 x 1010 6.01 x 1010 + 8.8£
mm
3 1.025 x 1010 1.07 x 1010 + $.h%
h 9.70 x 1010 9.08 x 101? + 6.39%
5 6.0U x 1010 $.Uk x 1010 + 9.9h%
Mean variation + 8.1*3
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Cell Recovery
The effect of different methods of separating mononuclear
cells from the whole spleen cell suspension was assessed as follows:
The spleen cell suspension, diluted in medium 199 * heparin
(10 units/ml) was layered over Ficoll/triosil mixture, and
centrifuged at 1,800 g for 30 minutes at U°C. Smears were made
from the initial suspension and from the recovered white cells,
and differential counts (polymorphonuclear and mononuclear cells)
were made on both. The initial cell count, divided into the
cell count of recovered white cells, x 100 gave the white cell
recovery as a percentage of the starting suspension. Recoveries
were variable but much lower than those in peripheral blood
(Mean Value 27% range 17-ii7£). In order to prove that selective
loss of one cell class had not occurred, lysis of red cells by
amonium chloride was performed. In this case, red cells only
were destroyed, and polymorphonuclear leukocytes were present with
mononuclear cells in the recovered suspension. There were no
significant differences in the numbers of T cells and B cells so
obtained, but values for Fc and C3 receptors and phagocytes were
markedly different, depending upon the polymorphonuclear
contamination.
Knowing the white cell recovery from Ficoll/triosil and
the differential counts before and after separation it proved
possible to calculate the mononuclear cell recoveries, and these
were of the same order as previously determined (22^). These
values are listed in the previous section.




1) The spleen was cleaned of adherent fat and blood clot,
and accurately weighed in a it litre sterile glass beaker.
2) The organ was then sliced into 2-It mm thick slices using
a sterile skin graft knife blade. The blood running from the cut
surface was collected on impervious "Benchcote" material (Waterproof
side up) and returned to the weighing beaker.
3) The beaker ♦ blood was reweighed, and by subtraction the
true spleen weight was determined.
h) From the spleen slices (from several separate areas of
the spleen) small chunks of tissue were gouged out avoiding
major vascular, capsular and trabecular tissue. These were
placed in a pre-weighed Petrie dieh which was covered to avoid
evaporation and accurately weighed. A cell suspension was then
made by grinding the tissue gently in medium 199 * heparin
(10 units/ml) and the residue washed well to ensure quantitative
recovery of cells. The cell count was performed and the numbers
of cells per gram of spleen weight were determined. This value
multiplied by the true spleen weight then gave the total spleen
cell count.
5) From the remaining spleen, blocks for (a) histology,
(b) specie}, histology, e.g. B.M. and inrmnoperoxidase and (c)
cell suspensions, were removed. (a) and (b) were appropriately
fixed.
6) The tissue for cell suspensions was teased apart with
fine pointed scalpel blades, and squeezing, slicing, and washing
in medium 199 * heparin, rendered into a single cell suspension.
Large/...
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Large clumps of cells, and residue were removed by filtration
through fine stainless steel gauze (80 or 120 mesh, Granton Wire
Works, Edinburgh). Viability was assessed by trypan blue dye
exclusion.
7) Smears for differential counts were made, the total cell
count determined, the suspension was layered over Ficoll/triosil
and centrifuged at 1,800 g for 30 minutes at U°C.
8) The white cell layer was recovered from the Ficoll/triosil
washed three times in medium 199, and the total white cell count
determined. Lmears were made for differential counting.
9) From these results, the following values were calculated
and noted: (a) total spleen cell count, (b) spleen cell
concentration (cell number per gram spleen weight), (c) cell
recovery and mononuclear cell recovery and (d) viability. The
cell suspension was now used to prepare rosettes in the standard
manner.
Separation of Galls from
Tonsil, Lymph Mode, Thymus and
Cell Lines
21U.
Preparation of Lymphoid Cells from Human Tonsil
Tonsils were collected fresh from the operating theatre into
sterile containers holding medium 199, with penicillin (2,000 i.u.)
and streptomycin (10 ug) per ml. The tonsil and medium were then
immersed in melting ice for conveyance to the laboratory.
On arrival the tonsil was sliced into flat sections 1 ram -
2 mm in thickness, and laid in a sterile Petri dish. The surface
was moistened with medium 19? and using a fine scalpel blade,
and where necessary a dissecting microscope, the foci of lymphoid
tissue were lifted out on the tip of the blade. Care must be
taken to avoid (a) bacterial and fungal colonies commonly found
in tonsillar crypts and (b) squamous epithelium which is in
close proximity of the lymphoid follicles. The lymphoid cells
separated were pipetted through 80 mesh stainless steel gauze to
remove cell clumps and disrupt germinal centres. They were then
washed three times. Viability was assessed by trypan blue dye
exclusion, and the cells reacted with red cells to form rosettes
as previously described.
Control sections from material dissected from tonsil showed
that the bulk of the tissue removed was of germinal centre
lymphoid type with a small addition of stromal lymphocytes and
connective tissue. The receptor profile of tonsil is regarded
as being similar to germinal centre in lymph node.
Reparation of cells from Lymph Node
lymph nodes were collected fresh from the operating theatre,
and/...
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and immediately transferred to a sterile container containing
medium 199. The node and medium were then cooled in melting ice
for conveyance to the laboratory. On arrival the node was
sliced using a skin graft knife blade, into 2 mm thick sections.
Care was taken to cut the nods as evenly as possible. Sections
for routine histology, and for imraunoperoxidase technique were
fixed in formalin. Special S.M. histology was taken and fixed
in glutaraldehyde (3%) in cacodylate buffer. The slice for
making cell suspensions was teased in medium 199, end the
suspension filtered through 80 mesh stainless steel gauze to
produce a single cell suspension. Smears of this suspension
were made, and the cells washed three times in medium 199.
Viability was assessed by trypan blue dye exclusion, the cells
counted and receptor profiles determined as previously described.
Dabs, fixed and unfixed, were prepared from the freshly
cut lymph node surface, and stained with Giernsa stain, or used
for histochemistry.
lymph nodes showing viability of less than 60% were not
used for study.
Separation of cells from Thymus Gland
Thymus glands collected either at autopsy from newborn or
from stillborn children, or glands removed in children undergoing
cardiac surgery were collected into medium 199, and cooled in
melting ioe for conveyance to the laboratory. On arrival they
were sectioned and teased into a cell suspension. In order to
prevent cell clumping, this was general/ done in 10-20% fresh
human/...
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human Ab serum, or in pancreatic DtiA' se to remove DMA which tends
to gel the resulting cell suspension. Once the cells have been
separated and washed, subsequent steps can be carried out in serum
free medium 199. Viability of the suspension was assessed, and
rosetting tests performed as before. Sections of thymus were
examined for the presence of germinal follicles.
Cells from Lymphoid cell lines
lymphoid cell line cells were grown in RFMI medium, or medium
199* with ~\Q% foetal bovine serum. Cells were harvested at a
density of 1-2 x 10^ cells/ml at the end of the rapid log growth
phase. This ensured that most cells were not in the pre-mitotic
phases of the cell cycle, and hence that the expressed receptor
pattern was as stable as possible under culture conditions. Cells
were washed in medium 199* the viability assessed, and rosettes set
up as previously described.
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The Receptor Profile of Normal lymphoid Tissues
Receptor profile of glass adherent and non-adherent cells
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Receptor profile of lymphoid cell lines
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The term receptor profile is used to describe the overall
pattern of surface features expressed on cells derived from a
particular tissue.
In the author's experience, and as shall be demonstrated, no
normal tissue containing lymphoid cells produces a profile consistent
with there being only one class of lymphoid cell present. The
result of quantitating cells with different surface features in
blood and in lymph node is to produce a value for the proportion
of cells with each surface feature which is more or less
characteristic for the tissue examined. This is called the receptor
profile of that tissue. The purpose of the investigations carried
out in this thesis was:-
a) to establish receptor profiles for each normal tissue
examined, for example blood, spleen, thymus, lymph node and tonsil,
and to compare these profiles with those resulting from similar
tissue in lymphoma. The degree of difference in the profile of
the normal as against the lymphoma lymph node allows the
comparison of normal with neoplastic cell population.
b) To use such tehcrxiques of comparison to investigate whether
lymphomas of one particular histological type produced a receptor
profile characteristic of that class of lymphoma.
c) To deduce from the study of normal versus lymphoma
receptor profiles, whether certain profiles could be correlated
with the subsequent clinical behaviour of the tumour. The control




1) The receptor profiles of adherent and non-adherent
mononuclear cells from blood was studied. The results indicate
that a proportion of glass adherent cells expressed Fc and C3
receptors and that the majority of such cells Ingested neutral red
dye in a characteristic fashion. This demonstrated that phagocytic
cells in blood exhibited the pattern of neutral red ingestion,
glass adherence, and expression of Fc and C3 receptors.
2) The receptor profile of blood, using both proportional
and numerical quantitation of receptors, showed that E rosetting
cells formed the majority population and that in common with
previously published results the expression of this receptor
correlated with the presence of cells with similar receptor profiles
derived from the thymus gland. These cells are T lymphocytes,
known to be the major population of recirculating lymphocytes from
animal experiments. The B cell population, identified by the
presence of surface immunoglobulin was shown to consist of at least
two classes of cell, based on the differences of surface behaviour
following complexing of fluorescein labelled antibody with the
surface Ig. The B cells showed either the capacity to cap surface
Ig, so called capping cells, or failed to cap their surface Ig, so
called non-capping cells. This proved to be an important phenotypic
difference between B cell classes.
Fc and complement receptors on peripheral blood cells were
expressed on the phagocyte population - a proportion of which
always expressed Pc receptors and complement receptors - and the
B cell population. The non-capping B cell population expressed
Fc/...
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Fc rather than complement receptors in blood.
3) The spleen lymphocyte population in health is drawn
mainly from the blood, as shown from animal experiments discussed
in the introduction. As expected, receptor profile of spleen
reflects the profile of normal blood, save that more B lymphocytes
are present and the concentrations of lymphoid cells are very much
greater. The same classes of cell are present as in blood, with
T lymphocytes, phagocytes, and capping and non-capping B lymphocytes
being identified. The most important discovery was that in
"normal" spleen, despite identical proportions of B cells T cells
and macrophages in the spleen in each sex, the quantitative dis¬
tribution indicates a clear sex difference. Males have more
cells in the spleen than females - a fact quite unknown until the
present study.
li) An important constituent of lymphoid tissue is the
germinal follicle. Experimentally it has been shown to be a
focus of lymphoblast transformation in the later stages of the
secondary response, although its functions are quite unknown.
It was considered possible that the lymphoid population of this
organelle might be unique, and probably B cell in type. The
difficulty of obtaining germinal centre tissue was overcome by
using tonsil, which because of its unique structure, lacks many
features characteristic of lymph node. Among these are the
absence of lymphatic sinuses (a macrophage rich area), and
medullary islands (where most primary response B lymphocytes 00010*)
and the paracortex (a T cell area). The receptor profile of
tonsil therefore should reflect the profile of transformed
lymphocytes/...
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lymphocytes of secondary response type:- the precursors of
secondary response antibody forming B cells (plasraablasts), or
the recirculating "memory" B lymphocyte. As the relevant section
shows a "follicular" receptor profile did indeed characterise
tonsil, and this was unlike the profile of normal blood or spleen.
The follicular B lymphocytes of tonsil are either (1) a mixture
of capping B lymphocytes expressing complement but not Fc
receptors, with a minority of non-capping B lymphocytes expressing
Fc receptors or (2) a mixture of a minority of capping B lymphocytes
which express Fc receptors with a non-capping B lymphoid
population expressing the C3 receptor. Either of these
alternatives is possible, and it is thought may reflect the
reactive state of the follicle at the time of sampling.
5) The receptor profile of the normal thymus gland, as
expected shows a preponderance of E rosetting cells (T cells).
A significant but small non-T cell population composed of B cells
and macrophages also occurs: these may represent the medullary
lymphoid populations known from experimental studies of thymic
lymphopoesis.
6) The receptor profile of several B lymphoid cell lines
was studied as a test of the capacity of the cell in culture to
retain surface phenotype. It was noted that although within
any single line, the expression of receptors was rather variable,
the features of capping and non-capping of surface Ig were
present. C3 and Fc receptors were expressed, only by capping
cell lines. In one cell line of non-capping cells only Fc
receptor was expressed. This data confirmed the findings
relating capping and non-capping behaviour to expression of Fc
and/...
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and C3 receptors, as found in studies of blood, and tonsil.
7) The receptor profile of normal and reactive lymph nodes
served as a model for assessing the lymphoma. Here the degree
of admixture of cells, T and B lymphocytes and macrophages
indicated possible ways of classifying lymphoma. The
characteristic receptor profile of blood, and of tonsil, were
seen in normal and reactive nodes. In addition three nodes
showed mature capping B cells with no Fc or C3 receptor. On the
basis of the receptor profiles for each of the normal tissues
and for the lymphoid cell lines a scheme whereby lymphoid
populations could be assessed in a single node, and that node
classified by means of its receptor profile, was developed, It
is this scheme, applied to lymphoma lymph nodes, which was
adopted as a method of classifying malignant lymphoma by the
surface phanotype of its constituent cells. A sufficient
experience of normal material enabled accurate comparison between
normal and lymphomatous tissue, irrespective of the primary origin
of the lymphoma. The following sections deal with the data
from normal lymphoid tissue.
Receptor profile of Adherent
and Non-Adherent Cells.
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Receptor Profile of Glass Adherent Cells
when peripheral blood mononuclear cells, obtained in a high
degree of purity, are separated and adhered to glass in the presence
of human AR serum, a mean 2U.6$ of cells adhere and 76$ + 7.73$
of cells are non-adherent.
The adherent population shows the presence of neutral red
phagocytes (91.38 + 1*.65$) which also express receptors for sheep
cells (1.0$ + 1.7$) XgO (lib ♦ 12$) and EAC (59 + 17$). A
proportion of glass adherent cells also exhibit fluorescence by
the sandwich technique showing diffuse surface fluorescence with
occasional confluent rings or caps (6.0$).
The act of adhering cells to glass alters the total numbers
of cells expressing receptors when total numbers of each receptor
in the glass adherent and non glass adherent populations are
summed, and compared with the numbers in the original suspension.
The chief gain is in cells expressing phagocytic potential. Upon
exposure to glass nearly all adherent cells exhibit the capacity
to ingest neutral red. In the residual population a variable but
diminished number of cells still exhibit neutral red phagocytic
capacity (6.8$ + 6.0$). Exposure to glass diminishes the numbers
of cells, compared with the original sample, that express E
receptors. The proportions of cells expressing Ec and complement
receptors are increased. Thus the exposure of peripheral blood
mononuclear cells to glass,
1) stimulates uptake of neutral red
2) increases proportions of EAO and Ec receptor cells
3)/...
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3) diminishes numbers of E receptor cells.
TABLE
Receptor profile of Glass Adherent, Eon Adherent, and Whole
flood Mononuclear Cells. (From Ficoll/triosil separated mononuclear
cell suspension).
Adherent Hon Adherent Whole Blood
Proportions 2l*.6 + 7 76.1* + 8 100*
Phagocytes 91 + 5 5.8 + 6 11*.7 ♦ 3.0
Fc Receptors 1*6 ♦ 12 32 + 15 2k * 8.0
EAC Receptors 59 ♦ 17 35 ♦ 9 21* ♦ 6.0
E Receptors 1*.0 ♦ 1.7 36.6 + 6 56.8 ♦ 8.0
Surface Ig Cells 6.0 + 1.3 28.7 + 8 29.0 ♦ 10
This experiment shows that following depletion of adherent
cells, the non adherent population is relatively enriched for B
lymphocytes (surface Ig bearing cells). Many E rosetting cells
fail to rosette following glass adherence. The presence of
adherent T cells and B cells, admittedly in small numbers is
surprising. The fact that adherence to glass also appears to
change in a subtle manner the reactivity of the population,
enhancing Fc and EAC rosetting, and increasing from Mx% to 20%
the absolute proportions of neutral red ingesting cells precludes
the use of glass adherence as a method of purifying lymphocytes.
This work was instrumental in influencing the decision to quantitate
receptors on unfractionated cell populations from lymphomas, thus
disturbing/...
22b.
dist urbing receptor patterns as little as possible. It should
be noted that not all glass adherent cells express Fc or C3
receptors, despite phagocytosis of neutral red.
The Receptor Profile of
Blood Mononuclear Cells.
22^.
tieceptor Profile of Cells from normal Blood
The receptor profile obtained from healthy individuals was
remarkably reproducable, even when mean cell recoveries from Ficoll/
triosil were low (30$ or so). Variation in individual normal
values is of the order of 20$, while the accepted normal mean
variation for white cell counting (by the chamber method) is
♦ 6$. The numbers of B lymphocytes sheep cell resetting, and
phatocytic cells can be obtained by calculation from the mono¬
nuclear cell recovery, the differential count, and the white cell
count. This has obvious value in investigating the blood in
lymphoma or leukaemia, providing the test is well understood, and
its drawbacks known.
The receptor profile of peripheral blood mononuclear cells
is shown in the accompanying table.




£ 1*6.9$ 1.01 0.23
Fc 3U.U$ 0.71* 0.23
C3 25.6$ o.55 0.26
IgM 1.1*0$ 0.03 -
Phagocytes 17.7$ 0.38 0.12
Capping 25.6$ 0.55 0.26
lion-capping 11*.1*$ 0.31 0.11
Total Fluorescence 1*0.0$ 0.86 -
Total Cells 101* 2.15 +0.1*3
The/•.#
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The figures shown are derived from the calculation of
numbers of rosettes per 10^ white cells. The mean recovery of
mononuclear cells was 3i*.39? for FT separated blood, and 1*6.82?
for dextran sedimented blood* the mean values shown were
obtained by combining data from the two separation procedures.
The levels of £ cells are higher, and T cells lower in dextran
separated blood than those for flcoll/triosil separated blood
in which E rosettes form 56.2? and surface Ig positive cells 30?
of the separated mononuclears. The standard error of counting
is assessed as _+ 6?, percentage variations less than this are
probably of little significance.
several observations are noteworthy and these are listed
below:
a) The numbers of complement rosetting, and surface ig
capping cells are virtually Identical, and this obtains for
individuals as well as over the whole series.
b) The numbers of neutral red ing sting and surface Ig
bearing non-capping cells are also nearly identical, and, at
first this suggested that non-capping cells were monocytes or
macrophages. Data from the glas.= adherent cell population
(which was virtually all neutral red positive and surface Ig
negative) proved that the non-capping population did not overlap
substantially with the neutral red ingesting population.
c) The non-capping £ lymphocytes population expresses the
Fc receptor not the receptor for complement, since Fc receptor
bearing cells exceed complement receptor bearing cells by a
similar degree as capping cells exceed non-capping cells.
Assuming/...
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Assuming that the phagocyte population is separate and expresses
both Fc and G3 receptors (as suggested by the adherent cell data),
the excess of Fc receptor must be (i) either on T cells or (ii)
upon non-capping surface Ig bearing lymphocytes.
d) The figures obtained for netural red ingesting glass
adherent cells consistently exceeded the numbers of morphologically
identifiable "monocytes" in the peripheral blood smears. This
finding suggests the existence of a population of cells,
cytologlcally lymphocyte like which ingest neutral red dye, and are
potentially glass adnerent phagocytes. Studies with enti-monocyte
serum show similar proportions (i.e. 1J>$ or so) of peripheral
blood mononuclears expresuing monocyte specific surface antigens
as were obtained in this study with netural red ingestion
(Stuart, A.£., personal communication).
These findings suggest a modification of the strict sub-
classification of peripheral blood mononuclears into phagocytes,
T lymphocytes and B lymphocytes. It is evident that two classes
of surface Ig bearing cells are present, one showing capping
surface Ig and expressing both complement and Fc receptors, and one
showing non-capping behaviour and expressing Fc receptor.
The blood mononuclear cell population demonstrated by these
experiments, with the potential size of each cell pool, is shown
below. hote that in Ficoll/triosil separated blood T cell
proportions are higher, and B cell proportions lower than those
given here, by about 10$.
T lymphocytes - hl%




Total cells by addition of the above
- receptors 26*.
- non-capping surface Ig,
Fc but not C3 receptor
ik%
- adherent neutral red
ingesting, Fc, C3 receptor
positive cells 17$
- 10$$
It is therefore unlikely that any significant "receptor
silent" or "null receptor" population exists in normal blood.
B cells are of at least two classes which differ in respect of




Cellularlty and receptor profile of normal spleens
The study contains, naturally, rather few examples of
"normal" spleens. The spleens referred to as "normal" have two
things in commoni an arbitrarily selected maximum weight of
350 gms, and they satisfy histological criteri of normality.
Those investigated were
1) Presence of germinal centres» few or none is normal.
?.) Presence of stainable iron: a little is normally present.
3) Absence of necrosis or fibrosis of the red pulp.
U) An absence of polymorphonuclear leukocyte infiltration
of red pulp.
5) An absence of major plasma cell infiltrates or of
granulomata.
Normal Spleen
The spleen weight is in grams, cell contration is in numbers of
cells per gram wst weight of spleen tissue.
Patient Age Sex Spleen Wt. Cell concentration Diagnosis
tn 57 M 92 gms 716.3 x 106 P.M. - MI.
N2 26 M 151 907.3 P.M. - drowned
K3 M 121 838.8 P.M. - RTA
NU M 272 U66.9 Laparotomy K.
*5 M 103 599.0 Ca Stomach
N6 1U M 185 h32.l» Traumatic
N7 63 M 118 U97.5 Traumatic
fl8 U7 H 150 59U.7 Traumatic
N9/...
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Patient Age Sex Spleen Wt. Cell concentration Diagnosis
N9 M 150 gms 100.0 x 106 Cystic Spleen
K10 68 X 128 765.6 Laparotomy
HI 2 63 F 160 377.5 P.M. - MI.
N13 F 160 25U.U P.M.
Kill 35 F 107 1*86.0 Traumatic
N15 F 97 1*58.8 Traumatic
N16 38 F 318 181*.6 Chondroma
H17 1*3 F 95 1*1*2.1 Traumatic
These criteria removed from the "normal" epleen series most
of the spleens from patients with haemolytic anaemia, or portal
hypertension. It was found that spleens from patients with
carcinoma of stomach showed decreased numbers of T lymphocytes and
lower cellularity than "normal" spleens whilst showing no
abnormal histological features (Habeshaw and Stuart, 1971* )• All
except one carcinoma of stomach spleens were excluded from the
series. It was demonstrated by statistical analysis (tie author
wo-old like to thank Miss S.M. Gore who performed these tests) that
significant differences were obtained whan spleens were compared
by sex of the spleen donor. These features are shown in the
accompanying table.
Receptor Profile of hormal Spleen* comparison male with female.
Percentage/•••
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Percentage Cells/gn Total Cells
A F M I M I
£ uo* ko% 233.6 x 106 187 x 106 3.U X 1010 2.99 x ,010
Fc 3U 30 200.9 x 106 111 X 106 2.95 X 1010 1.73 x ,o10
C3 32 28 199.7 x 106 106 x 106 2.77 x 1010 1.66 x 1010
IgH - - - - - -
neutral
red
Phagocyte 10 17 60.08 x 106 62 x 106 0.88 x 1010 0.97 x ,o10
F capping 33 29 193.0 x 106 108 x 106 2.03 x 1010 1.69 x 10*°
F.i«. caps 12 12 72.8 x 106 UU.6 x 106 1.06 x 1010 K58•O 1010
Total
cells 95 98 591.5 x 106 367.6 x 106 8.37 x 1010 h.97 x ,o10
Weight 166 gin 156 gm
Note difference in cells/gm and total cells between males and females
are significant (P 0.05). Females have fewer T cells and comparatively
more macrophages in the spleen than do males. Data from 17 spleens,
11 males and 6 females.
The use of the cell concentration as a major variable in
assessing spleen cellularity is forced upon the investigator by the
variability of the organ itself. It is accepted that the biological
significance of spleen cell concentration is not known, but the fact
that significant differences in this parameter for males and females
is shown suggests that the variable measured is a real biological
phenomenon.
U) The Receptor Profile of Tonsil.
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Receptor Profile of Tonsil tissue
The receptor profile of tonsil was regarded as being
representative of germinal follicular lymphoid tissue, as material
separated from tonsil was largely of germinal centre origin. (The
examples quoted form a part of the thesis of Mr. Paul Wilson (1976)
under the supervision of the author.) There is wide variation in
the results from tonsil lymphoid tissue receptor studies, as could
be expected from the nature of the material under study. nonetheless
a characteristic receptor profile has emerged from the tonsil,
shown in the accompanying t ble.
Receptor Profile of Germinal Centre Cells (Tonsil) 32 Camples.
Percentage Range of Values SD
E 36 (18 - 53) ♦ 8%
Fo 9 ( 1 - 18) ♦ 5%
C3 20 ( 6 - 35) ♦ 11
IgM 1 - -
Phagocytes 3 ( 1 - 7) 1 2
Capping 17 ( h - 32) * h
Ron Capping 15 ( 1 - 35) 1 9
Total B cells 32
Total Cells 71% Mean Viability 70%
(E ♦ RR + FL)
Rote that in Tonsil non-capping cells are nearly as common as




As in blood, two classes of B lymphocytes are present, those
with capping surface immunoglobulin and those with non-capping
surface immunoglobulin. The proportion of non-capping surface
immunoglobulin bearing B cells is much greater in tonsil than in
normal blood, spleen or lymph node. There is an excess of
complement expressing B cells over those expressing Fc receptors. The
major immunoglobulin class associated with tonsil germinal centre B
lymphocytes is IgG rather than IgM as with peripheral blood B
lymphocytes, and these cells may have their Fc receptors already
occupied by their own, or other cells surface IgG. The immunoperoxidase
stain has failed to show significant intracellular immunoglobulin in
any germinal centre in either tonsil or lymph node.
In the absence of a paracortex in the tonsil, the T lymphocyte
proportions are surprisingly high, and must reflect the presence of
T lymphocytes within germinal centres themselves, or within the
closely attached corona of lymphocytes which surround the germinal
centre. Nevertheless T cells are a constant population, and must
be regarded as a normal component of follicular lymphoid tissue.
Studies of the secondary immune response in experimental
animals show the follicle to arise in B lymphocyte areas of the
lymph node cortex. Germinal follicles localise antigen following
an IgM primary response, or in a secondary immune response.
Antigen penetration is slow, and is accompanied by progressive
lymphoblastic transformation of follicular cells. The follicular
cell profile is not derived from any single lymphocyte class but




1) Gapping, with Fc and C3 receptors
2) Capping, with C3 receptors and no Fc
3) Kon-capping expressing Fc receptors
U) Non-capping expressing C3 receptor.
Results from individual tonsils support the existence of
these classes and the "follicular profile" is commonly found in
lymph node. The follicle profile arises from a mixture of
several sub-classes of £ cell.
The follicular profile is either (a) or (b).
a) Gapping B cells with Fc end C3 receptor as a minority
population associated with a non-capping B cell
expressing 03 receptor as the majority population.
b) Capping B cells with C3 receptors and no Fc receptor
as a majority population, with non-capping B cells
expressing Fc receptors as the minority population.
The iteceptor Profile of Thjmus
Gland.
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Receptor Profile of Human Thymus Gland
dome difficulties were encountered when assessing the
receptor status of human Thymus gland cells. One feature was the
way in which receptor profile varied with the viability, when
viability was low, proportionally fewer T cells and more B cells
were encountered. ho attempt was made to separate thymio lymphoid
populations into cortical and medullary components, and the finding
on at least two occasions of medullary germinal centres in
histological sections of the sampled thymus gland indicates that
thymic lymphocytes may not be as "pure" as some published work
might suggest. In the data presented about 10# of the cells in
human thymus were non-T lymphoid (3 cells) or phagocytes. The
receptor status of medullary epithelial cells is not known, and
they were sparsely represented in the samples studied.
Receptor Profile of Human Thymus Gland
(19 Determinations, 7 foetal, 12 child thymuses; ho adult)
Mean Percentage of Range
Total Cells
E Rosettes 7h (31.8 - 92.5)
Fc 9.6(15.2)# (1.9-U0.U)
C3 5.2M10.1S> ( 0.2 - 25.3)
Phagocytes 1.7 ( 1 3.5)
Surface Ig 12^.23 (19.32)* ( 0.2 - 57.5)
Mean Viability 83.5 (67 - 99 )
The receptor profile of the thymus gland shows a preponderance
of E resetting cells, and relatively few B lymphocytes. As shown
by/...
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by ♦ two thymus samples in the series showed presence of at least
one germinal centre; the figures in brackets show the effect of
including data from these cases. As a consequence of poor red
cell sensitization, in some cases the levels of EAC or JSAIgO and
£ rosettes detected exceeded total viability. Data from these
cases has not been included.
Heceotor Profile of dome Lymphoid
Cell Lines.
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The receptor profile of several lymphoid cell lines was
studied with two aims in views- firstly to see if distinctive
receptor profiles were present in lymphoid cell lines and secondly
to see if any of the receptor profiles identified in blood, or
tonsil lymphocyte populations were stable in tissue culture over a
large number of cell divisions.
Receptor Profile of lymphoid Cell Lines
Figures given are percentages of total cells.
Total
Cell Line E Fc 91 Igh Phagocytes Capping Surface
Jijoye 5.0 0.1a 0.1a 0 0 Nil 78
GSI 6.0 20 11.0 0 11.0 Present 68.6
BLAI 3.0 57.0 13.0 3.0 27.3 Present 72.0
EBU Nil 5 0.3 0.2 0.8 Present 76
KUS2 2 0.7 h 0 5 all 56
SAUDI 3 32.0 3 3.0 21 Nil 52
BAJI 9 16 2.0 0 8.0 Nil 68
The results for each cell line were rather variable and
dependent upon culture conditions. Expression of surface Ig was
enhanced by washing in acetate buffer. The cells classed as
"phagocytes" showed coarse often single granule uptake of neutral
red. Fc and C3 receptors are only expressed in cell lines showing
capping behaviour. The expression of Fc receptors by the DAUDI
cell line is rather variable} this cell line has no capping cells.
Expression of surface Ig, in most instances was diffuse and non-
capping rather than "dotty" in distribution. The data is the
mean/...
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mean values of 5 separate determinations of receptors on each cell
line.
The cell lines showed some interesting characteristics
a) The cell3 composing them all secreted Ig on their surface,
and the expression of surface Ig was enhanced by washing in acetate
buffer (as reported by Hutteroth, 14.twin and Gleve, 1972).
b) Of the cell lines reported U showed no capping surface
Ig bearing ceils whilst three showed the presence of capping
cells.
C) Two out of three capping cell lines expressed complement
receptor.
d) ho non-capping cell line expressed complement receptor.
a) One non-capping cell line expressed the Fc receptor
strongly (MUDI) and another (HAJI) weakly. SBU cell line
(derived from Burkitt*s lymphoma) did not express Fc or C3
receptors, but contained capping surface Ig bearing cells.
Surface Ig expression was difficult to demonstrate, but with the
lmmunoperoxidase technique the cell line EBU was shown to have
weak intracytoplasmic immunoglobulin (^- heavy chain only) with
surface Kappa chain. This is illustrated.
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Figure 6: Detection of Intracellular Immunoglobulin by the
Imntunoperoxidase (P.A.P.) technique
Cells of the 1BU cell line, illustrated here, showed
capping of surface Ig detected by Immunofluorescence
with polyvalent antiserum, but had no Fc or C3
receptors. Immunoperoxidase reaction revealed gamma
heavy chain intracellularly, reactions with Kappa,
lambda, IgM, IgA were negative. This profile was
tinlike that of B1 lymphocytes (non-capping and intra-
cytoplasmic Ig negative) found in other cell lines
cultured from Burkitts lymphoma. The cells would
thus be classified as BU.
Formalin fixed cell deposit stained for gamma





The receptor profile of normal end reactive lymph node colls
The result of receptor studies on normal and reactive lymph
node cells is shown in the accompanying tables. Study of these
receptor profiles show some interesting features listed be lows
a) In most instances the numbers of fluorescent capping
cells, i.e. those which cap surface Ig, are in predominance over
the non-capping cells. In some reactive nodes this effect is not
seen, especially in two cases where non-capping cells equal or exceed
capping cells (cases Blair and Rae.).
b) In some nodes showing follicular hyperplasia, the
receptor profile is similar to the receptor profile of tonsilar
lymphoid tissue where most cells are derived from germinal centre.
In these cases, the manbers of complement roeetting B cells exceed
the numbers of 3 cells expressing Fc receptors.
c) In nodes with marked plasma cell reactivity, the numbers
of capping B cells are generally high, the complement and Fc
receptor values are low, and a receptor silent population is
present. This is seen from the data where S rosettes, phagocytes
and total fluorescent cells are summed. When this total is less
than the viability, receptor silent plasma cells are found to be
present. In such cases this is confirmed by histologic;.!,
examination.
d) In nearly all cases there is no clear predominmce of
one class of cell. A few cases show an excess of T lymphocytes
over/...
The Receptor Profile of Normal and Reactive
i^Kph Nodes.
2l;1 .
over B lymphocytes and macrophages, but usually no single cell
class is predominant.
RECEPTOR PROFILE OF 17 NORMAL LYMPH NODES
Figures given are as a percentage of total cells present
Name E rosettes Fc rosettes Complement rosettes Fhagocytes Capping Non Capping Viability Comment
Scott D. 57 38 - - 2a 9.0 87 paraaortic Node
Muir 31 29 19 7.0 17 10.0 67 Child 12 years Groin Node
Findlayson 30 16 20 12.0 20 7.0 60 Groin L. Node
McGovern p. 53 38 29 1.U 2a 3.0 sa Child age 12 Normal Node
McGovern R. 18 17 22 a.o 25 5.0 85 Child age 11 Normal Node
Coleman 38 13 52 27.0 26 9.0 80 Sinus hyperplasia
Cowe U1 2h 31 1.0 26 11.3 76 No details
Dryburgh 50 hS " 27.0 13 9.a 76 Aged 10 Mesenteric lymph
node Normal
Fee U8 56 36 20.0 13 3.0 85 No details
Ramsay 59 26 15 5.0 29 5.1 80 Frozen section L. node
Normal
Tait 35 29 33 7.0 31 2.0 7a Axillary node Normal
Clark 51 7 5 11.0 9 a.o 8a Plasma cell reaction
Scott A. 25 12 - - 29 8.0 87 Sinus hyperplasia
Cameron 32 11 2h 10.0 38 16.0 - Groin lymph Node Normal
Williams 9 1 h 11.0 30 13.0 66 Mesenteric node
follicular hyperplasia
Simpson U8 22 h0 11.0 30 5.0 " Follicular hyperplasia
plasma cell reaction
Thompson 5U 8 2h 2.0 17 1.0 73 Follicular hyperplasia
The criteria of "normality" were 1) histology showed preservation of normal architecture 2) lymphadenopathy, if present, was limited to single
group of nodes 3) nodes removed from patients with no disease of lymph nodes, but in which nodes formed an incidental part of a laparotomy or
biopsy specimen. Most nodes in this group show "sinus hyperplasia" "follicular hyperplasia" or"moderate plasma cell reaction" and nearly all
were enlarged.
RECEPTOR PROFILE OF 12 REACTIVE :LYMPH NODES
Figures given are as a percentage of total cells present-.
Name E ixjsettes Ft rosettes C3 rosettes Neutral red Capping Non Capping Viability Comment
Dixon 56 21 33 7.0 U5 12 6h Dorfman's Sinus Histiocytosis with Massive
lymph adenopathy
Dewar 22 11 27 2.0 32 U 70 Generalised lymphadenopathy sinus hyperplasia
with granuloma formation
Rusby 37 27 16 11.0 21 13 70 H.D.N.S. but node studied not involved: follicular
hyperplasia
Scott aa 2h " " 2h 7 75 HD uninvolved node with polymorph infiltration,
follicular reaction
Muir 55 12 35 5.0 10 5 71 Plasma cell reaction, follicular reaction,
granulomata - toxoplasmosis
Murdoch 3h 20 6 9.0 18 3 91 Marked plasma cell reaction + histiocytosis
lipomelanotic reticulosis
Ross 55 18 Uo 27 28 h 95 Shows sinus histiocytosis lymph adenopathy and some
necrosis, no lymphoma
Edwards Ui liO - 26 Ih 8 82 Node shows mixed follicular and paracortical
hyperplasia
Rae 35 5 33 1.0 15 15 6a Follicular pattern, L. node uninvolved, from
patient with H.D.
White 52 9 - 8.0 16 5 68 Groin L. node. Dermatopathic Lymphadenopathy
Maule 18 7 2 7.0 U8 3 78 Pronounced follicular hyperplasia
Blair 56 29 - - 12 17 - Hodgkins node, not involved showing mixed sinus and
follicular hyperplasia
Criteria of "reactivity" were 1) histology showed gross distortion of normal architecture 2) lymphadenopathy if present was generalised
3) nodes from patients with a known primary disorder of lymph node (e.g. Hodgkin's Disease) but without involvement and U) nodes showing
the characteristic diagnostic appearances of extreme reactivity, e.g. lipomelanotic reticulosis.
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The interpretation put upon these phenomena is as follows#
The normal or reactive node contains B lymphocytes at all stages
of development as they mature from recirculating small lymphocyte
to the antibody forming plasma cell. 3 lymphocytes in blood
exhibit four qualities}
a) capping surface Ig
b) the presence of Fc and complement receptors
c) a sub population of non-capping 3 cells
d) a lack of intracytoplastic immunoglobulin.
The normal lymph node would therefore be expected to contain
calls with these qualities derived from blood, admixed with a
resident population derived from the germinal centre, composed of
cells which have complement rather than ?c receptors, and almost
equal numbers of capping and non-capping cells. [he resulting
B lymphocyte profile will therefore depend upon the ratio's in
which these B cell subclasses are mixed within the node. dome
nodes exhibit a profile very similar in proportion to that in
normal blood, save that T lymphocytes proportions are lower, and
B lymphocyte and macrophage proportions generally higher than in
normal blood.
lymph nodes showing follicular reactivity have the profile
of germinal centre cells, rather than blood lymphocytes.
Una normal and two reactive nodes (Clark, Williams and
naule) show a profile which is distinctive and unlike that of
normal blood, or the germinal centre. In these nodes there are
large numbers of capping 3 cells, a small proportion of non-
capping cells, and few rosettes formed with either Fc or complement
coated/...
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coated red cells. Histologically these nodes show cells with
small amounts of cytoplasmic Immunoglobulin and often numerous
plasma cells.
The receptor profiles obtained in cell lines show sever*.!
types of P lymphocytes the chief distinction being between cells
which cap surface Ig, and cells which fail to cap surface Ig.
Lines GSI and BLAI show capping behaviour, and can express Fc and
complement receptors, and are similar to 8 lymphocytes of normal
blood. The BAUDI cell line shows non-capping behaviour but possesses
Fc receptors, and cell line EBlt shows capping behaviour but has
neither Fe nor complement receptors.
The experiments described lead to the conclusion that
several subclasses of B lymphocyte are normally present which
differ in their ability to cap surface immunoglobulin, and in the
expression of Fc and complement receptors. These subclasses ares
1) Capping, Fc and complement receptor bearing B lymphocytes,
found most commonly in lymph nodes and blood and constituting the
major class of B lymphocyte. The surface Ig class expressed is
nearly always IgM but there is no intracellular immune, lobulin.
2) Mixtures of capping and non-capping B cells, expressing
complement receptor and little or no Fc receptor, and containing
no cytoplasmic immunoglobulin. This is the follicular B
lymphocyte profile.
3) A B lymphocyte showing capping behaviour, with little or
no Fc or complement receptor expression, often associated with
plasma cells. Found mainly in late stages of follicular
reactivity and similar in phenotype to the EBLi cell line.
As/...
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As previously mentioned in two reactive nodes from cases
(Blair, Itae) of HodgkLn* s Disease in which the nodes were not
involved, non-capping B cells expressing the Fc or complement
receptor are found. The non-capping Fc receptor type is also
found in the D&UDX cell line. They probably represent additional
B lymphocyte subclasses. Finally a cell type is present in
lymphoid cell lines (KUS2, JUOYE) which has non-capping surface
Ig and fails to express Fc or complement receptors.
The expression of these surface features can be interpreted
as a sequence of "differentiation steps" in the B lymphoid
population. These subclasses can be arranged in a logical
sequence from Immature to mature B lymphocyte forms. The sequence
envisaged is as followst
B1 lymphocyte, non-capping surface Ig, no intracytoplasmic
Ig, do Fc or complement receptors, expressing IgM or IgD surface
immunoglobulin.
B2 lymphocyte, non-capping surface Ig, no intracytoplasadc
Ig, expresses the Fc receptor, or more rarely the receptor for
complement, and probably IgM surface Immunoglobulin (B2.C, B2.Fc).
B3 lymphocyte, which shows capping surface Ig, and can
exist in three forms: B3.1 - blood lymphocyte with complement
receptor and Fc receptors, B3.2 - the follicular B lymphocytes and
B3.3 - "stromal" lymphocyte, found in perifollicular tissue,
expressing Fc receptor but not complement receptors. Surface
Ig is presumed to be Ig£i (B3.1, B3.3) or IgG (B3.2).
BU lymphocyte, which shows capping surface Ig, and little
or nc Fc or complement receptor. It occurs in association with
plasma/*••
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plasm cells, Surface Ig I3 probably IgG,
3$ lymphocyte, with large amounts of intracytoplasmic Ig,
and no Fc or complement receptor.
The classification of normal ami reactive nodes by this
ebbawe is shown.
B Cell Class of Normal and Reactive Lymph Xodea
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Further divisions of lymph nodes into those showing B or
? cells, or macrophages as the predominant cell type, and those
which show a mixture of such cells were devised to assist in the
breakdown of lymphoma lymph nodes into useful categories.
The criteria employed were as follows t-
Lf one class of cell was proportionally greater than the sum
of the other cell classes combined, then the node is said to show
predominance of that cell class.
If no single class of cell is proportionally greater than
the sum of the other cell classes combined, the node is said to
be of "mixed" receptor profile. This is illustrated
graphically (Fig. 7 ) where, it should be noted, small corrections
for viability have been made.
lost normal lymph nodes are T cell predominant, car mixed in
class, and T cell predominance is slightly more common in normal
nodes. Few normal or reactive nodes are B cell predominant.
Thus/ ...
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Thus the classification of normal and reactive nodes shows
1) ftin® normal nodes ar® T c®ll predominant with B cell
subclasses being B3.1 in It, B3.2 in 3# undetermined in 2, and
Bit subclass in one.
2} Two normal nodes are B cell predominant, one of
follicular lymphocyte subclass (B3.2) and one of prosecretory
lymphocytes (Bit).
3) Six normal nodes are of mixed class, three of B3.1
subclass and two of subclass B3.2, and aiemdetermined B3.
It) Five reactive nodes are T cell predominant, with B cell
subclasses of two B3.2, one Bit, one B2 and one unclassified B3.
5) One reactive node showed B cell predominance, this being
of Bit subclass.
6) Six reactive nodes showed a mixed profile, one of 33*1
subclass, one of B3.2 follicular lymphocytes, two were of B3.3
subclass and one was of B2 subclass, one was unclassified 33*
218.
Summary Table showing receptor profiles of tiormal Lymphoid tissue
Figures shown are percentage of total cells present.
Class of Cells 2 Rosettes Fc OjS Phagocytes Capping Son-Capping
Adherent 1* U6 59 91 6.0
Hon Adherent 37 32 35 7 29
Whole Blood (FT) 57 21* 21* 15 29
Whole Blood (D ♦ FT) 1*7 3k 26 18 26 11*
Spleen (Hale) ko 3k 32 10 33 12
Spleer (Female) 1*0 30 26 17 29 12
Tonsil 36 9 20 3 17 15
Thymus 7k 10 5 2 11*
L.hode (unreactive) 39 21* 26 11 21* 8
l.Hode (reactive) k\ 19 21* 10 21* 8
hotes. Receptor profiles are distinctive in that Spleen profiles
resemble normal blood, and reactive lymph node profiles are similar
to tonsil. The exception is the thymus which shows high levels
of £ rosetting cells.
FT ■ Ficoll Triosil separated mononuclear cells
D * Dextran sedimented blood mononuclears.
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b) Classification by surface receptors
2h9.
The study and classification of lymphomas is currently
strongly based on Histological (Rappaport, 1966) or on cytological
(Lukes and Collins, 1975) classifications of the affected lymph
nodes. These classifications, which are summarised In Tables I
ar II, are of practical use in applied pathology, tad that of
R&ppaport has achieved very wide acceptance.
morphological classifications, however, suffer from some
drawbacks, and are generally unsuitable for experimental
investigation since they are based on clinical and therapeutic
effectiveness as their main criteria, and are not intended as an
attern? t to explore the biology of lymphomatosis disease. The last
re; 1 attempt to synthesise the then known facts about the biology
of the lymphoid system, and to apply these facts into a scheme
which included lymphomas, is met with in the illfatea
classification proposed by iiobb Gmith (1936). This failed, not
because the idea was wrong, but because knowledge of the functions
of lymphocytes and related cell types was very incomplete. The
failure of such schemes was responsible for the "hard line" taken
by Gall and Mallory (19i*2) in their insistence on therapeutic and
clinical effectiveness as the final justification of any
classification scheme. oince that time the pathological diagnosis
of lymphomas has drifted away from the mainstream of biological
investigation of the lymphoid system, and only recently has the
isolationist trend of the pathologist been reversed, with attempts
once again being made to unite the pathological appearances with
biological reality.
The chief architects of this reversal in policy have been
Lukes/...
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Lukes and Collins, who, since I960 have with increasing
influence, proposed that lymphomas should be classified
according to the cytological features expressed by lymphocytes
during their development and maturation. In the latest variant
of their proposed scheme, Lukes and Collins (1975) classify the
lymphoid cell tumours under T cell lymphomas, B cell lymphomas,
Histiocytic lymphomas, and lymphomas of undetermined class.
In the category of T call lymphomas, three variants are
proposed, (a) Mycosis Fungoides and Lez&ry'b Syndrome, (b)
Convoluted T lymphocyte, and (c) Irawunoblastic T lymphoid
sarcoma. The first category forms a special case in which the
neoplastic cells show the presence of convoluted nuclei in
some instances, but are classified as T lymphoid on the basis
of E receptors. The other category of convoluted lymphocyte
lymphoma is stated to be frequently associated with a
mediastinal mass and occurs in the young. The marrow is
frequently involved and the condition is often found to be
leukaemic, in which instance it is sometimes called Sternberg
Sarcoma" after the author of the first accounts of the
co-existance of mediastinal lymphoma with leukaemia (Sternberg,
1916). More recently a single case, reported by Smith et al.
(1973) was shown to have T cell markers on the tumour cells,
and the leukaemia lymphocytes. Lymphomas of convoluted
lymohocytes are said to be non-cohesive, infiltrative cellular
neop asms, arising initially in the paracortical ares of the
lymph node. The larger cells show a characteristic "chickens




The classification of the B lymphocyte neoplasias (B cell
lyrrphomaa) depends upon the "Follicular Centre cell" concept.
In this, Lukes and Collins attempt to relate the cytological
features of neoplastic lymphocytes to the appearances of nonr 1
transforming lymphocytes in the germinal centre of the human
tonsil, and to lymphocytes transformed in vitro by mitogens such
as PHA or lipopolysaccharide. The normal germinal centre
contains histiocytes (tingible body macrophages) dendritic
reticular cells, and B lymphocytes. These are of two fundamental
typest- type I with cleaved nuclei and basophilic or pyronino-
ohilic cytopla.s. . This assail cleaved lymphocyte, under the
influence of the antigen retaining dendritic cell, undergoes
transformation and further nuclear cleavage producing the second
class of B cell. By enlarging developing cytoplasmic Bilk and
thus acquiring a rim of pyroninophilic cytoplasm the small
cleaved cell becomes the large cleaved cell. Following this
step, the cleavage disappears, the nucleus develops a prominent
nucleolus or sometimes two nucleoli along the nuclear axis - and
the cell reaches the large non-cleaved stage. The small and
large categories of lymphocyte are divided according to whether
their nuclei are smaller or larger than the nuclei of the
accompanying non-neoplastic histiocytes. The end result of
the small cleaved - large cleaved - large non-cleaved is the
plasma cell secreting Ig.
This pattern of lymphocyte development, from the dormant
small Lymphocyte to the large transformed germinal centre cell
is supported by the experimental evidence of lymphocyte
transformation/...
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transformation. Kxperiments with flash labelling of germinal
centres shows that label tends to appear first in the mantle zone
of small lymphocytes, and later in the lymphoblasts of germinal
centres (Kitrou et al., 1969). This evidence demonstrates that
go minal centres are foci of antigen retention wheie B lymphocytes
undergo transformation to lymphoblaats.
Lukes and Collins found that in the majority of nodular and
diffuse non-Hodgkin lymphoma the neoplastic cells conformed to
the morphology of follicular centre cells. In noduiar
lymphomas the nodules were composed principally of cleaved or
non-cleaved cells, or were mixtures of the us two cell types,
id ffuse lympho ma were of similar constitution, but showed more
variability in cell size. On the basis of these findings it
was proposed that the follicular centre cell neoplasms be graded
into small cleaved, large cleaved, small non-cleaved and large
non-cleaved types. If mixtures of cells occurred, classification
is made on the basis of the predominant cell type, although
prognosis depends on the frequency of the large non-cleaved cells
which are the determining factor.
In other types of lymphomas, notably the T cell lymphoaata
histiocytic lymphoma and diffuse lymphomas of B cell type
(Burkitts type of lesion) the characteristics of follicular
centre cells are absent.
The important features of this classification scheme are
that an attempt is made to relate the normal features of the
reactive lymph node to the neoplasms of lymph nodes, and
secondly it introduces the concept of "maturation block* of the
B/...
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B lymphocyte as an explanation of the accumulation of lymphocytes
of one particular type in a lymphoma. The advantages of the
concept of "maturation block" as an explanation of the phenomenon
are
a) it is known that B lymphocytes experiment illy can be
arrested in some phase of their differentiation, as
for example the arrest of antibody secretion by
committed B cells by suppressor T cells.
b) it explains why continuous production and turnover
of cells within a tumour can occur, while the
morphological features and surface phenotype of the
cellr remain constant.
e) it explains the fact that tumours of B cells rafcely
progress into tumours of functional plasma cells,
an event certain to occur unless B cell




Classification of happaport 1966
1) Malignant lymphoma, Undifferentiated (U.L,)
Definition a malignant tumour of retioular tissue that is
composed of primitive reticular cells shoving no appreciable
histiocytic or lymphocytic differentiation.
la) Malignant Lymphoma of Burfcltt (B.L.)
r multifocal malignant lymphoma of poorly differentiated
.lymphocytic type. A characteristic features is the
presence of histiocytes containing nuclear fragments
(Tingible Body Macrophages) evenly scattered throughout the
tumour.
2) Haligru nt Lymphoma. Histiocytic (lietlculum Dell Sarcoma)(D.H.L.)
(li.H.L.)
Definition<- a malignant tumour of reticular tissue
composed predominantly of neoplastic histiocytes in varying
stages of maturation and differentiation•
3) Malignant Lymphomat Mixed tell (Histiocytic-Lymphocytic)(MLH ♦ L)
Definition:- a malignant tumour of reticular tissue that
is characterised by proliferations of neoplastic histiocytes
and lymphocytes without appreciable predominance of either
cell type.
k)/
U) Malignant lymphoma, Poorly Differentiated lymphocytic (DPDL)
(unsL)
(Lymphoblastic Lymphosarcoma)
Definition:- a malignant tumour composed of lymphocytes
that show varying degrees of nuclear atypia and immaturity,
5) Malignant Lymphoma, well Differentiated, lymphocytic (HWDL)
(DWDL)
{Lymphocytic lymphosarcoma)
Definition:- a malignant tumour that is composed of
lymphocytes which have the morphological features of mature
oellular forms, and which do not possess the usual
cytologic&l features of malignant cells.
Note that in the category of Histiocytic Lympha®* Rappanort
laye stress on the importance of intercellular retioulir.
as a di&gno tie feature.
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TABLE II
Lukes and Collins Classification
tmmmmmmmmmmmmmmmmimmmmmmmmtm ■ ■ i ■ imnni m\\ »n i » >i—i
1) Undefined
2) T cell
a) i'iycosis Fungoides and Sesary*s Syndrome
b) Convoluted Lymphocyte
c) laemnoblastic Sarcoma T cell type
3) B cell
a) Small lymphocyte (SL)
b) Plasmacytoid lymphocyte t associated with CLL
or Hacroglobulinaemia. (PcL)
c) Follicular Centre Cell (which may be follicular,
diffuse, follicular and diffuse, or sclerotic)*
1) Small Cleaved (SC)
11) Large Cleaved (LC)
ill) Small non-cleaved (Burkltts lymphoma)(variable
else non-cleaved cell) (Sf»C)
iv) Large non-cleaved. (LUC)
d) Immunoblastic sarcoma of B cells.
U) Histiocytic type (HL)
5) Unclassifiable (UL)
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Classification by surface recentors
The technique of classifying lymphoid tumours by the surface
phenotype of the tumour cells is new* The available data from
publish© reports, suoeiarised in the introduction, shows that cost
lyr ) ioid tumours are composed of B lymphocytes. T*»ours of T
lymphocytes occur as well as macrophage tumours but these are rare.
Furthermore examples of tumours bearing both B and T lymphocyte
markers, and tumours which fail to show any surface markers have
been described. Any useful phantoypic classification should
recognise these classes of tumour. An allowance must be made for
the prt xjnderance of B lymphocyte tumours, by devising some
reliable method of subclaa3ii'ying b lymphocyte tumours since
otherwise the majority of tumours discovered will be allotted to
the same class, even though of different histological pattern
and prognosis. The questions asked in devising an effective
classification were
1 ) Which markers should be employed to detect the different
classes of cell? The markers chosen must characterise the T
cell, B cell, and phagocyte, and must be sufficient to identify
subclasses of B lymphocyte.
2) Can the surface phenotype studies identify a neoplastic
population if the lymphoma resembles normal lymphoid tissue in
failing to show a single population of lymphoid cells?
3) What rules are needed to interpret the data to produce
a consistent and reliable classification?
U) How to prove that such a classification relates to the
histological/#••
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histological appearances and the clinical behaviour of the tumours
concerned.
1 ) The Markers to eaaplo?,'
The definition of the subclass T lymphocytes is by enumerating
rosettes formed with the sheep erythrocyte. B lymphocytes are
defined as cells which synthesise surface immunoglobulin detectable
by an immunofluorescence technique. Phagocytes are defined by
their ability to ingest colloidal neutral red dye.
These three markers alone allow the identification of f
lymphocytes, B lymphocytes and phagocytes, but do not allow the
identification of tumours bearing more than one class of surface
marker, and are insufficient to detect subclas.es of 8 lymphocyte.
Experience with normal tissues has shown that the additional
markers for complement and Fc receptor, an the capping or non-
capping distribution of Ig anti-lg complex on the B cell surface
are necessary to subclaasify B lymphocytes.
2) Identification of the neoplastic population
Experience with normal lymphoid tissues shov that no tissue,
with the possible exception of thymus, is composed so ley of a single
class of lymphoid cell. normal or reactive nodes contain
approximately equal numbers of t lymphocytes and B lymphocytes.
The germinal follicle shows s unique receptor profile i which both
oappixu a h non-capping B cells, and T cells occur. There is
expression of Fc and complement receptors, but complement
receptors are present on more cells than the Fc receptor. The
resulting/...
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resulting profile is interpreted as a mixture of subclasses of B
lymphocytes. In blood, capping B lymphocytes and non-capping B
lymphocytes are present, and the FC receptor is present on more
cells thrn the complement receptor. This profile is interpreted
as r mixture of subclasses of B lymphocyte. Several different
expressions of surface Ig, Fc and complement receptors are
possible. From normal data, and the published accounts of B
lymphocyte differentiation the following classes of B lymphocyte
can be identifiedi-
31 ^on-capping surface Ig
12 hon-capping surface Ig with Fc receptor (B2.Fc) or
complement receptor (B2.C)
B3 Capping surface Ig with Fc and C3 receptors (B3.1) vith
complement receptor only (B3.2) or with Fc receptor
only (B3.3)
BU Capping surface Ig with no Fc or C3 receptor
13$ Lacks surface markers, but has intracytoplasraic
Immunoglobulin.
It is obvious that no "neoplastic" expression of these normal
lymphocyte markers can be detected in tumours of B lymphocytes, and
there is thus no possibility of differentiating "normal" from
"neoplastic" B lymphocytes on the basis of these surface features
alone. In the absence of specific markers of neoplasia the
diagnosis of lymphoma remains firmly in the province of the
histopathologic. The receptor classification can indicate an
anomalous receptor profile - as when a follicular B lymphocyte
receptor profile is seen in blood B lymphocytes - and this may
suggest/.••
260.
suggest a lymphoma but Is never diagnostic. In lymphomas too the
degree of admixture of cells may not allow any single class of
cell to be selected as the neoplastic population on the basis of
its predominance. It was therefore recognised that the "receptor
profile" of the t'amour is probably of more fundamental importance
to the classification scheme than the individual characteristics
of the cells it contains.
3) The rules of classification
The rules required to produce a reproduceable classification
cm the basis of the receptor profile are straightforward. They
are listed below »-
1} The proportions of each class of cell in the tumour are
examined, and that tumour classified as a tumour of the
predominant cell class. There are six divisions allowed
(1) T cell predominant, (2) B cell predominant, (3)
macrophage predominant, (h) predominance of receptor
silent cells and (5) tamours in which no cell class
exceeds the sum of the other two. There are tumours (6)
in which the sum of B cells, T ceils and macrophages,
as characterised by the surface markers specific for
these cell types exceed substantially the total viable
cells in the suspension examined. These are classed as
"receptor overlap". The first classification step
therefore divides all lymphomas into six classes
1) T cell predominant




h) Predominance of receptor silent cells
5) Mixed tumours in which no single class is
predominant
6) Receptor overlap.
The scheme is illustrated in Figure 7*
Since no subclasses of T lymphocytes or macrophages can be
identified by the techniques employed, no further useful
classification of T cell predominant or macrophage predominant
tumours is possible. Similarly receptor overlap, and receptor
silent tumours cannot be further subdivided. This leaves tumours
of mixed cell type and tumours showing B lymphocyte predominance
as those capable of being further subclasslfied.
a) Tumours of B lymphocyte predominance
These are subdivided on the basis of the B lymphocyte
subclass of the cells they contain. There are eight possible
subdivisions of this group. The first and most important step is
to decide whether capping or non-capping B cells are in the majority.
If capping B cells are more common than non-capping B cells the
tumours are of B3 or BU class. If non-capping cells are the
greater population the tumour is of B1 or B2 subclass. The
subsidiary classification depends upon the expression of Fc and
03 receptors.
If the greater population is non-capping and expresses no
Fe or 03 receptor the tumour is classified as B1•
If the greater population is non-capping, but expresses




26 Normal L. Nodes 4
29 Lymphoma L. Nodes O
Figure 7» Definition of Categories of Lymphoma by Cell
Class
The diagram is constructed as a plot of percentage
T cells against percentage B cells, as percentages
of Total Viable Cells# Lines are drawn to indicate
B cells ♦ T cells less than $0% to give the triangle
at lower left, in which the lesion is composed of
receptor silent ceils or macrophages# Lines drawn
at T cells • 50$ and B cells " $0% of viable cells
thai enclose a central triangle (Mixed) in which
neither B nor T cells predominate. Finally the line
T cells + B cells " 100$ separates receptor overlap
tumours (to the right) from T cell predominant (Upper
triangle) and B cell predominant (lower triangle). To
use the diagram the constituent cells of the tumour
are expressed as a percentage of total viable cells
and the proportions of T cells and B cells thai
determine the area of the plot in which the tumour
lies. Some of the lymphomas (open circles) and normal
or reactive nodes (solid triangles) have been plotted,
The distribution clearly shows (a) the extent of B
cell predominance in lymphomas (b) the tendency of
normal values to fall in the T predominant or mixed
categories. No normal nodes show receptor overlap.
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If the greater population is of capping B cells and they
express
a) C3 and Fc receptors - it is clatallied as B3»1
b) C3 but no Fc receptor - it is ciasilfied as B3.2
c) Fc but no C3 receptor - it is classified as B3.3
d) Ho Fc or G3 receptor - it is classified as BU.
If the tumour is mainly composed of cells containing
intracytoplasroic immunoglobulin it is classified as B$.
*>) Tuaouis shoving no predominance of any cell type (aixed tumourb )
In these tumours, there is a largest population which may be
T lymphocytes or B lymphocytes. Macrophages hare never formed
the largest population in a mixed tumour. These tumours are
classified on the basis of the B cells they contain. obviously
it cannot be argued that they are B cell tumours but T cell
"tumours" cannot be usefully subdivided, whereas B cell tumours
can. Mixed tumours are therefore classified as for the B cell
predominant tumours. Most of the mixed tumours do how b
lymphocytes to be the largest single cell class.
AcceptorPredomiant
Tiymphocytepredominant ;>acropha^epredominant ilecentorSil nt Blymphocytepredominan GappingSurfaceIg 33.1-BloodLymphocyte B3.2-Follicularlymphocyte B3.3-Parafollicularlymphocyte 'it-Pro-aecretorylymphocyt B$-Plasmacell
Lymphnode KaceptorOv rlap (Tcell♦Surfi eIg) (Tcell♦Fcreceptor) (TceLl♦03receptor)
..on-cappingSurfaceIg B1surfaceIgalone Bf.FcsurfaceIg♦Fcreceptor B2.CsurfaceIg♦C3receptor
rixedReceptor
BlymphocytelargesTlymphocyte singlecellasslarg tsingle class Macrophagelargest singleclass CappingSurfaceIg B3.1-loodlymphocyte
r\3
B3.2-Follicularlymphocytep B3.3-ParafollicularLympho yte Bit-Pro-secretorylymphocyt B5 -Plasmacell
Asmallnu beroftumoursayrem inunclassifi bleac rdingthischeme -e.g.thosexpres ng C3orFcreceptoronly.Nomixedtu ursfmacrophagesw rse n,ando lnefTcells(Pati t Thompson,n dularlymphocyticlymp a).
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bode Predominant hixed Cell class Histology
Hall ♦ B1 DHL
Hogg ♦ B1 DH/DPDL
iiaith ♦ - B3.2 DHL
Ross ♦ - Macrophage DHL
Oliver ♦ - Receptor DHL
Silent
Ritchie ♦ - Receptor DHL
Silent
Baird ♦ - Overlap DHL
Moyes ♦ - Silent DHL
Johnstone ♦ B1 DHL
As shown 5 nodes in this series were of mixed class and
15 showed predominance of B cells, four were receptor silent,
two nodes showed T cell predominance (one only by a very small
margin) and two showed receptor overlap. There was one macrophage
tumour. Three of the diffuse lymphocytic lymphomas (DLL) and two
nodular lymphocytic lymphomas (HLL) showed mixed receptor profiles.
All B1 tumours, end all B2 tumours were B cell predominant, the
only mixed tumours being tumours of B3 lymphocytes.
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In the description of receptor profiles in non-Hodgkin
lymphoma, it is apparent that there is not necessarily any
correlation between the functional characteristics of the cell
(as assessed by membrane receptors) and its morphological
appearance. Where such a divergence is apparent, the preferred
classification of the cells is that based on the receptor profile.
Some means of classification of B lymphocyte and mixed
tumours was required, and that adopted was based on the study of
normal tissues, lymphoid cell lines, and from the available
literature. The primary division was between cells which
showed "capping" surface Ig, and those which failed to cap.
-hen "capping" against "non-capping" cells for B lymphocyte
lymphomas and normal lymph nodes are graphed (see Fig. 8) it is
apparent that in most mixed tumours, and normal nodes, capping
cells exceed non-capping cells substantially. In lymphomas,
particularly the B lymphocyte predominant tumours, it is not
unusual to find non-capping cells exceeding capping cells in
number. won-capping lymphomas were allotted to categories 31 or
B2, depending upon the expression of the Fc and C3 receptor.
Son-capping lymphomas were generally not found to express
complement receptors.
The capping lymphomas of B cell predominant or mixed type
were allotted to categories B3» BU depending upon the expression
of Fc and C3 receptors in the name manner as normal or reactive
lymph nodes were classified. B lymphocytes of the B3 class
could be further subclaasified on the basis of their receptor
profilei— the subclassification adopted is according to whether
the/...
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Capping/Non-Capping surface Ig bearing cells in 26 Normal Control lymph Nodes ( A )
and 22 B cell lymphomas O
70 - Normal Lymph Nodes A
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Figure 8t Plot of Gapping B lymphocytes against Non-capping B
lymphocytes in 26 Normal or Reactive nodes and 22 B
cell or Mixad lymphomas
The normal or reactive nodes (solid triangles) show
in all but 2 cases a predominance of capping cells.
Six of the lymphomas (open circles) express a normal
B cell profile (clustered to the left). In the
central group the proportions of non-capping cells
are above normal, but are still exceeded by capping
cells. To the right, the group of 8 B1 and B2
lymphomas are quite clearly distinguished. The
tumours shown were classified as B cell predominant
or mixed.
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the B lymphocytes exhibited the profile of blood B lymphocytes
(B3.1) germinal centre B lymphocytes (follicular type B3.2) or
the profile of lymphocytes exhibiting capoing behaviour and /c
receptor only (parafollicular type B3.3).
The possible B lymphocyte subclasses, described by these
testa are El, B2 with Fc receptor, B2 with C3 receptor, B3.1* B3«2,
B3.3, Bit and B$. In practice, the profile B2.C was encountered
rarelys- in leukaemia blood, and in Hbdgkln*s disease. The
profile of B5 was encounted only once.
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IntracytopjUsfBio immunoglobulin
As an aid to classification, sections of lymph node tumour
were examined for intracytoplasraic immunoglobulin by the imrouno-
peroxidaae technique.
Material was available from 20 of the 31 lymphoma cases, of
which four showed positivity.





Gaffney HPDL BU IgA ^ambda chain
dmith £• isPDL B3.1 Weak uambda chain only
MeGrail DPDL B3.3 Igh only
Cairns DWDL IgI4, weak IgU, Kappa chain
Of the other tumours no material was available from Monroe
(BU) arid in Dobie (BU) some cells showed weak IgH an Kappa
reactivity, but most cells were negative. ho lymphomas of B1, B2
or receptor silent class showed any positivity. The distinct
pattern of strong staining of Cairns stood in contrast to the
other cases, only Gafffaey showed unequivocal staining of most of
the tumour cells and the reaction was much weaker than that of
Cairns. The results showed that intracytoplasmic Xg is
expressed in tumours of BU and B5 class in the majority of cells,
and in a minority of cells in B3.1, B3»3 and BU classes.
Borderline positivity is difficult to assess in all but B$ tumours.
Intracytoplacmic/. •.
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Figure 9t Schweigger oeidel sheath from the Spleen in
Hodgkin's Disease
The illustration shows the macrophages of the
sheath* (blue) containing iron in close relation
to IgG containing cells (brown). The arteriole
is present at lower right.




Intracytoplaarnic iwBunoglobulin of IgQ clasa was found most
frequently in sections from Hodgkin's disease nodes and spleen.
In spleen particularly the nuefefjrs of ig positive cells were
markedly increased in comparison to normal spleen. Dual staining
for iron (PBR reaction) and for Intracytoplass&c Ig showed IgO
containing plasma cells of both Kappa and Lambda chain type to be
closely associated with iron containing splenic macrophages
especially in the ellipsoids (Schweigger Seidel sheaths) of the red
pulp. This striking association (Fig. 9 & 10) probably explains
the observations of Order (1971) that in Hodgkin's disease
antibodies to ferritin can regularly be fO'xnd. The Reed Sternberg
cell in Hodgkin's disease exhibited a variable pattern of itaining
with some cells showing unequivocal positivity for IgG or igh
with Kappa chain, while others showed no reaction. The findings
strongly suggest that the Reed Sternberg cell is a derivative of
B lymphoid cells but that a great variability in arao unfc of
intracytoplasmic Ig secreted is encountered.
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Figure 10; inwunopToxldasa/PBH reaction In Hodgkin'e Spleen
Asingle IgO containing cell (brown) in intimate
contact with the cytoplasm of an iron containing
macrophage (blue)
PJl.P. Istnunoperood.dase and Prussian blue
reaction
x 630
REFERENCES - CHAPTER 16
CALL, E.A. and MALLORY, T.B. (19^2) Malignant lymphor tt a clinico-
pathological survey of 618 cases. Amer. J. Path. JH9, 3B1-U29.
EDKIS, R.J. and COLLINS, R.D. (1975) New approaches to the
classification of the lymphomata. Brit. J. Cancer. 31, suppl. 2,
1-28.
MITROU, P.S., QUISSER, W., LENNERT, K. and SANDRITTER, W. (1969)
Kobinierte autoradiographischcytophotometrische untersuchungen
von kelmzentrumscellen der nensehlichen tonsille. Virch. Arch.
(Zellpath.) I, 156-170.
ORDER, S.E., PORTER, M. and HELLMAN, S. (1971) Hodgkin*s disease:
evidence for a tumour associated antigen. New. Eng. J. Med.
28£, U71-U7U.
HAPPAPORT, H. (1966) Tumours of the haeraopoetic system. In Atlas
of tumour pathology. Section III, Fasc. 8. Armed Forces
Institute of Pathology, Washington, D.C.
ROBB-SMITH, A.H.T. (1936) Reticulosis and reticulo3arsarcoma: a
histological classification. J. Path. I4.7, 1j75-1i80,
SMITH, J.L., BARKER, C.R., CLEIN, Q.P. and COLLINS, R.D. (1973)
Characterisation o lignant mediastinal lymphoid neoplasm
(Sternberg sarcoma) as thymic in origin. lancet _I, 7U-77.
STERNBERG, C. (1916) Leukosarcomatose und myeloblasten leukemia.
Beitrage zur pathologischen anatoraie und zur allegemienen
pathologie (Zeigler's Beitrage) 61, 75-98.
agS&LTS
The Lymph ;<ode In lymphoma
n) In the nodular lymphocytic lymphoma.
b) In the diffuse lymphocytic lymphoma.




Bacaptor profilae In nodular ikyphocytlo lyaphowaa
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Nodular Lymphocytic Lymphomas
All patients In this group had nodular lymphocytic lymphoma
of poorly differentiated cell t;pe by Rappaport*s classification.
In all but one, the diagnostic biopsy was lymph node. in one
patient the diagnosis was made on involved spleen. In several
patients, blood receptor profiles were studied at time of biopsy
and at monthly intervals thereafter with the patients on treatment.
Only one patient in this group is dead. The B lymphocyte
subclasses in nodular lymphoma are mature in form. Two patients
had, in addition, chronic lymphocytic leukaemia at the time of
diagnosis. Two patients in this group have had splenectomy, in
one (Muir) it was the only material available for study, in a
second (Robertson A.) it was removed during laparotomy for disease
progression.
' odular Lymphocytic Lymphoma


































































The receptor profiles reveal two nodes of "mixed" status, both
exhibiting B3.1 subclass of B lymphocytes. Of the remainder, three
are of B lymphocyte predominant BU subclass, one of B3.2 subclass
(follicular subclass) and one is T cell predominant with B3
lymphocytes of uncertain subclass. Only one patient in this group
has died, and this patient is discussed in the text. The node of
McKenzie was the only B2 tumour in this group.
Receptor Profiles in Nodular lymphocytic Lymphoma













































E Pc 91 Phagocytes GaPPinS Non-capping
28 23 17 6 57 27
26 8 7 2 38 2
26 38 29 3 33 7
(In HcKenzie », the lymphoma nodules were separated from the adjacent
lymphoid tissue and their profiles studied separately. The nodules
show an excess of B2.Fc lymphocytes, while in the paranodular tissue
B2.C lymphocytes are the major cell class. On this basis th»i
tumour was classified as 32.)
Patients with nodular lymphocytic lymphomas occasionally show
chronic lymphocytic leukaemia as in the examples given below.
Percentage figures are given as percentage of total cells, the







E 8 31 2.25 38 1.09
Fc 6 36 0.99 28 0.795
C3 4 26 1.73 7 0.19
Phagocytes 17 22 1.43 11 0.32
Capping Cells 38 17 1.11 14 0.41
Non-capping
Cells 27 18 1.20 1U 0.41
Differential
Count
Pblys. 25 64 «•
Monos/...
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Munroe A. Mode Blood (1) ^ Blood (2) ✓
Percent Percent (x 10 ml) Percent (x 10 ml)
Monos. ?5 36 -
Mononuclear count - 6.65 x 10^ - 2.88 * 10^
In this patient, at the time of biopsy a circulating abnormal
cell population was present. These cells were of (B2) rather than
blood type (B3.1). One month later, after treatment, the white
cell count was lower, but the circulating cells were still of 32.Fc
rather than blood class (B3.1). This patient did well, and still
survives 26 months after biopsy. The lymph node pattern was B
predominant Bit class. Macrophage numbers were elevated in node
and blood, and T lymphocyte numbers were raised (1) or normal (2).
By contrast the patient Robertson, showed an abnormal blood
receptor profile, and no response to treatment. The original
nodular lymphoma progressed rapidly and at autopsy was of diffuse
rather than nodular type. The receptor profile of the node at
diagnosis was B lymphocyte predominant and of follicular type
(B3-2). The data is shown below. Percentage figures are
percentage of total cells, and the quantitative data are presented
as millions of cells per ml.
Robertson A. Rode Blood (1) ✓ Blood (2) ,
Percent Percent (x 10 ml) Percent (x 10 ml)
£ Ui* U1 0.37 U8 0.6U
Fc 21 28 0.25 39 0.53
C3 Uh 3 0.02 37 0.51
Phagocytes 6 Mi 0.13 8 0.1
Capping/...
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Robertson A. Mode Blood (1) ^ Blood (2) ^
Percent Percent (x 10 ml) Percent (x 10 ml)
Capping 30 19 0.17 8 0.1
Non-Capping 25 27 0.21* 12 0.16
Receptor Silent - Mil - 21* 0.32
mononuclear Cells 3&X 2.1* 38% 3.8
B Cell Class B3.2 B2.ite ?
Receptor silent cells appeared in the blood within 1 month of
diagnosis. The receptor profile of blood B cells was B2.Fc.
With treatment (blood sample 2 obtained 1 month before death), the
blood showed the presence of receptor silent cells (2U£). Ron-
capping cells exceeded capping cells, both Fc and C3 receptors
were expressed on the B cell population, and on some of the cells
which were surface Ig negative. This suggests that in this case
the receptor silent population was derived from primitive B
lymphocytes.
This patient also had the spleen removed at laparotomy} the
organ was not involved, and showed normal cellularity, and normal
weight, and the B cells were of B3.1 class. Hie patient died
2 months after diagnosis.
Robertson A. Spleen weight 105 gm. *'otal cells 6.89 x 10*°
cells per g». 656.2 x 10^.
Rosettes Percent Mass per gram
E Uk 287.6 x 106
Fo 28 1 80.9 x 106
03/•••
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U2 276.2 X ,o6
11 70.5 X 106
31 200 X 106
16 10U.7 X 106
The data shows that even in a group of histologically
uniform tumours occasional individuals exhibit atypical features*
The features suspected of association with poor prognosis in this
case are (1) the primitive B2.C nature of the blood lymphocytes
despite the mature lymph node population and (2) the presence of
a receptor silent eell population in blood approximately one month
before death*
The nodular lymphoma of McKenzle
In this macronodual tumour, the nodules were separated by
dissection and the receptor profile of nodules and paranodular
tissue assessed separately* The distinctive profiles of each are
well shown, but contrary to expectation, the complement receptor
bearing B cells were lower in the nodule than in the paranodular
tissue, while in germinal centres complement rosettes are higher
than Fe rosettes* In the nodules of this tumour, the Fc receptor
cells substantially outnumbered the 03 receptor cells, and T cells
were present. The substantial excess observed of non-capping
cells to capping cells is a feature sometimes associated with
follicular B lymphocytes of tonsil, but germinal centre cells are
of/...
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of B2.C rather than B2.?c class. The Fc receptor excess shows
clearly that the nodules in this case do not correspond to the
profile of normal Germinal centre and the large numbers of non-
capping cells support a classification B2 lymphocytes in a B
lymphocyte predominant tumour.
The receptor profile of nodular lymphoma was expected, on the
basis of the similarity between the germinal centre cells and the
nodular lymphocytic lymphoma cells (which Lukes would classify as
small cleaved), that follicular B3.2 patterns would predominate.
Unexpectedly the profiles showed three B lymphocyte predominant
i& tumours, two predominant and one mixed £3*1 tumours, one B2
predominant, and one T predominant tumour with B3 lymphocytes. Only
one patient with a follicular pattern (B3.2) emerged (itobertson A.)
and this patient died rapidly with diffuse lymphoma at autopsy and
a leukaemia of receptor silent cells.
Chaptf 18
Bwptor profil>s in dlffa— lymphocytic lyphowi
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The Diffuse Lymphocytic Lymphomas
These tumours showed no evidence of nodularity, and were
classified according to Rappaport as mixed cell (with equal numbers
of lymphocytes and histiocytes), poorly differentiated lymphocytic,
or well differentiated lymphocytic tumours. Diffuse histiocytic
tumours, and diffuse undifferentiated tumours were classified
together and are discussed in the section of histiocytic lymphoma.
Among this group of tumours, there was considerable
heterogeneity of receptor profile, of histological appearance, and
of survival.
Diffuse lymphocytic Lymphoma
Clinical Data, and Receptor Classification
Name Histology A/D Time
Tmo.)
Age Sex Clinical Stage Receptor Profil
Velzisn DWDL A 2 56 M IV CLL B1
Moodie DPDL D 2 76 F Extranodal B2.Fc
Predominant
Robertson J. DPDL D 6 68 M xV B2.C
Predominant
Fraser DWDL A 12 60 M IV B3.?
Predominant
Bathgate DWDL A ♦ 56 M II B3.1 Mixed
Swanson DPDL D 8 63 F II B3.? Mixed
McGrail DPDL A 1li 68 M IV B3.3 Mixed
Cairns DWDL DQ ♦ 68 M II BJ> Predominant
Wilson DPDL A 12 8 F I T Predominant
Kerr DPDL D h 70 M IV Receptor Silent
Laverick D.Mixed A 111 1li F II Receptor Overla
Reid DWDL A 1 67 M IV CLL B2
♦Long/...
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* Long term survivors. Death (Cairns) due to myocardial
infarction, patient had Waldenstrom's disease. The patients
Velzian and Reid both bad CLL associated with lymphadenopathy.
They are described with this group, and considered later in detail
in the text.
Of the twelve tumours examined, two were CLL associated at
diagnosis, and two were tumours of B2 lymphocytes. Of the B3
tumours, two were unclassified, one was B3.1 arid one was of B3.3
pattern. The only B5 tumour in the series occurred in this group.
To emphasise the heterogeneity of the diffuse lymphocytic lymphoma>
one T cell predominant, and one receptor silent case occurred in
this group of lesions. Receptor overlap was present,in one case,
and mixed E and Fc receptor bearing cells were found in the node
and blood of the B2 lymphoma of Robertson.
Diffuse Lymphocytic lymphoma
Receptor Profile
Name Viability E Rosettes Fc 23 Phagocytes Capping Non-Capping
Velzian 90 59 2 1 1* mm 99
Moodie 88 6 55 mm 2 30 36
Robertson J. 91 28 58 1*9 11* 15 28
Fraser 80 11* - - 8 1*2 17
Bathgate 80 38 23 22 1* 33 7
Swanson 90 50 23 - - 1*3 7
McGrail 75 1*6 67 8 6 31 9
Cairns 93 11* 1* 1* 1 53 + Plasma Cells
Wilson 76 61* 11 13 1* 3 -
Kerr 88 11* 17 21 3 1 2
Laverick 69 1*9 1*0 30 12 - -
Reid 81* 11 2 6 9 5 11*
The/...
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The interpretation of the diffuse lymphocytic lymphomas is
rendered more complex because they are not a single disease, but
on the basis of data obtained in this study include at least seven
separate entities. These will be discussed in the following
order (1) the receptor overlap tumour, (2) receptor silent tumour,
(3) T cell predominant tumour, (1;) lymphoma, (5) B3 tumours,
(6) the B2 tumours and (7) diffuse lymphoma associated with
leukaemia.
(1) Cases of receptor overlap
The tumour in this case (Laverick) is illustrated (Figs. 11,
12, 13.) It is similar in receptor profile to a case of diffuse
histiocytic lymphoma (Balrd) discussed later. The biopsy
consisted of a large node from the groin, which communicated with
a sinus opening onto the skin surface. There was other
lymphadenopathy at diagnosis. As the receptor profile shows,
the bulk of the cells were showing E rosettes with high Fc and C3
rosettes. Surface Ig bearing cells were not estimated, for
technical reasons, but Fc and C3 rosettes, which give reliable
estimates of B cell numbers indicated 30-kQ% B lymphocytes. The
viability in the node was low, but despite this, there was clear
evidence of tumour cells exhibiting E, Fc and complement rosettes.
On this basis the lesion was classified as "receptor overlap".
Polymorph contamination was present and neutral red ingesting
phagocytes were fairly numerous.
.Receptor overlap was noted in the peripheral blood of one
other case (Robertson) in this group. The receptor profile of
the/...
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Figure 11x Histological Appearance of a Receptor Overlap Tumour
This node from patient IAVERICK was classified as a
diffuse lymphocytic lymphoma of mixed histiocytic
and lymphocytic pattern.
Haematoxylin and eosin x 600
Figure 12i K.M. Appearance of Receptor Overlap Tumour
A typical cell shows a v acuolated cytoplasm with
numerous mitochondria, large nucleus, and irregular
nucleolus. These cells expressed receptor for both
sheep red cells and complement.
E.M. x 2,$00
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the peripheral blood is shown below. Despite showing no overall
receptor overlap in the node as in the first case, £ and Fc
receptor overlap was shown using mixed rosetting with human Fc
and sheep cells in the blood and node. The glass adherent/non-
adherent cells in this patient were also examined, proportions
were essentially normal.
Patient Robertson (1-5 blood profiles; 6 lymph node.)
Figures are given as percentage of total cells.
E Fc £3 Phagocytes Capping Non-capping E/Fc Mixed
1) 8U U5 52 - 23.5#
2) 65 - 53 7 2 All cells showing faint fluorescence
3) 27 U2 10 10 21 10 6.7#
U) 38 29 30 18 29 7 11#
5) U8 19 28 mm 20# showing £ rosettes and fluorescence
6) 28 58 h9 1U 15 28 21#
With a majority of 28# of non-capping cells present the
profile is B2.C - 20#, B2.Fc - 8#, B3.1 - 15#, T.Fc - 21#, T - 8#
and phagocytes - 15#. When the mixed E and Fc (T.Fc) rosettes
are allowed for the profile is simplified into the classification
B2.G, and the profile is B lymphocyte predominant.
Of the two patients showing E and Fc, E and fluorescence, and
E and complement rosette overlap, one has done well despite "bad"
histology (Laverick), and one with poorly differentiated diffuse
lymphoma/...
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Figure 13: E.H. Appearance of Receptor Overlap Cell
This high power E.M. of a portion of the cytoplasmic
of a singLe tumour cell from patient LA.VEHICK shows
numerous cytoplasmic polyribosomes and a prominent
leash of intracytoplasrnic microfilaments.
E.M. x 31,250
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lymphoma has done badly. If the overlap is taken account of,
the receptor profile of B cells in the lymph node tumour of
Robertson is B2, with B2.G cells predominating.
2) Receptor silent tumour (Kerr)
The patient with this tumour presented with small velvety
slightly raised and pigmented placques in the skin. He also
had lymphadenopathy. A lymph node biopsy was performed, and
a • i. . . *
peripheral blood studied at the time of biopsy. The data are
shown below, and include data from a second blood sample removed
after relapse, shortly before death.
Kerr. Receptor profile of blood (1) (2) and lymph node (3).
Values are given as percentage of total mononuclear cells.
E Rosettes Fc £3 Phagocytes Capping Non-capping Silent
1) 1|2 32 28 1 3 3 23
2) 10 17 18 1 h 1 67
3) 111 17 21 3 1 2 63
Mononuclear cell count (1) 5.60 x 10^/ml (2) 27.9 x 106/ml WBC per ml.
In both the first and second blood samples there are cells
lacking surface Ig but expressing some C3 and Fc receptors. E.M.
showed these to be rather granular in appearance} they probably
represented myeloid cells:- a leukoerythroblastic blood picture
due to replacement of marrow by lymphoma. There was an initial
response/...
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fflgure 1U: The E.M. Features of Receptor Silent Cells (Kerr)
As this low power E.H. picture shows, the receptor
silent cells of patient Kerr, were of obvious
"lymphoid" morphology. The closely packed cells
in this section from lymph node show irregularity
of nuclear outline and "empty" cytoplasm, with




Figure 1$: The E.M. Features of Receptor Silent Cella (Kerr)
At higher magnification the absence of
intracytoplasmic fibrils and endoplasmic reticulum
and the presence of clusters of polyribosomes is




Figure 161 The Features of iieceptor client Cells (Kerr)
This cell from the receptor silent tumour of
patient Kerr illustrates the quite marked nuclear
irregularity of cells in this tumour. Theis are
several structureless dense bodies in the
cytoplasm and some vacuolation of the cytopl asm.
x 3)17^«
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figure 17i E.M. features of Circulating Receptor Silent
Cells (Kerr)
The appearance of tumour cells, isolated from the
blood, is shown here. The same nuclear irregularity
ia seen in some cells, and electron dense bodies are
bodies in the cytoplasm. The adjacent neutrophil




response to chemotherapy, but bone marrow involvement became
widespread with termination in a leukaemic state. Survival from
diagnosis was five months. The histological appearances are
illustrated (Figs. 11*, 1f>, 16, 17.).
3) T cell predominant tumour
This patient, an 8 year old girl, presented with some mild
constitutional symptoms and a single node in the neck. The
histological appearances were those of a diffuse poorly
differentiated lymphocytic lymphoma (Fig. 18). The receptor
profile showed T cell predominance. T cell neoplasms are rare,
and rapidly progressive and generally leukaemicj this patient
did not have leukaemia. Reactive lymph nodes do show extensive
T cell predominance but rarely to the extent shown in this
patient. Despite these observations, the histological
appearance is that of lymphoma. Subsequent investigations have
revealed a toxoplasma titre of 1:8,000 (IgG antibody). The
patient is well.
Wilson. lymph Node.
E Rosettes Fc £3 Phagocytes Gapping Non-capping Viability
6h% 11 13 h 3 Nil 76
h) 15 Lymphoma (Cairns)
This patient, had Waldenstrom's disease for about 18 years
before/...
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Figure 18: The E.M. Features of a T Cell Predominant Tumour
(Wilson)
This tumour, showing the features of diffuse poorly
differentiated lymphocytic lymphoma, was composed
of E rosetting cells. The irregularity of nuclear
outline and chromatin density are features said to
be suggestive of T lymphocytes. The cell cytoplasm
is ill defined, and widespread interdigitation of




before a relapse necessitated repeat biopsy. The receptor
profile is shown. A feature was the presence of IgM secreting
lymphocytes, which were also PAh positive, in sections from the
node. The patient responded to chlorambucil, but died some
months later suddenly from a myocardial infarct. These tumours
must be quite rare, since this is the only example so far studied.
The appearances are illustrated in figures 19 and 20.
5) The B3 tumours
This class contains the longest survivor of the whole
series (/ 20 yearsj Bathgate) and one of the shortest survivals in
the series (Swanson,<8 months). Only U patients out of 12 had
B3 tumours compared with U out of 9 of the nodular lymphocytic
lymphoma group. The patient who did badly has very incomplete
data, and was lost to follow up for some time so no account of
the mode of progress of the disease can be given. The receptor
profile of Bathgate is B3.1 (blood lymphocyte) and tliis
corresponds to the profile of stable chronic lymphocytic
leukaemias. The tumour of HeOrail is interesting as one of the
few B3.3 tumours in the series (parafollicular cells, capping
with an Fc receptor).
6) The B2 tumours
The predominant tumour of Mooaie was roost unusual in being
a diffuse lymphocytic lymphoma of the thyroid gland. Regional
nodes were also involved. The predominant cells composing
this/...
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Figure 19: The E.M.Features of a B$ lymphocyte Predominant
Tumour (Cairns)
____
This low power E.M. picture clearly shows the
characteristics of secretory B lymphocytes (B5)
in Waldenstrom's disease. The cells show
extensive development of rough E.R. and




Flgore 201 The E.M. Feature > of a Secretory B lymphocyte (35)
(Calms)
This cell, typical of those found in the B5 tumour
of patient Cairns, shows well developed Golgi
apparatus, and dilated endoplasmic sacs containing
IgM antibody shown by the immunoperoxidase react.ion.
The mitochondria show degenerative changes and




this tumour were large lymphocytes, expressing surface Ig in a
non-capping form, but exhibiting Fc receptors (B2.Fc). As shown
previously, if the receptor overlap (E and Fc) from the node of
Robertson is taken into account, the B cells in this lesion are
also B2, and the lesion a B2.C lymphoma.
Patient - Moodie (1) thyroid B2 lymphoma and Robertson (2)
corrected for mixed E and Fc receptors.
E Fc C3 Phagocytes Capping Non-capping
1) 6 55 Nil 2 30 36
2) 7 37 h9 11a 15 28
7) Diffuse lymphocytic lymphomas associated with leukaemias of
CLL type.
The two cases Velzian and Reid are examples of a unique
syndrome encountered in diffuse lymphocytic lymphoma with CLL.
In both cases, there appears to be a "block" to the secretion of
surface Ig by the tumour cells at diagnosis. These cells appear
to be "receptor silent". On storage, or after trypsinisation it
is discovered that the cells regain the capacity to secrete
surface Ig, showing their B lymphocytic origins. The B cell
subclass of these lesions is not clear. Velzian has been
classified as B1, and Reid as a B2 tumour.
Patient Velzian.
This patient presented with enlarged nodes in the neck, and
a/ ...
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a high white cell count (220 x 10^/ml). The histological
features were those of a diffuse lymphocytic lymphoma, of well
differentiated type, and the peripheral blood showed the
appearances of chronic lymphocytic leukaemia. The receptor
profile of the lymph node and blood at diagnosis is shown below,
and the histological appearances illustrated (Figs. 21, 22).
Receptor profile lymph node (1) and blood (2).
Patient Velzian (diffuse lymphocytic lymphoma, well differentiated,
with CLL) Figures are given as a percentage of total cells.
E Fc C3 Phagocytes Gapping Non-capping
Node 59 2 1 U ^Diffuse Fluorescence
Blood 33 3 1 2 13 0
* From these profiles, the lymph node cells were predominantly
Ig bearing, but on repeated washing NO surface Ig could be
detected. Following storage and typsinisation the following
profiles were obtained.
E Receptor Silent Capping Non-capping
Node 27% k0% 10£ $%
(Storage)
Node 17% 20% h% k$%
(Trypsin)
Blood 20% ^0% y% 62%
(Storage)
Blood 6% NIL $% 60%
(Trypsin)
Further studies showed that when treated with anti-Kappa and anti-
Lambda light chain serum 60$ of cells showed staining, in contrast
to/...
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Figure 21: The E.M. Features of Well Differentiated Diffuse
lymphocytic Lymphoma (Velzian)
Although the surface phenotype in this patient was
atypical, the features shown here are those of any
well differentiated lymphocytic lymphoma. The
small lymphocytes show regular nuclear outlines, and
although some contain numerous riboscmes there is
little rough E.R. in evidence. The cells showed no
intracytoplasmic Ig, but expressed surface Kappa
chain after trypsinisation and in vitro culture.
E.M. x 1,500
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to the 1 y% obtained in the original sample. After treatment for
3 months, the white cell count in blood was 9.6 x 10^ ml, and
the following receptor profile was obtained.
E Fc C3 Phagocytes Gapping Non-capping
Blood 15 38 30 1 0 60$ Kappa 3$ Kappa
3$ Lambda k% Lambda
The interpretation of these findings are that in the
initial blood and node samples, the cells expressed Kappa chain
only which was not detected by polyvalent antiserum. Following
trypsinisation, the cells expressed non-capping surface Ig
detected by polyvalent antiserum. Furthermore with anti-Kappa
chain antiserum, the cells showed capping behaviour. There is
an improvement in cell maturity in the blood with treatment, with
the cells in the last sample showing B3.1 receptor profile.
The initial diagnosis was of a B1 lymphoma, and this
classification is adopted. The complexity of the receptor
profile is thought to arise from "blocking" of lymphocyte
differentiation in vivo.
Patient leid
This patient presented with lymphadenopathy and chronic
lymphocytic leukaemia. The biopsy showed well differentiated
diffuse lymphocytic lymphoma. The receptor profile for the
lymph node and diagnostic blood sample is shown below.
iteceptor/...
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Figure 22i The E.M. Appearance of CLL Cells from the Blood of
patient Velzian
The cells show typical features of CLL cells, with
ribosome rich cytoplasm, and a few strands of rough
E.R, In this Ficoll/Trioail preparation the cells
were initially receptor silent, but after washing
expressed non-capping immunoglobulin reacting with
polyvalent antiserum. The predominant surface Ig
was Kappa chain. A slow response to treatment was
associated with the reappearance in the blood of
cells rich with the B3.1 phenotype.
E.M. x 7,000
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Receptor profile of lymph node (1) and blood (2) of patient
Reid (diffuse lymphocytic lymphoma with CLL).
E Fc C3 Phagocytes Capping Non-capping
Node (1) 11 2 6 9 5 0
Blood (2) 1.5 15 0 7 0 2
A large population of receptor silent cells was present,
but following trypsinisation or storage $0% of cells became
positive on testing with anti-Kappa antiserum, and with polyvalent
antiserum which did not stain the cells initially. Subsequently
three receptor studies on the blood of this patient were done,
on the two days subsequent to biopsy (1, 2), and three months
later (3). The results are shown below.
Receptor Profile of Blood - Patient Reid.
Figures given are as percentages of total cells.
E Fc 91 Phagocytes Capping Non-capping
Blood (1) 0 37 8 1 2 1li
Blood (2) 0 20 0 u 0 0
Blood (3) 1 15 k 5 3.3 53 Kappa
28 Lambda
An interesting feature was the presence of the Fc receptor
which developed on the blood cells of this patient on storage and
in later blood samples. Anti-light chain antisera of both
Kappa and Lambda specificity induced capping reactions, but the
majority/...
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majority of cells showed non-capping behaviour.
The extraordinary similarities between these two cases
indicate a syndrome in which the maturation of cells in vivo
is "blocked", and which can be reversed by trypsinisation of the
cells and storage at h°C in serum free medium.
Both patients showed light chain expression only, initially,
but developed sufficient heavy chain synthesis to be detected by
polyvalent antiserum following trypsinisation. Velzian was
classified as a B1 lymphoma, Keid as a B2 lymphoma by reason of
the Fc receptor present on his peripheral blood ana lymph node
cells (B2.Fc). In Reid, substantial numbers of cells with
Lambda chain surface immunoglobulin were present in blood,
compared with the monotonous Kappa chain monoclonality of
Velzian. ' The B cells of Velzian capped well in the last sample
giving a B3.1 receptor profile.
Both patients are currently alive, but response to therapy
in both has been slow in comparison with the well differentiated
chronic lymphocytic leukaemias.
Bwptor ProfAl» In Histiocytic Lyphoam
ChaptT 19
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Receptor Profiles In histiocytic lymphoma
Ten patients had diffuse lymphocytic lymphomas on the basis
of Rappaport's classification. The receptor studies showed
marked heterogeneity of this group, and survival data supported
this view. Three of this group were extranodal, one a primary
lymphoma of thyroid, one a lymphoma involving sacrum, and one a
tumour of the orbit. Receptor data in one further case was
obtained from the spleen.
Receptor silence was present in three of the ten cases.
All the cases were diffuse, there were no nodular histiocytic
lymphoma in the series.
The receptor profiles of this group and the clinical data
are shown in the tables below.
Receptor profiles in diffuse histiocytic lymphoma
Figures given are percentage of total cells.
Name Viability E Rosettes Fc 91 Phagocytes Capping Non-caj
Adams 82 19 1* 10 1 13 51
Hall 81* 10 1 1* 10 11* 59
Hogg 71 20 1 1 11* 2 56
Smith 76 37 10 29 1 38 22
Ross 90 15 P 12 60 16 10
Oliver 85 30 6 8 1* 6 0
Ritchie 70 50 1* - - 1* 0
Baird 85 58 1*3 68 22 15 17
Moyes 75 8 15 18 3 11 8
Johnstone 82 8 6 3 1 Nil 71*
From/...
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From the data shown, it is evident that four tumours were
of undifferentiated B lymphocytes (B1 ) and three were receptor
silent. Only one tumour of B3 lymphocytes was found and this
was follicular (B3.2). One true histiocytic or macrophage
tumour was noted, and there was one case of receptor overlap.
Diffuse Histiocytic lymphoma
Clinical data and receptor classification
Name Histology A/D Time (Mo) Age Sex Clinical Stage Receptor
Profile
Adams DHL D 3 - M Extranodal B1
Predominant
Hall DHL D 2 70 M II B1
Predominant
Hogg DH/DPDL D h 76 F Extranodal B1
Predominant
Smith DHL D 5 hk M II B3.2
Predominant
Ho as DHL D 5 70 M III Macrophage
Oliver DHL D 12 72 F III Silent
Ritchie DHL D 18 26 M IV Silent
Baird DHL A 18 6h F II Overlap
Moyes DHL A 2 56 F Extranodal Silent
Johnstone DHL D 3 66 M IV B1
Predominant
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Analysis of the results in diffuse histiocytic lymphoma
B1 Tumours
Tumours of B1 lymphocytes do occur, but these cells are never
encountered in normal lymph nodes, spleen, blood or tonsil except
possibly as a very small minority population. One tumour
classified as B1 but associated with "receptor block" was
encountered in the diffuse lymphocytic lymphoma group. Two of the
four B1 histiocytic lymphomas were extranodal in origin; in Adams
the lesion was a mass overlying and involving the sacrum, and in
Hogg it was a primary lymphoma of the thyroid gland. The tumour
in Hall was associated with leukaemia and Johnstone became
leukaeroic before he died.
The receptor profiles of the B1 lymphomas show remarkable
homogeneity, perhaps seen best in the data of Johnstone and Hogg.
Figures given are percentage of total cells.
Name E Rosette Fc £3 Phagocytes Capping Non-capping
Johnstone 8 6 3 1 Nil 74
Adams 19 4 10 1 13 91
Hall 10 1 U 10 14 59
Hogg 20 1 1 14 2 56
The majority of surface Ig bearing cells are non-capping, and
virtually no expression of C3 or Fc receptor occurs. Two cases
show substantial macrophage populations. Non-capping B cells
lacking Fc and C3 receptors occur in lymphoid cell lines, and these
may/...
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may be regarded as B1 prototypes.
In patient Hogg* cells from the original biopsy failed to
show intracytoplasmic Ig, although marked pyroninophilia was
observed in touch preparations. Following trypsinisation and
culture, the cells showed the presence of intracytoplasmic IgG
after 72 hours, and morphologically resembled plasma cells. The
parallel between this tumour and the EBU cell line is striking,
and the resynthesi3 of cytoplasmic Ig suggests strongly a "receptor
block" similar to that in Velzian or Raid of the diffuse lymphoma
class. The longest survival in this group was four months, and
no tumour responded satisfactorily to treatment.
Receptor Silent Tumours
These tumours, present in Oliver, Ritchie and Moyes behaved
in the same way as that of Kerr (diffuse lymphocytic lymphoma). The
tumour cells failed to exhibit surface Ig, even after trypsinisation
(Moyes) and had no detectable receptor for sheep cells, Fc or
complement. They failed to concentrate neutral red dye. The
diagnostic biopsy in the case of Oliver was lymph node, and
receptor studies were made at the time of diagnosis.
After initial response to treatment this patient relapsed and
finally died with generalised lymphadenopathy, and undifferentiated
tumour in kidney and lung at autopsy. Even at autopsy, the
histological appearances cannot exclude anaplastic carcinoma
arising in lung or kidney, although the clinical presentation was




Figure 23t The Appearance of Receptor Silent Cells in
Peripheral Blood (Oliver)
This patient had a receptor silent tumour,
histologically classified as diffuse histiocytic
lymphoma, terminating fatally after 12 months.
Abnormal circulating tumour cells /ere present,
and the appearance of these cells in a blood
smear is illustrated. They are cytologically
primitive cells with abundant cytoplasm, and
exhibit cytoplasmic and nuclear vacuolatlon.




Ritchie presented initially with an enlarged node in the
neck, and the initial diagnosis was that of lymphocyte depleted
Hodgkin's disease. There was a temporary response to radiotherapy,
but relapse soon followed with the development of splenomegaly and
involvement of the lymph nodes in the coeliac axis leading to
duodenal obstruction. The spleen was massively enlarged at
laparotomy and proved to be extensively involved with lymphoma.
Shortly before death, receptor silent cells appea.od in the
peripheral blood. The E.M. appearances in the spleen of this
patient is illustrated (Fig. 2li). Receptor studies were done on
the spleen.
Moyes presented with an orbital tumour, which on removal was
reported as a poorly differentiated plasmacytoma of the orbit.
This was treated with radiotherapy, but short ly after neck gland
enlargement was noted, and a diagnostic lymph node biopsy was
reported as showing an undifferentiated tumour compatible with the
diagnosis of histiocytic lymphoma.
These three cases illustrate the extreme difficulty of
accurate histological diagnosis in undifferentiated tumours of this
type. In these cases, the receptor silent nature of the cells
does not support a firm diagnosis of lymphoma, although the
presentation, histological features and clinical behaviour is
that of lymphoma. This particularly applies to patients Oliver
and Moyes, although there is little doubt that the tumour in
Ritchie was a lymphoma.
The receptor profile of these patients is shown and the
tumour cells of Ritchie and Oliver are illustrated (Figs. 23, 2li).
Oliver/...
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Figure 2it: Electron Micrograph of the Receptor Silent Tumour
of Ritchie
The receptor silent tumour of Ritchie, in contrast
to that of Kerr, was composed of cells with
Irregular nuclear contour and electron dense
cytoplasm. In the spleen they were closely
applied to the reticulin fibre framework.
Occasional examples shewed well developed E.R. and
Golgi apparatus and had abundant mitochondria.
Similar cells were present in the circulation.
The cells of this tumour clearly differ from those
of patient Kerr (Figs 1U-17) although both were





Smear8 from this lesion showed the large cells comprising the
neoplastic population formed 70$ of the lymph node population. The
small lymphocytes formed the remaining 30$. All the small cells
formed E rosettes, but failed to express Fc or C3 receptors. Many
of the large cells showed weak diffuse surface staining with anti-
Ig antisera, but this staining was readily eliminated by washing.
The receptor profile is shown below
Figures given are percentages of total cells.
E Rosettes Fc £3 Phagocytes Capping Non-capping Silent
Node 30$ 6$ 7$ h% 6$ - 65$
As shown the contaminating population of small lymphocytes
is overwhelmingly composed of T cells, with a few mature B cells
present. The clinical stage at diagnosis was 1B, but was stage
IIIB at lit months and the patient died 16 months after diagnosis.
Ritchie
The first receptor studies of spleen, and blood, were
carried out fifteen months after the initial diagnosis, and three
months before death. From the spleen suspension, a pure
population of neoplastic cells was obtained by density sedimentation
through bovine serum albumin. These cells were completely




and spleen neoplastic cells (illustrated). The receptor studies
are shown below. They include spleen (1) and blood (2) and a
second blood sample obtained just before death (3)


























The increase in receptor silent cells in blood, and the
proportional decrease in T cells is well shown. Most of the
splenic lymphocytes were T cells. The tumour cells were not
phagocytic.
Moyes
The receptor profile of the neck lymph node is shown below.
The cells shewed marked cytoplasmic pyroninophillia, but exhibited
no receptors, and were not phagocytic. Intracytoplasmic Ig was
not present. Many of the contaminating normal lymphocytes were
B cells and relatively few T cells were present. Figures given
as percentage of total cells.
E Hosettes Fc £3 Phagocytes Capping Non-cspping Silent
L.Node 856 \$$ 18J6 3% 11 % 8% 67%
Many/...
313.
Many of the Fc and C3 receptors detected were present on
contaminating polymorphs, and not on the B lymphocytes. The
histochemistry of the cells in this lesion is shown below.
Non Specific Esterase (ASD chloroacetate) +++
Acid Phosphatase +++
Sudan Stain occasional positive granules +
Peroxidase
Alkaline Phosphatase
P.A.S. Stain granular ♦
M.G.P. Stain +++
Immunoperoxidase, negative for A, G and M chain, Kappa
and Lambda.
These results clearly exclude a myeloid, or histiocytic
origin, but are compatible with some reported findings in
anaplastic carcinomas. According to one pathological opinion
the lesion is a carcinoma. This patient was still alive three
months after diagnosis but died soon after.
All of the three patients with receptor silent tumours in
this group have died. This fact taken in context with the
findings of receptor silent populations in Robertson A. (Nodular
lymphocytic lymphoma and Kerr (Diffuse lymphocytic lymphoma)
where receptor silence again occurred during progress of the
disease implies an ominous prognosis for patients with this
class of neoplasm.
33.2 lymphoma (Smith)
The receptor profile in this patient showed a predominance
of B lymphocytes, of which the majority were capping and
expressed/...
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2$t The Histiocytic lymphoma of Smith
This tumour, vhich had the surface phenotype
B3.2, is composed of large irregular cells
admixed with small lymphocytes. The tumour
is noteably more "lymphoid" in character
than other histiocytic lymphomas in this
series.
H St E stain x 600
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expressed the complement receptor. The profile looked similar
to that of germinal centre, and was classified as B3.2. The
profile is shown below.
Receptor profile of Smith. Figures given are percentages of
total cells.
® £2 Phagocytes Gapping iMon-capping
37 10 29 1 38 22
The patient never gained complete remission and died 5 months
after diagnosis. The histological appearances are illustrated
(Fig. 25).
True Histiocytic Lymphoma
The lymph node in Ross showed a singular receptor profile.
In a node where most cells were viable, the majority were
macrophages as assessed by neutral red uptake. On tissue culture
many of the cells were morphologically normal macrophages, and
the majority were phagocytic for antibody coated cells. 26% of
the cells were B lymphocytes with capping surface immunoglobulin
on the majority, i.e. mature B lymphocytes. Tumour cells showed
the capacity to ingest antibody coated erythrocytes. The
receptor profile for blood is shown below. Phagocytes were
numerous, although the white cell count did not reach leukaemic
proportions. The complement receptor cells in node were B
lymphocytes/...
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Figure 26t The Histological Features of True Histiocytic
Lymphoma (Ross)
This tumour was the only example in this series
of a lymph node tumour demonstrated to be of
mononuclear phagocytes. As the histology shows
the cells were separate, polygonal and pleomorphic
with variable amounts of abundant cytoplasm.
H & E Stain x 600
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Figure 27: Surface Fhentotype of True Histiocytic Lymphomas
Absence of B Hosetting (floss)
This illustration shows a large tumour ceil in
contact with a small lymphocyte which has bound
sh^ep erythrocytes: (E rosette). The absence of
E resetting by the tumour cell is clearly shown.
Phase contrast, living cells.
X 720
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figure 28; Surface Fhenotype of True Histiocytic Lymphoma:
Phagocytosis of IgG Coated iied Cells (Ross)
Cultured cells from the lymph node were glass
adherent, and as shown here exhibited phagocytic
activity. The binudeate tumour cell has
ingested a clump of erythrocytes and other debris
into a single abnormally large phagocytic vacuole.
The erythrocytes, added shortly before this
photograph was taken, were coated with IgG antibody,
and several are shown adhering to the cell processes
on the right.
Phase contrast, 2 hour culture, IgG sensitised
red cells added 30 minutes, living cells.
x 1,000
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Figure 29: Electron Microscope Appearance of True Histiocytic
Lymphoma (iiosa)
A single cell from the tumour of itoss Is Illustrated.
The appearances are of a mitochondria rich cell,
with well developed Golgi apparatus and a few strands
of smooth E.K. The cell surface lacks the
characteristic ruffles of the normal macrophage* but




lymphocytes, but the population in blood rosetted strongly with
both complement coated and antibody coated red cells. The
histology of the tumour is illustrated (Figs. 26, 27, 28, 29).
Receptor profile in Node (1) and blood (2) of patient Ross.
Receptors given as a percentage of total cells.
E Fc £3 Phagocytes Gapping Non-capping
Node (1) 15 Phagocytic 12 60 16 10
Blood (2) 38 58 67 1*6 18 1
This patient showed no response to treatment and died
5 months after diagnosis.
Receptor Overlap
The lesion of Baird, classified as diffuse histiocytic
lymphoma, gave a receptor profile very similar to that of
Lavericfc, classified as a diffuse mixed lymphocytic and histiocytic
lymphoma. In a node where 85$ of cells were viable, the sum of
E rosetting cells, phagocytes, and surface Ig bearing cells was
112$. This means at least 27$ of cells have dual markers for T
cell and B cell, or T cell and macrophage. It was noted that a
few tumour cells did not exhibit markers, which confirms the
receptor overlap on the remaining cells. As with Laverick, the
patient has done well despite "bad" histology, and these findings
suggest that a subclass of lymphoma exists, of mixed histiocytic
and/...
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Figure 30: Histological Appearance of a Receptor Overlap
Tumour (Baird)
aactions of this tumour show cells with marked
nuclear hyperohromatism, Much shrinkage artefact
is present. Compare these features with the
tumour of Laveriok (Figure 11) which was of different
histological appearance, yet both tumours were of
the same surface phsubtype (Receptor Overlap) and
both responded well to chemotherapy.
H & £ Stain x 600
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'Ic'-ire 311 Surface Fhanotype of a Haceptor Overlap Tumour
(Baird)
The appearances of two tumour cells In a complement
rosette preparation are shown. One cell has bound
a single complement sensitised red cell (and hence
is not counted sis a rosette) and the other forms
the characteristic tight cluster with red cells.
In this node 68£ of the tumour cells formed
complement rosettes, and $8% rosetteu with sheep
erythrocytes.




and lymphocytic or histiocytic histology, showing receptor overlap,
which carries a better than average prognosis for tumours of these
histological classes. The histological appearances are illustrated
(Figs. 30, 31) and should be compared with those of Laverick
(Fig. 11) who had a similar kind of tumour.
Receptor Profiles in Leukaemia
Chapter 20
Contents
a) Acute lymphocytic leukaemia
b) Chronic myeloid leukaemia
c) Chronic lymphocytic leukaemia
d) Monocytic leukaemia
e) Receptor profile in hairy cell leukaemia
(leukaemic reticuloendotheliosis)
f) Receptor silent leukaemia
321*.
Summary table of patients with le.Jtaeraia either as a presenting
feature or occuring with lymphoma.
Figures given as percentages of total cells,
Patient Type of
Leukaemia E Fc C1
5
Phagocytes Capping Non-capping
Turnbull ALL 3 3 1 27 Nil
Klimzcak Monoblastic 5 56 1*1* 50 Nil Diffuse 100£
Piakowsky CLL 9 17 1 1* 5 78
Smith "Hairy Cell" 3 - 11* Nil Nil 70*
Russel CML 12 55 8 3 12 8
Mowatt CLL 28 36 22 18 18 1
Cooke ALL 91 5 1 Nil 1 Nil
Blake CLL 2 9 2 11* 13 81*
Velzian CLL 33 1 1 2 1 66
Reid CLL 2 15 0 7 0 53
Walkingshaw Lymphocytosis 59 15 30 9 23 16
Coburn CLL 11 1* 2 Nil 2 1
Kerr RSL 10 17 18 1 It 1
Note that in all cases here, the white cell count exceeded
£
10 x 10 ml with the exception of patients Walkingshaw, Russel, and
Mowatt.
* The cells are here classed as non-capping, although NO evidence
for synthesis of surface Ig was obtained, and they are not B cells.
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Receptor Profiles in Leukaemia
Leukaemias were not a major part of this study but on
occasions the author was asked to investigate leukaemias to
discover the nature of the leukaemia cell. In some cases of
lymphoma the disease was associated with leukaemia (as in Velzian
and Reid) and in others a leukaemia of receptor silent cells was
present (as in the patient Kerr). These cases have alreacfy been
documented, but summaries of the data are included in this study.
Each case or group of cases is discussed separately. The data
shown in the summary table is based upon the first sample of
blood from each patient.
Acute lymphocytic leukaemia
Two cases of acute lymphocytic leukaemia in children were
studied. Only one blood sample was available from each, as both
died within a short time of diagnosis. The receptor profiles of
the two cases were very different, that of Turnbull being the more
common "receptor silent" leukaemia, that of Cooke being the more
rare T cell acute lymphocytic leukaemia.
ALL Receptor Profiles
Figures are given as percentages of total cells.
E Fc CJ} Phagocytes Capping
Turnbull 3 3 5 1 27






The patient Cooke was a 12 year old boy with a mediastinal
6
mass on X-ray, and a white cell count of 37 x 10 /ml. These cells
were lymphoblastic and acid phosphatase positive. He died within
2h hours of admission to hospital. Turnbull was a female child of
8 years with recently diagnosed ALL. She was very ill on admission
and died 2 days after the peripheral blood study. The white cell
count was 80 x 10^/ml, and the cells were lymphoblastic, and acid
phosphatase negative.
Chronic Myeloid Leukaemia
This single case of chronic myeloid leukaemia had been
treated and was in apparently good health at the time of study.
The patient had had a splenectomy, and the white cell count in the
sample was U.8 x 10^/ml. The study was undertaken at the
haematologist's request to see if receptor studies could detect an
abnormal population of "Myeloid" cells in a blood showing none of
the cytological abnormalities of CML. The receptor profile is
shown below.
CML Keceptor Profile compared with normal blood values.
The figures given are as percentages of total cells.
Patient E Fc £3 Phagocytes Capping Non-capping
Eussel 12 55 8 3 12 8




As indicated, a receptor silent population is present, which
expresses/...
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expresses, on some cells, Fc receptors. 65£ of cells are of this
type and 32^ of these (allowing for Fc receptor on all B cells and
macrophages) express the Fc receptor. This is an abnormal
population, but it cannot be termed "myeloid" on the evidence given.
The absolute values of each class of cell are shown below, together
with the values and S.D. for normal blood. As seen, the total
number of T cells is low, and that of Fc receptor bearing cells
high. B cell, complement receptor and phagocyte levels are
considered normal.
Patient Russel. Absolute numbers in millions of cells per ml of
blood compared with normal values.
H £2. 92 Phagocytes Gapping Non-capping Total
Normal 1.01 0.7k 0.55 0.38 0.55 0.31 2.25
(+0.23) (+0.23) (+0.26) (+0.12) (+0.26) (+0.11)
Russel 0.58 2.6k 0.38 0.1U 0.58 0.38 U.80
The mononuclear cell count is marginally higher than normal
but the distortion in receptor profile is quite clearly seen. The
conclusions are that even with adequate treatment, and apparent
health, abnormal cells can persist in the circulation at lea-t in
this single case of CML.
Chronic lymphocytic leukaemia
The cases of chronic lymphocytic leukaemia were Piakowsky,
Mowatt, Blake, Velzian, Reid and Cobum.
The/...
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The receptor profiles obtained in serial studies at monthly
intervals of the patient Piakowsky from diagnosis to death, are
shown below.
Receptor profile of Piakowsky. Blood samples (1) 20/12 (2) 2l*/3
(3) lU/U (U) 1/6. The patient died 2 days after the last blood
sample. Figures given are either in millions of cells ml (WBC
count) or as percentage of total cells.
WBC count E Fc C3 Phagocytes Capping Non-capping
1) - 9 17 1 h 5 78
2) 19.1 11* 16 5U h 1*8 5
3) 23.5 5 9 18 8 58 Nil
h) 26.5 6 13 68 5 Nil 91
The cells composing the leukaemic population synthesised
surface Ig. With treatment there was a rapid maturation of cells
with an increase in complement receptor. The initial profile was
that of a B1 lymphoma with weak expression of the Fc receptor. This
rapidly changed, with treatment, to a cell type of B3.2 class. The
cells subsequently matured to a Bi; class (sample 3) but did not
show cytoplasmic Ig. At this stage a receptor silent population
was present, and by the next month (sample k) the circulating cells
had changed to a B2.C cell type. It is not possible to conclude
that these changes were intrinsic differentiation steps or whether
they were induced by treatment. The squence of change in surface
phenotype is BI B3.2 Bh
(1) (2) RS B2.C
(3) (U)
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The case confirms, once again, the ominous prognosis of
neoplasms containing receptor silent cells, and non-capping
lymphocytes of B class. T lymphocyte and phagocyte levels were
increased (in absolute numbers) over normal values.
The patient Mowatt was an atypical GLL, with a low WBC count
at presentation. The presence of receptor silent cells was noted
on both occasions of study, but the recovery on Ficoll/triosil
separation was only 10%. This higilights one of the difficulties
of working with leukaemic blood. It is not possible to draw
valid conclusions from a cell population representative only of
10% of the starting population. The differential count on both
occasions was 1$% polymorphs, 2$% lymphocytes, k% monocytes, 8$
eosinophils and hQ% atypical lymphocytes. There was evidence of
cell death in the Ficoll/triosil separated smears. The patient
died four months after diagnosis.
Receptor profile of blood of Mowatt, sample (2) one week after
sample (1). Figures are given as a percentage of total cells.
Sample £ Fc C3 Phagocytes Gapping Non-capping Silent








Another patient Blake had an acute relapse of chronic
lymphocytic leukaemia, and she died within 2h hours of obtaining
the first blood sample. The white cell count was 268 x 10^ per ml
and lymphoblasts were virtually the only cells present. The
receptor/...
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receptor profile is shown below. Figures given are as a
percentage of total cells.
E £2 Phagocytes Capping Non-capping
292 Ik 13 8U
Studies with anti-light chain antisera showed all the capping
cells to express lambda chain, while all non-capping cells were of
Kappa chain type. It is doubtful that all neutral red ingesting
cells were of monocyte class, similar cells occur in lymphoid cell
lines (e.g. the DAUDI cell line). On the basis of the receptor
profile this lesion was classified as a B1 leukaemia.
The patient Coburn had a "classical" CLL lesion and blood
samples were obtained at the first visit, and a repeat sample
one week later. Because the differential count showed atypical
lymphocytes (}6%) he received treatment and the effect of this is
shown by comparison of sample (1 ) with sample (2). The white cell
count on the first occasion was $.£> x 10^/ral, and on the second
2.75 x 10^/ml. Absolute values of each cell class are shown
together with values from normal blood. He responded well to
treatment and was still alive 2 years later.
Receptor profile patient Coburn, sample (1) and (2). The
absolute values are given as millions of cells per ml. of blood,
the other values are as percentages of total cells. Normal
absolute values are shown in the last line.
E/...
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E Fc 63 Phagocytes Capping Non-capping
Sample (1) 11 1* 2
0.57 0.21 0.09
Sample (2) I46 25 18
1.26 0.69 0.51













S.D. (+0.23) (+0.23) (+0.26) (+0.12) (+0.26) (+0.11)
As shown, despite the reduction of cell counts, values for
E rosettes (T cells) increase to normal levels, as do Fc and 03
receptor bearing cells. The receptor silent population does not
express surface Ig detected by polyvalent antisera, but unhappily
studies were not done using anti-light chain antisera in this case.
These cells are probably B cells to judge by expression of Fc and
C3 receptors, and like Eeid and Velzian might be presumed to
express Kappa or Lambda light chain only.
Receptor profiles of Reid and Velzian have already been
discussed in the section on diffuse lymphoma. The blood data
are repeated here for comparison with data from Coburn.
Velzian Receptor profiles of blood (1) at diagnosis (2) after
storage, 2ii hrs at U°C (3) after trypsin (h) after 3 months




E Fc C3 Fhagocytes Gapping Non-capping
Sample(1) 33 3 1 2 13 0
Non-capping cells with anti-light-chain 60 Kappa 13 Lambda
Sample (2) 20 - - -
The surface Ig was detected with polyvalent antiserum.
Sample(3) 6 5 60
The surface Ig was detected with polyvalent antiserum.
Sample (ii) 15 38 30 10 (60% Kappa) (3$ Kappa)
( ) ( )
( 3% Lambda) {\\% Lambda)
63$ 1%
Reid. Receptor profile of blood (1) at diagnosis (2) 2l± hrs after
diagnosis (3) 1+8 hrs after diagnosis (1+) two months after diagnosis
(5) three months after diagnosis. figures shown are as a
percentage of total cells present. Surface Ig (1) (2) and (3)
with polyvalent antiserum.
E Fc £3 Fhagocytes Capping Non-capping
Sample (1 ) 1.5 15 0 7 0 2
Sample(2) 0 37 8 1 2 111
Sample(3) i© 20 0 k 0 0
Sample (1+) 1 15 h 5 3 53 Kappa
28 Lambdf





Receptor profiles of the patient KHraczak are shown as
an example of a typical leukaemia of monocytes and promonocytes.
The receptor profile of blood was quantitated on 3 occasions on
9/h (1) 12/JU (2) and 13A (3)« The white cell count was
110 x 106 cells/ml, and most cells showed the cytological features
of monocytes. The receptor profiles are shown below.
Patient Klimczak. (Peripheral blood) Figures given are as a
percentage of total cells present.
E Fc C3 Phagocytes Gapping
Sample (1 ) 8 61* 56 61 50
Sample(2) 7 55 31 Ji8 18





♦These two samples studied with polyvalent, and monospecific
antisera.
Upon incubation of the cells for 2 hr. at 37°C, Mx% rosetted
with and 37% ingested ox C3 red cells. After 2 hrs. incubation
at 37°C, 2.5% rosetted with, and 57% ingested ox Fc reagent. The
cells were PAS positive, but Sudan black negative. An interesting
feature was the high level of surface Ig positivity seen in this
blood. On trypsinisation it proved impossible to remove surface
staining without disrupting the cells, proving that Ig was mainly
intracellular, although all capping Ig was removed with trypsin.
The/...
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The Ig present, by monospecific antiserum, proved to be IgD, and
it was furthermore shown that overnight incubation in the patient's
serum was necessary to preserve the IgD staining. If incubated in
normal serum overnight, all staining of the cells disappeared.
The reasons for this phenomenon are not clear, but the cells showed
absolutely no evidence of Ig synthesis when cultured in normal
serum. The interpretation of these results is that in the
patient the monocytes exhibited cyt.ophilia for IgD, which was
ingested and became localised to phagocytic vacuoles, giving rise
to a "dotty" fluorescent pattern which resisted mild trypsinisation.
On culture in a neutral serum, no detectable immunoglobulin was
synthesised by the cell, and neither was IgD detected on the
surface or inside the tumour cells. The serum levels of IgD in
the patient were nomal. The patient has done well and is
currently in remission. The receptor profile shown below is the
latest available, the white cell count is now 5.7 x 10^/ml.
Receptor profile of patient Klimczak in remission. Figures given
are as percentages of total cells.
E Fc £3 Phagocytes Capping Non-capping
SU 12 U2 ifl Nil 16
Notice that T cells are at above normal levels (2.9 x 1O^/ml,




Receptor profile in Hairy Cell Leukaemia, (leukaemlc retlculo-
endotheliosis)
Examples of this condition are rare, and this patient was
studied in an attempt to characterise the leukaemic cells.
Blood wan obtained on 3 occasions, (1) and (2) one week apart, and
sample (3) two weeks later. The spleen was also examined.
The surface Ig bearing cells were not "B" cells, as far as could
be ascertained, since no resynthesis of surface Ig could be
demonstrated following trypsinisation.
Receptor profile of Smith: Samples (1), (2) and (3) Hood,
sample (1*) spleen. figures given are as percentages of total
cells present.
Sample (D (2) a) (k>
E 3 9 3 3
PC Aggr. 69 3 33
C3 11* 7 - 2
IgM 18 51* - 1
Phagocytes Nil 1 - 28
Capping 70 80 76 81*
Son-capping 0 0 0 0
Fc(Hu) Aggr. • am 17
The cells expressed IgM receptors, and were found to be the
only IgM receptor positive cells in non-Hodgkin1s lymphomata.
The/...
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The cells showed a weird pattern of staining with monospecific
antiserum, 31 % were Kappa chain staining and showed capping, with
66% Lambda chain positive and capping. 20% of cells expressed
gamma heavy chain, but did not cap, and J+1 % capped with anti
chain. Anti-delta and anti-alpha heavy chain staining was weak
and non-capping in character, about 22% of cells staining with
each. Immunoglobulin expression therefore was polyclonal in
nature and when surface Ig was removed the hairy cells failed to
resynthesise surface Ig ( 10% positive in 2h hrs.). Histochemically
the leukaemia cells were esterase and acid phosphatase positive,
and peroxidase negative.
The cells survived storage, and culture quite well. They
were non-phagocytic and non-glass adherent. Anti-monocyte serum
(courtesy of Dr. A.E. Stuart and Mrs. G. Young) failed to react with
these cells. Marked coagglutination of the cells occurred when
tested with heavily sensitised IgG coated ox or human erythrocytes.
The conclusions show that the cell of leukaemia reticulo-endotheliosis
is non-Ig-synthetic, has IgM receptors, and marked Fc receptor
activity, but weak C3 receptor expression. It appeal's to be
cytophilic for immunoglobulin of IgM, and IgG classes especially,
but fails to restore surfaoe Ig in 90% of the population following
trypsinisation. It does not react with sheep erythrocyt.es, change
its differentiation in culture, adhere to glass or exhibit
phagocytic activity. It fails to express monocyte specific surface
antigens. The patient has currently survived five months, and
remains comparatively well. The serum IgM level is 1,250 international
units (50-250 iu is normal) and the increase is polyclonal.
A/
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A case of lymphocytosis
Occasionally patients present with abnormalities which are
not necessarily leukaemic, but which give rise to anxiety on
examination of the blood film. Walkingshaw is such a patient,
presenting with a febrile illness, abnormal liver function tests,
and a markedly abnormal blood film characterised by a low number
of polymorphonuclear leukocytes, and an absolute lymphocytosis.
The mononuclear cell count was U.67 x icfi/nil with a differential
of 27$ polymorphonuclears, 71$ lymphocytes and 2$ monocytes. The
receptor profile and absolute cell counts are shown below. The
receptor profile (1) is given as a percentageof total mononuclear
cells, the quantitative data (2) as millions of cells per ml of
blood. Normal values (3) are shown in the last line.
E Fc C3 Phagocytes Capping Non-capping
(1) 59 15 30 9 23 16
(2) 2.81 0.70 1.38 0.1*2 1.07 0.75
(3) 1.01 0.7U 0.55 0.38 0.55 0.31
As shown there are significant increases in T cells, in the
complement receptor, and in capping and non-capping cells.
Phagocytes are not significantly increased and Fc receptor levels
are normal. This patient was suspected clinically of having




A number of receptor silent leukaemias have developed in
patients with lymphoma (Kerr, Ritchie). Acute lymphocytic
leukaemia is either receptor silent or T cell in type. The example
given here is the blood of patient Kerr, studied on two occasions
during the progress of the disease. Sample (1) is the receptor
profile on diagnosis, with absolute values (2) and sample (3) was
studied three months later, with absolute values (U). Figures
given are as percentages of total cells present, or as millions
of cells per ml. The white cell counts (J2% (1,2), \&% (3>i±)
6 6
mononuclears) were 5.6 x 10 /ml (samples 1 and 2) or 27.9 x 10 /ml
(samples 3 and h )• Normal values are given in the last line.
E Fc C3 Phagocytes Capping Non-capping Silent
(1) U2 32 28 1 3 3
(2) 1.71 1.3 1.13 0.0U 0.12 0.12
(3) 10 17 18 1 U 1
(it) 1.13 2.0U 2.12 0.12 0.1*8 0.16
Normal 1.01 0.7U 0.55 0.38 0.55 0.31
It is obvious that the values in (it) are normal, except for
the excess of Fc and C3 receptor, which however, can be present on
only a tiny minority of the receptor silent population. Here the
normal blood lymphocytes co-exist in normal numbers with a large
number of unidentifiable tumour cells, which, although lymphoid in
morphology, are not functionally lymphocytic. In the last sample,
a leuko-erythroblastic blood smear was obtained due to replacement
of marrow by tumour. Many of the nucleated red cell series, and
juvenile/...
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juvenile polymorphs were lost on the ficoll triosil gradient,
but early myeloid series cells were present in the tested sample,
and probably account for the Fc and complement receptors detected.
Examination of smears shows convincingly that most cells present
were neoplastic cells of lymphoid morphology.
This study of leukaemic blood emohasises that the examination
of the surface phenotype of mononuclear cells can (2) convincingly
demonstrate the class of cell involved in most cases, (b) allows
quantitative monitoring of the response to treatment, (c) confirms
that the major classes of lymphocyte demonstrated in lymph node
can with certainty be identified also in leukaemic blood. There
is no obvious phenotypic difference between the cells in the node
of patients with lymphoma and in the blood of patients with
lymphocytic leukaemia.
lymphocytic leukaemia was of cells classifiable as T cells,
B cells or receptor silent cells, as found in the study of
lymphoma lymph nodes. Apart from the single case of leukaemic
reticulo-endotheliosis, no characteristic "leukaemia" profile
was discovered in lymphocytic leukaemias of either acute or
chronic type.
Predictive Value of Receptor Classification
Chapter 21
a) Relationship of clinical stage, receptor classification
and histology to prognosis in patients with non-
HodgfcLn lymphoma and leukaemia.
b) Statistical appendix. Method of analysis of receptor
and survival data.
3U0.
The relationship of clinical stage, receptor classification, and
histology to prognosis In patients with non-Hodgkin lymphoma, and
leukaemia.
The predictive value of receptor studies in lymphoma is based
on statistical evaluation of criteria such as the relationship of
the class of tumour determined by histology, or by receptor studies
to the survival of the patient. There is an appendix to this
section which explains the methods used to test the difference
between patients with B1 and B2 lymphomas, or with B3 and Bli
lymphomas on the basis of their survival, and investigate whether
the clinical staging of such tumours was an influence on the
different survival characteristics observed. The calculations
shown were due to Miss S.M. Gore (Department of Medical Computing
and Statistics, University of Edinburgh). They show that in the
lymphomas examined, the survival data correlates strongly with
receptor classification, the less well differentiated B1 and B2
tumour patients having a poorer prognosis than the patients with
the better differentiated B3 and BU tumours. There appears to
be no correlation with the clinical staging of the disease at
diagnosis.
The table which follows summarises the nodular, diffuse and
histiocytic lymphoma and the leukaemia data to date relating
survival and histological class, to surface receptor characteristics.
The experimental survival curve (illustrated Fig. 32) calculated
for all patients with B1 and B2 lymphomas (group B), and with B3
and BU lymphomas (group A), shows a very marked difference in
survival/..*
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Experimental Survival Curves for Receptor Groups A, B.
— Receptor group A (B3, B4)
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Figure 321 Relationship of B Cell Subclass in Lymphoma to the
Survival Characteristics of B1 and B2 , and B3 and
Bh lymphoma Patients«
The plot is of probability of survival for each
patient in group A (E3 and Bl± lymphomas) and for Group
B (B1 and B2 lymphomas) against survival time in
months. The graph clearly illustrates that
populations A and B are significantly different in
terms of survival. It also shews the better prognosis
for patients in group A as against group B. In group
A, patients have approximately 8 out of 10 chances of
surviving 10 months, >4iile in group B patients have
roughly 2 out of 10 chances of surviving the same
period. As shown in the statistical appendix, the
significance of the differences between population
A and population B increases with increasing time of
study.
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survival between these two groups (P 0.02). Insufficient
numbers of the other classes of lymphoma does not allow significant
testing. It is pertinant to note that all patients with receptor
silent tumours or leukaemia have died (six patients in all), only
one patient out of six with B1 lymphoma or leukaemia remains alive,
two out of four patients with B2 lymphoma have died, yet in the B3,
BU and B$ subgroups of lymphoma only 1* deaths are recorded in
fifteen patients. Of the deaths in bhe B3, BU and B$ group, in
the patient A. Robertson a B2.C and receptor silent population was
present in blood before death, the patient Cairns died from
myocardial infarction, the patient A. Smith had a diffuse
histiocytic lymphoma of B3.2 profile, and the death of Swanson
remains unexplained due to inadequate data. Both patients Smith
Robertson had B3.2 predominant "follicular11 tumours, and these
were the only two tumours showing the B3.2 follicular profile in
the entire series. The laboratory impression that patients with
capping B cell tumours do better than patients with non-capping B
cell tumours is confirmed statistically. The relationship between
subclass of B lymphocyte and survival is not as well established
in the small series here. It is noteworthy that (1) no patient
with a BU tumour had died (b) no patient classified as having a
B3.1 tumour had died (c) both patients with B3.2 tumours have
died. The major problem in relating these subclasses to survival,
is the gathering of sufficient numbers of patients to test each
subclass, statistically, for survival value against each other.
This would require a minimum of ten patients within each subclass,
probably eighty to one hundred patients in all, and would require
an/...
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an additional 2-3 years of clinical follow-up.
The relationship of the receptor profiles to the
histopathology of the lesions shows that, using Rappaport's
classifications, there is good correlation between the nodular
lesions, and the B3 and BU lymphomas, with rare exceptions
(e.g. McKenzie). There is also good correlation between the
diffuse histiocytic lymphoma category and poor prognosis, because
of the large number of receptor silent and primitive B1 lymphocyte
tumours in this group. In the diffuse lymphocytic lymphoma class,
in several cases there is no obvious correlation between the
histological subtype, the receptor profile and survival.
Patient Subtype Rappaport Subtype Lukes Receptor Class A/D(months)
Velzian DWDL SL B1 A(2)
Swanson DPDL LG B3 D(8)
McGrail DEDL SC B3.3 A(1U)
Wilson DPDL T cell T A (8)
Laverick DM(H+L) LC Overlap A(fli)
Reid DWDL SL B2 A(3)
In the cases illustrated here, the histological evaluation
is a better guide to prognosis in Swanson (by both Rappaport and
Lulce's classification) and offers a worse guide to prognosis in
McGrail, (poorly differentiated by RappaporUs classification, B3.3
by receptor classification), Wilson, (poorly differentiated by
Rappaport's classification, T lymphocyte predominant by receptor
classification/...
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classification) and Laverick, (mixed histiocytic and lymphocytic
tumour by Rappaport, large cleaved cell by Luke's, receptor overlap
by receptor classification). The patient Raid has responded
poorly to treatment] despite "good" histology by both Rappaport
(diffuse well differentiated) and Luke's (small lymphocyte) the
*
clinical response to date is like that of a poor prognosis B2
lymphoma as classified on the basis of the receptor profile.
A weakness of both Luke's and Happaport's or indeed any
histological classification is the failure to iientify probable
good prognosis tumours (for example Laverick and Baird - receptor
overlap) in a class (histiocytic lymphoma) which includes the very
bad prognosis B1 and receptor silent tumours identified by receptor
studies. The role of surface phenotype assessment in evaluating
the prognosis of lymphoid tumours is that of an aid to conventional
histological interpretation. It is importantly not claimed as a
diagnostic test in lymphoma, a role more suited to conventional
histopathology. In particular the value of receptor studies lies
in their ability to identify the class of tumour cell, and to
indicate likely clinical behaviour of tumours in the diffuse
lymphocytic and diffuse histiocytic (small lymphocyte, small cleaved
and large cleaved groups of Luke's) groups where the techniques
offer a real advantage over conventional histopathology.
* Since this statement the patient has made a good clinical




Receptor Histology Histology from
Class Rappaport Lukes Ve diag.
mths.
^ , Clinical ,f ,, . AdditionalLead Name Sex Age _ ,
Stage Comment
Bl DH LNC mm 3 D mm HA M - intranodal
(Sacrum)
B1 DU LNC - 3 D 17 GJ M 66 Leukaemic
B1 DH LNC - 2 D II DH M 70
B1 DO INC - k D - IH F 66 Extrsnodal
(thyroid)
B1 IMDL SL A k - IV RV M 56 Leukaemic
B2Fc/B2.C NPDL SC A 12 mm III JMcK M 35
B2.FC DPDL LC - 2 D SM F 76 Extranodal
(thyroid)
B2.C DPDL LC - 6 D IV JR M 68
B3.2 DH LC mm D II AS M lilt
B3.1 NPDL SC A 26 - III MM F 71 Involved Sple
B3.? DNDL SL A 1U - IV JF M 60 Leukaemic
B3.1 NPDL SC A 16 - III ES F 72
B3.2 NPDL SC • 2 D IV AR F - Developed
Receptor
Silence
B3.1 NPDL SC A 18 mm IV HR F 5li
B3.? NPDL SC A 1li - II JT M 63
B3.1 BWDL SL A * - II JB M 56*Long term
survivor 20y+
B3.? DPDL SC - 8 D II AS F 63
bU NPDL SC A 26 mm III AM F 73
bU NPDL SC A 15 - IV AD M 71
b!i NPDL SC A 17 - III DG F li3
B3.3 DPDL SC A 16 - IV TMcG M 68














Receptor Histology Histology Ali,e from ^ Clinical ^ ^ Additional
Class Rappaport Liikes diag. Stage Comment
mths.
Silent DH ItfC - 12 D III JO F 72
Silent DH IMC - 18 D IV JR M 26 Involved Spleen
Silent DFDL LC - h 0 IV JK M 70 With leukaemia
Overlap OH LC A 16 - II LL F 1U
Overlap OH imc A 20 mm II RE F 6k
Silent DH LNC « 3 D n CM F 56 Orbital tumour
3U7.
Relationship between Survival) Histological type and Receptor class





Velzian M 56 DWDL A 1* B1
Adams M - DHL D 3 B1
Hall M 70 DHL D 22 B1
Hogg F 76 DPDL D 1* B1
Johnstone M 66 DHL D 3 B1
Reid M 67 DWDL A 3 B2.FC
Hoodie F 76 DPDL D 2 B2.Ec
Robertson M 68 DPDL D 6 B2.C
McKenzie M 35 NPDL A 12 B2.Ec/B2.C
Robertson E 51* NPDL A 12 B3.1
Smith E. E 72 NPDL A 16 B3.1
Muir E 71 NEDL A 26 B3.1
Bathgate M 56 DWDL A 8 B3.1
Robertson A. E 51* NPDL D 2 B3.2
Smith A. M 1*1* DHL D 5 B3.2
McGrail M 68 DPDL A 16 B3.3
Eraser M 60 DWDL A 11* B3(unclassified)
Swanson E 63 DPDL D 8 B3(unclassified)
Thompson M 63 NPDL A 11* B3(unclassified)
Munroe E 73 NPDL A 28 Bl*
Dobie M 71 NPDL A 15 Bii
Gaffney E 1*3 NPDL A 17 Bl*
Kerr M 70 DPDL D 1* Silent
Oliver E 72 DHL D 12 Silent
Ritchie M 26 DHL D 18 Silent
Moyes F 56 DHL D 3 Silent
Baird/«. *
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Baird F 6k DHL A 20 Overlap
Laverick F 1li DMLL A 16 Overlap
Ross M 70 DHL D 5 Macrophage
Cairns M 68 DWDL D 8 predominant
Turribull F 8 ALL D 2 days Silent
Cooke M 12 ALL D 1 day T cell
Piakowsky M 56 CLL D 6 B1
Mowatt M 69 CLL D k Silent
Blake F - ALL D 1 day B1
Coburn M - CLL A 2k B3?
Klimczak F 55 MI/EKE A 2 Monocytic
Smith M 62 IRE A 2 Unknown
3k9.
Statistical Appendix. Method of Analysis of Acceptor and Survival
Data.
Survival data on 19 lymphoma patients are analysed by the
regression methods due to Cox (1972). The explanatory information
on each patient is B cell receptor classification, and clinical
staging.
Clinical stages 1-U have been condensed to a binary
observation "coded staging" on each patient. Stages 1,2 are
coded 0, while tumours staged as 3> k are coded 1. Five of the
nineteen patients have "coded staging" 0. The coding scheme adopted
follows the clinical significance of clinical staging although a
more powerful explanator may result from coding stages 1,2 and 3
as 0.
lymphomas are assigned to groups A, B according to B cell
receptor classification. Group A is the set of 12 lymphomas
which are classified as B3, Bl*. The remaining 7 lymphomas are
B1, B2 and constituted group B.
The composition of groups A, B by age and sex is shown in
table 1(a), 1(b). Neither factor is associated with group,





, 7 11 *A2e is unImown
for 2 patients
B 2 U 6





A 5 7 12
B 5 2 7
Total 10 9 19
Preliminary analysis of the survival since biopsy of group
A, B patients (Table 2) involves the estimation and plot of
experimental survival curves for the two groups, shown in Figure 32,
For each group, to calculate the likelihood of a patient in that
group surviving for at least t months after biopsy, denoted by
H(t). The plot of H(t) against one T is the experimental




TABLE 2 Survival Data and Explanatory Variables
Patient Number Coded clinical Receptor Group Death 58 1 Survival in
Stage Conaored ** 0 Months
1 1 B 0 1
2 0 B 0 1
3 0 B 0 1
li 1 A 1 2
5 1 B 1 2
6 1 B 1 3
7 A 1 5
•3 1 B 1 6
9 A 1 8
10 1 B 0 9
11 1 A 0 10
12 1 A 0 12
13 1 A 0 13
1U 1 A 0 ill
15 1 A 0 ill
16 A 0 1li
17 1 A 0 15
18 1 A 0 2li
1? 1 A 0 26
TABLE 3/..
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TABLE 3 Experimental Survival Curves
Time in Months Probability (group A patient Probability (group B patient









We shall now consider whether the increased survival in group
A patients is indeed attributable to receptor classification or
whether the apparently better prognosis for group A patients is
accounted for by differing staging within groups A, B. The
problem is formulated neatly in the following model.
If a patient has survived for t months after biopsy, the
risk or hazard to that patient of dying within a short interval






risk of dying in the
x - - - - x interval(- - - -)
a + t + dt ^ t ^ dt,
given that the patient
survived ( ) from
0 to t.
The notation and nomenclature suggest the definition t "time -
specific*1, since dependent on the time t already survived, "failure
rate" indicates the risk or rate of failures or deaths among
patients who have survived for a specific time, t months after
biopsy.
Cox suggests a model in which the time-specific failure rate
for patient i, ^(t), is the product of two components one of which
is the time-specific failure rate for a "standard" patient denoted
by Q(t), while the second is a function of the explanatory
information for patient i, which I shall denote as f(i).
An example is helpful.
Mac Standard has time-specific failure rate Q(t).
Pat Aye is another patient in a ficticious series. Information
explaining her survival prognosis is available. We estimate that
the function f evaluated for Pat is 3, and hence, according to
Cox's model
(t) - (t) * 3
Pat °
Warning that if both Mac and Pat survive for t months after
biopsy then Pat has risk three times greater than Mac of dying
very/...
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very shortly after t.
Honey Bee is a further patient for whom the value of the
function f is ■§•. Honey is lucky. Given that both she and Mac
have survived for t months the risk that Honey shall die in a short
interval after t is half the corresponding risk for Mac. Thus
(t) " Q(t) * £
Honey
In the present study the information which may be important
in predicting patient survival is coded clinical stage, receptor
group.
Define for patient i the following variables
Z^i " 0 if patient i has coded stage 0
1 if patient i has coded stage 1
= 0 if patient i belongs to receptor group A
(i.e. B3, BU lymphoma)
1 if patient i belongs to receptor group B
(i.e. B1, B2 lymphoma)
Following Cox we shall consider the function
f(i) - «P (pl2ll - b2 a21)
that the hazard or time-specific failure rate for patient i at time
t is
±(t) - Q(t) f(i)
- Q(t) exp (B1Z11 + B2Z2i) (1)




Refer to Table 2.
Q(t) » time specific failure rate for patient 9 who has * 0, - 0
- Xt) exp (B,0 + B O) from . . . . (1)
o i «





(t) • time-specific failure rate for patient 10 who has10
Z1 ■ 1» Zg ■ 1 •
Q(t) exp (B1.1 + B2»1)
o
(t) asp (B1 + b2)
The method of analysis is by comparison of models, searching
for a model which adequately fits the data and involves a minimum
number of explanatory variables. The explanatory variables "coded
staging", "receptor group" are cf interest in the present study.
The search for an optimal model is as follows.
Include both explanatory variables
(t) - Q(t) exp (B1Z1 + BgZg) Model 1
and derive our estimate for goodness of fit of Model 1«
OndLt the variable "coded staging", fitting
(t) - Q(t) exp (BgZg) Model 2.
Compare the goodness of fit estimates for models 1 and 2.
Does model 2 fit the data significantly less well than the full
model, model 1 ? If so, the variable omitted, "coded staging",




Consider a third model, discounting the variable "receptor
group"
(t) * -ft) «xp Model 30 «1
Again compare the goodness of fit estimates from models 1 and
3, in order to decide how seriously the fit has been impaired by
disregarding the explanatory information "receptor class".
xhirther investigation of models 1, 2, 3 involves comparison
of each in turn with the null model
(t) « (t) Model 0
o
which claims that neither explanatory variable is necessary for
the prediction of survival.
Results Section
The analysis of changes in the log-likelihood when
different models are assumed is presented in the statistical
appendix.
When both "coded" staging and receptor class are included
as explanatory information the improvement in fit of model - for
the time-specific failure rate or risk - to data is not significantly
greater than the fit when no concomitant information is
considered in the prediction of survival. It is noted from this
model that "coded staging" and "receptor class" are negatively
correlated in the present data set, so that one or other may prove
explanatory.
Indeed it is established that regression on "receptor group"
as the sole explanatory variable results in a markedly improved
fit of model to data (0.0J? p 0.10, test statistic = 3.39 X2)
than/*..
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than is established using the null model in which no concomitant
information is accounted for. Equally the importance of "receptor
class" is assessed and confirmed by measuring the impairment to
goodness of fit which results when the full model ("coded staging",
"receptor class") is reduced by discounting the information
"receptor class". The impairment is significant (test statistics
* U.978. The test statistic is distributed as j 0.01>p<0.05)
and hence indicates that receptor class is an important explanatory
variable.
The analysis leads to an estimated 90% confidence interval
for the regression coefficient on receptor class: 1.53 +1.37
(0.17, 2.90). We deduce that the hazard or time-specific failure
rate in receptor class B (B1, B2 lymphomas) is U.6 times that for
group A patients. The corresponding 90% confidence interval for
the multiplying factor is (1.2, 18.2).
That "coded staging" is not our informative explanatory
variable is similarly established by the two methods described
with reference to receptor class. The present series of 19
patients however includes only 5 lymphomas coded 0 for staging.
Further study is necessary before clinical staging is confidently
described as a valid predictor for survival prognosis.
Statistical Appendix
Model 1 (t) -o(t) exp <B,zi . b2z2)
Model 2 (t) "o(t) exp ( ♦ b2z2)
Model 3 (t) •o(t) exp )
Model 0 (t) - o(t)<i
where/...
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where ■ 0 if coded staging is 0 (stages 1, 2)
■ 1 if coded staging is 1 (stages 3> ii)
Z2 • 0 if receptor class for patient is A (B3> BU lymphoma)
■ 1 if receptor class for patient is B (B1, B2 lymphoma)
and B.j , B^, Q(t) are estimated from the data for each model.
Analysis
Model 1 Test statistic with 2 degrees of freedom (distributed
Hence model 1 does not fit the data significantly better than
the null model, model 0.
Model 2 Test statistic with 1 degree of freedom (distributed as
Hence (0.05 P 0.10) receptor class is an important
predictor of survival
B2 - 1.53 Var (B2 ) - 0.695.
Model 3 Test statistic with 1 degree of freedom (distributed as
4' 0.10 * *"61
4) - 3.39
4,0.10 - 2-71 ' 4,0.05 " 3-6U
2
Xj ) ■ 0.68. Hence "coded staging" does not appear to
be an important predictor of survival. However, only
5 of the 19 patients have clinical stage coded 0 and this
model is not powerful due to small sample size. Further
data/...
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data are necessary to draw valid conclusions.
Change in Maximum - Log Likelihood
Model Maximum Log Change in Maximum Log Significance










- 13.309 201-12) - 2.2*66 X?
Interpretation: disregarding the
explanatory information "coded
staging" does not markedly impair
the goodness of fit.
Prefer model 2 to model 1.
NS
(Coded - 12*.565 2(L-L ) - i*.978 jq
Staging) Interpretation: omitting the
information on receptor class has
seriously impaired goodness of
fit.
Prefer model 1 to model 3.
0.01^ p<-0.05
0.01C p <.0.05
CONCLUSION: Receptor class is the
minimum necessary explanatory infor¬
mation useful in predicting survival:
Accept Model 2.
In paragraph 2 of this report it is noted that the coding of
clinical staging follows the American interpretation of staging,
namely that stages 1 and 2 are considered alike, and separated from
the more advanced lymphoma in stages 3 or 2*. In the present series
of 19 patients, however, only 5 have stages 1,2 lymphoma, so that
coded/,,.
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coded stage 0 is represented by only 5 patients. Model 3 in the
above discussion is correspondingly weakly founded.
An alternative coding scheme would be to group stages 1, 2,
3 separating off the most advanced stage 1*. Eight patients in the
present series have stage h lymphoma. Allowing this scheme an
analysis was made which led to the same conclusions as those reported
above.
The patients in this series were retested three months after
the analysis presented here. The experimental survival curves
clearly show that B3> BU patients have a better prognosis in terms
of survival than B1, B2 patients. Paralleling the previous
analysis the data were inspected using
1) Cox^ regression model B, « 1.85* SE * 0.7U6 p^ 0.025.
2) Peto & Peto's logrank test, with comparison when the
underlying distribution if lognormal or normal p<0.02.
This shows that with increasing time of study the differences in
survival pattern between patients with B1 and B2 lymphomas and patients
with B3 and Bli lymphomas becomes more highly significant (p <>0.05
p<0.02).
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a) Changes in the spleen in Hodgkin's disease.
b) Changes in the lymph node and blood in Hodgkln's
disease.
c) The nature of the Reed Sternberg cell, and
abnormalities of lymphocytes in Hodgkln's disease.
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Hodgkin's Disease
The study of Hodgkin's disease involved three related but
independent investigations} firstly the study of the spleen in
which quantitative data were sought in order to monitor the changes
in cell populations during the disease, secondly, typical Hodgkin's
disease receptor profiles were looked for in involved lymph nodes,
and in blood, and thirdly the biology of the Reed-Sterhberg cell
was studied from its surface phenotype as detected by receptor
studies, and for presence or absence of cytoplasmic immunoglobulin.
On the basis of the findings a theory of the pathogenesis of
Hodgkin's disease is proposed.
Studies of Hodgkin's Disease Spleen
Spleens from patients with Hodgkin's disease undergoing
laparotomy for staging, were collected. The total cell count,
cell concentrations, receptor profiles and histology were all
determined as in "methods". Blocks were also stained by the
imntunoperoxidase technique to detect Ig bearing cells.
Some precautions need to be taken to ensure that involved
tissue is not missed, as involvement of spleen is an important
matter in staging and managing Hodgkin's disease. To this end,
each 2-h mm slice (after taking material for receptors, cell counts
and special histology) was fixed for 2h hours in neutral 10$
formalin solution and then again sectioned at 2 mm thickness with
a skin graft knife blade. All significant nodular white areas
were removed and blocked for diagnostic evaluation. If no
involvement/...
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involvement was apparent, 9 standard micro blocks were taken from
each spleen. Fourteen male, and six female spleens are incorporated
into this study. Two male and two female spleens showed involvement
with Hodgkin's disease, the others showed either a reactive pattern
with germinal centres, eosinophil and neutrophil infiltration of red
pulp, non-Hodgkin's granulomata, or a "normal" pattern without these
features.
In some later spleens (Bull, Reynoldsand Kowbel) full
quantitative data was not obtained, but receptor profiles were
studied, especially in respect of IgM receptors.
Hodgkin's diseased Spleens
Patient Age Hex Spleen height Cell Concentration Diagnosis Histology
hi 27 m 1*60 gms 31*1.3 x 106/gm HDNS Reactive
H2 15 m 160 1*93.8 HDLP Normal
H3 21*. m 265 158.5 HDLP Normal
Hi* 11* m 312 155 HDLP Reactive
H5 11* M 100 800.0 HDNS Normal
h6 18 m 138 310.2 HDNS Reactive
H7 3U M 200 1235.5 HDDS Normal
K8 12 m 109 1*1*9.5 HDLP Normal
H9 33 M 165 381.9 HDNS Reactive
H10 66 M 253 276.7 HDLP Diffuse
Involvement
HI 2 M 310 1*19.1* HDMO Nodular
Involvement
H13 35 M 270 372.2 HDMC Normal
Hll* 8 m 11*2 516.2 HDMC Normal
H15 1*2 M 90 218.9 HDMC Normal
H16 11* f 102 752.0 HDLP Reactive
HI 7 19 f 92 510.9 HDNS Reactive
H18 20 f 189 391.5 HDNS Reactive
H19 21* F 335 656.1 HDNS Nodular
Involvement
H20 71* f 782 181.6 HDLD Nodular
Involvement
H21 21 f 117 327.1* HOLD Normal
Mean spleen wt. males 198 gm. females 269.5 gm.
363.
Receptor Profile of Hodgkin's Disease Spleens
Values given are percentage of total cells. Ficoll triosil
separated mononuclear cells, mean viability 90%
Patient Sex E Rosettes Fc 22 Phagocytes Capping Non-cap]
H1 M 55 29 61 19 10 21
H2 M 1*2 31 1*1 1*5 31* 27
H3 M 28 2 - - 7 1
Hi* M 63 38 30 6 32 20
H5 M 1*1* 26 30 5 28 13
H6 M 1*2 68 63 25 26 11
H7 M 50 39 21 1* 39 8
H8 M 31* 16 35 21* 21 13
H9 M 53 38 50 9 18 1*6
H10 M 1*8 6 - 18 15;
H12 M 52 27 52 5 1*1* 9
H13 M 52 1*1 1*9 6 39 17
Hli* M 1*1 20 21 9 59 10
H15 M 1*6 33 38 21* 27 12
H16 F 35 25 28 11 18 6
H17 F 25 31 35 5 8 1*7
H18 F 31* 1*5 29 32 29 15
H19 F 1*8 1* - - 21* Nil
H20 F 53 39 51* 31 25 19
H21 f: 23 - - 11* 35 7
Bull F 27 7 55 7 1*6 8
Reynolds M 1*6 26 1*0 5 33 8
Kowbel M 62 21* 5 19 17 Nil
Involved Spleens
In involved spleens, the receptor profiles of involved
tissue differed from uninvolved tissue. In the example shown
below the receptor profiles of involved and uninvolved tissue
are/.■•
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are shown, for a case with nodular involvement of the spleen.
Patient Uninvolved Tissue Involved Tissue
DW (H7) Percentage Cells per gm Percentage Cells per i
E Rosettes 3U 1U3 x 106 50 212 x 106
Fc 27 112 x 106 39 165 x 106
C3 k6 193 x 106 38 158 x 106
Phagocytes 12 50 x 106 12 51 x 106
Capping 17 71 x 106 19 82 x 106
Ron capping 1 6 x 106 8 32 x 106
In this case, as in most cases examined, involved tissue
shows increased numbers of T lymphocytes and increased proportions
of these cells. The uninvolved tissue shows increased numbers of
complement rosetting cells which exceed the totals-of B cells and
macrophages combined. This singular feature, which occurs in some
but not all cases of Hodgkin's disease, is not present in involved
tissue. As shown in the receptor profiles of HodgfcLn^ spleen, an
excess of complement receptor cells was found in the cases H1 and H6
designated below.
Case Sex Status of Spleen Excess C3 receptors over
B cells + Macrophages
H1 M Reactive not involved 11$
H6 M Reactive not involved 7$
From the receptor data it appears that in these two cases
T cells in Hodgkin*s disease posses C3 receptors. This phenomena
was/...
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was later shown to be due to IgM receptors on Hodgkin's disease
cells.
Abnormalities of B cells in Hodgkin's disease
In three cases of Hodgkin's disease, an excess of non-capping
B cells over capping B cells was shown. The receptor profiles for













This is an unusual feature of Hodgkin's disease, and occured
only in uninvolved spleens in Hodgkin's disease of nodular sclerosing
subtype. Despite the findings in non-Hodgkin*s lymphoma and
normal spleen, that non-capping cells do not express C3 receptors,
but are more often of the B2.Fc class, in these cases C3 rosette
levels were not low despite the predominance of non-capping B cells.
Rather low levels of phagocytes were present and cannot be the
source of the anomaly. The conclusion is that in some cases of
Hodgkin's disease the B cell population can be non-capping, yet






The greatest proportion of phagocytes encountered in normal
6
spleens was 26%, and the highest concentration was 125 x 10 /gm. In
Hodgkin1s disease spleens these levels of phagocytes were equalled
or exceeded on six occasions* The patients in which this occuirdd
are shown below.
Case Histology Sex Spleen Status Phagocytes phagocytes/gin
Number
H2 HDL? M Normal k$% 230 x 106
H6 HDNS M Reactive 25* 32 x 106
H8 HDLP M Normal 2h% 100 x 106
H15 HDMC M Normal 2h% 52 x 106
H18 HDNS F Reactive 32% 32 x 106
H20 HDLD F Nodular 31* 56 x 106
Involvement
As can be seen in only one patient (H2) was the concentration
of phagocytes greater than that encountered in normal spleen. This
evidence shows that abnormalities of spleen phagocyte populations
are not a feature of Hodgkin1s disease, despite the histological
evidence of granuloma formation in reactive Hodgkin1s disease
spleens.
Sex Differences in Hodgkin1s Disease Spleen
The most surprising feature to emerge from this study was
the obvious sex differences between normal male and female, and
Hodgkin1s disease male and female spleens. This finding requires
that/...
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that the appropriate control for male Hodgkin's disease spleen is
the normal male spleen, and for female Hodgkin's disease spleen,
the normal female spleen. The tables of comparison for male, and
for female spleens, are shown. The principal differences are
shown in the summary table, for male and female spleens from patients
with Hodgkin's disease, compared with normal male and female controls.
Mean Values for Hodgkin's Disease Spleen. Male compared with Female.
10
Rosettes Percentage Cells/gm x 10 Total cells x 10
Male Female Male Female Male Femals
E 1*6 36 201 169 3.98 U.56
Fc 30 29 131 136 2.59 3.67
C3 1*0 39 175 183 3.U7 1*.90
Neutral Red
Phagocytes
15 19 66 89 1.30 2.i|0
Capping 29 23 127 108 2.51 2.90
Non-capping 16 19 70 89 1.39 2.1*0
TOTAL CELLS 106 97 1*37.8 1*69.9 8.67 12.69
Spleen Weight 198 270
Note: mean total B cell concentration Male HD spleens (197 x 10 )
are equal to mean total B cell concentration for female HD spleens
(197 x 106). Female HD spleens are significantly larger than male
HD spleens (p 0.05) and in comparison with normal spleens the
increase in spleen weight in Female, but not in the male, is
significant. There is a significant decrease in cell concentration
in male HD spleen compared with normal male spleen (p 0.05) and a
significant/...
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significant increase in cell concentration in female HD spleen
compared with normal female spleen (p 0.02).
Comparison of Normal Male Spleen, with Hodgkin's Disease Male Spleen.
Percentage of rosette forming cells, with absolute values of cell











Spleen weight 166 198








TOTAL CELLS 95% 106% 591.5* U37.8*
Note: the tendency for the cell concentrations of all cells except
phagocytes and non-capping B cells to show a decrease in male HD
spleen. The only significant difference (**) is between the total
cell concentration of the normal male spleen which is higher than
that of the male HD spleen (p 0.05).
Comparison/..,
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Comparison of Normal -Female spleen with Hodgkin's Disease Female
spleen. Percentage of rosette forming cells, and absolute
values of cell concentration (No. of rosetting cells per gm spleen wt.)
Rosettes Percentage Values Cell concentration (cells x 10^
Normal HD Normal HD
E Uo 36 187 169
Fc 30 29 111 136
C3 28 39 106 183
Neutral Red
Phagocytes
17 19 62 89
Capping 29 23 108 108
Non-capping 12 19 i+JU.6 89
Spleen Weight 156 270
TOTAL CELLS - - 367.6 107.8
Note s that female HD spleen is enlarge! compared with normal
female spleen (p 0.05). There are more phagocytes, and non-
capping cells than in normal female spleen, and T cell concentrations
are decreased. These changes are not in fact significant,
probably because of the small numbers of spleens in the female
series. Cell concentration is significantly increased in female




Comparison of total cell counts (No. of cells x 10 ) of Normal
Male and HodgkLn's Disease Male Spleen, and Normal Female and
HodgkLn»s Disease Female Spleen.
Rosettes Total Cells-Male Spleens
(x 101U)
Total Cells Female Spleens
(x 10TU)
Normal HD Normal HD
E Rosettes 3.U0 3.98 2.99 a.56
Fc 2.95 2.59 1.73 3.67
03 2.77 3.147 1.66 a. 90
Neutral Red
Phagocytes
0.88 1.30 0.97 2.ao
Capping 2.83 2.51 1.69 2.90
Non-capping 1.06 1.39 0.68 2.ao
TOTAL 8.37 8.67 U.97 12.69
Males: spleen weight in HD patients is increased, but cell
concentration is lower than in normal male spleen. The only-
changes are minor variations with absolute increases in complement
receptor cells, and in phagocytes.
Females: in Hodgkin's disease patients total cell numbers,
T cell, B cells (especially non-capping) and phagocytes are raised.
These values are probably significant, bearing in mind that the
number of available spleens in the female series is too low for
rigorous statistical analysis. In both male and female, T cells,
complement receptor cells, phagocytes and non-capping B cell3 are
increased.
371
Summary Table; Sex differences in Hodgkin's Disease
Features Difference from Normal Statistically
Significant
Spleen weight Male Increased No
Spleen weight Female Increased ?< 0.05
Cell concentration Male Decreased p<o.o5
Cell concentration Female Increased p<o.og
T cell concentration Male Increased No
T cell concentration Female Decreased No
Phagocyte concentration Male Increased No
Fhagocyte concentration Female Increased No
B cell concentration Male No change No
B cell concentration Female Increased No*
Total cell count Male Decreased P<0.05
Total cell count Female Increased P <0.02
Total T cells Male Increased No
Total T cells Female Increased P<0.05
Total B cells Male No change No
Total B cells Female Increased P<0.05
* Significance not attained in the small number of cases available.
Comparison for all other receptors showed no constant
relationship to sex or to Hodgkin^s disease, although changes in
capping and non-capping £ cells and complement receptors have been
already commented upon. The B cell concentration (*) would
probably/...
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probably be significant if more cases had been available, as this
result just failed to reach significance in females.
In male Hodgkin's disease spleen the spleen weight is
increased but the total cell counts remain low, and cell
concentration is decreased. Therefore despite a slight increase
in proportion of T cells in male Hodgkin's spleens, the actual T
cell numbers and concentration fail to reach a significantly
increased level. In female spleens, spleen weight cell
concentration, total cell count, the total numbers of T cells, the
concentration of B cells and the total numbers of B cells are
increased. When compared with diseased control spleens, the cell
concentration, and the total numbers and concentration of B cells
remain significantly raised in the female.
These findings show that Hodgkin's disease produces profound
alterations in the cellularity of both male and female spleens.
In males, there is a tendency for the cell counts to fall and,
despite increased proportions of T cells in the male spleen their
total number or concentration is not increased. Thus Hodgkin's
disease in the male results in decreased lymphocyte concentrations
in the spleen, without profound changes in the T cell, B cell or
macrophage proportions. In the female, the most marked increase
is in total cell number and in the B cell number and concentration.
The total numbers of B cells in female spleens do not exceed
the total numbers in male spleens. In this series involved and
uninvolved spleen data are pooled, since the numbers of involved
spleens are too small for separate statistical evaluation, but as
shown T cell levels in involved spleen tissue were higher than in
uninvolved/...
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uninvolved spleen. The evidence indicates (1) a clear sex
difference in the response of spleen cell populations in Hodgkin's
disease (2) abnormalities of B cell populations in the female but
not in the male (3) an increase in the proportion and concentration
of T cells in Hodgkin's tissue and (U) an excess of complement
receptor bearing cells in some uninvolved Hodgkin's disease spleens
of nodular sclerosing subtype.
The findings in spleen led to further studies of Hodgkin's
disease, using samples from lymph node and blood. Unlike lymph
nodes from non-Hodgkin» s lymphomas it was not possible to classify
Hodgkin's disease nodes for the following reasons: (1) most
involved nodes were T cell rather than B cell predominant, (2) B
cells in Hodgkin's tissue may express complement receptor while
tailing to cap surface Ig (B2.C class), (3) there was a distinct
overlap between T cells and complement receptor bearing cells in at
least two cases. These features compromised attempts to classify
B lymphocytes in Hodgkin's disease lymph nodes. In addition plasma
cells were frequently present in Hodgkin's disease lymph nodes where
they sometimes formed a substantial "receptor silent" population.
They were detected by the immunoperoxidase technique. Few involved
lymph nodes were available for study, and In most instances blood
receptor profiles were within normal limits. The relevant data
are examined in the next section.
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lymph Nodes In Hodgkin's Disease
An examination of quantitative data in the Hodgkin's disease
spleen led to the discovery of several features which appear to be
peculiar to Hodgkin's disease. These were:-
(a) The T lymphocyte predominance of involved areas of
spleen compared with uninvolved areas.
(b) An excess of complement receptor bearing cells over the
sum of B cells and macrophages in uninvolved HodgfcLn's
spleen.
(c) The presence of B2 cells of B2.C class (complement
receptor bearing) which are postulated to occur in
germinal centre. In other lymphomas and in blood B2
cells usually express the Fc receptor (B2.Fc).
(d) The sex differences between male and female Hodgkin's
disease spleen.
Only eight involved Hodgkin's disease lymph nodes were
available. Ho general conclusions could be reached on such
limited numbers, and quantitative investigation of these parameters
are omitted.
The receptor profiles of involved Hodgkin's disease lymph
nodes, and of these nodes when the subtype of Hodgkin's disease
is considered a variable, are given in the following two tables.
Heceptor/...
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Receptor Profiles In Involved lymph Nodes in Hodgkin's Disease
Figures as percentage of lymph Node Cells.
Patient Viability £ Rosettes Fc C3 Phagocytes Capping non-capping
Muir 60 31 29 k9 1 17 10
Cochran 78 69 31* 88 2 18 6
Dunmore 66 1*1 6 5 12 25 -
Henderson 70 36 19 35 I* 13 17
Jacob 80 66 26 25 2 19 9
Stewart 70 65 56 52 11 12 1*
iiae 71* 51* 7 1 1* 9 11
heIvor 70 33 6 20 h 10 12
Histological subtype Patients Sex
HDMC Rae, Cochran, Jacob% Mclvor M.MJ4.F.
HDNS Dunmore, Henderson M.F.
HDLP Stewart, Muir M.M.
HDLD None.
Receptor Profile for Subtypes of Hodgkin's Disease
Subtype Viability E Fc C3 Phagocytes Capping Non-capping
HDMC 76 56 18 31* 3 11* 10
HDNS 68 39 13 20 8 19 9
HDLP 65 1*8 1*3 51 6 15 7
There/...
376.
There are no significant differences because of the small
numbers of nodes in the series. There are some interesting features,
firstly that T cells do appear to be raised in HDMC subtype, secondly
that complement rosettes are much increased in HDLP subtype. One of
the mixed cellularity group (Cochran) showed increased complement
rosettes. In the cases Cochran, Stewart and Muir complement
rosettes exceeded the sum of capping cells, non-capping cells and
macrophages as shown for two spleens in the series. This
apparent overlap of complement rosetting cells and T cells is
probably due to IgM receptors on T cells in Hodgkin's disease.
377.
The specific features of Hodgkin's disease in the individual
cases mentioned are now considered.
T cell predominance
T cells exceeded the sum of B cells and macrophages in all
the lymph nodes examined. In cases Muir, Dunmore, Henderson, the
predominance of T cells can scarcely be regarded as significant.
Moreover the normal or reactive lymph node can also show T cell
predominance so the validity of this finding is difficult to
assess. In cases Cochran, Jacob, Stewart and liae the excess of
T cells over other cells is very marked, being k3%> 37%, 3&% and
30$ respectively. All these patients are male, three with
Hodgkin*3 disease of mixed cellular!ty (HDMC) and one with
lymphocyte predominance (HDLP).
The pattern of T lymphocyte predominance found in the
Hodgkin's disease node stands in marked contrast to the findings
of B lymphocyte predominance in non-Hodgkin's lymphoma. Several
alternative explanations of these locally elevated tissue levels
of T cells are possible:*
1 ) T cells may be neoplastic
2) T cells may be functionally immature, failing to
"peripheralise" or mature in Hodgkin tissue.
3) The T cells could be co-operating with abnormal B
cells in an ineffectual immune response.
U) The T cells could be reacting against a neoplastic
B cell population.
It is important to know whether Hodgkin tissue invariably
contains high proportions of T lymphocytes, and to know whether
such/...
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such T lymphocytes are normal or abnormal. If the T cells are
reactive, their presence in Hodgkin tissue could be accounted for
by the sequestration of reactive cells into involved tissue, with
local elevation of T cell levels, and corresponding depletion of
T cells in blood or spleen. If this is the case, involved
spleen should show greater T cell proportions, and numerical
increases in T calls with corresponding depletion of blood or node
T lymphocytes. In uninvolved spleen T cell levels should be
decreased, while levels in the involved node should be increased
beyond normal values. Finally if T cells are functionally
immature or neoplastic the "sequestered" population might show-
surface features indicating abnormality. In the following three
examples, the first (Jacob) shows evidence of sequestration of T
cells from uninvolved spleen into lymph node, the second (McKillop)
fails to show sequestration of T cells into involved spleen, and
the third (Cochran) shows evidence of seqiiestration of abnormal
T cells from blood into lymph node.
In Jacob the receptor profile of uninvolved spleen showed a
normal percentage of T cells (h&%) but a reduction in T cell
6 6
concentration (101 x 10 s normal male 233 x 10 ) implying that
there could be sequestration of T cells from the uninvolved spleen
into the involved lymph node. The T cell predominance in the
lymph node was very marked (37/0# If high T cell levels do
signify sequestration of T lymphocytes around foci of active
disease, the phenomenon does not occur in every case.
In McKillop, a male with HDMC and involvement of the spleen,
T cell levels were $3#2$, 1)47 x 10^ despite the presence of
Hodgkin»s/...
379.
HodgkLn's disease in the spleen.
In other cases (case DW/H7) involved spleen tissue showed
increased T cell numbers and proportion compared with uninvolved
spleen. In Cochran, the blood was studied at the same time as the
lymph node biopsy, and with the same test particles. The data for
lymph node (1) and blood (2) in terms of percentage values and
quantitative data (3) are shown below. Figures given are either as
percentages of total cells, or as millions of cells per ml. Nonaal
blood values are shown in the last line(h).
E Fc £3 Phagocytes GaPPinS Non-capping
(1) 69 3k 88 2 18 6
(2) 1*9 36 n 2 8 28
(3) 2.lid 1.80 0.036 0.11 0.1*2 1.38
(U) 1.01 0.71* 0.55 0.38 0.55 0.31
In this example, the mononuclear cell count was 5*02 x 10 /ml.
with 61$ mononuclears on differential count. There is no evidence
of T cell depletion, in fact circulating T cells are more than twice
the nonaal number. The most striking evidence is of sequestration
of complement receptor cells from blood into lymph node. These
cells must be T cells, since a very marked T cell C3 receptor
overlap is present in node with C3 depletion in blood and leads
to the conclusion in this example that most of the apparent C3
receptors are on T cells and not B cells. The overlap of E and
C3 rosetting will be examined later. The conclusions reached in




(1) It does not occur in every case.
(2) There is no firm evidence that it is due to overall
sequestration of normal T cells with T cell depletion
of other compartments (e.g. blood, spleen).
(3) It has been shown in one case to be associated with
sequestration of an abnormal T cell population
apparently bearing complement receptors.
(li) In this series T cell predominance occurred only in
male patients, a point of little significance since
only two involved nodes from females have been
examined.
The Excess of complement receptors over the sum of B cells and
macrophages.
In the spleen series, 2 cases, both with uninvolved spleen
tissue showed an excess of complement receptor bearing cells over
E cells and macrophages. This fact shows that T cells apparently
express a complement receptor. The lymph node of Cochran also
showed this phenomenon. The lymph nodes of Muir, and Stewart also
showed complement receptor excess. The lymph node data showing
the magnitude of the excess is illustrated below. The data from
the two spleens (Hi and H6) is included.
Patient/...
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Patient C3 Excess C3 receptors over B cells E rosettes
and macrophages
HI 61% 11% 55%
H6 6$% n h2%
Cochran 88% U2% 69%
Muir h9% 21% 31%
Stewart $2% 35% 65%
In the involved nodes showing the phenomenon, quite marked
C3 receptors excess is noted, amounting to almost half the lymph
node population in the case of Cochran. Only 3 out of 8 nodes
show the effect, one from Hodgkin's disease of mixed cellularity,
and two from cases of lymphocyte predominant Hodgkin1 s disease. The
entire series shows T cell and C3 receptor overlap on 5 occasions
out of 31 cases. The discovery of this phenomenon, never observed
in normal nodes and rarely in non-Hodgkin lymphoma appeared to be
specific for HodgldLn's disease. Since T cells are known under
certain circumstances to express receptors for IgM, and such cells
never normally exhibit receptors for complement (C3), it was
decided to review cases for evidence of IgM receptors, since this
ligand could account for these gross overlaps between E and 03
rosettes.
IgM Receptors
Although frequently employed as a negative control for the
complement rosette with the sheep erythrocyte, very infrequent
IgM/...
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IgM rosettes were seen in normal tissue. Using ox red cells and
IgH antibody a search for IgM receptor bearing cells was carried
out in blood, lymph node, and spleen of Hodgkin's disease patients.
The results obtained are shown below. Figures given are as




















E Fc G3 IgM Phagocytes Capping Non-capping
25 - - 12 32 37
3h 27 hS 17































As this table shows, on 3 occasions (Smith - blood, Walker -
spleen, and Siram - blood) significant numbers of IgM receptors were
observed on cells in cases of Hodgkin's disease. In each case a
large proportion of phagocytes were present (32?, 12?, 15?) and in
one case (Walker) there was an excess of C3 receptor over B cells




presence of Hodgkin's disease in the patient, the tissue does not
have to show involvement.
The other cases show suggestive increases in IgM rosetting
cells - the upper limits of normal being 8$, the mean value being
2.8/6. The mean value of IgM rosettes in the cases shown (excluding
Smith, Walker and Simm) was 3.6^ and including all cases 9*5% •
Subclass B2 lymphocytes in Hodgkin's disease
In 2 reactive lymph nodes from cases of Hodgkin's disease, a
follicular receptor profile was obtained, in which B2 lymphocytes
predominated. Similar findings occurred in some spleens in the
series (Hi, H9, H17), but only in the nodular sclerosing subtype
of Hodgkin's disease. The receptor profiles of tissue in which a
predominance of B2 lymphocytes over B3 ceils was seen are shown
below. Figures given are as percentages of total cells present.
Patient Tissue E Fc C3 Phagocytes Capping
H1 Spleen 55 29 61 19 10
H9 Spleen 53 38 50 9 18
Hi 7 Spleen 25 31 35 5 8
Blair Node 56 29 mt - 12






In 5 patients with Hodgkin's disease, in uninvolved tissue,
the receptor profile shows non-capping B cells to be the
predominant B cell type. This is unusual in comparison to normal
nodes/.••
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nodes, where excess of non-capping cells is never seen.
In the series of Hodgkin's involved lymph nodes, the pattern
of B2 lymphocyte excess was observed once only (Henderson). In
this node complement receptor bearing cells were in excess, and the
B cells could be classified as B2.C as in the spleens of cases Hi,
H9, Hi 7 and the node of Rae. Insufficient data is available for
the lymph node of Blair.
There is thus evidence that in uninvolved tissue of the
nodular sclerosing subtype of Hodgkin's disease (HDNS - 3 cases) or
mixed cellularity subtype of Hodgkin's disease (HDMC - 1 case) or in
a minority of involved nodes containing Hodgkin's tissue of HDNS
type (1 case) the class of B lymphocyte present is B2.G (rather than
B3 subclass which are the most common normally).
This feature can, on histological grounds, be linked to the
follicular reactivity seen in uninvolved lymphoid tissues in the
course of Hodgkin's disease. Such changes are clearly reactive,
and not "neoplastic" and correlate with the descriptive histogenesis
of nodular sclerosing Hodgkin's disease. In this subgroup there
i3 evidence of a hypersensitivity reaction in the tissue, with
necrosis, heavy neutrophil and eosinophil polymorph infiltration,
and plasma cell accumulation. These events certainly represent
antibody mediated hypersensitivity of type II or III, which result
in necrosis, complement fixation and neutrophil and eosinophil
chemotaxis. The antibody may be produced local-ly, and is probably
IgG in type as can be concluded from study of these hypersensitivity
reactions. It is suggested that the excess of B2.C cells seen in
Hodgkin's disease is due to marked follicular reactivity as a
consequence/..•
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consequence of a secondary humoral immune response.
In this brief survey of Hodgkin's disease several facts
clearly emerge.
1) The disease in males and females shows a different
pattern. From the spleen, data, in males the cellularity
of the spleen is less than in normal males, while in
females the reverse is the case.
2) There is evidence of abnormality of the T cell
population in that
a) overlap between E rosettes and C3 receptors is noted
b) T cells probably express IgM receptors in some cases
of Hodgkin's disease.
3) Attention is drawn to the follicular reactivity in Hodgkin's
disease as a consequence of which B cell populations of
B2.C subclass are occasionally encountered.
lj.) In at least two cases there is clear evidence of the
sequestration of T lymphocytes from the blood into an
involved lymph node.
These changes reflect an abnormal immune response. The T
cells encountered may be immature T cells or T helper cells which,
by virtue of IgM receptors, localise in Hodgkin tissue in an
attempt to initiate a secondary humoral immune response by B
lymphocytes resulting in germinal follicle formation and plasma
cell accumulation. There is evidence that macrophages may be
increased in number in areas where IgM receptor bearing T cells are
found, and if substantiated this would imply the release of
lymphokines (migration inhibition factor) by activated T cells on
contact/...
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contact with antigen. (In other words could provide evidence for a
delayed type of hypersensitivity reaction). The further studies
are based on this interpretation of Hodgkin,s disease, and in
particular sought to elucidate the following points.
a) Is there morphological evidence which supports the concept
of secondary stimulation of B cells with their
transformation into plasma cells?
b) Do lesions occur in regions where T cells are likely to be
found?
c) What relationship is there between the Heed Sternberg cell
and the presence of activated T cells?
Evidence for the presence of plasma cells in Hodgkin's disease
Using the immunoperoxidase technique it is immediately obvious
that in spleen, lymph node and in Hodgkin's tissue, plasma cells
secreting IgG antibody, of either Kappa or Lambda light chain type
are much more frequent than in normal lymphoid tissue. This is
particularly striking when Hodgkin's disease is compared with the
other lymphomas in which intracellular immunoglobulin is but rarely
found. Moreover, lymphoblasts containing IgG or IgM antibody are
relatively frequent in Hodgkin tissue, though rare in all except
extremely reactive lymph nodes. Very marked plasma cell
accumulations around non-Hodgkin's granulomata are noted in some
cases. However, in common with reactive nodes, intracellular
immunoglobulin is never present in germinal centre cells, despite
the often prominent follicular hyperplasia. The appearances of
sections/...
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S£H® 33: Immunoperoxidase Reaction In Hodgkln'g Disease
In this section from a Hodgldn's disease lymph node*
the upper centre field shows a cell staining
intensely for IgG antibody (brown). Another plasma
cell occurs to the left of the field, and to the
lover right is an "Owl's eye"* lacunar cell* typical
of nodular sclerosing Hodgkin's disease. Note the
absence at cytoplasmic staining of this cell.
P.A.P. Immunoperoxidase for IgG Counterstain
Haeraatoxylin Oil Immersion x 1*200
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sections stained for intracytoplasmic immunoglobulin are
illustrated (Figs. 5, 33)•
In sections stained conjointly for iron (FBR) and immunoglobulin
a striking feature was the association between iron containing
macrophages and antibody forming plasma cells. This was most
marked in the red pulp, where it frequently involved the sheathed
arterioles (Schweigger Seidal sheaths). As shown macrophages in
this region often contained iron, and plasma cells in close
association were invariably found (Figs. 9> 10, 3U). The
principal interest of this observation lies in the findings of
Order, Porter and Hellman (1971) of an antigen associated with
Hodgkin's disease which later proved to be ferritin. Banding in
the B2 region of the electrophoretic strip has been noted to occur
with regularity in electrophoresis of Hodgkin's serum, and the
material responsible for this banding is a complex of transferrin
and Ig3antibody (Habeshaw - personal observations). These
observations strongly support the argument that abnormal immune
responses occur in Hodgkin's tissue, even to antigenswhich are of
widespread distribution. It furthermore seems to imply a lack of
T cell suppression of B lymphocyte responses in this disease.
Intracellular immunoglobulin does occasionally occur in cells
of Heed Sternberg type, and in "reticular lymphoblasts" and lacunar
cells. These features (Fig..35) show that abnormal morphological
foims of "plasma cells" could be part of the neoplastic component
of HodgkLn tissue.
Areas in which Hodgkin's disease lesions are found
In/...
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Figure 3k: Immunoperoxide ;e Reaction In jodgfrin'e Disease
A section stained for IgQ antibody (brown) and
iron (blue) reveals a elose association between
several iron containing macrophages and a single
antibody forming cell. It is suggested that
this association acoomts for the ferrit maaaia
and the presence of ferritln/antLbody complexes
known to be a feature of Hodgkin's disease.
P.A.P. immunooeroxidase for IgG/FBR reaction
x 600
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Figure 351 Irarounoperoxidase Reaction In Hodgkin's Disease
In this section from the lymph node of RAE, stained
for Kappa chain by the P.A.P. technique several Heed
Sternberg cells exhibit definite cytoplasmic
staining above background levels* These cells may
be morphologically- bizarre equivalents of the plasma
cell.




In the spleen early involvement can be found to occur in
regions of thymic dependency. These are in the periarteriolar
sheath, and at the margins of follicles where the peripheral white
pulp (a B cell area) lies adjacent to the marginal sinus (through
which T cells migrate to reach the periarteriolar lymphoid sheath).
In the lymph node no good examples of paracortical involvement were
seen, but in lymphocyte predominant forms of the disease, the
paracortex may be substantially increased. The impression from
histology is that HodgkLn's lesions occur first at the meeting
points of T and B cells areas, and that there is morphological
evidence of hyperactivity of both B and T cell components in node
and spleen.
Relationship between the Heed Sternberg cells and the activated
T lymphocyte _.
In this study numerous examples of Reed Sternberg cells were
seen. Their surface features were variable, but some characteristic
abnormalities were observed.
In suspensions of Hodgkin's disease lymph node, Reed Sternberg
cells, and the other abnormal cell types were constantly found
closely associated with T lymphocytes. The co-rosettes are
illustrated (Figs. 36, 37) and it is clearly seen that convoluted
small lymphocytes are the major cell class. These T lymphocytes
can also be shown, in many instances to express Fc receptors and
this is known to indicate an "activated" T lymphocyte. Occasional
abnormal forms of lymphocytes occur:- the hypersegmented lymphocyte,
but what these represent is unknown. They frequently play no part
in the interaction with the Reed Sternberg cell, but often show E
rosetting/...
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Figure 361 The Head Sternberg Cell in Ho dgkin'3 Disease
A binucleate Heed Sternberg cell is shown,
surrounded by small lymphocytes, some with
convoluted nuclei. This cell was isolated
from an involved lymph node (Rae).
Cytocentrifuge preparation, Giemsa Stain
x 1,000
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Figure 37i The deed Sternberg Cell In Hodgkin's Disease
This uninucleate Seed Sternberg Cell is surrounded
by small lymphoc ytes and some adherent IgG sensitised
ox erythrocytes. The appearances suggest weak Fc
receptor expression by both the deed Sternberg cell
and the surrounding lymphocytes, and this is
confirmed by studies in which the clusters are
dispersed with the enzyme pronase.




Figure 38t Convoluted Lymphocyte8 in Bocigkin's Disease
A cluster of convoluted lymphocytes shewing rosette
formation with sheep erythrocytes.
£ rosettes, cytocentrifuge preparation, Giemsa stain
x 900
Figure 391 Convoluted lymphocytes in Htodgkin's Disease
This cytocentrifuge preparation clearly shows that a
substantial part of the small lymphocyte population in
involved Hodgkin's disease nodes may be of convoluted
lymphocyte type.




rosetting capability and may express the Fc receptor. These
cells are illustrated (Figs. 38, 39)*
Reed Sternberg cells themselves expressed the Fc receptor, but
not the complement receptor, and occasionally showed the presence
of non-capping surface Ig. This would be evidence for the Reed
Sternberg cell being a B2.Fc lymphocyte. These features were not
constant} some showed the presence of weak intracytoplasmic
staining for IgG or more rarely IgM, which would suggest B cells
of B5 differentiation subclass. Yet others (the majority)
expressed no surface features other than clustering with T cells, and
the presence of the Fc receptor. Reed Sternberg cells did not
react with sheep erythrocytes (and are thus non-T) or with anti-
monocyte serum (A.E. Stuart - personal communication) and are not
macrophages. The conclusions are that the Reed Sternbeg cell is,
in a minority of cases, demonstrably a B lymphocyte, either of
B2.Fc subclass or of B5 subclass. It appears to be associated with
activated or committed T cells in an attitude of co-operation.
(There was no evidence of cytotoxicity by the T cells against the
Reed Sternberg cell. Indeed, only "healthy" Reed Sternberg cells
associated with T cells). The implications are strong that the
abnormalities observed in Hodgkin's disease centre on T cell
induced B cell stimulation as seen in the production of a secondary
humoral immune response. This failure may be due to some
abnormality of the B lymphocyte, since bizarre morpholigical forms
of this cell are encountered in this disease. There are abnormally
large accumulations of actively secreting plasma cells. In
Hodgkin's disease the lesions seen represent an abnormal secondary
immune/...
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immune response in which T helper cell function is intact, but
in which suppression of B cell function is lacking. There are
two aetiological possibilities
a) A defect in T cell suppression, and T cell cytotoxicity
is present, but the T helper functions are preserved.
Any antigen could then initiate a HodgkLn-type disease,
which because of stimulation of B lymphocytes coupled
with lack of immune surveillance eventually results in
a neoplasms of B lymphocytes or associated cells.
b) A virus in B cells (e.g. EB virus) is not eliminated in
the usual way (by DTH reaction) because of a T cell
defect (cytotoxic T cells not present). The virus
causes T helper stimulation because of its antigenicity,
to which the target B cell is partially refractory
because of its virus burden.
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Receptor classification, its validity and its limitations
The data presented represent the first systematic study of
lymphomata in which the tumours have been classified by the surface
characteristics of the cells in the affected lymphoid tissue. The
classification scheme employed was based on a thorough survey of the
known facts about the behaviour of normal lymphoid cells during
their differentiation from the stem cell to the functional end cell
in both humoral and cellular immune responses. The survey included
a detailed assessment of the known surface characteristics of each
cell class, and a tentative scheme of normal differentiation
markers for B lymphocytes was proposed. A detailed investigation
of the characteristics of lymphoid cells from normal tissues
showed the necessity of including in such a scheme methods of
comparing the normal "receptor profile" with the receptor profile
of neoplastic tissues. It became clear that in some cases the
receptor profile of the tumour closely resembled the receptor
profile of blood (B3.1) or tonsil (B3.2) lymphoid tissue or was
indistinguishable from profiles obtained from normal or reactive
lymph node (B3«3, Bii). This fact precludes the use of surface
phenotypic studies, such as those described, to diagnose lymphoma.
The diagnosis of lymphoma depends upon the histological appearance
of the biopsied tissue, and not upon its receptor profile.
In comparing normal with neoplastic tissues, it was apparent
that neoplastic tissues showed B lymphocyte predominance more
commonly than normal lymph node or spleen, and that they also
showed the presence of three unique receptor profiles not seen in
normal lymphoid tissue. These were called receptor silence,
receptor/...
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receptor overlap and B1 lymphocyte predominance.
As a result of these observations, it was proposed that the
neoplasms be classified
1) according to the predominant cell class
2) if no class was predominant, according to the subclass
of B lymphocyte.
The possibility that subclasses of B lymphocyte were present
in lymphoid tumours was indicated by the following observations.
Differences in capping of surface Ig anti-lg complexes between
immature and mature B lymphocytes have been shown (Sidman and
Unanue, 1975a,b), and differences in expression of the Fc and C3
receptor on immature (Metcalf et al., 1975) blast transformed
(Moller, 197U) or mature secretory (Corte et al., 1976) E lymphocytes
have been reported.
Studies of normal blood showed that two subclasses of B
lymphocyte were present (B3.1 and B2.Fc). Studies of tonsil
showed that an additional two subclasses of B lympnocyte, B3.2,
B2.C, were present and studies of lymphoid cell lines showed the
relationship between capping and non-capping behaviour, and the
presence of Fc and 03 receptors. The receptor profile of normal
or reactive nodes, showed two further classes of B lymphocyte to
be present (B3»3» BU), and the presence of BU phenotype by the
cell line EBU was demonstrated.
The scheme eventually used in the classification of lymphomata
depended upon determination of the proportions of each cell class
(T/...
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(T lymphocyte, B lymphocyte or macrophage), and the subsequent
determination of the major B lymphocyte subclasses in each tumour.
In order to achieve tfcis, a minimum of 6 observations must be made
on the cell suspension from each tumour - the numbers of E, Fc and
complement rosettes, the numbers of mononuclear phagocytes, the
distribution of the surface Ig anti-Ig complex and the numbers of
surface Ig bearing cells. When this classification scheme was
applied to a series of 30 non-Hodgkin lymphomas and 9 leukaemias
in only two cases (myeloid leukaemia and leukaeraic reticulo-
endotheliosis) was there failure to classify- the tumour by this
scheme.
The incidence of the different types of non-Hodgkin Lymphoma in
this series.
The receptor profile showed that of the 31 tumours studied
the different cell types occurred as follows:
B1 - 5 times, B2 - 1+ times, B3 - 10 times, Bk - 3 times,
Bf> - once, Receptor overlap - twice, macrophage - once, T cell -
once and receptor silent tumours - U times. The most common
profiles identified in the lymphomas were of B3 sub-class, which
formed approximately one third of all lymph node tumours. The next
most common B subclass found was B1, forming 1 $% of solid lymphoid
tumours. Receptor silent tumours, and B2 tumours were found on 1+
occasions (13$) and B3 on 3 occasions (10%) in non-Hodgkin
lymphomas. The incidence of Bfa, receptor overlap, macrophage and
T lymphocyte tumours cannot be reliably assessed in this small
series/...
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series, but probably amounts to no more than 3-6% of non-Hodgkin
lymphomata in each case. These frequencies are summarised below.










T cell 5 Nil
The receptor profile of the lymphoma lymph node resembles the
normal lymph node profile in about half the cases (B3 + 32 + BU ™ 53/0,
but in the remainder is clearly different, usually because the B
lymphocytes are more primitive (B1) or the cells lack surface markers
altogether. In all the B1 and B2 lymphomas, the profile is of B
lymphocyte predominance, while in the B3, lymphomas the profile
is B predominant in only 8$% of the cases, the remaining 1J># showing
a mixed pattern. This again differs from the normal lymph node,
where 1 9% only show B lymphocyte predominance, \\6% are of mixed
pattern and 36% show T cell predominance. The non-Hodgkin lymphoma
lymph node can be said to differ frcm. the normal or reactive lymph
node by (1) the more primitive nature of the cells composing the
tumour/...
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tumour, and (2) the tendency of the node to show B lymphocyte
predominance, rather than a mixed or T cell predominant pattern.
B lymphocyte predominant tumours form between 60 and 70% of all
non-Hodgkin lymphomas, the remaining 30-2*0# being receptor silent, mixed,
T cell, receptor overlap or macrophage tumours.
The relationship of receptor studies to morphology and clinical
behaviour.
Most of the tumours classed as B3 or Bl* were nodular poorly
differentiated, nodular small cleaved cell, or diffuse small
lymphocyte in type, and there was good agreement in this group
between the histological assessment, the receptor profile and
survival. Most of these did not progress appreciably over the
time they were studied.
The tumours classified as histiocytic lymphoma, shewed
marked heterogeneity of surface phenotype including receptor
silence, receptor overlap and B1 lymphocyte tumours. Only one
example of true "histiocytic lymphoma" - a macrophage tumour was
seen. Patients in this group did uniformly badly, with the
exception of "receptor overlap" tumours which responded readily
to treatment and did not recur. In diffuse lymphocytic lymphoma,
there was relatively poor agreement between the cytological
assessment of differentiation and the receptor profile.
There is a strong correlation between the receptor profile
of B1 lymphocyte tumours and the presence of receptor silent
cell populations and prognosis. It has been statistically
shown that (1) B1 and B2 lymphocytic lymphomas are distinct from
B3/...
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B3 and Bii lymphocytic lymphomas whan the survival of patient is
considered. B1 and B2 tumour patients have a significantly
lower probability of survival than B3 and Bli tumour patients.
(2) clinical staging of the lymphoma is of less importance in
predicting survival than determining the receptor class to which
that tumour belongs.
The findings in Hodgkin' s disease
A study of Hodg^ix!'s disease spleen showed that in males
the effect of the disease was to decrease the cell count per gram
of spleen and the total cell count, while in females the cell
count per gram, and the total cell count was higher than in normal
female spleen. In the female the concentration of T cells is
decreased, while there are suggestive but not significant
increases in the concentrations of non-capping B cells and
phagocytes. The total numbers of T cells and B cells in the
female spleen in Hodgkin's disease are significantly increased,
to the levels found in normal male spleen.
In involved spleens there was some evidence of increased
T cell proportions, and concentration in the involved area. In
the nodular sclerosing subtype of Hodgkin's disease the uninvolved
spleen showed an excess of complement receptor cells over the
combined sum of B colls and macrophages.
Investigations of seven involved lymph nodes showed clearly
that T cell proportions were raised in some, but not all cases of
Hodgkin's disease. The same excess of the proportion of
complement receptor bearing cells over B cells and macrophages
was/...
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was found In lymphocyte predominant HodgTdLn's disease. IgM
receptors on T cells in HodgfcLn's disease were probably present in
5 out of 31 cases, and were directly demonstrated in blood (2) and
spleen (1) of a further 3 cases.
From the results presented the following features, unique to
Hodgkin's disease as far as is known, have been demonstrated:
a) that Hodgkin, s disease affects the cellularity of
male and female spleen differently.
b) That abnormal T cells, bearing IgM receptors and cross
reacting with IgM and complement coated red cells are
present in a minority of Hodgkin's disease patients.
c) That increased numbers of T cells in Hodgkin tissue,
although present in some patients, are not found in
every case, and in one patient the T cells described
were abnormal T cells reacting with IgM and
complement coated red cells.
d) That uninvolved nodes, and spleen contained in some
cases B cells exhibiting non-capping behaviour and
bearing complement receptors (B2.C class). Their
presence correlated with follicular hyperplasia in
the tissue studied. The nature of the Reed
Sternberg cell was investigated, and it was shown
that in some cases it resembled a B2.Fc lymphocyte,
occasionally showed, intracytoplasmic immunoglobulin,
and was frequently surrounded by activated T cells




It was hypothesised that In Hodgkin'a disease, T cells were
immature, exhibiting helper cell rather than suppressor cell, or
cytotoxic activity, and that the B cell was both the target for
helper activity, and the source of antigenic stimulation of the
T cell.
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Of the three quotations proceeding the introduction to this
thesis, two emphasise the role of the pathologist as a "pathological
physiologist" and the third summarises the difficulties which would
have faced any pathologist approaching the subject of lymphomas
two decades ago. The fact that in the interim a vast expansion of
knowledge about the life cycle of the lymphocyte,, and the origins
and life history of the mononuclear phagocyte occurred, allows a
survey of lymphoma from the standpoint of pathological physiology
for the first time. The price paid for an increased understanding
of the nature of lymphomas is the inevitable Increase in the
complexity of the classification schemes employed in their diagnosis.
For example Rappaport (1966) lists 6 major classes of lymphoma
(Hodgkin's disease classified separately). Lukes (1975) currently
lists 11 types. The receptor studies presented in this thesis show
clearly the existence of 12 distinct receptor profiles in lymphoma/
leukaemia and when the predominant and mixed primary classification
is also employed an additional h categories at least can be
distinguished. The indications are that in lesions diagnosed
histologically as non-Hodgkin lymphoma, as many as 17 separate
subclasses of this disease can be demonstrated by surface phenotyge
as shown in this series. The techniques employed all detected
normal phenotypic features of lymphoid cells, no attempt has been
made to detect abnormal or neoplastic features 3uch as tumour
associated surface antigens, although these are known to exist
(Billing, Rafizadeh and Terasaki, 1975j Pendergrass et al., 1975J
Baker/,.,
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Baker, Ramachander and Taub, 197U)• If both surface antigen
class, and surface phenotype were used together to classify lymphoid
tumours it is probable that many more subclasses might be found.
In addition, the cases in the present study are few, since lymphoma
of non-Hodgkin type remains an uncommon disease. More extensive
studies could reveal further phenotypic profiles again increasing
the potential pool of subclasses of lymphoma. At present it is
not possible to reliably estimate the potential numbers of
subclasses of lymphoma detectable by methods in use today, but
they will almost certainly exceed 20. When it is considered that
each subclass may exhibit different clinical behaviour, response
to therapy and so on it is evident that the classical pattern of
assessing survival in each subgroup and empirically developing
appropriate foims of therapy for each subgroup would be an
enormous task, and probably beyond the capabilities of current
medical practice, even allowing that sufficient standardisation
of techniques between individual centres enabled valid comparisons
to be made.
There is an easier road to take. If the true nature of
proliferations of lymphoid tissue could be understood, and if the
lymphoma could be interpreted as a perversion of the normal
functions of lymphoid tissue, then the identification of the reactive
state of the cells in the lymphoma could serve as the basis for
rational therapy. This approach is far from being a fully
developed diagnostic procedure but it is presented here in the
hope that it may influence future approaches to the classification
and therapy of lymphoma.
Identification/
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Identification of lymphoid tumours according to their cellular
constituents
In the introduction, the definition of lymphoma adopted
included in this group of diseases tumours of the constituent cells
of central (thymus, bone marrow) or peripheral lymphoid tissue.
The constituent cells concerned are derivations of the lymphoid
stem cell, the monocyte precursor cell (colony forming unit) or
derivatives of coelemic epithelium (the reticular cell). This
group of tumours includes all tumours of the cells shown in the
table below.
Constituent Cells of Lymphomas
Derivatives of lymphocyte system
1) Bone marrow precursor (stem cell)
2) Thymocyte
3) Peripheral T lymphocyte
h) B lymphocyte
5>) Plasma cell
Derivatives of the mononuclear phagocyte system







(c) Derivatives of coelemic epithelium and mesenchymal
derivatives.
1) Reticulin fibre forming cell (mesenchymal)
2) Dendritic cell of germinal centre
3) Reticular cell (coelemic epithelium)
These cells generally show surface features which allow their
detection in lymphomas, and these are shown below:
Constituent Cells of lymphoma
Surface features of each class
(a) Derivatives of the lymphoid system
1) Stem cells No surface Ig
No Fc or C3 receptor
No receptors for E
2) Thymocyte E Rosette positive
Surface Ig negative
No Fc or C3 receptor
May have IgM receptor






May express Fc receptor
if activated.
U09.
U) B lymphocyte £ receptor negative




Derivatives of the Mononuclear phagocyte system
1 ) Colony forming unit Surface Ig negative
May have Fc receptor
No C3 receptor
Hon phagocytic






3) Monocyte Has monocyte specific
surface antigen
Fc and 03 receptor
positive







U) Macrophage Has monocyte specific
surface antigen
Fc and C3 receptor positive
Surface Ig negative
Ingests neutral red dye
Phagocytic
Adherent to glass and
plastic
(c) Derivatives of coelemic epithelium and
mesenchymal derivatives
1) Reticulin fibre forming cell Surface Ig negative
Non phagocytic
No Fc or C3 receptors
Extracellular "coat"
Adherent to glass and
plastic
2) Dendritic cell of germinal
centre Surface Ig negative
Non phagocytic

















2) Endothelium Nob known
There are thought to be 12 different classes of cell of
different histogenetic derivation which could give rise to tumours
diagnosed as lymphoma. The receptor profiles obtained through the
use of simple surface receptor and tissue culture techniques
correspond to the known phenotypic characteristics of some of these
cell classes. Superficially the value of these studies lies in the
identification of the class of cell by the surface characteristics,
and in assessing the survival of patients with each class of tumour.
Receptor silent tumours
In the case of receptor silent tumours, the detection of cell
class appears to indicate the prognosis, since all patients with
these tumours have died despite therapy. This is not a satisfying
conclusion for two reasons:- firstly the receptor silent tumours
are of different cell types and histological pattern (compare
patients Kerr and Ritchie) indicating heterogeneity within this
group, and secondly the lymphoid stem cell, the colony forming
unit, and the reticular cell classes would all be classified as




Possible origins of receptor silent tumours
a) Lymphocyte (? tumour of Kerr)
b) Bone marrow lymphoid stem cell (? receptor silent ALL)
c) Mononuclear phagocyte stem cell (? none in this series)
d) Reticular cell tumours (? tumour of Ritchie)
e) Reticulin fibre forming cell (? none in this series)
f) Undifferentiated tumours of epithelial derivation (? tumour
of Moyes)
The fact that receptor silent tumours occur tends to obscure
the more important question why should cells lacking surface
phetiotypic markers give rise to tumours with a poor prognosis?
There are two possibilities, firstly that such cells are by nature
undifferentiated and so have a greater potential for growth, and
secondly that the surface phenotype dictates the behaviour of the
cell as it interacts with the other cell classes in lymphoid tissue.
In the absence of any receptor by whiuh control over its growth and
differentiation could be exerted by surrounding cells, the tumour
cell exhibits a constant and uninhibitable tendency to proliferate
without differentiation. This conclusion may apply not only to
lymphoma but to all classes of malignant neoplasm, and brings into
question the concept of biological control of growth of cells through
modifications of the cell membrane (reviewed by rfallach, 197$)»
Further discussion of this topic is beyond the scope of this thesis,
but if the cell surface is the eyes of the cell, the receptor silent
tumour is a tumour of "blindly" proliferating cells. The intrinsic
capacity to differentiation is lost, and growth can be controlled
only/*..
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only by the recognition of and reaction to the surface antigens of
the neoplastic cells (immune surveillance)(Burnet, 1972).
Macrophage tumours
Tumours of the mononuclear phagocyte system pose similar
problems. In this case tumours of promonocytes or monocytes are
likely to prove leukaamic (monocytic and promonocytic leukaemia)
since these cells arise in bone marrow, and exist only in the
circulation. Their surface receptor characteristics differ but
slightly from the mature tissue fixed macrophage (Fc and C3
receptors) but their phagocytic capacity (except for vital dyes)
is less pronounced. The mononuclear phagocyte system is
phylogenetically very primitive proceeding the evolution of the B
lymphocyte and T lymphocyte systems. Control over mononuclear
phagocyte proliferation is therefore likely to be intrinsic rather
than influenced by T or B lymphocyte products. There is evidence
that proliferation of the promonocyte (colony forming unit) might
be non specifically suppressed by activation of T lymphocytes
(McNeil and Killen, 1971b), but in the interactions between
lymphocytes and macrophages, stimulation and suppression appears
to operate one way (macrophages lymphocytes) with little evidence
of control of macrophage production and differentiation directly
by the lymphocytes. There is a form of feedback on the macrophage
by T and B lymphocyte products, lymphokines producing non-specific
local immobilisation (M.I.F.) or proliferation (Mitogenic factor)
of macrophages, and B lymphocytes producing chemotactic and phagocytic
behaviour through antibody and the interaction of that antibody and
complement/...
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complement with the Fc and C3 receptors on the macrophage. This
feedback affects macrophage behaviour rather than the kinetics of
mononuclear phagocyte production. The presence of the Fc
receptor on the monocyte and macrophage appears to determine the
capacity of lymphoid cells to interact with the macrophage rather
than the rate of macrophage production or the differentiation of
tissue macrophages from monocytes. What does control the rate of
production of mononuclear phagocytes? It was shown by Smith and
Stuart (1975) that simple lipid esters such as cholesterol oleate
and ethyl palmitate affect macrophages directly producing effects
upon macrophage motility and spreading upon glass. Cells treated
with ethyl palmitate appeared to lack receptors for Fc portion of
IgG, which may imply interference with Fc receptor synthesis by
the macrophage. The intravenous injection of lipids, particularly
cholesterol oleate, produced an initial depression of phagocytosis
of foreign red cells, and changes in the distribution of red cells
between liver (normal controls) and spleen (treated animals).
Electron microscope studies revealed the appearance, in the livers
of lipid injected animals, of numerous immature bone marrow derived
monocyte precursors, which were observed to change in situ to
Kupffer cells (Stuart and Smith, 1975)* In treated animals there
was profound depression of the immune response, due to impaired
macrophage function. The lymphocytes were unaffected. This series
of experiments shows that the monocyte precursor can be generated
from bone marrow U8 hours after reticuloendothelial blockade with
lipid. The mechanisms of control of this production are not known,
but increase in the numbers of colony forming units from the bone
marrow/...
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marrow can be detected following blockade. This argues strongly
for a control mechanism acting through the monocyte precursor for
maintaining the numbers of circulating and tissue macrophages
(Dewar and damage, personal communication). The differentiation
of mononuclear phagocytes is little understood. Preliminary work
shows that human monocyte specific antigen can be detected on bone
marrow precursors, and on tissue macrophages, but the mechanism by
which the circulating monocyte matures to the tissue fixed
macrophage is still obscure. In this thesis data from monocytic
leukaemia and the solitary true histiocytic lymphoma show no
significant differences in surface phenotype excepting the presence
of IgD in the cells from the patient with monocytic leukaemia.
It is noteworthy that circulating monocytes in the case of
histiocytic lymphoma (Ross) were markedly elevated. The
interpretation favoured is that macrophage numbers in tissue are
determined by the rate of production of monocyte precursors in bone
marrow from the stem cell. There is continuous maturation of the
cells so produced from circulating monocyte to tissue macrophage.
The presentation of mononuclear phagocyte tumours therefore depends
upon the rate of cell production, and the eventual tissue
localisation of the tumour cells. There is no evidence for specific
control of production by lymphocytes, although tissue localisation
could be influenced by either antibody production of lymphokine
secretion. Tumours of macrophages can therefore for practical
purposes be regarded as tumour of the series stem cell, the nature
of the tumour (histiocytic lymphoma, monocytic or promonocytic
leukaemia) being determined by the kinetics of cell production and
cell/...
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cell death rather than a maturation sequence of individual
differentiation steps as proposed for B and T lymphocytes.
In the two examples given (receptor silent tumours, macrophage
tumours) assessment of differentiation is not possible, in the first
case because differentiation markers are absent from the cell, and
in the second because the whole life cycle of the cell is encompassed
by a single differentiation step (from stem cell promonocyte) as
shown by the presence of Fc and C3 receptors on both "mature" and
"primitive" cell forms, and the occurrence of a single class of
surface antigen on all cells of this lineage.
B lymphocyte tumours
In the hypothesis of Salmon and Seligmann (197li) the B cell
neoplasm was considered as a tumour evoked by (a) a primary, or
intrinsic neoplastic event, coupled with (b) antigen stimulation.
This resulted in the development of neoplastic B cells, at
different stages of their maturation cycle. This very useful
method of assessing B cell tumours has been adopted here. It
must be emphasised that since the methods used assess only normal
phenotypic features of cells, no opinion as to their "malignancy"
can be offered. In order to show that the cells in a lymphoma are
truly "malignant", it is necessary to demonstrate a tumour specific
or neoantigen on or in the cells, by the use of a monospecific
antiserum. The data presented apply, then, only to the variations
in normal phenotype which occur as B cells differentiate. The
fact that such phenotypic profiles occur at all in B lymphocyte
tumours is strong evidence in favour of the mode of development of
these/•..
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these tumours as proposed by Salmon and Seligmann. On this basis,
in the following section the application of the phenotypic staging
of B cell to the lymphoma is examined.
14.18.
Differentiation of B lymphocytes and its relationship to tumours of
these cells
The T and B lymphoid populations take origin from a bone
marrow stem cell. The different classes of T cell and B cell were
purported to arise through the inductive influence of the Bursa
equivalent tissue (in the case of B lymphocytes) or the thymic
epithelium (T lymphocytes). It is now known that in both B and
T lymphocyte systems, the T or B lymphocyte is committed before
entering bursa or thymus. Pre-bursal B lymphocytes in the chicken
are shown to express surface IgM antibody (Jankovic et al., 1975)
and in thymus deprived, and congenitally thymusless mice, T cells
expressing theta (thy 1) antigen do occur (Raff, 1973j Loor and
Roelants, 197U). In mammals, evidence for the inductive role of
bursal equivalent tissue for B lymphocyte maturation was never
conclusive, and it is likely that immature "pre-bursal" B lymphocytes
are formed directly from a stem cell precursor. These uncommitted
cells, seed to the peripheral lymphoid tissues, (Nossal and Pike,
1973) encounter antigen, especially in sites such as the lamina
propria of the gut and become committed to eventual antibody
formation by antigen. This process is termed "antigen drive" and
is probably necessary for the expansion of the B cell population
in normal animals (Nieuwenhuis et al., 197Ua,b). The immature B
lymphocyte can be arrested in its development by continuous
treatment of the intact animal with anti u chain antisera, which
reacts with the surface u chain. Such treatment prevents the
further development of the immature B cell, whilst not affecting
the immature B lymphocyte. Neonatal mice so treated fail to
develop/...
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develop normal B cell populations (Raff et al., 1975)* The immune
response of B cells from neonatal animals can be abolished by the
contact in vitro between specific antigen and the B cell reactive
to it. Adult B cells were not affected (Metcalf and Klinman,
1976). The immature B cell fails to develop into an antibody
forming cell within 2 days of antigen challenge, and using this
criterion it was shown that foetal mice contain no mature B cells,
but that these develop very rapidly between 3 and 5 days after
birth (Rosenberg and Cunningham, 1975)* Sidman and Unanue (1975b)
showed inhibition of early (immature) B lymphocytes by anti¬
immunoglobulin antisera, and related this inhibition to failure of
the immature B lymphocyte to cap and hence shed the blocking complex
on its surface. The relationship between the capping of cells and
the ability to escape from antigen induced or antibody produced
blockade shows clearly that inhibition of capping by drugs prolonged
the effect of blockade and prevented resynthe3is of surface Ig.
Inhibitors of protein synthesis were ineffective in preventing
blockade. The complete recovery from blockade occurred in about
o
10 minutes at 37 C consistent with the capping and shedding of Ig
anti-Ig complex (Ivanyi, Fuensalida and Lydyard, 1976). Confirmation
of the existence of mature, immature and secretory IgM. bearing
lymphocytes has been shown. Type I cells (immature antigen
inexperienced or virgin B cells) synthesised and released 7S IgM
rapidly, Type II cells (small resting memory B cells) synthesised
and released 7S IgM slowly, and type III cells (secretory "plasma
cells") released 19S IgM rapidly, mainly from stored cytoplasmic
IgM (Melchers, Cone, Bon Boehmer and Sprent, 1975)- The ability
of anti-allotype or anti-immunoglobulin antisera to blockade the
immature B lymphocyte can persist for long periods in vivo.
Anti-/...
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Anti-allotype antisera administered to neonatal rabbits within
2-5 days of birth brought about complete suppression of secretion
of that immunoglobulin allotype. Delay beyond day 6 produced only
partial suppression of shorter duration (Lowe and Catty, 1976).
These findings all suggest the existence in the neonate of a surface
Ig bearing, u chain expressing, non-capping B lymphocyte, which is
easily inhibited from further maturation by the presence on its
surface of complexes of surface Ig and antigen, or anti-Ig surface
Ig immune complexes. This population is quite distinct from that
appearing in adult life, capable of capping, not inhibited by
complexes, and showing the ability to shed capped surface Ig and
regenerate this molecule.
The existence of these two major classes of B lymphocyte was
grasped as the central theme for the classification of B lymphomas,
non-capping lymphomas exhibiting the surface characteristics of
immature or transformed B cells, capping lymphomas corresponding
to the more mature adult B lymphocyte.
The B1 category of tumour, expressing surface Ig, non-capping,
and lacking receptors for complement and IgG corresponds very
closely to the descriptions of B lymphocyte characteristics in the
neonate, and also the cell grown in vitro from splenic colonies in
the mouse (Metcalf et al., 1975)• Importantly most of the B1 tumours
in this series were either leukaemic or extranodal as would be
expected in a cell corresponding to the neonatal B lymphocyte.
The B lymphocyte is unique in the ability of cells of this
class to undergo transformation following antigenic stimulus, and
to show thereafter markedly different behaviour from similar B cells
not/...
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not exposed to antigen. In particular a substantial proportion
develop into antibody synthesising plasma cells, and a smeller
number persist as memory lymphocytes. During these phases of
development changes in the surface phenotype of the cell occur.
It has been shown that B lymphocytes acting as precursors of 7S and
19S antibody forming cells express the 03 receptor. Depleting
populations of complement rosette forming cells following
sensitisation subsequently prevented an adoptive immune response
on transfer of complement receptor depleted cell suspensions
(Mason, 1976a). The same author has also shown that, in rats,
the IgG memory cells has two subclasses, one of which has the
complement receptor, the other not. These did not appear to
represent different stages in the maturation of memory cells. A
small number of IgG secreting precursors were found to show surface
IgM and would give rise to an adoptive IgG response when transfused
with T lymphocytes. Complement receptor was found on memory B
lymphocytes secreting either IgH or IgG antibody, but most
complement receptor expressing cells were IgM positive (Mason,
1976b). Moller,(1 975) showed that non-specific excitation of the
B cell surface by occupation of the C3 receptor was sufficient to
trigger transformation and antibody production. The antibody
secreted, and its specificity was determined by the presence of
antigen. In other words antigen selected the cell to respond, and
the response was triggered by complement acting t rouljh the
complement receptor. This "two signal hypothesis" was explored
further by the demonstration that binding of antigen alone to the
surface Ig receptors for antigen was not sufficient to trigger
blast/...
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blast transformation and antibody secretion, unless a second
signal was delivered via the 03 receptor, or unless complexing and
extensive cross linking of surface receptors by antigen was
achieved (Moller, Coutinho and Persson, 1975)* The conclusions
reached also showed that there was no synergistic response to
thymus independent antigens (LPS) and polyclonal B cell activators
and that occupation of the complement receptor is not necessarily
the only second signal. Antibody against surface Ig, and T cells
can also act as triggers for B cell transformation and antibody
synthesis in capping B lymphocytes. Stimulation by complement
alone does not initiate antibody synthesis (Moller and Coutinho,
1975). What happens to B lymphocytes engaged by antigen and
triggered by a second signal? As shown by2huderer and Askonas
(1976) antibody secreting cells will spontaneously develop, and
from IgM bearing B lymphocytes will differentiate IgM, IgG and IgA
secreting mature lymphocytes. Antibody forming B lymphocytes can
themselves be "blocked", by the continued presence of immunogenic
antigen (Schrader, 1975). This blockade can be reversed by the
removal of antigen from the surface of the cell by washing or
trypsinisation. Another form of blockade of antibody forming
cells can be produced by a subclass of T lymphocytes - the
suppressor T cell (Baker, 1975)* The suppressor T cell acts
principally by limiting the degree to which B lymphocytes proliferate
in response to antigen. Following contact with antigen, especially
one causing blast transformation, B lymphocytes are observed to
develop into one of two forms. The majority are small lymphocytes,
with high density capping surface Ig but without intracellular Ig.
A minority are infrequent large cells with intracellular Ig and the
ability/...
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ability to secrete free Ig into the medium (Askonas et al., 1976).
It has been demonstrated that the Fc receptor was present upon cells
secreting Ig, but not upon non-secretory cells in the MFC 11 mouse
myeloma (Corte et al., 1976). It is often assumed that the
specificity of the antibody produced does not vary during growth
and development of the B lymphocyte. There is no a priori reason
why this need be so, and it has been shown that daughter clones
isolated from single antibody forming cells can subsequently
synthesise 2 or 3 different and distinct antibodies. The
suggestion is made that antibody diversity, that is the range of
different specificities of antibody produced in the whole animal
may only develop after the stimulus which produces proliferation in
the B lymphocytes (Cunningham and Fordham, 19710 • The data
presented here together with that in the introduction (Problems of
B cell differentiation Chapter 10), allows a fairly full construction
of the life history of the B lymphocyte including points at which T
cell and macrophage co-operation, and at which blockade can occur.
In addition it is possible to indicate the likely surface phenotype
of the cells at any stage.
The separate forms of B lymphocyte developing from the stem
cells are clearlys-
1) Non-capping, IgM bearing, Fc and C3 receptor negative,
virgin B cells blockaded by surface complexes of antigen
and surface Ig, or anti u chain, anti-allotype or anti¬
idiotype antisera. They rapidly synthesise monomeric
surface IgM.
2) The memory B lymphocyte of the IgG response (IgG memory
cell), which possesses the Fc receptor (Earaasaray et al)
and/...
and the C3 receptor.
3) The C3 receptor bearing, IgM bearing, cell which is not
a precursor of the IgG secreting B lymphocyte. This cell
is probably the one triggered by LPS and complement,
giving a thymus independent IgM antibody response.
b) IgM bearing cells which differentiate into IgM, IgA, or
IgG secreting lymphocytes.
5>) The prosecretory committed lymphocytes which exhibit
inhibition by free antigen, or are prevented from
proliferation by suppressor T cells.
6) Small lymphocytes without intracellular Ig.
7) Larger lymphocytes with intracellular Ig.
In normal human blood, tonsil, and lymph node, B lymphocytes
exhibited several receptor profiles which are held to correspond
to the classes of cell listed above. The most common B cell was
a small, capping, brightly fluorescent cell, expressing C3 and Fc
receptors (B3-1 cell). In lymph nodes showing follicular
hyperplasia, and in tonsil, two classes of cell were described}
the non-capping B lymphocyte with C3 but no Fc receptor, and the
capping B lymphocyte with C3 but no Fc receptor (B3.C, B3.2 cells).
It is thought likely that the B2.C cell is a blast transformed B3.2
cell} neither show any trace of intracytoplasmic Ig. A capping
lymphocyte expressing only the Fc receptor, with no C3 receptor or
cytoplasmic Ig was the predominant cell type (B3.3) on some lymph nodes.
Finally a capping cell, snail, and found in constant association with
plasma cells was also present in some samples (BU). Plasma cells
were termed B5, and all showed intracytoplasmic Ig. The category
of/.•.
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of non-capping B lymphocyte with no Fc or C3 receptor has been
referred to as analogous with the immature B lymphocyte of the
mouse, and a class of similar cell bearing Fc receptors was found
in both lymph node and in blood (B2.Fc).
The B1 lymphocyte, corresponding to the immature B cell must
transform eventually into the antibody secreting plasma cell.
The data from Sachs, Lieberman and raul (1971;) indicates clearly
that the B1 lymphocyte in mice lacks the C3 receptor. The data of
Metcalf, Warner, Nossal, Miller, Shortman and Rabellino (1975) show
that the Fc receptor is acquired before the C3 receptor. Activation
of Fc and C3 receptor bearing B cells causes blast transformation
and loss of C3 receptor (Moller, 197ii). Loss of Fc receptor
probably occurs only when the cells bearing it secrete IgG onto
their membrane (Ramasamy et al, 197U) or have that receptor occupied
by extraneous IgG aggregates or immune complexes. Precursor cells
of IgG secreting cells have IgM antibody and C3 receptors on their
membranes. Cells present in the mouse spleen will differentiate
into antibody secreting plasma cells over a period of 17 days
(Zauderer and Askonas, 1976). It takes k days for the B1 lymphocyte
to become refractory to inhibition by anti-ailotype antisera (Lowe
and Catty, 1976), and mature B cells require 3-5 days to become
the major B cell population in the neonatal mouse (Rosenberg and
Cunningham, 197 5 )• Thus in a minimum period of k-5 days, and
pos sibly as long as 17 days the B1 lymphocyte should gain an Fc
receptor (B2.Fc) gain C3 receptor (B3.1) undergo blast transformation
losing C3 receptor (B2.Fc) differentiate into a memory cell
population possessing Fc and C3 receptors (B3.1), into a secretory
B/...
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B lymphocyte losing Fc and C3 receptors (BU) and maturing to the
secretory B cell stage (B5). The sequence shown is that of B1 -
B2.Fc - B3.1 - B2.FC - B3.3 - BU - B£. The problem, not yet
solved, is of the loss and gain of the C3 receptor during
transformation. The B3.1 cell transforming to B2.Fc cell will be
followed in this sequence by the B3.3 cell. Similarly blast
transformation of the B3.2 cell with loss of C3 receptor would
result in a B1 cell which could then differentiate to a Eli cell.
It can be assumed that "blast transformation" results in a non-
capping B lymphocyte of B1, B2.Fc, or B2.C class and my own
observations suggest this is so. The transformation of cells with
Fc receptor and complement receptor will produce the B2.Fc cell
rather than the hypothetical B2.G cell, although B2.C cells may occur
if transformation is triggered via the Fc receptor in absence of (J3.
The sequences favoured are as follows
Note that the transformation B2.Fc to B3.1 is reversible, as the B3.1
cell may well be a circulating IgG memory cell generated from the
follicular sequence (B3.2 cells) back via the sequence B3.2 - B1 -
B2.Fc - B3.1 -
The relationship between the different subclasses of B
lymphoid tumour can now clearly be seen.
The B1 lymphoma is of a poorly differentiated cell arising in
bone marrow, extranodal sites and nodes. The lesion would be
expected, in some cases, to exhibit the characteristics of "blockade"
in that trypsinisation and subsequent culture should allow
differentiation/...
Bl - B2.Fc - B3.1 - B2.Fc - B3.3 - Bl* - B&
\ bi - BU - B5
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differentiation either into the B2.Fc cell or into the El* cell and
plasma cell. The B1 cell is derived either from the lymphoid stem
cell, or from blast transformed B3.2 cells -which have lost 03
receptor, as may occur if transformed via the Fc rather than the C3
receptor.
The B2.Fc lymphoma is either derived from the B2 cell (by
maturation) or i3 derived from the B3.1 cell by transformation and
loss of C3 receptor in the presence of complement. The B3.1 cell
is the most common class of B lymphocyte. It is either an IgG
memory cell derived from follicular B3.2 cells, or is a non-
transformed committed B cell destined to secrete IgM resulting from
antigen drive acting on the B1 cell.
The B3.3, Bl* and lymphomas are the result of maturation
arrest after secondary antigen stimulation in the sequence leading
up to the IgG or IgM antibody secreting plasma cell.
The B3.2 cell is strongly associated with the follicle in
tonsil and hyperplastic nodes, and must derive from an IgM bearing,
committed B3.1 cell, the precursor of the IgG secreting plasma cell.
It may have a transformed equivalent - the B2.C cell.
The possible sites and mechanisms of maturation block or arrest in
lymphoma
Lymphomas of B1 cells are equivalent to leukaemias of these
cells, and both may arise from an intrinsic defect of the immature
B lymphocyte resulting in failure to undergo maturation. They
could also arise as a consequence of blockade by antigen, or by
surface bound immune complex, and in the case of HOgg this clearly
occurred/...
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occurred. It is reasonable to predict that a proportion of
B1 lymphomas will be due to transformation of B3.2 cells, with
subsequent blockade. These lymphomas are not due to an intrinsic
defect in the B1 lymphocyte. Blockade will fix immature B lymphocytes
in the transformed state. Possible mechanisms are blockade by
antigen antibody complexes on the cell surface. This hypothesis
is eminently testable, as unblocking will result in reversion to
a Bl* or B5> cell (as in Hcgg) or to a B2.Fc or B3«1 cell (as in
Velzian or Reid) depending on the derivation of the B1 cell in the
first instance. Needless to say, the data presented indicate
that conversion of a B1 lymphoma to a B2.Fc, B3.1, BU or tumour
by therapeutic measures should result in a vast improvement in
prognosis (e.g. patients Velzian and Reid).
The B2.Fc cell can arise from two separate segments of the
maturation sequence: (1) it can derive by maturation from the B1
cell under the influence of antigen} (2) it may be a transformed
B3.1 memory cell arrested in the transformed state} the subsequent
cell may be B3.1 or B3.3.
The sequence with points at which blockade has occurred are
shown belowi
In this sequence, category 1 tumours should occur during a
primary response - or first exposure of the neoplastic B cell clone
to antigen. Category II tumours could occur in B3.1 memory cells
transformed by antigen, particularly if antigen excess or immune
complexes/...
1) B1 - B2.FC .
2) B3.1 - B2.FC





complexes are present. Category II tumours could also occur during
a normal primary Immune response due to extrinsic blockade. The
ability to test experimentally for these tumour categories is not
currently available, although B2.Fc tumours due to maturation block
should differentiate into B3.1, or B3«3 cells if the blocking agent
could be removed. Agents causing B cell transformation (endotoxin
Fokeweed mitogen or other polyclonal B cell activators) may be
aetiologically related to the development of B2.Fc lymphomas.
The B3.1 lymphoma is quite common, and may be B predominant or
mixed. B3.1 lymphocytes are unstimulated memory cells, derived
from the transformed B2.Fc cell. They can arise directly from the
antigen induced maturation sequence B1 - B2.Fc -B3.1 under genetic
control (Gelfand et al., 1 91k)* Failure of the B1-B2.FC - B3«1
lymphocyte maturation sequence to progress beyond this point will
result in accumulation of B3«1 lymphocytes. The B3.1 cell can
also be derived from the transformed B2.Fc cell. This is a cyclical
process where blast transformation of the B3.1 cell, with loss of
C3 receptor produces the B2.Fc cell which matures again into the
B3.1 cell. This would result in the expectation of cells showing
B3.1 and B2.Fc profiles in B3.1 lymphomas where antigenic
stimulation is still present (e.g. the nodular tumour of McKenzie),
the role of antigen being to perpetuate the transformed state.
The B3.1 cell might also mature via the B2.Fc cell into the
B3.3 cell, identified by Mason (1976) as the small IgM memory cell
lacking C3 receptors. These various maturation sequences of the
B3.1 cell indicate that the opportunities for transformation into
more primitive forms (B2.Fc) are slight, whereas differentiation
towards/...
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towards the mature (B3.3 - BU - B5) cells would be the natural
tendency of B3.1 neoplasms. It is not surprising then that in this
series the B3.1 neoplasms carried a good prognosis. The sequence
B2.Fc - B3.1 - B3.3 is probably dependent upon co-operation between
B cells and macrophages, in that differentiation of memory cells
into antibody forming cell precursors depends upon appropriate
macrophage presentation of antigen.
The B3.2 lymphomas, and the contentious blast transfomied
equivalent, the B2.C cell, have been referred to as the follicular
sequence. Understanding of the sequence is limited by failure to
comprehend the role of the germinal follicle in the immune response.
Follicular lymphocytes can give rise to plasma cells, but the most
reasonable explanation is that the follicle acts as a region for
lymphoblast transformation of committed B3.1 cells (to B2.G cells)
expressing a high affinity for antigen localised to the dendritic
macrophage. T cell co-operation occurs possibly within the
follicle - and T cell suppression, limiting generation of low
affinity cells - could also occur in this site. Since one of the
committed memory cells is of B3.1 receptor profile, the probable
sequence is B3.1 - B3.2, followed by blast transformation of the
B3.2 cell to either the B2.C cell, or to the cell from which
the whole sequence of B lymphocyte generation can be res-arted .
In this case transformation is via the Fc receptor rather than reception
of a second signal via the 03 receptor,
j B2.C - Bit - B$
B3.1 - B3.2
- B2.Fc - B3.1 - IgG memory cell
- B5 - IgG secreting plasma cell
The only two patients with tumours of B3.2 profile have died, with
peculiar/...
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peculiar receptor profiles and leukaemic transformation. One was
diagnosed as nodular lymphoma and progressed rapidly to diffuse
lymphoma with leukaemia. This aggressive behaviour is
comprehensible if transformation of B3«2 to B1 cells could be
demonstrated experimentally. It is doubtful, if B2.C lymphomas
occur, that any better prognosis would result from the sequence
B3.1 - B3.2 - B2.C. The only pathways for the differentiation
of the B2.C cell lie in the sequence B2.C - B3.2 - BU - B5 with the
risk of transformation into a B1 neoplasm. It is of interest to
note that most nodular lymphomas have a B3.1 or Bit profile, and do
not share the characteristics of the true follicular neoplasm -
B3.2 lymphoma.
The BU - B5 sequence can occur in theory from the primary
response resulting in IgM secreting B$ cells, or the secondary-
response resulting in IgG secreting B$ cells. The first sequence
is probably most common in non-Hodgkin lymphoma, and does not
involve derivation of the Bit cell from the suspect B3.2 precursor.
The sequence is B3.1 - B3.3 - Bit - B$, with loss of complement
receptor possibly by an intermediate B2.Fc transformation induced
by antigen (B3.1 - B2.Fc - B3»3 - BU - B5). Ina progressive
primary response rapid evolution of Bl+ and BJ> cells could occur
by the sequence B1 - B2.Fc - B3.3 - BU - B$ without involving the
B3.1 cell. Diminished availability of antigen in the later stages
of this sequence would allow B3.1 cells to accumulate.
There is a further pathway by which BU and Bj> cells of the
secondary response type (IgG secreting) must be generated, and this
involves the generation of the B1 cell via blast transformation of
the/...
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the B3.2 cell with loss of C3 receptor. This sequence may be
implicated in Burkitt's lymphoma since the Burkitt*s derived cell
lines all showed either B1, or BU receptor profiles.
B3.2 - loss of C3 receptor, transformation - B1 - Bi* - B$
This sequence clinically should arise in chronic, long standing
immune responses and should be preceeded by follicular hyperplasia.
In none of the lymphomas examined was there clear evidence of
the sequence 33.2 - B1 - BU - B5, and none of the non-Hodgkin
lymphomas showed intracellular IgG as might be expected in mature
secondary response cells. There was, however, clear evidence of
an aberrant follicular response in Hodgkin's disease, with B2.C
cells present in some samples and with many aberrant IgG containing
plasma cells detected in Hodgkin tissue.
This e: ercise shows how it is possible to relate the known
facts about B lymphocyte development in the immune response, to
human lymphoma. By assuming a simple system of maturation blocks,
it is possible to predict the origins and likely outcome of any
lymphoma profile which is of B cell predominant, or of mixed cell
type. It is also possible that in the future manipulation of the
immune response may give rise to rational lymphoma therapy based
on the identification, staging and sequencing of B lymphocytic
lymphoma. The following table summarises the relationship of B
cell •ub-types in non-Hodgkin lymphoma
fielationship/ . . .
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Relationship of B cell subtypes In lymphoma
Precursor Subclass of tumour Next cell in
subclass cell maturation sequence




(This represents an active primary immune response with antigen
present)
B3.1 B2,Fc B3.1
(This represents blast transformation of B3.1 cells in B3.1 lymphoma)
B2.Fc B3.1 B3.3
B2.Fc B3.1 B2.FC
(This represents a quiescent phase between two transformation events)
B2.Fc B3.1 B3.2
(The possibility of developing into a B3.2 tumour is present)
B3.1 B3.2 B2.C
B3.1 B3.2 B1







(This may be the sequence in HodgfcLn's disease)
Bit
(multiple myeloma or Waldenstrom's disease)
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Differentiation of T lymphocytes and its relationship to tumours of this
cell class
The T lymphocyte develops from a stem cell precursor in the
bone marrow, and acquires the characteristic T cell surface
antigen (thy 1 ) in the mouse before entering the thymus to
proliferate. Such cells have a low density of thy 1 antigen, and
do not recirculate in thoracic duct lymph. Their life span is
1-2 days, and they rapidly accumulate following surgical removal
of the thymus. Implantation of a thymus graft produces a fall in
bone marrow release of these cells and control over bone marrow
production is probably mediated via a humoral factor. They also
express the TL antigen normally present only on thymocytes in
TL + mice (Roelants, et al., 1976).
The thymocyte itself shows characteristics in which it
differs from the "peripheralised" T lymphocyte. Thymocytes can
bind IgM antibody (Webb and Cooper, 1973). They express the TL
antigen strongly whereas peripheral B lymphocytes do not, and this
antigen is also found on leukaemic cells in TL + mouse strains.
However, peripheral T lymphocytes can also carry the TL antigen,
although it is masked and not detectable by conventional techniques
(Komuro, Boyse and Old, 1973)* Thymocytes express little H2
antigen in mice, and do not recirculate, most dying in situ shortly
after formation (Stobo, Rosenthal and Paul, 1973). The thymic
epithelium acts as an "inducer" of thy 1 and TL antigens on
thymocytes in the mouse (Mosier and Pierce, 1972).
The peripheral lymphoid tissues in mice contain T cells which
are distinguished by their expression of the Iy antigens. Immature
T/...
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T cells are by 123 positive, as found in neonatal mice. In adults
Iy 2 and by 3 positive, and by 1 positive T cells occur, and these
show different functional characteristics. The cell with by2/by 3
surface phenotype is the cytotoxic T lymphocyte, the cell with Ly 1
surface phenotype shows helper cell activity (Cantor and Boyse, 1975a,b).
These phenotypes are stable, even in leukaemia the neoplastic cells
preserve their ly surface phentotype (Takahashi, 1972). There have
been several reports that "activated" (that is mature reactive T
lymphocytes) express receptors for the Fc portion of IgG (Yoshida
and Andersson, 1972). In the mouse 20$ of thymus cells expressed
Fc receptor (Andersson and Grey, 197U), and Fc receptors have been
found on human T cells (Ferrarini et al., 1975). IgM receptors
were described on human T cells (thymocytes especially) (Morietta
et al., 1975) and in the mouse on cytotoxic T lymphocytes (Lamon
et al., 1975). T lymphocytes are therefore of several different
classes, pre-thymic, thymic, helper T cell, cytotoxic T cell, and
transformed (activated) T cell.
The receptor techniques used can detect E rosetting cells,
and show E rosetting cells expressing IgM. and Fc receptors. The
subclasses of T cell detectable by current technology in man, are
therefore the E rosetting cell (including thymocyte and peripheral
T cells of both helper cell and cytotoxic cell class) the E rosetting
cell with Fc receptors (activated T cell, or T killer cell) and the
I rosetting cell with IgM receptors (thymocyte and cytotoxic T cell).
The only two neoplasms in which T cells were the predominant cell
included a solid tumour in the neck (Wilson) in a young female with
a raised toxoplasma titre, and the acute lymphoblastic leukaemia
(Cooke)/...
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(Cooke) in a boy with mediastinal enlargement on 1-da.j (Sternberg
sarcoma). These two tumours behaved very differently despite
their common receptor features. The tumour of Wilson was removed,
and has not recurred and she remains well. The leukaemia of Cooke
proved rapidly fatal. Undoubtedly these were neoplasms of differing
malignant potential. The lymphoma of Wilson arose in a local
cervical node, with no blood or bone marrow disease detectable, and
no other lymphadenopathy. The association with toxoplasmosis is
problematical, but the response to intracellular parasites is T cell
mediated, and toxoplasma may have either precipitated the
presentation of this lymphoma, or may have occurred because of
defective T cell mediated immunity. The case of Cooke is
suggestive of a tumour of immature thymic T lymphocytes, or perhaps
even of a pre-thymic lesion since bone marrow was also involved.
The cell showed acid phosphatase activity, and this may correlate
with primitive thymic or pre-thymic T cell tumours.
Although only two thymus derived lymphoid neoplasms occurred
in this series, the estimation of T cells in each case turned up
some interesting features.
1) High levels of T cells were found in the tumours of
Bathgate, Swanson and McGrail. All were diffuse well differentiated
lymphomas of B3 cells. In the nodular group Smith E., and Thompson
showed high T cell levels with B3 profiles. In Thompson there was
a slight predominance of T lymphocytes, but for practical purposes
this tumour was regarded as being of mixed receptor profile.
2) In the case of Robertson J., T cells bearing Fc receptors
were found in substantial numbers in the blood. The lymph node
also/...
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also showed the presence of Fc receptor bearing T cells, and
allowing for their presence the receptor profile in the node was
B2.C. This is clear evidence for the association of activated T
lymphocytes with a B lymphoid population of follicular profile.
%
In the other B3.2 follicular tumour (Robertson, A) T cell levels
were high, but mixed E and Fc rosettes were not evaluated. There
is a suggestion again that follicular B cell neoplasms (B3.2 or
B2.C) show features unlike those of other tumours of similar
histological type.
3) Receptor profiles in Hodgkin's disease also showed T cell
abnormalities. There was a marked T lymphocyte predominance in
involved tissues, and T cells of abnormal morphology, and expressing
IgM receptors i*ere detected in some cases. The B cell receptor
profile was frequently follicular, with numerous B3.2 or B2.C cells
present. The points of interest can be summarised in the table
below.
Association of T cell subclasses and B lymphocyte subclasses in
lymphoma.




(E + IgM rosetting)
Activated T cell







The interactions of T cells with B lymphocytes is known
to/...
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to occur at certain stages of the immune response. T helper
cells induce proliferation, with antibody secretion by committed
secondary response IgG secreting B lymphocytes. T suppressor
cells act by suppressing proliferation of the committed precursors
of antibody forming cells. The B lymphocyte of the secondary
response can exhibit the follicular profile (B3.2) and T cells are
found in substantial numbers with B3.2 cells in the germinal
follicles of tonsil. in subsequent differentiation (El; - B5) T
cells play no part. The tumours of B3.2 profile are in this
series either associated with activated T cells, or with immature
T cells as in Hodgkin's disease. These findings strongly imply
that both Hodgkin's disease, and tumours of follicular profile
occur at a level of B cell differentiation corresponding to the
secondary immune response.
In tumours not of follicular profile, the association of
T cells with B cells of B3.1 or B3*3 subclasses is very similar
to that of normal lymph node. If it can be assumed that the
normal node contains committed lymphocytes (B3.1) ready to
respond by follicular transformation (B3.2 cells) to stimulus by
antigen, T cells may be required to present antigen to B3.1
cells either directly or via the dendritic (? reticular) macrophage.
The B3.3 cell profile may indicate cells arising from the alternative
sequence B1 - B2.Fc - B3.3 and these may be precursors of IgM
antibody producing cells in the primary response to antigen.
Injection of an antigen experimentally is known to result in a
non-specific sequestration of T cells into spleen and lymph
nodes (Black, 1975) and this contrasts with specific sequestration
of antigen primed B lymphocytes to the spleen in adoptive immune
responses/....
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responses (Sprent and Lefkoutis, 1976). High T cell levels might
therefore be expected in any node undergoing primary stimulation, or
in the resting phase after a primary response. T cell Infiltration
is only of pathogenetic significance where the B cell profile is
follicular, as this indicates an active secondary immune response
and implies the presence in the affected node of the initiating
antigen. In the active phase of T cell/B cell interaction, T
cells might be expected to express either Fc or IgM receptors.
The sequences of B lymphocyte development as might be
encountered in the normal immune response are shown in the
accompanying table. It is probable that receptor profiles in
lymphoma identify cells arrested in one part of this maturation
sequence:- e.g. the multiple myeloma might be represented by the
top line of sequence (3). The Key summarises the events precipitating,
and phenotypic changes associated with, the shift of each cell in the
sequence and these are lettered above the arrows representing the
sequence changes. The important conclusion is that probably only
$ sequences of B cell maturation exist, and therefore B cell tumours
are tumours occurring during one of these 5 maturation sequences.
In practical terms, this reduces the number of phenotypic subclasses
of B cell lymphoma from 12 to 5 functional subclasses of B cell
tumour.
UUo.
Maturation sequences in normal immune responses by B lymphocytes
as characterised by sui'face phenotype changes
1 ) Normal Maturation sequence to primary response (Igft)
Stem cell - B.1 5 B2.Fc - B3.1 - B2.Fc - B3-3 - BU - B$
2) Generation of primary IgM response from primed B lymphocyte
challenged by antigen.
B3.1 - B2.Fc - B3.1
EVB3.3 - Bli - B$.
3) Maturation sequence of IgG memory cell to secondary response plasma
cell, and regeneration of IgG memory cell in the follicular cycle.
(see U) B3.2 - B1 - B3.2 - B1 - B1 - Bli -
^ G
B B2.Fc - B3-1 - Follicular cycle
h) Generation of IgG memory cells (B3.2) in the follicular cycle
B3.1 - B3.1 - B2.C - B3.2
$) Production of plasma cells during follicular involution
B3.1 - B3.1 5 B2.C - B3.2 - Bli - B£.
KET: Step A ■ Normal differentiation
Step B - Antigen drive with division and daughter call
transformation
Step C » Normal maturation of blast cell to small lymphocyte
Step D • Transformation by antigen and complement loss of
C3 receptor.







Clonal expansion and maturation to antibody
secreting cell (division without blast cell
transformation)
IgM to IgQ switch
Transformation by antigen alone in absence of




Cells bearing both B and T cell markers, including Fc and
C3 as well as E rosetting capacities were found in patients Baird
and Laverick. The T cell bearing Fc receptor alone is not unusual,
according to the literature already reviewed. T cells bearing
complement receptors are rare, but were detected in Hodgkin's disease
as cells exhibiting an affinity for bound IgM used in preparation of
the complement sensitised cell. The cell expressing receptors for
E, Fc and IgM could therefore account for tumours exhibiting overlap
characteristics. The nature of this cell is unknown, but it could
for instance be an activated T lymphocyte, of immature or recent
thymic derivation. In the tumour of McKenzie a second type of
overlap was observed, where F. rosetting cells exhibited surface
Ig. Two explanations of this phenomenon are known. Firstly
antibody binding to the T call may be formed by B cells in the
lesion. In the mouse spleen a subpopulation of thy 1 positive
and surface Ig positive cells are detected, and T cell cytophilic
antibody may play a role in T-B cell co-operation (Playfair, 19710 •
The second possibility is that B lymphocytes were manufacturing
antibody with anti-sheep red cell specificity, giving rise to
immune E rosettes (Steel, et al., 19710•
Lin and Hsu (1976) demonstrated dual E and complement
receptors on peripheral blood leukocytes from a patient with
lymphosarcoma and leukaemia. The same cells expressed IgM and
IgD immunoglobulins on the cell membrane. The receptor was not
directed against IgM since the assay involved the use of zymosan
coated with human complement directly. IgM receptor bearing
T/...
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T lymphocytes form a subpopulation of T cells which fail to exhibit
C3 receptor when tested with zymosan coated with complement.
Mitogen activated T lymphocytes, which express Fc receptors failed
to express receptors for IgM (McConnell and Hurd, 1976).
In summary receptor overlap tumours can be shown to be of
the following types
a) T cell expressing IgM receptojs (E, IgM, spurious 03
rosette).
b) T cell expressing Fc and C3 receptors (E, Fc, 03, No
IgM receptor).
c) T cells expressing surface Ig and 03 receptors (E,
surface Ig, C3)
The presence of an Fc receptor on T cell tumours indicates
"activation" and is a normal T cell characteristic. The presence
of IgM receptor indicates a T cell subclass, which does not
correspond to the activated T cell, and is probably immature.
On the basis of the two cases reported here, it is clear
that receptor overlap tumours show histiocytic, or mixed
lymphocytic and histiocytic histological pattern. They may be
leukaeraic (Lin and Hsu, 1976). The prognosis in the two cases
in this series has been noteably good, despite the primitive
appearance of the cells in diagnostic biopsy. Most other cases
of receptor overlap tumours reported have been in poorly
differentiated lymphocytic or histiocytic tumours.
UUh.
nummary of proposed classification scheme based on surface
phenotype In non-Hodgkin lymphoma. The present histological
equivalents are shown In brackets.
1) Receptor silent tumours
a) lymphoid stem cell (ALL)
b) Lymphocyte - poorly differentiation ("null cell
tumours) (DPDL)
c) Mononuclear phagocyte stem cell (ALL)
d) Reticular cell tumours (HL)
e) Reticulin fibre forming cell tumours (Fibrogenic) (HL)
f) Undifferentiated epithelial tumours (undifferentiated
carcinoma, included only in view of the difficulty in
diagnosis from true lymphoma) (U)
2) Tumours of Macrophages
a) Promonocytic and monocytic leukaemia (SAME)
b) True histiocytic lymphoma (macrophage tumour) (HL)









(HL, DLL (PD), CL, ALL)
(HPDL, HL, DWDL, DPDL, CLL)
(CLL, NPDL, DWDL, DPDL)











£) Receptor Overlap Tumours
a) T cell with IgM receptor
b) T cell with Fc and C3 receptors
c) T cell with surface Ig and 03 receptors
(? Hodgkin's disease)
(dm (l + h), hl)
(lymphosarcoma cell
leukaemia)
6) Leukaemlc Reticulo-endotheliosls (LEE)
a) Polyclonal surface Ig with IgM receptor
Note: that B2 and B3 tumours may be either predominant or mixed.
Hodgkin's disease is ommitted, but shows both B and T cell
abnormalities and must be classified separately.
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The practical Implications of this work
Receptor studies are sophisticated and expensive of time,
money and materials. Whether such work will continue in the
future obviously depends upon the value of such studies today. The
exercise should be shown to be relevant to medical practice, and not
merely of academic interest.
The surgeon or physician treating a lymphoma has a right to
the best advice the pathologist can offer. Because of the
unpredictable clinical behaviour of this disease, most classification
schemes emphasise prediction of prognosis, and response to therapy
as their goal. The study of surface phenotype is of better
predictive value than current histopathology. It clearly demonstrates
the differing prognosis of non-capping and capping B lymphocyte
tumours, and even in a small series studied over a short time, highly
significant (p 0.02) differences in survival characteristics in these
two subclasses were shown. The ominous prognosis in receptor silent,
and B1 lymphoid neoplasms has been justified in nearly every case.
The solid lymphomas showing T cell predominance and receptor overlap
have responded better than current histopathological experience could
predict. Finally the local lymphoma group in practice find value in
the surface phenotype studies$ for the first time physician, surgeon
and radiotherapist know the class of cell they are dealing with, and
can plan treatment accordingly. If macrophage tumours prove
resistant to radiotherapy and susceptible to chemotherapy, valuable
clinical time is not lost in irradiating an unresponsive tumour -
as would probably happen if the lesion was diagnosed simply as
Histiocytic/...
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Histiocytic lymphoma. On the other hand, if the clinician knows
that the tumour is of mononuclear phagocytes, and treats the patient
as for monocytic leukaemia considerable benefit to the patient might
result. The two patients with receptor overlap tumours responded
well to the treatment they received, in other cases of receptor
overlap tumour the same treatment can be recommended as and when
they occur. In 331 lymphomas, and receptor silent tumours none of
the present regimes offers a satisfactory chance of cure. New
thinking about the therapeutic challenge of these lesions is long
overdue. In lymphomas showing a follicular profile (B3.2) it
would now be considered essential to monitor the patient closely,
with repeat biopsy if necessary to anticipate conversion to a B2.C
or B1 lymphoma even if the histology is that of a nodular tumour.
As these examples show the subclassification of lymphoma, by surface
phenotype must now be regarded as an acceptable and desirable
clinical investigation.
Medicine is about the diagnosis and treatment of patients
with disease. Foremost in the minds of many clinicians is the
question of how to treat lymphoma In the best possible way} which
treatment offers the greatest chance of survival? The problem is
rendered more acute in lymphoma by the perplexing variety of
response of such tumours to treatment, the large number of treatments
available, and the occurrence of many cases of lymphoma in children
and young adults. This natural concern has resulted in an
extraordinary number of therapeutic trials of chemotherapy in
lymphoma. Most trials compare treatment A with treatment B in
lymphoma of the same histological type. A distressing feature
of/...
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of such trials is the regularity with which the pathological
appearances are accepted as sacrosanct, while the response of
individual patients is ignored as being "atypical".
As an example consider that in part of a recent, as yet
unpublished, trial a comparison is currently being made of two
cytotoxic drug regimes in histiocytic lymphoma. The patients'
lesions have all been diagnosed by a panel of pathologists as
this entity. Although marginal differences in response of all
patients with H.L. between the two randomised treatment groups
are observed some individual patients do appreciably better on one
drug than the other.
In this thesis, as has been shown, disease diagnosed as
histiocytic lymphoma contains receptor silent, receptor overlap,
B1, B3, macrophage and B2.Fc lymphomas. In other words some of
these tumours are not even tumours of comparable cells, yet all
are subjected to the same drug treatments, with the predictable
outcome that some patients improve and some do not. If accurate
trials of chemotherapy are to be performed knowing at least the
class of tumour cell in the lymph node is mandatory. No one would
think of treating warts and carcinoma of the lung in the same way,
yet it is possible that some B3«1 lymphomas are as "benign" as the
former, and receptor silent tumours are as malignant as the latter.
Both may be treated in the same way because their histological
appearances indicate that they are the same lesion. Obviously
future clinical trials of chemotherapy in lymphoma must include at
the very least a determination of tumour cell class by phenotypic
studies before any valid comparison cante made between two forms of
chemotherapy. An emphasis must also be placed upon the response
of the individual patient; those doing well on a particular drug
must/,..
must be assessed to discover why. Perhaps they have a responsive
tumour (e.g. Laverick) or they may have a B3.1, B3-3 or BU lesion,
in which case the response is governed by the tumour cell subclass
and may be unrelated to the type of treatment received.
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The future identification subclagsificatlon and sequencing of
lymphoma by phenotypic studies
There is a limited area in which phenotypic studies, in the
future, can contribute substantially. The techniques developed
for the identification and subclassiflcation of lymphoid cells in
the normal immune response could be the forerunner of "sequencing"
techniques applicable to B lymphocytic lymphomas. The material so
far presented in this thesis is concerned with (a) identification
of cell class and (b) subdassification of B lymphocyte tumours.
Sequencing is a natural extention of subclassification techniques
to identify the precursor cell of the lymphoma, and its successor in
the differentiation sequence. Once the sequence of surface phenotype
expression is established it can be compared with the differentiation
sequence of normal B lymphocytes and the pathological lesion
identified in terms of function as well as surface phenotype.
Sequencing methods
One technique has already been described; that of unblocking
"blocked" 3 lymphocyte tumours by proteolytic digestion of the cell
surface. This produced changes from receptor silent - 31 - B3
cells (Velzian), B1 - B5> cells (Hogg) and B1 - 32.i?c cells (Heid).
These small fragments of differentiation sequence could correspond
to normal maturation sequence of cells (a) from stem cell to blood
B lymphocyte (Velzian : Stem cell - B1 - B2.Fc - B3.1), (b) in
Hogg the generation of secondary response plasma cells from IgG
memory cells (B3.2 - B1 - B1 - BU - B5) part of the follicular cycle,
and /...
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and (c) in Held (B1 - B2.Fc) a restricted part of the normal
maturation sequence.
Identification of precursor cells cannot yet be achieved,
although it is to be hoped that antisera might establish in which
part of the differentiation pattern the sequence lay. The presence
of secretory lymphocytes containing IgM or IgO antibody clearly
indicates late primary (B3.3 - BU - B5) or secondary response
(B3»2 - Bl| - BE>) sequences. The association of non-capping cells
of B2.Fc or B2.C pattern theoretically corresponds to a blast
transformation event in either primary or secondary response.
Identification of the next cell in the sequence allows definitive
localisation of the event in the pathway of B lymphocyte
differentiation. Much work has yet to be done. Firstly the
establishment of the normal sequence of B lymphocyte development
must be achieved. Secondly methods must be developed for inducing
the tumour cell to differentiate into its end cell, or into the
subsequent phenotype. Thirdly having achieved this the site of
maturation airest must be identified. Finally the event leading
to maturation arrest must be investigated.
In this thesis I have shown that lymphomas can be classified
according to their phenotypic features by the means of simple
functional tests. The Identification of subclasses of B lymphocytes
has been demonstrated. I have attempted to illustrate the value of
regarding the lymphoma as an abnormal immune response with reference
to actual cases, and have shown the relationship between subclasses
of B lymphocytes and prognosis. I have developed a theoretical
scheme based on current knowledge which shows the likely sequence
of/...
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of surface phenotype changes in the various maturation pathways of
the normal B lymphocyte. The potential for sequencing of lymphomas
based on this scheme is shown. It is to be hoped that further
development of phenotypic analysis will lead to a better understanding
of the nature of malignant lymphoma and to significant improvements







The most pleasant part of writing this thesis is the
opportunity it gives to accord to colleagues the thanks they deserve
for advice, assistance and guidance given during the tedious process
of preparation and writing. I have profited greatly from
discussions with colleagues in many disciplines and should like to
include in a general "thank you" Dr. I.I, Smith, Professor W. Ford,
Professor C.C. Bird, Dr. Howard Davies, Dr. C. Inchley, Dr. Spedding
Mieklem, Dr. Donald Weir and Bill McBride.
A special tribute is deserved by "The girls in the lab",
Dr. A.E. Dewar, Mrs. G.A. Young, Miss E. Ramage and Judi Jacobs
who helped the work along, giving valuable technical assistance and
remaining cheerful and efficient during some veiy busy sessions.
Dr. A.C. Parker, and Miss C. Wilson (Department of Haematology, Royal
Infirmary, Edinburgh) were very helpful, frequently obtaining blood
samples .from patients under study and introducing a note of urgency
and reality into the work.
Sheila Gore provided invaluable assistance, especially with
the statistical analysis of the spleen data and calculating the
survival curves for the non-Hodgkin's lymphoma series. Apart from
her professional expertise she also taught valuable lessons, some
in data handling and presentation, without which much of my effort
would have been in vain.
It is a genuine pleasure to record the support given in all
stages of this work by Professor A.R. Currie in whose department it
was carried out. Not only was he instrumental in providing
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excellent laboratory facilities, without which much of this work
would not have been possible, but also allowed me more than my share
of time to devote to experimental work and retained an active
interest in my progress throughout.
It is valuable for any research worker to be associated with
a group of individuals sharing a common interest. In this regard
the physicians, surgeons, haematologists and radiotherapists of the
Edinburgh lymphoma Group provided both the material on which this
work was carried out, and the necessary stimulus needed to ensure
progress. The founding of the lymphoma Group and its organisation
was largely the achievement of one man, Dr. A.E. Stuart, who was
also appointed supervisor of this thesis. It would not be possible
to itemise all the points at which I have received help and support
from Angus Stuart. He was the first to suggest that I let Nature
do the experiments and use her results. He provided material
support for this work, and was always ready to suggest sensible and
worthwhile areas of activity. We collaborated closely over much of
the work, specifically that on Hodgkin's disease, and wrote several
papers together. It is difficult to imagine what might have been
but the existance of this thesis is in major part due to the valued
support of Dr. Angus Stuart and I am pleased to record this tribute
to him.
It is sad to relate that ny thanks to one individual should
be recorded after his tragic death at the age of k7» John Hackay,
Senior lecturer in the department of Bacteriology and I used to meet
nearly every week to discuss common interests in immunology and
virology relating to lymphoma, and to his main interest, rheumatoid
arthritis./...
U55.
arthritis. Over a number of years his criticism and advice proved
valuable to me on many occasions and I valued him as a close friend.
His loss marks the and of an era, which I should like to close by-
dedicating this thesis to his memory.
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synopsis Expression of B and T lymphocyte receptors has been studied in seven cases of reticulum
cell sarcoma. In one case, surface receptors and tests of phagocytic function demonstrated the
histiocytic origin of the neoplastic cells. In four cases, tumour cells expressed both B and T lympho¬
cyte markers (two cases) or showed a normal pattern of expression of B and T lymphocyte markers.
In the other two cases, lymphocyte receptors were not detected, and there was no evidence of
phagocytic function: this class of receptor-silent tumours is of uncertain pathogenesis. The signifi¬
cance of these observations is discussed.
In man the different classes of lymphocyte are
morphologically indistinguishable by light micro¬
scopy, but can be detected by tests which show
differences in the reactivity of the cell surface. B
lymphocytes carry stainable surface immuno¬
globulin (Froland, Natvig, and Berdal, 1971) and
express receptors for complement and the Fc por¬
tion of the immunoglobulin molecule (Shevach,
Jafife, and Green, 1973). T lymphocytes lack stain-
able surface immunoglobulin but show the ability
to bind washed sheep red cells (Froland, 1972)
under experimental conditions. There is also evi¬
dence to show that T lymphocytes carry surface
antigens which are not present on B lymphocytes
but which they share with brain (Brown and Greaves,
1974). By exploiting these differences in surface
reactivity, or antigenicity, B and T lymphocytes can
readily be identified and quantitated in human
peripheral blood (Brown and Greaves, 1974;
Habeshaw and Young, 1975).
There have recently been attempts to identify
neoplastic cells of B and T derivation in neoplasms
of the lymphoid and haematopoietic systems (Smith,
Barker, Clein, and Collins, 1973; Shevach et al
1973; Edelson, Kirkpatrick, Shevach, Schein,
Smith, Green, and Lutzner, 1974; Jaffe, Shevach,
Frank, Berard, and Green, 1974). In chronic
lymphocytic leukaemias most of the examples so far
studied have shown the neoplastic cells to be B cell
in type (Pincus, Bianco, and Nussenzweig, 1972;
Piessens, Schur, Moloney, and Churchill, 1973;
Mellstedt and Petterson, 1974). These cells express
generally a single heavy chain component indicating
a clonal origin (Silberman and Schrek, 1974). In
some cases the neoplastic cells lack receptors for
complement (EAC) (Shevach et al, 1973) or carry
HTLA (human thymic lymphocyte antigen), a T cell
marker (Edelson et at, 1974). In other leukaemias, a
prolymphocytic leukaemia (Dewar, Habeshaw,
Young, Stuart, Parker, and Wilson, 1974) and a
variant of chronic lymphocytic leukaemia (Shevach
et al, 1973) cells bearing both B and T lymphocyte
markers have been described.
In solid tumours of lymph node, lymphocyte
receptors of both B and T type have been described.
In a lymph node secondary associated with thymic
lymphoid tumour the cells were of T lymphocyte
derivation (Smith et al, 1973). In nodular lympho¬
cytic lymphoma, the tumour cells were of B deriva¬
tion, corresponding to the follicular cells of the
normal germinal centre (Jaffe et al, 1974).
Cellular infiltrates in skin associated with mycosis
fungoides, Sezary cell leukaemia, and lympho¬
sarcoma have also been studied (Edelson et al, 1974).
In all cases the infiltrating cells show the charac¬
teristics of T lymphocytes.
Macrophages, which may be confused with lym¬
phoid cells, can also be identified in cellular in¬
filtrates, for example, in grafts during rejection and
malignant leukaemic reticuloendotheliosis. ThisReceived for publication 10 December 1974. in
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technique makes use of the IgG-sensitized red cells
which adhere to macrophages in frozen sections of
the appropriate tissue (Shevach et al, 1973). This
technique can be used to identify complement (EAC)
or immunoglobulin (EA) receptors in tissue, but it
is not suitable for the localization of the sheep
receptor (E) expressed by T cells (Shevach et al,
1973; Jaffe et al, 1974).
There is no firm conviction as to the derivation of
the less well differentiated lymphoreticular neo¬
plasms classified as reticulum cell sarcoma. Gall
(1958) proposed that within this group of tumours
was a group characterized by the resemblance of
tumour cells to histiocytes (macrophages), an entity
which he termed "histiocytic malignant lymphoma'
(see review by Stuart, 1974). Lukes (1968) suggested
that the neoplastic cells were of lymphoid origin
from their morphological resemblance to follicular
centre cells. If either of these opinions is correct, a
study of the surface receptors of tumour cells from
reticulum cell sarcoma might show conclusively
their origin either as T or B lymphoid, or as
histiocytic, thus allowing conclusions to be drawn
as to the pathogenesis of individual tumours.
In this study an attempt has been made to identify
the neoplastic cell population of reticulum cell
sarcoma as being either of T or B lymphoid origin as
proposed by Lukes, or as being truly histiocytic, ie,
macrophage-like, as proposed by Gall (1958).
Materials and Methods
CONTROL LYMPH NODES
Control lymph nodes comprise two groups, the
first consisting of nine nodes from groin, axillary,
cervical, or abdominal groups removed from patients
with non-neoplastic conditions. These were classi¬
fied on the basis of site of origin and light micro¬
scopic appearance. The second group consisted of
five nodes removed from patients with systemic neo¬
plasia (carcinoma or Hodgkin's disease) which were
not microscopically involved by the tumour. These
were classified according to site and diagnosis of the
primary condition. All nodes were obtained as
fresh surgical specimens within minutes of their re¬
moval.
NEOPLASTIC LYMPH NODES
These were received as fresh surgical specimens,
and were immediately received into Hanks BSS or
medium 199 and chilled in ice. The diagnosis of
histiocytic lymphoma (reticulum cell sarcoma) was
made by frozen section and subsequently confirmed
by paraffin section and electron microscopy. The
source was inguinal (case 4) cervical (cases 1, 3, 7),
and axillary (cases 2, 5). An enlarged spleen, almost
totally replaced by tumour, was the source of cells in
case 6.
PREPARATION OF LYMPH NODE CELL
SUSPENSIONS
The lymph node was sliced into small fragments and
immediately transferred to Hepes buffered medium
199, containing 10 units heparin/ml. The fragments
were further teased under the medium and cells
washed out by gentle pipetting. Cells were filtered
through stainless steel gauze, washed twice in
medium 199, and the concentration was adjusted to
3 x 106/ml. Samples were smeared and stained with
Giemsa, and viability was assessed by trypan blue
dye exclusion.
PREPARATION OF SPLEEN CELL SUSPENSION
(CASE 6)
Albumin gradients were used to concentrate neo¬
plastic cells from the crude spleen suspension.
Discontinuous gradients of bovine serum albumin
were set up at 2, 4, 8, 12, 17, 22, 28, and 35 % from
stock bovine serum albumin (Armour) diluted with
medium 199. Each layer was 4 ml in volume, and the
gradients were loaded with 5 ml of cell suspension
containing 100 x 106 cells. Sedimentation was
allowed to continue for two hours at room tempera¬
ture under gravity. All cell suspensions were tested
for viability and smears were made at each frac¬
tionation step to ensure that suspensions were
representative. Fraction 6 (22% albumin) contained
60% large abnormal cells, and was used in the
receptor studies.
PREPARATION OF RED CELLS AND ROSETTES
Washed sheep red cells (E), sheep red cells sensitized
with IgG antibody (EAlgG), and sheep red cells
sensitized with IgM antibody and complement
(EAC) were used in the rosette tests.
E rosettes
E rosettes were prepared by centrifuging washed
sheep erythrocytes, together with lymph node cells in
a ratio of 40:1, at 80 x g for five minutes. Incuba¬
tion was continued for two hours at 4°C, and lymph
node cells binding three or more erythrocytes were
counted.
IgG rosettes
IgG rosettes for detecting Fc receptors were pre¬
pared by sensitizing sheep cells with purified anti-
sheep RBC IgG for one hour at 37°C. Sensitized
cells were washed once in phosphate-buffered saline
and screened for microscopic agglutination. Rosette
formation was assessed as for E rosettes.
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EAC rosettes
Sheep red cells were sensitized with rabbit antisheep
RBC IgM for one hour at 37°C, and then reacted
with either guinea-pig or human complement, using
a two-stage sensitization procedure. The exclusion
of sheep cell determinants was shown by rosetting
with IgM-coated sheep cells alone. Sheep cells
sensitized with complement were incubated with
lymph node cells in a ratio of 40:1 at 37°C for
10 minutes, followed by two hours at 4°C. Quantita¬
tion of rosettes was as for E rosettes.
IMMUNOFLUORESCENCE
Detection of immunoglobulin-bearing cells was
performed using a sensitive 'sandwich' technique.
The morphology of immunofluorescent cells was
assessed by dark ground and phase-contrast micro¬
scopy.
PHAGOCYTIC CELLS
Phagocytic cells were assessed functionally by their
ability to ingest neutral red.
The techniques employed here have been described
in detail elsewhere (see Habeshaw and Young, 1975).
Results
MICROSCOPY
Microscopy of our seven cases shows that all of them
conform to the usual view that reticulum cell
sarcomata are composed of large cells with moderate
amounts of cytoplasm and large vesicular nuclei
which frequently contain nucleoli (fig 1). Electron
microscopy of five tumours confirmed that certain
features were common to all although differences in
the degree of cytoplasmic differentiation were noted.
As a rule the cytoplasm contained large numbers of
ribosomes with quite variable amounts of rough-
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Fig 1 Representative light microscopic appearance of
reticulum cell sarcoma. H & E X 600.
surfaced endoplasmic reticulum. Also mitochondria
were abundant. All cases showed prominent
nucleoli and the nuclei often contained deep clefts or
had a lobulated appearance (fig 2). The neoplastic
cells did not form fibres to any conspicuous degree
and when dendritic cells were found they were inter¬
preted as part of a population of normal residual cells.
Ingestion of dead cells by macrophages was noted
but there was no indication of overt phagocytosis by
Patients Diagnosis Site F(%) EAIgGC/o) EAC r/o) NR (%) Fluorescence (%) Viability ( %)
1 Reactive sinus hyperplasia Coeliac 55 18 40 27 32 65
2 Normal Groin 42 70 46 10 — 80
3 Reactive Axilla 41 8 — — 22 82
4 Follicular reactivity Mesentery 38 13 52 27 35 80
5 Sarcoid reaction Cervical 41 24 31 — 40 76
6 Sinus hyperplasia Mesentery 49 45 — — 22 93
7 Reactive Groin 51 7 9 11 13 84
8 Reactive Groin 32 11 24 10 53 86
9 Reactive Groin 30 16 20 12 27 50
10' Carcinoma Neck 42 18 15 18 32 68
11 HDLP2 Mesentery 56 — — — 29 66
12 HDLP Groin 31 29 49 1 27 55
13 HDLP Groin 24 12 — — 37 87
14 HDNS3 Mesentery 37 27 16 11 33 78
Table I Control lymph nodes (non-neoplastic, reactive, or normal on histological examination)
'Additional nodes from patients nos 10-14 with carcinoma or Hodgkin's disease were normal or reactive on histological examination.
2HDLP = Hodgkin's disease lymphocyte predominance; 3HDNS = Hodgkin's disease nodular sclerosis.
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Fig 2 Representative electron microscopic appearance of reticulum ceil sarcoma. X 3750.
tumour cells. The degree of cytoplasmic differentia¬
tion varied between different tumours and between
cells of the same tumour.
RECEPTOR STUDIES
The receptor pattern of lymphocytes from both
groups of control lymph nodes indicates quite wide
variability dependent upon the site of origin,
viability, and reactive status of the node (table I).
In general the proportion of T lymphocytes is lower
and of B lymphocytes higher than in peripheral
blood. The macrophages are more numerous than in
peripheral blood, although stromal macrophages
are probably not represented in our preparations.
The following ranges of cell receptors were obtained:
E rosettes (T cells) 30-55%, EAIgG rosettes 7-70%,
neutral red phagocytes l-0%-27%, EAC receptors
9-52%, and immunofluorescent cells (B cells)
13-53%. In general the addition of totals of cells
expressing receptors for sheep cells, cells showing
stainable immunoglobulin, and the functional
phagocytes ingesting neutral red gave a total equal
to the percentage of viable lymph node cells.
The values for receptors in the neoplastic nodes
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was at least as variable as in normal nodes (tabic II).
In two cases (3 and 1) the receptor patterns were
indistinguishable from those of normal nodes. In


















Kl 67 28 20
R2 15 — 60 12 26 63
S3 37 9 1 — 39 76
L4 49 40 12 30 — 69
B5 72 43 22 68 32 85
07 30 6 4 7 6 85
Table II Receptor pattern of reticulum cell sarcomas
in lymph node
lymphocyte or T lymphocyte receptors. The phago¬
cytic population was low in case 3, suggesting that
these were normal lymph node macrophages and not
of neoplastic derivation. In the first case (KI) the
majority of cells carried T cell markers, but viability
and phagocytosis were not assessed and it did not
prove possible to distinguish morphologically the
neoplastic cells from reactive lymph node lympho¬
cytes.
In case R2 the proportion of T cells was low, as
was the total of cells expressing EAC receptors. The
percentage of neoplastic cells ingesting neutral red
was significantly greater than in control lymph
nodes, and these accounted for the bulk of the viable
cells. Overnight culture of these cells resulted in a
glass-adherent population of large cells with con¬
voluted nuclei. Some of these ingested red cells coated
with IgG when incubated with them for two hours
at 37°C (fig 3). Many of the cultured cells were
indistinguishable from normal lymph node macro¬
phages, others had large basophilic nuclei, and a few
were binucleate. Phagocytosis of cell debris was
widespread in the culture preparation. The pre¬
dominance of phagocytically active cells in the
original cell suspension, and the presence of morpho¬
logically bizarre phagocytic cells expressing re¬
ceptors for IgG, lead us to conclude that in this case
the tumour cells were of histiocytic, not lymphoid,
derivation. Of the population expressing immuno¬
globulin determinants by fluorescence a minor
population only showed the confluent ring or cap
staining associated with B lymphocytes, a point
reflected by the low level of cells expressing comple¬
ment receptors—also a marker of B lymphocytes.
In case S3 the receptor pattern is within normal
limits.
In case L4, the percentage figures for E, EAIgG,
Fig 3 Very large eel! in overnight culture of lymph
node cells (case 2) which showed IgG receptors.
Note phagocytic vacuole containing erythrocytes.
Phase contrast X 700.
EAC, and fluorescent cells also do not differ signifi¬
cantly from normal values. Elowever, in this case
the total of class-specific receptors expressed exceeds
the total of viable cells and leads to the conclusion
that at least one population of cells must express
receptors not generally expressed by cells of that
class. This is reflected in the totals for cells express¬
ing T lymphocyte receptors (E) and receptors for
EAIgG, which are normally expressed by a propor¬
tion of B lymphocytes and macrophages and not by
T cells. Phase-contrast examination revealed rosette
formation (by large neoplastic cells) with sheep red
cells (E), immunoglobulin (EAIgG), and complement
(EAC)-coated red cells, supporting the concept of
'receptor overlap' (figs 4, 5, 6).
In case B5, this overlap of receptors is confirmed,
especially in relation to the T cell marker E, and the
B cell receptor for EAC, whose combined total is
126% in a population where only 85% of cells were
viable. Phase-contrast examination showed that in
addition a minority of tumour cells failed to rosette
with any of the particles (figs 7 and 8).
Cases R6 and 07 show the presence of a large
J. A. Habeshaw and A. E. Stuart
Fig 4 Tumour cell from case 4 showing rosetting
with sheep erythrocytes. Phase contrast X 700.
Fig 5 Large EAIgG rosette from case 4. Phase
contrast x 700.
Fig 6 Tumour cellfrom case 4, showing adherence
of EAC-coated red cells. Phase contrast X 700.
Fig 6
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Fig 7 EAC rosette and large solitary cell from case 5.
Dark ground illumination X 400.
Fig 8 E rosette and large tumour cell from case 5.
Dark ground illumination x 400.
receptor silent population. Cells forming rosettes
from the spleen preparation in case 6 can be ac¬
counted for by the contaminating lymphocytes and
macrophages in the cell population (table III).
ing no tendency to localize in caps or patches on
the cell surface.
Discussion
Receptors as Percentage Differential Count as Percentage
E 5 Tumour cells 60
EAlgG 18 Small mononuclear cells 23
EAC 18 Polymorphonuclear
leucocytes 7
Table III Receptor studies on albumin gradient
fraction of spleen ceil suspension from case R6
In case 7, phase-contrast microscopy showed that
readily identifiable viable tumour cells comprised
over 60% of the cell population studied. The great
majority of these cells failed to rosette with any of the
test particles or to ingest neutral red, although some
weak EAlgG and E rosettes were formed by tumour
cells. A feature of interest in this case was the
tendency of the tumour cells to show weak diffuse
surface fluorescence with polyvalent antisera. This
staining was not of the type associated with B
lymphocytes, the staining being very weak and show¬
This study of surface characteristics of malignant
cells isolated from lymph nodes was facilitated by
the choice of reticulum sarcoma where the cells are
large and distinctive; furthermore in all our cases
the entire node was replaced by tumour tissue
obliterating the underlying architecture. Thus the
receptor studies reflected the surface constitution of
apredominantlytumourceil population. Nevertheless
it may be difficult to distinguish between reactive
lymphoid cells and neoplastic lymphocytes when the
cells are in suspension and reference to histological
sections is necessary to identify the nature of tissue
taken for experiments.
In one case (2) we are confident in asserting a
histiocytic origin for the neoplastic cells, since these
were phagocytically active both in the original sus¬
pension and in tissue culture, and expressed re¬
ceptors for EAlgG in culture. In addition, these cells
lacked receptors for both E and EAC (T and B
lymphocyte markers).
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In two cases (4 and 5) overlap of receptors was
noted. Since examining these nodes we have de¬
veloped techniques which allow simultaneous detec¬
tion of T and B cell receptors, and an additional
case of prolymphocyte leukaemia has been de¬
scribed in which this phenomenon occurred (Dewar
et al, 1974). Other authors have also noted the
expression of receptors for IgG (Yoshida and
Andersson, 1972) by T lymphocytes undergoing
transformation, by cells derived from chronic
lymphocytic leukaemia (Shevach et al, 1973), and by
circulating cells in an uncharacterized lympho-
proliferative disorder (Sandilands, Gray, Cooney,
Browning, Grant, Andersson, Dagg, and Lucie,
1974). A small population of normal peripheral
blood lymphocytes bearing both B and T cell
markers has also been described (Dickler, Adkinson,
and Terry, 1974). There are therefore two possible
conclusions to be drawn from cases 4 and 5; either
the neoplastic population is derived from a subclass
of lymphoid cells bearing both B and T markers, or
the population is derived from T lymphocytes which
have acquired B cell markers during neoplastic
transformation (or vice versa). In both cases the
origin of the neoplastic cells is lymphoid rather than
histiocytic.
In cases 6 and 7, the tumour cells were receptor
silent, and therefore not classifiable as either lym¬
phoid or histiocytic in origin. In case 6, and one other
receptor silent lymphoma we have studied, progres¬
sion of the disease was rapid and both patients died
within six to nine months of diagnosis. This might
suggest that receptor silence is an ominous prog¬
nostic sign in lymphoreticular neoplasia. It could be
due to loss of receptor characteristics by dedifferen-
tiation of the neoplastic cell, or suggest an origin
from a receptor silent class of cell possibly of stromal
origin (reticulum cell or reticular macrophage).
The presence of small, but detectable amounts of
immunoglobulin on the tumour cells in case 7 do not
necessarily imply a B cell origin. Weak, diffuse
fluorescence of this kind can be observed in carci¬
noma cells from secondarily involved lymph nodes,
and may represent the presence of circulating anti-
tumour-cell antibodies. It is worth mentioning that in
our experience carcinoma, or malignant melanoma,
cells from involved nodes are also receptor silent.
In our two receptor-silent cases the mode of pre¬
sentation, the histological appearances, and the
subsequent clinical behaviour exclude the possibility
of metastatic carcinoma or malignant melanoma.
Receptor studies are expensive in time and it is
pertinent to ask what contribution they can make to
the understanding of lymphoid neoplasms. The con¬
tribution of such studies to pathology and medicine
has already been assessed (Wybran and Fudenberg,
1974). In the field of lymphoid neoplasia, the present
study has confirmed the views of Lukes and of Gall
in proposing lymphoid and histiocytic origins
respectively for this group of neoplasms. The overall
picture is far from clear; in particular no explana¬
tion for the neoplasms with normal ratios of B and T
cell markers is satisfied by the current dogma of
clonal origin from a single class of neoplastic lym¬
phocyte. Two possibilities are perhaps worthy of
further examination: first that the neoplastic state
requires the participation of both B and T lympho¬
cytes, as do the normal phenomena of antibody
secretion and germinal centre formation. As an
alternative, perhaps a fixed neoplastic population
sequesters from the circulation a reactive lymphoid
population which proliferates in concert in the
environment of the node. It is hoped that further
investigations of the solid tumours of lymph nodes
will cast more light on a difficult subject.
Dr Angus E. Stuart is indebted to the Cancer
Campaign for a research grant; both authors express
their gratitude to Mrs G. Young for invaluable
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Extramedullary Plasmacytoma of Stomach
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A single case of gastric plasmacytoma showing unusual clinical and pathological
features is described. The patient had gluten sensitive enteropathy, and showed in¬
creased circulating IgA levels prior to gastrectomy. Progression of the disease was
associated with both K and L light chain proteinuria, hypoalbuminaemia, and vaso¬
pressin resistant polyuria. Pathological investigation revealed the coexistence of IgA
secreting soft tissue plasmacytoma, with IgG secreting myeloma. The significance
of these findings is discussed.
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Of all extramedullary plasmacytomas the
majority occur in the submucosa of the
upper air passages, less than 10 % oc¬
curring as primary neoplasms in the gastro¬
intestinal tract (Wiltshaw 1971).
We report here a plasmacytoma of the
stomach associated with gluten-sensitive en¬
teropathy and diffuse, systematic myeloma¬
tosis of differing clonal derivation.
CASE HISTORY
(Mr. J.M. - Date of birth Oct. 19, 1926)
In 1967 the patient sustained a right hemiplegia
related to a left carotid artery stenosis, followed
by good recovery of function and he was subse¬
quently given a two-year course of anticoagulants.
In 1969 he was diagnosed as having gluten-
sensitive enteropathy with steatorrhea and total
villous atrophy on jejunal biopsy; total remission
of symptoms followed a gluten-free diet and vita¬
min supplements.
In Dec. 1971 an osteolytic lesion was demon¬
strated in the upper end of the left femur follow¬
ing pain in the left thigh. This lesion was pre¬
sumed to be a metastasis from an undiagnosed
primary tumour and was treated in April 1972
by local radiotherapy (to a total of 2,200 rads)
followed by a rapid relief of symptoms and
marked subsequent radiological improvement.
In luly 1972 the patient was admitted for the
investigation of persistent iron deficiency anaemia
and because the stools were persistently positive
for blood. A barium meal and endoscopy showed
an infiltrative lesion in the region of the pyloric
antrum. At this time there was a marked rise in
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TABLE 1
Levels of serum immunoglobulin during the course of the disease
Date
May 31, 1972







IgG 880 mg/100 ml 1,700 mg/100 ml 2,100 mg/100 ml
IgA 2,375 mg/100 ml 550 mg/100 ml 540 mg/100 ml
IgM 22 mg/100 ml 150 mg/100 ml 94 mg/100 ml
Normal values: IgG 800-1500 mg/100 ml, IgA 140-170 mg/100 ml, IgM 50-110 mg/100 ml.
the serum IgA fraction to a level of 2,375 mg/
100 ml (see Table I). No protein was detected in
the urine. At laparotomy the tumour was found
to involve the pyloric region of the stomach, the
base of the mesocolon and the origin of the
middle colic vessels; there was no obvious glan¬
dular enlargement and the liver was macro-
scopically normal. A Polya gastrectomy was car¬
ried out and part of the transverse colon was
resected. Histology revealed a plasmacytoma of
the stomach (Figure 1). Postoperatively the serum
IgA concentration fell to near normal levels (see
Table I). At this time the liver function tests were
normal except for a raised serum alkaline phos¬
phatase of 26 KA units/100 ml.
He was first seen for assessment at the Royal
Infirmary, Edinburgh, in Aug. 1972 when a skeletal
survey showed no abnormality and histology of
specimens from marrow obtained by aspiration
and trephine was normal. No further treatment
was given at that time and the patient remained
in good health until late Dec. 1972 when he was
referred because of marked lymphadenopathy in
the right side of the neck and left axilla. Biopsy
of a cervical node was consistent with a diagnosis
of plasmacytoma. The serum alkaline phosphatase
estimation was now 40 KA U/ml being of liver
origin on electrophoresis. Repeated bone marrow
smears were normal. The patient was started on
prednisolone and melphalan in doses of 40 mg/
day and 4 mg/day respectively. Therapy was dis¬
continued after five days when signs of small
intestinal obstruction developed. Because of copi¬
ous vomiting, the patient was treated with i.v.
fluids and nasogastric suction. Although there
was radiographic evidence of hold-up at the site
of the gastric anastomosis, the symptoms sub¬
sided gradually. On Febr. 15, 1973 a definite mass
was felt in the central epigastrum and the serum
IgG was considerably elevated (see Table I). The
serum albumin had fallen to 2.1 g% and sacral
oedema was noted. For the first time, kappa and
lambda chains were found in the urine and a cold
haemagglutinin in the serum. The direct Coombs'
test was positive to a titre of 1:80. The patient
developed remittent fever and the peripheral white
blood count rose to 27,000 u\, 92 % of the cells
being neutrophils. Repeated blood cultures were
sterile and culture of urine and swabs from the
nose, throat and axilla yielded no significant
growth. The patient was transfused with blood
and given kanamycin i.m. 50 mg daily. He then
developed hyponatraemia, the serum sodium
falling to 114 meq/litre and serum chloride to
88 meq/litre. This was thought to be due partly
to loss of sodium into the 'tissue compartment'
because of hypoalbuminaemia. Treatment with
salt-poor albumin and fluids was instituted and
thereafter the serum sodium rose and serum
albumin reached 3 g/100 ml. The patient then
developed polyuria and within 10 days the diuresis
had risen to 11 1. The urinary osmolality varied
between 280 and 290 m.osm/1 and administration
of vasopressin tannate i.m. failed to induce re¬
duction in urine volume or an increase in urine
osmolality. Thereafter the patient's condition de¬
teriorated rapidly due to a chest infection and
he died on March 8, 1973.
PATHOLOGY
Postmortem findings
Specimens of duodenal and jejunal mucosa
were obtained within 2 h of death, and
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immediately fixed for microscopic examina¬
tion. Postmortem was performed 12 h after
death showing an emaciated man, with en¬
larged cervical (1-2 cm), carinal (3-5 cm),
mesenteric (3-5 cm) and para-aortic lymph
nodes. A tumour measuring 3 x 5 x 2 cm
was present in the upper anterior media¬
stinum, secondary nodules were present in
the pancreas, both kidneys, and tumour in¬
filtration was present in both lung bases.
The tonsils were involved, but no macro¬
scopic tumour deposits were found in
sternal, vertebral, costal or pelvic bone
marrow. No osteolytic lesions were found
in the femora, or skull. The liver showed
fine surface nodularity with dilation of in-
Figure 1. The primary tumour in stomach. The
gastric epithelium is darkly staining, and the
glands separated by a dense infiltrate of mono¬
nuclear cells. - P.A.S. x 95
trahepatic bile ducts associated with a de¬
gree of obstruction at the porta hepatis by
enlarged lymph nodes. The brain showed
an old cystic infarct (2.5 x 1 x 5 cm). Ureters,
bladder and prostate were macroscopically
normal.
Microscopic examination
The primary tumour was an infiltrating
poorly differentiated plasmacytoma re¬
placing gastric mucosa and infiltrating
muscle coats (Figure 1).
In all the effected lymph nodes, tonsil,
pancreas, and kidney the histological fea¬
tures were those of a poorly differentiated
Figure 2. The appearance of tumour in lymph
node. A focus of normal lymphocytes contrasts
with the large neoplastic cells, some of which
show the features of plasma cells. - H. & E. x 425
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plasmacytoma composed of large pleomor¬
phic cells with abundant basophilic cyto¬
plasm (Figure 2). Methyl-green pyronine
stains showed a number of small islands of
tumour cells staining intensely with pyro¬
nine scattered in a uniform population of
poorly pyroninophilic cells. No stromal
component could be identified in reticulin
stained preparations. The tumour in the
mediastinal mass, tonsil and cervical nodes
was less well differentiated than that in
other sites. Necrosis was obvious in mesen¬
teric and para-aortic nodes.
The bone marrow from ribs, sternum and
vertebral column was excessively cellular,
and showed diffuse infiltration with imma¬
ture, though well differentiated plasma cells,
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Figure 3. Bone marrow. Numerous immature
plasma cells are present as a diffuse infiltrate. -
Giemsa stain x 425
quite unlike those found in the lymph nodes
(Figure 3).
The portal tracts in the liver were ex¬
panded by loose connective tissue contain¬
ing plasma cells, lymphocytes, and neutro¬
phil polymorphs. The pancreas showed,
apart from tumour infiltration, prominent
islet tissue and some interlobular fibrosis.
The jejunal mucosa showed the typical
light and dissecting microscope appearance
of sub-total villous atrophy.
In the kidney the principal features
were widespread interstitial oedema of the
medulla, with 'myeloma kidney' changes
in the proximal cortical tubules, and the
presence of cortical tumour nodules.
Amyloid was not present.
* " • •
* • •% Immunological studies
Clinical quantitation of immunoglobulin
was by the method of radial gel diffusion.
In addition, urinary and serum components
were identified by immunoelectrophoresis
with monospecific antisera.
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Immunofluorescent studies
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Material was obtained post-mortem from
lung, kidney, liver, lymph-nodes and bone
marrow. It was immediately snap frozen
onto dies. Frozen sections and freeze dried
paraffin-impregnated sections were cut and
stained for IgM, IgA, IgG and kappa and
lambda light chains by both direct (rabbit
anti-immunoglobulin - FITC conjugate)
and indirect (goat anti-rabbit — FITC con¬
jugate) methods. Appropriate controls were
included at each step.
Immunofluorescent studies showed the
tumour in lymph nodes to stain exclusively
for IgA and lambda chains. Staining was
not uniform, occurring in clumps of cells
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corresponding to the patchy pyroninophilia
already described (Figure 4).
In the portal tracts, IgG and IgA staining
cells were both present, IgG cells pre¬
dominating, and both classes of light chain
were found.
In the kidney there was strong tubular
staining for both kappa and lambda chains,
and tubular IgA was present in the medulla.
The bone marrow showed a very pro¬
nounced predominance of well differentiated
plasma cells staining for IgG; although both
classes of light chain were present there
was a marked excess of kappa over lambda
chain.
Control sections showed weak non-spe¬
cific staining in kidney, liver and lung, but
lymph nodes showed very little non-specific
staining.
Electron microscopy
The plasmacytoid nature of the tumour cells
in the lymph nodes was confirmed. Further¬
more, several of the tumour cells contained
crystalline linear deposits showing a light
band periodicity of 11 nm, and a dark band
periodicity of 11.8 nm. This material oc¬
curred exclusively in dilated endoplasmic
sacs, related to the Golgi areas of the tu¬
mour cells (Figure 5). In addition nearly all
tumour cells contained prominent intra¬
nuclear inclusions.
DISCUSSION
This case adds one more report of gastric
plasmacytoma to the 21 reported in the
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Figure 4. Typical appearance of tumour in lymph
nodes by immunofluorescence. Indirect staining
for IgA. - x 800
Figure 5. Endoplasmic crystalline inclusion in a
tumour cell. - x 68,750
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world literature up to 1971. (For reviews
see Hampton & Gandy 1957, Annamun-
thodo & Robertson 1958, Remigo & Klaum
1971). However, the case presented here
contributes some further details to the as¬
sembling clinico-pathological picture of the
entity of gastrointestinal plasmacytoma.
In this case gluten-sensitive enteropathy
existed before diagnosis of plasmacytoma.
This was proven by biopsy, clinical inves¬
tigation, and response to therapy. The
pathological features of sub-total villous
atrophy were also present at autopsy. In
the literature, most authors stress gastro¬
intestinal symptoms - often associated with
gastric ulceration - and loss of weight as
presenting symptoms of gastric plasma¬
cytoma, although documentation of mal¬
absorption syndrome has not been reported
to date. Rappaport et al (1972) described
the pathological features and demonstrated
severe plasma cell infiltration of the in¬
testinal mucosa and submucosa in Mediter¬
ranean abdominal lymphoma with mal¬
absorption. In this series 16 out of 20
cases subsequently developed malignant
lymphoma. Although no plasma cell tu¬
mours were reported, the authors state
that in Mediterranean lymphoma with mal¬
absorption - 'the possibility is suggested
that this abnormal, though probably not
neoplastic proliferation of plasma cells is
a morphological manifestation of an im¬
mune deficiency state which predisposes the
patient to the development of malignant
lymphoreticular neoplasms'.
In contrast to the case of gastric plasma¬
cytoma reported here, the features of Medi¬
terranean abdominal lymphoma are partic¬
ularly well documented in regard to the ab¬
normal proteins secreted by the tumour cells.
In the majority of cases the paraprotein con¬
sists of alpha chains only (a-chain disease)
(Seligmann et al 1971). In our case the ab¬
normal protein appeared as a fairly diffuse,
myeloma band on electrophoresis, and re¬
acted both with anti-a-chain antisera and
with anti-lambda-chain antisera. By im¬
munofluorescence the tumour cells ex¬
pressed both a-chain and lambda-chain
determinants.
In two cases, reported by Hefferman
(1947) and Ruland (1954) primary gastric
plasmacytoma was followed by the devel¬
opment of skeletal plasma cell tumours.
In this respect Line & Lewis's case (1969)
is also of interest as a mediastinal tumour
was present, with a clavicular deposit of
tumour, and light chain of immunoglobulin
in the serum. In our case, the patient in
the later stages of his illness developed a
raised serum IgG, and at this time both
kappa and lambda light chains were present
in the urine. The direct Coombs' test be¬
came positive. The demonstration, post¬
mortem, of the IgA, lambda chain secreting
nature of the plasmacytoma does not ac¬
count for the presence of the urinary kappa
chain, nor the elevated serum IgG. Serum
M protein components (light chains) were
present in the cases described by Line &
Lewis (1969) and Remigio & Klaum (1971).
Urinary M proteins, or Bence Jones protein¬
uria are generally not present in soft tis¬
sue plasmacytoma (Snapper 1953, Dolin &
Dewar 1956), but may be so when skeletal
'metastases' or co-existent multiple myeloma
is present. In our case serum IgA was ele¬
vated initially but fell when the primary
tumour was resected. Light chains were
present in urine only when elevated IgG
levels were found, and then both classes of
light chain were present. This finding sup¬
ports the view that soft tissue plasma¬
cytomas are not generally associated with
Bence Jones proteinuria. This is probably
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due to the relatively small mass of plasma
cells, but in cases of a-chain disease renal
excretion of a-chain is notably poor (Selig-
mann et al 1971). Lymphomas of the gut,
for example Waldenstrom's disease of the
stomach (Froget et al 1972) or Mediter¬
ranean abdominal lymphoma (Rappaport
et al 1972), are frequently associated with
abnormal serum IgM or IgA paraproteins,
which are poorly excreted in the urine.
In view of the post-mortem appearance
of diffuse myelomatosis of bone marrow,
the great preponderance of cells secreting
IgG and kappa chain in the bone marrow,
the elevated serum IgG and the kappa chain
proteinuria, we believe that these features
indicate myelomatosis of different clonal
origin from the primary plasmacytoma. It
is also possible that the previous reports of
bone involvement in soft tissue plasma¬
cytoma might, in some instances, have been
due to co-existent myelomatosis of different
clonal origin. The late onset of light chain
proteinuria was related to a period of
marked renal dysfunction, ADH resistant
polyuria, and low serum albumin. The
pathological features found in the kidney
were those of myeloma kidney and similar
to those described by Remigio & Klaum
(1971). Amyloid was not present in our
case although para-amyloid deposits were
present in cases described by Ruland (1954)
and Annamunthodo & Robertson (1958) in
lymph nodes. Low serum albumin can exist
without the nephrotic syndrome in patients
with primary amyloidosis with renal in¬
volvement, the serum albumin level being
below the threshold value for renal filtra¬
tion. Although amyloid was not present in
this case, both kappa and lambda chains
and IgA were present in the renal tubules
and interstitium, and may have produced
an equivalent effect to the deposition of
amyloid.
Finally, attention is drawn to the crystal¬
line deposits observed in the cells of this
tumour which are identical with those de¬
scribed in the cells of acute promyelocytic
leukaemia (Cawley & Hayhoe 1973). It is
relevant to note that myelomatosis ter¬
minating in acute leukaemia has been de¬
scribed in four cases (Videbaek 1971) and
monocytic leukaemia in three (Osserman
1971).
The case described conforms to the gen¬
eral features of previously described cases
of plasmacytoma of the gastrointestinal
tract, notably in respect of widespread
lymph node metastasis with haematogenous
spread to kidney, lung and pancreas (Wilt-
shaw 1971). The clinical features illustrate
the well documented initial favourable re¬
sponse of a solitary myeloma of bone to
radiotherapy, and the recentless progression
of a soft tissue plasmacytoma. In retrospect
it seems possible that the patient would
have benefitted from a course of predni¬
solone and melphalan following the resec¬
tion of the gastric tumour, despite the
initial good subjective response to surgery
and the fall in serum IgA.
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Quantitation of Subclasses of Mononuclear Cells in Normal
Human Blood by Membrane Receptor Studies
J. A. Habeshaw and Gillian A. Young
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Summary. A technique for quantitating mononuclear cells expressing E, EA(IgG),
EAC receptors, immunoglobulin carrying cells and phagocytic cells in normal
human venous blood is described; normal values for each of these classes of mono¬
nuclear cell are established. The effects of different methods of cell preparation have
been considered: these were found not to have a significant effect on the final values.
In addition, we describe a second category of 'fluorescent non-capping' cells and
show that these are numerically equivalent to cells which ingest neutral red.
Tuch recent progress in cellular immunology has been based upon the concept of the thymic
lependent 'T cell' and thymic independent 'B cell' lymphoid systems. Currently, attempts
re being made to explore the heterogeneity of lymphocyte populations in man, by use of
urface receptor detecting techniques believed to identify specifically either class of lyrnpho-
:yte. It has also been shown that monocytes, macrophages and their precursors share some
>f their surface receptor properties with lymphocytes. When polymorphonuclear leucocytes
nd red cells are removed from the venous blood, the residual mononuclear cell population
lymphocytes and monocytes) is rich in the class specific receptors for sheep erythrocytes (E),
he receptor for IgG immunoglobulin (EA(IgG)), and the receptor for complement (EAC).
The Complement Receptor (EAC)
The EAC receptor is found on B lymphocytes (Lay & Nussenzweig, 1968; Pincus et al,
972). In chronic lymphocytic leukaemia lymphocytes expressing EAC receptors are in-
reased, as are cells carrying surface immunoglobulin (Wilson & Nossal, 1971; Pincus et al,
972). The macrophage also expresses a receptor for EAC (Mantovani et al, 1972).
The IgG Receptor (EA(IgG))
Receptors for the Fc fragment of IgG are present upon blood monocytes, hepatic, and
picnic macrophages (Huber et al, 1969). Both IgG and EAC receptors on macrophages arc
mportant in phagocytic reactions. Monocyte receptors for IgG are labile, and are regenerated
ifter phagocytosis (Schmidt & Douglas, 1972). Most antibody-forming cell precursors also
lave receptors for IgG (Bastcn et al, 1972).
The Sheep Erythrocyte Receptor (E)
A large proportion ofhuman blood lymphocytes express a receptor for sheep erythrocytes
Correspondence: Dr J. A. Habeshaw, Department of Pathology, University Medical School, Teviot Place,
idinburgh EH8 9AG.
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(E) (Brain et al, 1970; Coombs et al, 1970). In primary immunodeficiency states, with absen
or depressed T cell function, E rosetting lymphocytes were reduced or absent, while in I
cell immunodeficiencies E rosetting cells were normal or increased (Auiti et al, 1973).
Surface Immunoglobulin
Immunoglobulin is readily detectable on the surface of B lymphocytes by direct or indirec
immunofluorescent staining (Papamichael et al, 1971; Froland& Natvig, 1972). Aggregate
of immunoglobulin and fluorescent anti-immunoglobulin occur as 'dots', 'rings' or 'caps' 01
the lymphocyte surface. The reaction seems to be due to the expression of light chains rathe
than heavy chain determinants (Biberfeld et al, 1971).
Phagocytic Cells
In the study of mononuclear cell receptors most authors remove phagocytic cells b'
adherence to plastic or glass surfaces, or to nylon wool columns, or by carbonyl iron ingestioi
followed by magnetic removal (Cutts, 1970). Effective markers for phagocytic population
are colloidal carbon (de Halleux et al, 1973), amaranthus starch and neutral red dye (A. E
Stuart and E. Dewar, personal communication).
EDTA Sensitive Receptors
EDTA has been used in receptor studies to prevent binding of immune complexes t<
macrophages (Bianco & Nussenzweig, 1971) and to inhibit spontaneous sheep cell rosettinj
(Jondal et al, 1972). It does not inhibit the binding of C3 by human monocytes (Shevacl
et al, 1972).
Class specific receptors on mononuclear cells differ from the receptors for antigen upoi
antigen binding lymphocytes, both in the number of cells reacting, and in the functioi
of the receptors. Receptors for antigen are present upon few lymphocytes and these antigei
reactive cells initiate the immune response. In human mononuclear cell populations th
function of receptors for sheep cells (E), Fc fragment oflgG (EA(IgC)), and complement (EAC
are not clear.
Knowledge of the number of each class of mononuclear cell expressing these receptor
provides a powerful diagnostic tool for the pathologist in the fields of immune deficiency
disease and lymphocytic or histiocytic neoplasms, and may give a more rational basis for th
treatment of these disorders by the clinician.
PLAN OF EXPERIMENTS
Preliminary Experiments
Before proceeding to the experimental series reported here, the metl ods of preparatioi
and standardizing the red cell suspensions, and the rosetting techniques used, were testci
using cell suspension from fresh human thymus glands. In a series of seven, the mean value
for E rosettes were 70%, EA(IgC) rosettes 12.8%, and EAC rosettes 2.4%, the mean viabilit
of the thymocytes being 84%. This showed that the methods employed for sensitization o
red cells effectively excluded E rosetting determinants on cells sensitized with IgG or com
plement.
In peripheral blood, the numbers of cells forming rosettes with EAC cells sensitized wit!
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ub-lytic concentrations ofhuman or guinea-pig complement were shown to be unacceptably
■ariable, due, it was thought, to variation in the numbers of monocytes expressing receptors
or complement. The two-stage technique reported here detected numbers of resetting cells
lumerically equivalent to the fluorescent B cell population detected by immunofluorescence,
nd in our hands proved less variable than the original single stage sensitization used before.
?he exact status ofthe complement receptor expressed is at present unknown, but the resetting
ells detected appeared to be B lymphocytes (which possess C3 receptors) and the sensitized
ed cells were agglutinated by anti-C3 (Meloy reagents) but not by anti-C4-
Experimental Series
In the initial experiments venous blood samples from 15 healthy subjects (nine male and
ix female) aged 20-60 years were studied in respect of total white cell recovery, mononuclear
ell recovery, E resetting, EA(lgG) resetting and surface inmiunofluorescent cell populations,
n addition, the reproducibility of the technique was assessed by repeat determinations of
hese characteristics at weekly intervals in three individuals.
Following this, a second series ofsamples from 12 different healthy individuals was studied,
k comparison of the number of cells was made for sheep cell (E) resetting, surface immuno-
luorescent, and phagocytic mononuclears following dextran sedimentation and ficoll triosil
eparation. On ficoll triosil separated samples, in addition, EAC and EA(lgG) receptor mono-
luclears were studied in the presence and absence of EDTA. From data accumulated in these
wo series quantitative values for the separate classes of peripheral blood mononuclears
vere calculated, together with standard deviations for both series.
MATERIALS
1) Ficolll Triosil Mixture
10 parts of 33.9% 'Trisosil 350' (Nyegaard & Co., Oslo) were mixed with 24 parts of 9%
Ficoll' (Pharmacia), sterilized by membrane filtration (pore diameter 0.22 f) and stored
.t room temperature in 10 ml quantities in siliconized universal containers. The specific
gravity was 1.076.
2) Sheep Red Blood Cells (E)
20 ml blood from a single sheep was obtained by venepuncture and mixed with 5 ml
klsever's solution containing penicillin 100 iu/ml, and streptomycin sulphate 200 /ig/ml
n the final mixture. Sheep cells were obtained weekly, and stored at 4°C. Cells were used
vithin 1 week.
3) Other Reagents
Stock solutions of veronal buffered saline (VBS), 0.10 m trisodium ethylenediaminctetra-
icetate (EDTA) and 1.0 m MgCl2 + o.i$ m CaCl2 were prepared (Rapp & Borsos, 1970).
VBS-G-EDTA. 100 ml stock VBS was mixed with 395 ml glass distilled water, and 5 ml
if warmed stock 10% gelatin solution, to give a final gelatin concentration of 0.1%. The
jelatin used was acid ossein (Credo Food Products Ltd), pi 7.1, and was devoid of anti-
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complementary activity. 450 ml of VBS-gelatin was mixed with 50 ml of stock EDT/
solution (VBS-G-EDTA). This solution was freshly prepared each week, sterilized by filtra¬
tion, and stored at 4°C.
VBS-G-Ca2 + Mg2 +. 20 ml stock VBS was added to 0.1 ml of stock i.om MgCl2 + o.i;
M CaCl2, and 1 ml of 10% gelatin solution (warmed) added. The total volume was made uj
to 100 ml with glass-distilled water. This solution was prepared fresh each day.
(4) Rabbit Anti-Sheep-RBC-IgM Haemolysin
This was prepared by the immunization of rabbits intravenously with sheep red eel
stroma according to the method of Kabat & Mayer (1961). The scrum obtained was titrated
and IgM antibody separated by gel filtration on Sephadex G-200, in Tris-HCl buffer, pH 7.3
The first peak effluent contained most of the antibody activity as judged by haemolytii
titration. Titres were 1 in 8500 for 100% lysis with 1 in 10 guinea-pig serum (complemen
Wellcome) diluted with VBS-G-Ca2+Mg2+. Sheep cells were sensitized with a 1 in 4001
dilution ofantibody.
(5) Rabbit-Anti-Shcep-RBC-IgG
This was prepared by the intraperitoneal injection of 10% suspension of washed sheej
red cells (5 ml) weekly for 6 weeks. Agglutination titres of purified IgG antibody were ii
2000. In some of the later experiments rabbit anti-sheep RBC serum (Wellcome Laboratories
was used, at a concentration of 80% of the minimal agglutinating titre.
(6) Fluorescence Antisera
Indirect immunofluorescence used polyvalent rabbit anti-human-IgG+ IgM+ IgA pre
pared by immunization of rabbits with purified pooled immunoglobulins separated fron
myeloma sera. FITC coupled goat anti-rabbit antiserum (Meloy reagents) was used in th«
second stage of the procedure. Commercially available polyvalent rabbit anti-human
IgG+IgM+IgA was also used (Sera Services Ltd). Aggregated material was removed ty
centrifugation for 2 h at 40 000 g before use.
(7) Neutral red was made up as a 0.01% solution in 9 g/1 NaCl (Saline), and sterilized ty
filtration.
METHODS
PREPARATION OF MONONUCLEAR CELLS
(A) Ficoll/ Triosil Separation
20 ml of venous blood from each subject was taken into 200 units preservative free heparii
(Evans Medical) or mixed with lithium heparin (Searle) in a plastic tube. A white cell coun
was done and smears made for later differential counting. 10 ml of anticoagulated blood wa
then carefully layered onto 10 ml officoll/triosil mixture, and centrifuged at 4°C for 25 mil
in standard siliconized universals at 800 g at the blood/ficoll interface.
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The whole leucocyte band was carefully removed and pipetted into plastic tubes containing
ml medium 199 (Wellcome) with heparin 10 units/ml. Cells were then washed three times
a large excess of medium 199 (280 g for 5 min), and resuspended in a known volume of
edium 199. Smears were made, and the total white cell count and recovery calculated. The
tal recovered cells were divided by the original blood volume to give the values per ml of
covered leucocyte population, from which data the mononuclear cell recovery could be
lculated. Viability was assessed by trypan blue dye exclusion, in all cell preparations.
>) Dextran Sedimentation
Blood was obtained as before; white cell counts and smears were made. 20 ml of blood
as mixed with 6.7 ml of 6% Dextran 250 (Pharmacia) in saline (fdter sterilized before use)
id incubated for 1 h at 37°C. The total supernatant plasma was removed and the leucocytes
ere washed as before. Smears of the cell suspension were made, and total white cell count
id recovery were calculated.
I) Ammonium Chloride Lysis
20 ml of heparinized venous blood was obtained as before. A white cell count was per-
irmed and smears were made. The blood was then centrifuged, the supernatant discarded
id the cells washed twice in a large excess of medium 199+ 10 units heparin/ml to remove
1 traces of serum. The third wash was in phosphate-buffered saline (PBS). Cells were
suspended in a small volume of PBS and added dropwise with stirring to a mixture of 9
irts 0.83% NH4Cl solution+ 1 part 0.85 M Tris buffer, at 4°C (see Dioguardi et al, 1963).
he optimal blood/NH4 volume ratio for complete lysis should be determined by experi-
Lcnt (about 10 ml for 1 ml blood). After incubation at 4°C for 10 min, the white cells were
covered and washed three times in medium 199. Smears of the recovered suspension were
Lade, and total white cell counts and recovery calculated.
All smears were stained with Giesma's stain, and differentials (500 cells counted) were
;rformed on whole blood and on the separated leucocyte populations.
PREPARATION OF RED CELLS
(1) Sheep cells (E) were washed four times in PBS, and made up to a standard concentration
f 400 x io6/ml.
(2) EA(IgC) (IgG sensitized cells). Washed sheep cells were incubated in 7S rabbit-anti-
iccp-RBC-IgG or rabbit-anti-sheep-RBC scrum, in a concentration equivalent to 80% of
ic minimum agglutinating titre for 1 h at 37°C. Sensitized cells were then washed twice
; PBS and resuspended at standard concentration in PBS (for EA(IgG) rosettes) or VBS-G-
DTA (for EA(IgG)-EDTA rosettes).
(3) EAC sensitized cells. Washed sheep red cells were sensitized in 1 in 4000 dilution of
ibbit-anti-sheep-RBC-IgM for 1 h at 37°C. Sensitized cells were then washed once in ice
)ld VBS-G-Ca2+Mg2+, and incubated 011 ice for 30 min with either fresh human
rum, or guinea-pig scrum (Wellcome) diluted 1 in 10 with VBS-G-Ca2+Mg2 + as a
)urcc of complement. They were then washed three times with ice cold VBS-G-EDTA,
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allowed to reach room temperature, and then mixed with human or guinea-pig serui
diluted I in 10 with VBS-G-EDTA. Incubation was then continued for a further 30 min ;
37°C, followed by washing twice in VBS-G-EDTA. The red cells were resuspended at
standard concentration in either PBS (EAC cells) or in VBS-G-EDTA (EAC-EDTA cells
Minimal lysis of sensitized cells occurred. Sensitized cells were prepared fresh and were nc
stored in excess of 24 h.
Preparation of Rosettes
In each case 1 x io6 leucocytes were mixed with 40 x io6 red cells of the appropriate su:
pension, in siliconized Wasserman tubes. The total volume was made up to 1 ml, with mec
ium 199, for E, EA(IgC), EAC rosettes, or with PBS for EA(IgG)-EDTA, EAC-EDTA rosette
EAC, EAC-EDTA and E rosettes were prepared by incubation for 5 min at 37°C, whi
EA(IgG), EA(lgG)-EDTA preparations were incubated for 10 min at room temperature. A
rosette preparations were then cooled to 4°C, centrifuged at 180 g for 5 min, and incubate
for 2 h at 4°C.
Resuspension and Counting
E rosettes: great care is necessary to ensure complete resuspension without disruption (
rosettes. Rosettes were resuspended by rotation of the tube on its long axis for a standar
number of turns (x 10). Other rosettes were resuspended by end over end inversion of tl
stoppered tube five times.
Suspended cells were drawn into a Pasteur pipette by capillary action. A single drop ju
sufficient to fill the chamber was placed on either side of a counting chamber (Improve
Neubauer) and the coverslip lowered into place and pressed down. Rosettes were enumerate
as lymphocytes binding three or more red cells, in at least three large squares on each side (
the counting chamber. E rosettes were quantitated as a direct percentage of viable monc
nuclears. All counts were performed in duplicate (two observers) and the values expresse
as the mean of the two counts; those varying by more than + 10% were repeated. Final]
white cell counts were performed on each of the rosette preparations. Rosettes were quai
titated as percentages of the recovered cell population.
Neutral Red Ingestion
1 x io6 white cells were mixed with 0.5 ml of neutral red solution and incubated at 370
for 10-15 min. The cells were pelleted gently and resuspended in a small volume of mediui
199. A drop was placed on a slide, covered with a coverslip and sealed with nail varnisl
The percentage of cells ingesting neutral red was quantitated excluding polymorphs (
present) and dead cells.
Immunofluorescence
The indirect (sandwich) technique was used in the series reported here. Optimal dilutioi
(as previously determined) of polyvalent rabbit anti-human IgM+IgG+IgA antibody we:
added to 2 x io6 washed leucocytes, the cells evenly suspended, and incubated for 10 min
37°C, in siliconized Wasserman tubes. The cells were then washed twice (280 g for 5 min) :
PBS, and cooled to o°C in melting ice. To the cell suspension was added a 1 in 20 dilution <
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:ITC coupled goat anti-rabbit-serum, and incubation at o°C was continued for a further
0 min. The cells were then washed twice in PBS, resuspended in a small volume, a drop
-laced 011 a slide and sealed under a coverslip. Slides were examined immediately, using a
leichart 'Zetopan' research microscope, with dark ground condenser, HBO 200 mercury
apour lamp, FITC-3 and BG-3 filters and amber eyepiece filter. Conventional illumination
ras employed alternately for cell counting and morphological assessment. Viable mono-
uclears only were counted in 20 high power fields (glycerol immersion x 800), and the
uorescent cells expressed as a percentage of mononuclears, omitting polymorphonuclears.
Two categories of cells were counted. Fluorescent capping cells had to show clear caps, or
onfluent ring fluorescence to qualify (see Fig ia, b, c) Fluorescent non-capping cells were
lassed as mononuclears showing small dots of fluorescence diffusely localized over the cell
urface (Fig id). This category ofcell does not cap during prolonged incubation, but fluores-
ent material gathers in a ring of small vacuoles just beneath the cell membrane.
Quantitation of Receptors in Whole Blood
From the white cell count, and the blood volume, the total WBC in the original blood
imple were calculated. The total of recovered white cells following separation was noted
rom the cell count and volume of the washed cell suspension. Differential counts in whole
lood and in the separated fraction enabled the mononuclear cell recovery to be calculated,
"he numbers of mononuclears expressing each receptor in the recovered fraction were
alculated. This numerical value, divided by the mononuclear recovery per cent, multiplied
y 100, gives the value for each receptor per ml of whole blood.
7ormula
Receptor per ml whole blood
No. of mononuclears with receptor in recovered population x 100
Percentage mononuclear recovery
1 practice the numbers of polymorphs in ficoll/triosil separated blood were very small, and
ar this method of separation correction for polymorphs in determining total mononuclear




By all methods of preparation more than 95% of cells excluded trypan blue in all cell
imples.
t) Differential Counts
On whole blood all total white cell counts, and absolute counts ofeach cell type, fell within
ae range of normal values.
(a) Ficoll/triosil suspensions. The mean value for polymorphonuclear contamination was
.9%, representing in absolute numbers a range from 0.0017 x io6 to 0.2844 x io6 cells/ml
50 J. A. Habeshaiv and Gillian A. Young
of the recovered suspension. Mean values for mononuclear cells were 0.96+0.53 x io6/ml ii
the same suspensions.
(b) Dextran suspensions. Mean values for recovered mononuclears in white cell suspension
prepared by dextran were 1.12 +0.48 x io6 cells/ml. Polymorphonuclear contamination wa
high, occasionally exceeding the differential counts in whole blood. (Mean values for poly
morphonuclears 32%, i.i6x io6/ml.)
(c) Ammonium chloride. Polymorphonuclear contamination was intermediate betweei
dextran and ficoll/triosil preparations, but still substantial. Leucocytes prepared by thi
method tended to clump.
(3) Mononuclear Cell Recoveries
Percentage values for mononuclear cell recoveries in both series are shown in Table I
Table I
Series I. Percentage white cell recovery, and percentage of mononuclear cell
recovery from ficoll/triosil gradients
% White cell % Mononuclear

















SD ±4-38 + 6.65
SE 4.96 11.42
Series II. Percentage of white cell recovery and mononuclear cell recovery
following separation on ficoll/triosil or dextran; series of 12 subjects, mean













Mean 52.0 46.8 16.4 34-0
Range (32-68) (37-68) (6-41) (14-61)
SD ±11.6 + 12.0 ±9-65 ±17
Classification of Mononuclear Cells
Fig i. Patterns of membrane fluorescence, (a) Confluent ring fluorescence, with early capping
(small B lymphocyte), (b) Fluorescent capping cell (large B lymphocyte), (c) Patchy membrane
fluorescence (large B lymphocyte), (d) Fluorescent non-capping cell. All photographs x 2000; living
cells, indirect membrane immunofluorescence.
Facing p 50)
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Fable II. Mean percentage values of mononuclear cells reacting with sheep (E), antibody coated erythrocytes
EA(IgG)) and of fluorescent capping cells and fluorescent non-capping cells obtained by repeat determinations on
:hree individuals: Subject I studied six times, Subject II studied on five occasions, and Subject III on four occasions,
with ficoll/triosil recovery, and WBC counts. Range of values for each subject given in parentheses.
EA^JgG) Fluorescent Fluorescent Recovery
Subject E receptor receptor capping non-capping of white WBC count/ml
cells cells cells cells cells blood
I 67/ 24.8% 14-4% 9-8% 10.62% 5.99 X I06
(58-70) (16-40) (11-19) (6-19) (6.3-15) (5.2-6.1)
II 55-1% 39-2% 10.6% 9-56% 14-2% 5.85 X IO6
(48-64) (31-47) (7-2-14) (7-2i) (11.6-17.7) (5.6-6.2)
III 60.0% 32.25% 14-25% 12.8% 14-25% 4.28 X I06
(55-63) (21-40) (13-15) (9-16) (12-17) (3.25-5.83)
By cither method of separation only a minority recovery of mononuclear cells was achieved,
md mononuclear recoveries with dextran and ficoll/triosil separations were similar. The range
af particles which could be studied was greater for the ficoll/triosil method than for dcxtran,
awing to the presence of receptors for EA(lgG) and EAC on the contaminating polymorpho¬
nuclear populations.
[4) Individual Variability
Repeat determinations were made 011 three subjects in this study at weekly intervals. The
data are given in Table IE Mean values, recovery, and white cell count are shown together
with the total range. Subject II is female, Subjects I and III male.
[5) Effect of Different Methods of Separation
In view ofthe potential criticism that the recovered cell population did not reflect accurately
the receptor status in whole blood, a comparison was made between dextran and ficoll/
triosil separated mononuclears in respect of fluorescent cells, neutral red phagocytic cells, and
spontaneous sheep cell rosettes. The assumption was that if one method of separation fav¬
oured one class of cell, this should be reflected in the compared figures. We believe the data
presented (Table III) suggest that E rosettes tend to be higher, and B fluorescent capping cells
lower in ficoll/triosil separated than in dextran scdimented blood, but this trend is not statisti-
Tabi.e III. A comparison of E resetting cells, fluorescent cells and phagocytic cells in samples
separated by dextran (12 individuals), ficoll/triosil (12 individuals) and ammonium chloride lysis
(three individuals); results given as cells/ml whole blood
Dextran sedimentation Ammonium chloride Ficolll triosil
E rosettes 0.83 x io6 + o.099 0.89 X io6 i.o XI06±0.23
Neutral red 0.52 x io6±o.i5 0.38 X io6 0.37X io6 + 0.12
Fluorescent capping 0.76 x io5 + o.I5 0.50 X I06 0.55 X I06 + 0.26
Recovery of mononuclears 46.8 + 12% 53-o% 34-0+17%
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Table IV. Values of subclasses of receptor expressing mononuclears x io6
per ml normal venous blood. Cells separated on ficoll/triosil gradient. Series
2, 12 subjects: ±SD and SE
No. x 106/ml SD SE
E 1.01 ±0.23 ±0.0532
EA(igC) 0.73 ±0.23 ± 0.0529
EA(igG)-EDTA 0.94 ±0.34 ±0.1186
EAC 0.59 ±0.30 + 0.0922
EAC-EDTA 0.94 ±0.53 + 0.2809
Neutral red 0.38 + 0.12 + 0.0137
Fluorescent capping 0.55 + 0.26 + 0.0658
Fluorescent non-capping 0.31 + 0.11 + 0.0122
Recovery of white cells 16.4% ± 9.65%
Mononuclear recovery 34-0%±17%
WBC count 5.98 + 1.28
cally significant. The choice of receptors for comparison is limited to those in which poly-
mononuclears can be excluded, by direct microscopy (as with neutral red or fluorescence) or
by absence of receptor (as with the E rosette).
(6) Normal Values of Receptor Mononuclears in Whole Blood
These are given in Table IV, and a comparison between the first series (15 subjects) and the
second series (12 subjects) is given in Table V. Two unexpected features are presented.
Firstly, the fluorescent non-capping population is quantitatively similar to the neutral red
phagocytic population. Secondly, the mononuclears expressing receptors for EAC and
EA(IgC) are numerically equivalent, but only in the presence of EDTA. A comparison be¬
tween the two series (Table V) shows that with normal subjects, using the standard tech¬
niques described, reproducible results can be obtained on separate occasions.






E 1.09 + 0.27 1.01 ±0.23
EA(igC) 0-73 ±0.36 0.73 ±0.23
FC 0.42 + 0.14 o.55±o.26
FNC 0.18 + 0.09 0.31 ±0.11
Recovery (whole WBC) 14.52 + 4.4% 16.14 + 9.69%
Recovery (mononuclears) 33-3 ±6.6% 34 ±17%
Mean WBC count 4.89± 1.18 5.98 ± 1.28
This table shows the reproducibility of the technique in assessing numbers
of receptor expressing mononuclear cells in two independent series.
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DISCUSSION
rechniques for the quantitation of subclasses of human mononuclear cells have been only
ecently established, and their value in clinical medicine has yet to be assessed. Before useful
:onclusions can be drawn from the 'experiments of nature' encountered clinically, the
lormal data must be established. Early in this study it was appreciated that percentage
juantitation alone, without reference to white cell count, or recovery of mononuclears was
)f very limited value. It was also clear that the simultaneous study of a wide range of recep-
ors was more likely to provide the basis necessary for the future interpretation of changes in
lisease.
One of the least satisfying findings was that none of the separation techniques employed
*ave more than a minority recovery of mononuclear cells. The quantitative study therefore
lad to be based upon white cell counts on whole blood, and raised the question of selective
lepletion of one cell class over another as a consequence of the cell separation procedure.
Vc were unable to show that significant alterations in classes of receptor bearing cells were
elated to the separation procedure, although in our hands ficoll/triosil separation resulted in
i relative enrichment of E rosettes and corresponding depletion of fluorescent capping cells.
Variability between individuals (Table II) can be accounted for by variation in white cell
count, mononuclear recoveries, and possibly other changes related to exercise or stress at the
ime of sampling (Steel et al, 1974). This does not entirely explain the source of 'internal
variability' noted in respect of certain classes of receptor in these experimental series. Within
he limits of experimental error it is usually possible to account for all peripheral blood
mononuclears by adding the totals of E resetting, EAC resetting (or fluorescent capping
:ells) and neutral red ingesting cells. Both B cells and monocytes have receptors for C3 and
or IgG. It appears from our data that for the monocyte to express these receptors by an
tdhercncc reaction, EDTA must be present. Divalent ions stimulate phagocytic uptake by
hese receptors, but not adherence (Rabinovitch, 1967; Mantovani et al, 1972). In the absence
jf EDTA, EAC-receptor bearing cells are quantitatively similar to the fluorescent capping
:ell (B lymphocyte). There is, however, a lack of correspondence between receptor expres-
;ing mononuclears of EA(IgG), EAC-EDTA, and EA(IgG)-EDTA subclasses and fluorescent
:apping cells, implying that a population other than the B lymphocyte may (a) carry surface
mmunoglobulin but not 'cap' and (b) express IgG receptors. Recently a population of
ynrphocytes in normal human peripheral blood expressing E and IgG receptors, and showing
;urface fluorescence, has been described (Dickler et al, 1974). Our observations support the
concept of a fourth class of mononuclear cell, but owing to the technique used for quantita-
:ion statistical verification of this concept is not possible. An additional cause of variation
tetween individuals observed in this series, lies in the reciprocal expression ofE and EA(IgG)
receptors. In both series, some individuals had high EA(IgG) resetting, and low E resetting
cells, and others had low EA(IgG) and high E rosetting cells. These trends were not statistically
iignificant in a small series, but they indicate that the patterns of E and EA(|gG) rosetting may
distinguish between individual subjects (e.g. Subjects I and II, Table II). The fluorescent non-
capping cell has not previously been described as a separate subclass of immunoglobulin
carrying mononuclear cells. It is quantitatively similar to the population of cells ingesting
leutral red, and might be regarded as monocytic. In our experience, cells front monocytic
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leukaemia which retain their capacity to ingest neutral red generally fail to stain for surfac
immunoglobulin, even though they express IgG receptors. Other authors describe fluorescen
cells similar to those described here, and regard them as B cell in type (Papamichael et ai
1971; Fr#land & Natvig, 1972).
The spontaneous rosetting of sheep cells with human peripheral blood mononuclears cai
undoubtedly define a subpopulation of lymphocytes. The evidence for the E recepto
lymphocyte being a 'T' cell is based largely upon studies of human thymus (Jondal et a,
1972; Silviera et al, 1972; Whittingham & Mackay, 1973) and of rosetting in parallel with "
cell quantitation by anti-thymocyte antiserum (Yata et al, 1973; Aiuti & Wigzell, 1973). Ii
our view it is premature to regard the sheep cell rosette test as an indicator of cellular im
munity in man as there is only circumstantial evidence linking deficiency of the E rosettini
population with absent or deficient T cell function. The usefulness of the E receptor lies ii
the consistent values obtained for E rosetting cells in normal venous blood, and it remain
to be seen whether depletion of this class of cell is associated with clinical evidence of dis
ordered T cell function.
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Fresh unfixed biopsy material of spleen and lymph nodes are routinely made
into single cell suspensions in this laboratory for diagnostic tests. This material
comes from a variety of conditions. It has been noted that cell suspensions from
tissues subsequently found to be marked with Hodgkin's disease show a
characteristic clustering of lymphocytes around larger cells which can be
identified as Reed-Sternberg cells. This clustering is visible within moments of
preparation of the cell suspension, as soon as it is placed under the microscope.
Similar clusters of lymphocytes can often be seen on imprints of Hodgkin tissue
stained with Giemsa, and it is likely that the phenomenon is representative of
some specific process occurring in vivo. Control suspensions of normal spleen
removed incidental to abdominal surgery, or after traumatic rupture, reactive
tonsillar tissue, and spleens, lymph nodes and peripheral blood leucocytes from
a variety of other conditions including malignancies have not been observed to
show clustering of this type. In this paper we explore the hypothesis that the
lymphocyte rosetting reaction may be useful in identifying the precursor of the
Reed-Sternberg cell. Because much of the work on the Reed-Sternberg cell has
been contradictory, the findings of others in relation to cytochemistry and
immunology have been correlated with our own. A brief account is given of
staining with anti-human monocyte serum.
Materials and methods
Source of material
Four lymph nodes and one involved spleen were obtained from patients with Hodgkin's
disease of mixed cellularity or lymphocyte depletion type. All contained numerous uni-
nucleated and multinucleated Reed-Sternberg cells on histological examination. The surface
was cut with a sharp knife and gently but firmly scraped. Cells removed in this way were
harvested in Medium 199 and washed once. Cytocentrifuged preparations contained
0-5 x 106 cells/ml which were centrifuged at 3 g for 10 min. in a volume of 0-5 ml.
Reed-Sternberg cells are defined as large cells, either uninucleate or multinucleate and
measuring 20-50 p. diameter. The nucleoli are characteristically prominent and eosinophilic,
the cytoplasm is extensive and appears pale pink after staining with haematoxylin and eosin
and light blue after Giemsa's method. The nuclear membrane is distinct and the nuclei are
often lobulated.
Chamber culture technique
The chambers consisted of a piece of perspex measuring 7-6 cm x 2-5 cm x 0-15 cm with a
circular hole of 1-25 cm diameter in the middle. The hole was covered on one side with a
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coverslip and sealed with silicone grease. The chambers and coverslips were exposed to UV
light overnight. They were filled with cell suspension using a sterile Pasteur pipette and
covered gently with another coverslip, taking care not to leave air bubbles in the chamber.
Time lapse cinephotography was done using a phase contrast inverted microscope fitted with a
warm stage. Time lapses of 5 s or 10 s were selected.
Cell receptors and membrane fluorescence
E rosettes were prepared by incubating washed sheep erythrocytes and lymph node cells in
a ratio of 40 : 1 for 10 min. at 37°C. The mixture was centrifuged at 80 9 for 5 min., cooled at
4 C and incubated at 4°C for 2 hr. The cells were gently resuspended in 5 ml of Medium 199
before cytocentrifugation.
IgG rosettes for detection of the Fc receptor were made by sensitising ox red cells for 1 hr
at 37°C with purified IgG obtained by injecting rabbits with ox erythrocytes.
Complement coated erythrocytes were prepared by mixing washed ox red cells with
purified IgM antibody and fresh human serum adsorbed with acetylated yeast ceil walls. The
mixture was incubated for 30 min. at 37°C and washed in appropriate veronal buffers con¬
taining calcium and magnesium ions.
Cells bearing surface immunoglobulin were identified in suspension preparations by
indirect immune fluorescence using both polyvalent and monovalent rabbit anti-human
immunoglobulin (for detail see Habesnaw and Young, 1975).
Anti-monocyie serum. Cytocentrifuge specimens fixed in ethanol were stained with an
anti-human serum (Stuart, Young and Grant, 1976) using indirect fluorescence combined
with phase contrast.
Cytocentrifugation of rosette preparations. Rosettes were formed by the incubation of the
appropriate red cell suspensions with iymph node cell suspensions, or pronase-treated cell
suspensions in the ratio ofjten RBCjto one]leukocyte (10 x 106 red cells +1 x 106 lymph node
cells) in a volume of 1 ml of Medium 199. The cell mixtures were incubated for 10 min. at
37°C, centrifuged at 80 g for 5 min., cooled to 4°C and incubated at 4°C for 2 hr. The
rosettes were gently resuspended, and diluted to 5 ml by the addtiion of Medium 199. 0-5 ml
was added to each cytocentrifuge chamber and spun at 150 r.p.m. for 5 min. in the cyto¬
centrifuge (Shandon-Elliot Cytospin). The specimens were then fixed in methanol and
stained with Giemsa's stain.
Cytochemistry
Preparation ofsubstrates
Non-specific esterase. 20 mg naphthyl acetate were added to 15 ml of 0-1 m phosphate
buffer (pH 7-3) and 15 ml distilled water. 20 mg " Fast Red TR " were added and stirred
thoroughly. The resulting solution was filtered and used almost immediately.
Acid phosphatase. 20 mg sodium naphthyl phosphate were added to 20 ml HC1-veronal
buffer mixture pH 5. Polyvinyl pyrrolidine and 20 mg " Fast Garnet GBC " were added,
stirred, filtered and used fresh.
Alkaline phosphatase. 20 mg sodium naphthyl phosphate were added to 20 ml TRIS
bufferpH 10. 20 mg " Fast Red TR " were added, and after stirring the solution was filtered
and used.
Peroxidase. 0-2 g benzidine was moistened with a few drops of distilled water and ground
in a mortar and pestle. 200 ml of distilled water were added and the solution filtered. 0-25 ml
fresh 3 per cent. FFCF was added to the filtrate.
Demonstration ofenzyme activity. All smears, dabs and cytocentrifuge preparations were
fixed in 90 per cent, ethanol for 2 min. except those investigated for peroxidase activity, which
were left unfixed. Non-specific esterase was demonstrated by incubation with the substrate
for 20 min. at 37°C. The slides were washed, counterstained with haematoxylin and mounted
in glycerine jelly. Acid and alkaline phosphatases were incubated for 30 min. at 37°C and
their subsequent treatment was identical to that of the esterase preparations. Peroxidases
were treated with 0-5 per cent, copper sulphate for 1 min. Benzidine solution was then
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applied for 5-8 min. Thereafter the slides were washed in water and counterstained with
neutral red. With these methods non-specific esterase acid and alkaline phosphatases
appeared as brownish-red areas. Peroxidase activity appeared blue.
Immunoperoxidase technique. (Taylor and Burns, 1974). Formalin fixed paraffin sections
were brought to alcohol. Endogenous peroxidase was inactivated with a methanol solution of
H2O2 and the sections treated with normal swine serum (1 in 20 in TRIS buffered saline).
Excess serum was poured off after 10-15 min. at room temperature. Specific rabbit anti-
human serum diluted in 1 in 20 normal swine serum in TRIS saline was applied at an optimal
concentration for 30 min. Purified antisera with activity against IgG, IgA, kappa and
lambda chains were used. Swine anti-rabbit serum, diluted 1 in 20 in TRIS saline, was
allowed to react with the sections for a further 30 min. at room temperature. After washing,
peroxidase rabbit anti-peroxidase immune complex solution (1 in 100) was applied for 3 min.
At the end of all stages the sections were thoroughly washed in TRIS buffered saline. The
sections were then exposed to DAB solution (3,3'diamino benzidine) prepared by adding
6 mg of DAB to 10 ml of TRIS buffered saline. Two drops of fresh 10 vol. H2O2 were added
to this solution which was used within 20 min. Colour reaction was developed for 3 min.
Prortase treatment of cell suspensions. Separation of lymphocytes from Reed-Sternberg
cells was performed by incubating a part of the fresh suspension with pronase solution at a
final concentration of 100 ug/ml at 37°C for 1 hr with intermittent agitations. This was
followed by washing three times in buffered saline pH 7-4. The cells were counted and their
viability assessed by exclusion of trypan blue. IgG-coated ox erythrocytes were used to test
for the Fc receptor followed by cytocentrifugation, ethanol fixation and staining by Giemsa's
method.
Results
Cinemicrophologrctphy. Time lapse films taken of the living cell suspensions
revealed a dynamic interaction between lymphocytes and Reed-Sternberg cells.
This intercourse was observed to be of two different types. Some lymphocytes
slide steadily over the surface of the large cells in a vermiform manner, never
ceasing their gliding movements around the central cells (figs. 1 and 2). Other
lymphocytes appear to form immobile attachments by their uropods to the
Reed-Sternberg cell. These cells are actively motile, but are attached by a
narrow thread of cytoplasm; this attachment seems firm—lymphocytes can be
seen tethered by an elongated process to the cell surface, with their nucleus and
most of their cytoplasm some distance away. Even when accidental currents of
fluid flow through the culture chamber these motile cells are not swept away, and
maintain contact with the Reed-Sternberg cell. The surface of the central cell
often becomes completely covered with lymphocytes, forming a structure like a
bunch of grapes (fig. 3). Lymphocytes arrive and can burrow their way into this
mass of cells. Once a lymphocyte becomes a participant in such a melee around
the Reed-Sternberg cell, it can still detach itself, but very often it appears to have
difficulty in doing so.
Although the Reed-Sternberg cell does not seem to suffer from these
inquisitive interactions, one typical cluster was observed and filmed in which
disintegration of the morula occurred, followed by desertion by the lymphocytes
of several dead Reed-Sternberg cells.
On several occasions cytoplasmic processes have been observed extending
from the Reed-Sternberg cell. These are of two quite different types. The first
type are long and thin, emerging from the surface like quills from a porcupine;
they do not branch and most adhere to glass (fig. 4). The other type are not
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adherent to glass, and resemble fronds or veils of membrane floating freely from
the surface of the Reed-Sternberg cell. They often show branching (fig. 5).
Macrophages do not participate in these reactions; they are more active than
usual, adhere rapidly to glass, and commonly show multinucleation.
Morphology of cytocentrifuge preparations and short term cultures
Cytocentrifugation of the cell suspensions followed by Giemsa staining
allowed morphological assessment of all the cells present in the suspension, in
particular the cells at the centre of the clusters which cannot be seen in normal
smear preparations. Binding of lymphocytes to those central cells appeared to
be strong, as the procedure of cytocentrifugation did not disrupt the majority of
rosettes and only infrequently were Reed-Sternberg cells seen without an almost
complete halo of surrounding lymphocytes. Cells in the centres of these
lymphocyte clusters showed a wide spectrum of shape and size. Large typical
Reed-Sternberg cells, ten times the diameter of adherent lymphocytes, were
always rosetied by lymphocytes (figs. 6 and 7). In addition to classical Reed-
Sternberg cells, smaller cells with large nuclei and with an abundance of cyto¬
plasm were part of the same central rosetting cell class. Smaller cells with
basophilic cytoplasm and nuclei only slightly larger than lymphocytes also
showed this distinctive rosetting reaction (figs. 8 and 9).
A subpopulation of lymphocytes was observed which showed a distinctive
lobulation of the nucleus. Some showed segmentation of the nucleus into three
or four lobes in a characteristic " clover leaf" form whereas others showed
irregular buds which projected from the surface (fig. 10). The cytoplasm did not
contain granules. Often these hyperlobulated forms were seen as participants in
the lymphocyte rosette around Reed-Sternberg cells.
Cultures of cell suspension maintained over 4 days showed greater numbers
of lymphocyte rosettes than did the cytocentrifuge preparations. Macrophages
were readily identified as single cells in these cultures and did not form rosettes
with lymphocytes as did the Reed-Sternberg cells. Dense clustering of lympho¬
cytes around small mononuclear cells was especially evident in cultures; the
nature of this central cell is not known but their appearance was quite different
from the mature Reed-Sternberg cell.
Tests with anti-human immunoglobulins. Reed-Sternberg cells, identified
under phase contrast illumination by their size, nuclear morphology and their
rosette of lymphocytes, were not seen to show any specific fluorescence with
polyvalent anti-human Ig serum. Occasionally a faint speckled fluorescence
was observed and dead Reed-Sternberg cells showed diffuse cytoplasmic
fluorescence. Antisera prepared against individual subclasses of immuno¬
globulin did not react with Reed-Sternberg cells. Although many lymphocytes
showed bright specific fluorescence it was exceptional to find fluorescence on
those lymphocytes surrounding Reed-Sternberg cells.
Tests with anti-human monocyte serum. The serum gave brilliant fluorescence
with glass adherent cells, macrophages and granulocytes. No fluorescence was
observed with Reed-Sternberg cells or attached lymphocytes.
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Membrane receptor tests. The ever-present lymphocyte rosette around the
Reed-Sternberg cell often prevented attempts to characterise the cell's receptor
profile. In fresh suspensions treated with sheep erythrocytes, E rosettes were
shown by nearly all lymphocytes forming clusters. E rosettes are fragile and
consequently the number seen in cytocentrifuge preparations is less than that
obtained by counting fresh cell suspensions. It was not possible to say whether
the Reed-Sternberg cell itself possessed receptors for sheep erythrocytes, but
where the lymphocyte rosette was incomplete no sheep cells were adherent.
The cytocentrifuge preparations revealed that a significant proportion of the
hyperlobulated lymphocytes described above were T cells. E rosettes were seen
around them in many cases and they often participated in the apparently
exclusive T cell rosette around Reed-Sternberg cells. It was not possible to
determine whether they were all T cells because, although no atypical lympho¬
cytes were seen with IgG or complement receptors, it is possible that disruption
of these rosettes occurred during centrifugation.
Pronase treatment of cell suspensions was successful in stripping the
lymphocytes from the surface of the Reed-Sternberg cell. After this treatment,
IgG sensitised red cells adhered to the surface in an apparently specific manner
(fig. 11). Attempts to demonstrate an Fc receptor on adherent T lymphocytes
were unsatisfactory.
Cytochemistry. Strong esterase activity, manifested by dense granular
brownish-red deposits of reaction product was seen in a population of large
round cells without adherent rosettes of lymphocytes, which were judged to be
macrophages. Macrophages from one patient who had been subjected to
lymphangiography before excision of his lymph node, showed very strong
esterase activity. In this case the macrophages formed esterase-positive multi¬
nucleated giant cells.
The majority of mature Reed-Sternberg cells were negative for esterase
activity, but in a significant number definite activity could be seen, consisting of
a diffuse faint reddish-brown stain. In a number of cases a small central
rosetting cell was seen to be esterase positive. Lymphocytes never showed
esterase activity and neutrophil polymorphonuclear leucocytes showed granular
positive activity.
No acid phosphatase activity was seen in any of the large number of Reed-
Sternberg cells examined. Specific activity was noted within large cells which
did not form rosettes and these were thought to be macrophages. No alkaline
phosphatase activity was observed in any ceils although positive controls showed
strong activity. Reed-Sternberg cells were uniformly negative for peroxidase.
Macrophages showed faint activity and neutrophil polymorphonuclear leuco¬
cytes showed strong activity.
Immxinoperoxidase. The method consistently demonstrated the presence of
immunoglobulin in plasma cells whose cytoplasm was stained deep brown.
Staining of Reed-Sternberg cells was very variable and frequently negative;
some uninucleate Reed-Sternberg cells gave a diffuse brown colour but this was
never as deep as that of plasma cells. Occasionally, control slides in which
saline was used instead of rabbit anti-human immunoglobulins antiserum
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showed a mild diffuse staining. This represents a non-specific adherence of
antibody at some stage in the procedure rather than a failure to block endo¬
genous peroxidase activity. Controls using DAB solution only on untreated
sections revealed no endogenous peroxidase activity within Reed-Sternberg
cells. The conclusion reached was that some, but not all, Reed-Sternberg cells
contained IgG but the reaction was weak when compared with plasma cells.
Discussion
Histological examination of Hodgkin's lymph node tissue sections has failed
to identify a convincing precursor of the Reed-Sternberg cell. We believe,
however, that the precursor can be recognised in viable single-cell suspensions.
A consistent interaction of lymphocytes around both classical Reed-Sternberg
cells and also around smaller mononucleated cells makes it possible to demar¬
cate a family of cells illustrating the maturation of the Reed-Sternberg cell from
its precursor. Cytocentrifugation of such suspensions allows the morphology of
the cells forming these rosettes with lymphocytes to be examined. Preliminary
observations have revealed a cell measuring 12-14 microns diameter with a
rounded nucleus and clear cytoplasm without granules which is moderately
basophilic. It appears lymphoid, but further characterisation in terms of
cytochemistry and immunology is obviously necessary.
Interaction of lymphocytes and Reed-Sternberg cells was described by
Pulvertaft (1959) who filmed the migration of lymphocytes over the surface of
the cell in cultures of tissue from Hodgkin's disease. He noted that no other cell
type formed such prolonged attachments but made no comment on the signifi¬
cance of the phenomenon as the function of the lymphocyte was still obscure at
that time. Clustering of T lymphocytes around Reed-Sternberg cells is now a
well-documented finding but interpretation of the significance of the phenom¬
enon has received scant attention. Perhaps the most acceptable interpretation is
that an immune response is mounted by cytotoxic T cells against the Reed-
Sternberg cell because of " foreign antigens " on its surface. Order et al. (1971)
have produced evidence which does suggest the presence of a tumour-associated
antigen in Hodgkin's disease to which lymphocytes may be reacting. Further¬
more, it is well known that lymphocyte predominance in this disease correlates
well with the patient's prognosis. Archibald and Frenster (1973) believe they
can show a correlation between the fraction of the Reed-Sternberg cell surface
occupied by lymphocytes and the amount of ultrastructural cytotoxic damage in
the cell. The mechanism of T cell cytotoxicity is still largely unknown but
recently some evidence has accumulated. Intimate contact between the T cell
and the target cell is requiredjand the cytotoxic event is probably secretory in
nature; active protein synthesis by the T cell is necessary. The result is a drastic
increase in the permeability of the target cell membrane followed by lysis
(reviewed by Henney, 1973). Kinetic evidence strongly suggests that cytolysis
results from the collision of a single lymphocyte with a single target cell (Wilson,
1965; Henney, 1971). If the process we have observed does represent T cell
cytotoxicity it is probably not the same process which Henney has described.
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It is certainly not a " one hit " phenomenon and the fact that clusters have been
observed in culture after 48 hr tends to refute the idea that an efficient cytotoxic
reaction is being mounted. It is possible that far from representing aggression
by T cells the clustering is a manifestation of a deranged process of intercellular
co-operation in which the Reed-Sternberg cell is a pathological variant of a cell
type which normally co-operates with T lymphocytes. Cell clusters are well
recognised in experimental immunology, with the central cell being either glass
adherent (and thus presumably monocytic in type) (Neilson et al., 1974) or B cell
lymphoblastoid (Jondai et al., 1975). The absence of activity of the mature
Reed-Sternberg cell with anti-monocyte serum makes it unlikely that it is derived
from a monocyte precursor, and it may be that the Reed-Sternberg cell is of B
cell origin. The segmented lymphocyte of clover leaf or budding appearance
was a regular feature in cytocentrifuged specimens (Stuart, 1976). Egan and
Garrett (1974) noted similar cells in the peripheral blood of patients with
advanced Hodgkin's disease, and Lucas (personal communication, 1976)
suggests these are reactive cells since he has observed them in children with
gastro-enteritis. We believe they may represent a population of reactive T
lymphocytes since they form rosettes with sheep erythrocytes.
Two different kinds of membranous processes were observed arising from
the Reed-Sternberg cell; these may have significance with respect to lymphocyte
interaction at the cell surface. It is perhaps premature to ascribe a function or
significance to these at the moment since they have been observed only on a few
occasions. However, it is tentatively suggested that one of the types may result
from the interaction of T lymphocytes at the surface of the Reed-Sternberg cell.
This is the branching veil-like structure seen waving about in the medium,
obviously not adherent to glass. Film sequences show that these fronds are left
behind when lymphocytes break free. The other kind of membranous processes
are readily distinguished; they arise from the perimeter of the glass-adherent
Reed-Sternberg cell, like quills of a porcupine. They also adhere to glass and do
not show branching. Their significance is unknown.
In common with most other workers we found no esterase activity in the
majority of Reed-Sternberg cells; however, appreciable activity was present in a
significant minority. This activity was faint and diffuse, often located opposite a
nuclear indentation. This demonstration of esterase activity agrees with the
results of Braunstein et al. (1962) although these authors detected stronger
activity in every Reed-Sternberg cell. However, it differs from the findings of
Dorfman (1961) and Kadin (1973) who found complete absence of esterase. It
may be possible to explain these contradictory findings in terms of a gradual loss
of esterase activity as the Reed-Sternberg cell reaches maturity; less likely is the
hypothesis that the Reed-Sternberg cell has more than one cellular origin.
Results with the PAP immunoperoxidase technique were similarly incon¬
clusive, some Reed-Sternberg cells giving a positive reaction and many remaining
negative. What is now required is evidence of the ability of some Reed-
Sternberg cells to synthesise IgG since these tests fail to distinguish between
synthesis and passive acquisition of immunoglobulin. Our experience with
surface membrane fluorescence suggests that if immunoglobulin is present at all,
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it is there in only small amounts. Further investigations of the surface mem¬
brane properties of the Reed-Stern berg cell were difficult to carry out because of
interacting lymphocytes. After treatment with pronase the Reed-Stern berg cell
was able to bind IgG-coated red cells in a specific manner thus indicating the
presence of the Fc receptor. The Fc receptor is possessed by monocytes and
macrophages (Huber et ai, 1969) and most antibody forming cell precursors
(Basten et a/., 1972). It has been described on T cells (Yoshida and Anderson,
1972; Devvar et oh, 1974). Of the reticulum cell class so far investigated,
neither the human reticular cell of Stuart and Davidson (1971), the mouse
dendritic cell of Steinman and Co'nn (1974) nor the dendritic reticular cell of
Nossal et al. (1968) express the Fc receptor.
The sheep erythrocyte resetting test showed that most of the surrounding
lymphocytes around the Reed-Stemberg ceil were T lymphocytes. Fluorescence
tests confirmed that B cells were only rarely present in the rosettes. The Reed-
Sternberg cell itself did not possess a receptor for sheep red cells, and failed
to react with anti-monocyte serum. Our results indicate that the Reed-Stemberg
cell is neither a T cell nor a monocyte. Surface immunoglobulin and peroxidase
reactions do not convincingly indicate a B celi origin but investigation of the
precursor cell as revealed by lymphocyte rosetting may yield useful information.
Summary
Clustering of lymphocytes around Reed-Sternberg cells was noticed in single
cell suspensions made from viable Hodgkin's lymphoid tissue. Cytocentrifuga-
tion of the suspension showed that clustering also occurred around a smaller cell
type, thought to be the precursor of the classical Reed-Sternberg cell. Time-
lapse cine films taken of the clustering showed unceasing activity on the part of
the lymphocytes migrating over the surface of the central cell.
Reed-Sternberg cells were reacted with anti-monocyte serum using indirect
fluorescence techniques. In its mature form at least, the Reed-Stemberg cell
showed no activity with the antiserum. No immunoglobulin was detected in the
Reed-Sternberg cell using fluorescence techniques, but a few Reed-Sternberg
cells showed diffuse cytoplasmic staining using the peroxidase-labelled antibody
technique.
Membrane receptor tests showed the lymphocytes surrounding the Reed-
Stemberg cell to be T-cells. After proteolytic enzyme treatment to free lympho¬
cytes from the surface, the Reed-Sternberg cell bound IgG-coated red blood cells
indicating a probable Fc receptor.
Cytochemistry demonstrated weak non-specific esterase activity in a small
minority of Reed-Sternberg cells, and absence of acid phosphatase, alkaline
phosphatase and peroxidase.
A subpopulation of lymphocytes with distinctive segmentation of the nucleus
was noted. These were often to be seen participating in lymphocyte rosettes
around the Reed-Sternberg cell.
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TWENTY-NINE CASES OF NON-HODGKIN LYMPHOMA
A correlation of surface receptors with
histological appearance using both the
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Sununary
The receptor patterns of cell suspensions from 29
cases of Non-Hodgkin lymphoma were correlated with the
histology of the nodes from which the cells were taken.
Twentytwo were judged to be B predominant or B mixed,
and because of this preponderance feha3e ware divided
by a method based on the distribution of surface immuno¬
globulin and the expression of Fc and receptors.
"Mature" B cell and B mixed tumours showing capping
surface Ig with Fc and/or receptors correlated well with
a nodular growth pattern and consisted of what Rappaport
call3 "poorly differentiated" lymphocytes equivalent to the
"small cleaved" cell as defined by Lukes and Collins. Ten of
the 14 patients in this receptor category are alive between
12 and 30 months after diagnosis.
Receptor silent and "immature" B cell tumours with
non-capping surface Ig correlated predominantly with the
Rappaport histiocytic lymphoma and Lukes and Collins' large
cleaved and large non-cleaveddlymphomas, though these jj
histological categories also included a wide variety of
other receptor types such as T call, Receptor Overlap and
the single true Macrophage tumour. Five of the 11 patients
with receptor silent or immature B cell tumours are alive
between 7 and 15 months after the diagnosis.
Diffuse mixed and diffuse poorly differentiated
lymphocytic lymphomas in Rappaport's classification
correlated poorly with receptors, mature and immature B cell




The first purpose of this paper is to show how
receptor studies on human lymphomata may be used to
identify the cells present (Table I; .figure 1), the
second is to assess the maturity of the B cell by a
number of cell surface markers, and the third is to
relate the surface markers to the histology of the
tumour. Previous attempts to identify the cells present
in human lymphomas by surface marker techniques (Brouet,
Labaume and Saligmann,1975; Cooper et al.,1975? Dorfman,
1975; Gajl-Peczal3ka, Bloomfield and Sosin, 1975;
Habeshaw and Stuart, 1975; Jaffe et al., 1975, Huang et
al.,1974; Peter, Mackenzie and Glassy, 1974; Stuart and
Habeshaw, 1976; Smith et al.,1973) have all shown that
most non-Hodgkin lymphomas consist predominantly of B
cells with a minority of T cells; a few are derived from
T cells and those arising from macrophages are distinctly
uncommon. Tumours without B, T or macrophage markers, we
call receptor silent. Some authors have encountered
tumours in which the sum of B cells and T cells appears
to exceed tha total cell count, Thi3 suggests simultaneous
expression by cells of both B and T characteristics, named
by us as receptor overlap (lin and Hsu, 1975; Habashaw and
Stuart, 1975; and Murphy, 1975).
The receptors expressed at different stages of B
cell differentiation in tha mouse have been well documented
(Gelfand et al.,1975; Metcalf et al.,1975; Ramasamy, Munro
a i
and Milstein,1974; Sidman and Unanua, 1975(a), (b) . These^'showed
failure of surface Ig to 'cap' (aggregate at one pole of
& ull c/eueto
the cell) in the immature stages^ As maturation
proceeds /
-5-
proceeds, the cells 'cap' surface Ig and express first
Fc and then both Fc and C-, receptors. The plasma cells,
or mature secretory B cells, have inconsistent surface
markers, but contain intra-cytoplasmic Ig. (Corte et al.,
1975). Wa and others have found identical variations in
the pattern of surface Ig, Fc and receptors in human
material such as normal peripheral blood (Habe3haw and Young,
1975), tonsil (Siegal, Grieco and Gupta, 1974), and in
lymphomas (Brouet et al.,1975; Dorfman, 1975; Jaffa et al.,
1975; Stuart and Habeshaw, 1976; Habeshaw and Stuart, 1975;
Moscatelli, Bricarelli and Quartino, 1976) . It therefore
seems likely that the sequence of phenotype change seen in
mature mouse B lymphoid populations also occurs in man. If
this were true, then the expression of surface Ig, Fc and
receptors may be a means of assessing cellular
differentiation in human B cell neoplasms. In this paper
we propose a scheme of B cell differentiation in human
Non-Hodgkin lymphoma based on the experimental and natural
observations previously cited.
Tumours in which the B cells express an undifferentiated
receptor profile should appear immature histologically and
behave aggressively clinically. The opposite should apply
to those tumours assessed as well differentiated by surface
A
markers. In this paper we test this hypotheses in 25 tumours
of B cell or receptor silence type.
MATERIALS /
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MATE RIALS AND METHODS
The techniques employed are described in outline
since details have been reported previously (Habeshaw
and Young,, 1975; Stuart add Habeshaw, 1976; Dewar et
al.,1975).
Lymph node call suspensions
Cell suspensions in tissue culture medium were
prepared from lymph node biopsies. Cells were not
fractionated and when viability wa3 less than 60 per
cent, the suspension was discarded. The material is not
selected in any way other than this and represents a
continuous series of cases.
Antibodies;- Rabbit anti-sheep-rad-call and rabbit
anti-ox-red-cell antibodies
IgM antibodies were prepared by the intravenous
immunisation of rabbits with boiled ox or sheep erythrocyte
stroma according to Kabat and Mayer (19 61) . The IgM was
obtained by Sephadex G 200 gel chromatography in O.Ira
tris/HCl or glycine buffer at pH 8.0 - 8.4. The first
peak effluent contained most of the IgM and most antibody
activity by tray titration.
Rabbit anti-ox-red-cell, anti-sheep-red-cell, and
anti-human-red-cell IgG antibodies were mads by conventional
subcutaneous and intraperitoneal immunisation of rabbits
wfcth the appropriate stroma. Purified IgG was obtained by
salting out, dialysis against distilled water, and batch
chromatography on DEAE cellulose.
Rabbit ant i-human-C and C. antisera were used to
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In 23 cases In this series particles were prepared,
and rosettes formed according to the standard methods
described by Habeshaw and Young (1975). In 6 cases, Fc and
receptors were prepared using rabbit anti-ox-rbc IgG (for Fc)
and rabbit anii-ox-rbc IgM + human R^ reagent (C^d receptor)
(Lachman et al.,1973). Controls showed that results obtained
with sheep or ox red cell were comparable for Fc and C^d
receptors. A heavily sensitised red cell is needed to detect
all cells expressing an Fc receptor. Mixed j£r and Fc receptors
were detected using human red cells sensitised with rabbit
anti-human-rbc IgG as previously described (Dewar et al.,
1974). Rosette counting is facilitated by the addition of
0.1ml of 0.01$ solution of acridina orange to the suspended
rosettes immediately before examination by fluorescence and
phase contrast microscopy. GBrostoff, 19^74) .
Immunolluorescent stalningi
Antibodies against human serum immunoglobulin were
obtained commercially, these included polyvalent rabbit anti-
human-iramunoglobulin (Nordic), FITC coupled goat anti-rabbit
serum (Meloy, Nordic), and monospecific antisera against
heavy (IgM, IgA, IgG, IgD) and light (Kappa,Lambda) chains of
immunoglobulins (Nordic, Meloy, Dakopats). Capping is a
phenomenon dependent upon the degree £>f cross-linking in the
surface Ig anti-Ig complex, and both temperature and time of
incubation. The conditions cited are those which specifically
favour the formation of 'caps' in normal B lymphoid tissue.
Increasing times of incubation beyond 30 minutes can lead to
cap shedding or interiorisation in normal lymphoid cells, and
give /
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giva rise to an erroneous measurement of B lymphoid call
numbers.
All antisera were centri£uged at llO,OOOg for one
hour before use to remove aggregates of Ig. They wera then
aliquoted in 0.1ml quantities and stored at -20°C for up to
one month. It should be emphasised that removal of aggregated
Ig from anti-human or anti-rabbit immunoglobulin antisara by
high speed centrifugation is essential - otherwise B cells as
well as all other cells expressing the Fc receptor will be
stained, and any capping which occurs is then due to capping
of Fc receptors rather than capping of surface Ig/anti Ig
complex.
In two cases, the capacity of the tumour call3 to
synth©3ise surface Ig following trypsinisation was assessed.
Cells were treated with 0.25% trypsin (Armour) in PBS for
30 minutes at 37°C, to abolish surface Ig staining entirely.
After washing, the cells were cultured in medium 199 + 10%
FCS for 24 hours and reassessed for presence of surface Ig,
and for intracytoplasmic Ig.
Receptor Terminology
Using these methods the tumours are assigned to the
classes indicated in Tables I and II according to the receptor
pattern that predominates over the sura of all others.
The term "Mixed" implies that no single class exceeded
the sum of all others. In each of these case3, the word




The sen3itlsatlon procedure described by
Dewar et al. (1975) ensures that single cells expressing
both T cell and B call characteristics are not overlooked.
Receptor Silence
Cell3 failing to express receptors by any of the
•Methods outlined are clearly of unknown origin and May be
derived from a metastatic carcinoma or sarcoma in a lymph
node. Where this has seemed likely on clinical and histo¬
logical grounds the case has been discarded, leaving,
nonetheless, some cases of histologically undifferentiated
neoplasms with an undoubted lymphomatous 'look' and
clinical findings appropriate to that diagnosis.
Histological and Cytological Evaluation
Tissue for histology was taken from the slice of lymph
node biopsy next to that from which the cell suspensions
were made. Fixation was in 10% formaldehyde in saline.
Sections were cut at 2.5 microns and stained with H & E,
Gordon and Sweet's reticulin, Giesma and Methyl-green Pyronin
stains. The tumours x^ere classified using the Rappaport
(1S56) and Lukes and Collins (1975) classifications.
Dabs of freshly cut lymph node surface and smear3 of
the cell suspensions were stained with May-Grunwald-Giesma.
As well as giving increased cytological detail of the cells,
these techniques helped us judge whether the cell populations
in the tissue sections was equivalent to that in the
suspensions. Intra„cyto»plasmic immunoglobulin content of the
tumours was assessed by the P.A.P. technique





The results of the receptor analysis are shown In
Table I which shows that 22 of the 29 tumours were
predominantly B cell. Nine of these 22 were classed
as "B mixed" since thay contained an appreciable number
of T cells. Two showed receptor overlap, one was a
macrophage tumour and the last a T cell tumour.
bci
Table II shows how the B lymphoma can be further
subdivided according to their expression of surface Ig,
Fc and receptors and cytoplasmic Ig. Although the origin
of receptor silent cells is unknown thay are included, for
convenience, with the B cells. The horizontal line indicates
an important division between tumours whose cells cap their
surface Ig called mature, and those that do not
(B^B2) regarded as immature. The mature cells express
receptors for Fc and immature cells may have no surface
receptors or an Fc receptor only, but never both Fc and C^.
Cases expressing only receptors on non-capping B cells
ware not seen in this series but may well occur. Capping of
(5fe<w
surface immunoglobulin (Fig.!) occurs mora rmwunnty in reactive
than in neoplastic nodes. Nevertheless a higher proportion
of non-capping cells were found in two highly reactive nodes
with germinal centres giving a B2 receptor profile. Eighty




Comparison of Receptor Patterns with Rappaport's
Histological Classification (1966)
telC
The correlation of histology with the surface
phenotype is shown in Table XII. Three of the four well
differentiated lymphocytic lymphomas (Fig.2) had cell3
that were mature morphologically and by their expressed
receptors. Two of these are alive and in remission, the
third also in remission, died of a myocardial infarct.
The fourth patient ha3 clinical features typical of
chronic lymphocytic leukaemia but, unlike the other
three, his lymphocytes in both blood and lymph node
biopsy expressed an immature receptor pattern.
In the nodular lymphomas, all were poorly
differentiated lymphocytic histologically (Figs.3 and 4),
. . all but one showed a mature receptor pattern and all
but one are alive and in remission. There was a sequential
change in the receptors of the patient who died. At biopsy,
of
the lymph node cells were B^ (with a high proportion T cells),
but the blood B lymphocytes were B2 with a receptor silent
population of 10%. In spite of histology that frequently
*
indicates a good prognosis, the patient had ra^dly
progressiva disease, 2d# l£en days later the receptor silent
population in the blood had risen to 40%. The patient died
soon after and autopsy showed a diffuse poorly differentiated
lymphocytic lymphoma. We have since encountered a case of *
follicular (nodular) lymphoma where the follicle centre cells
wore unusually large and there were numerous mitotic figures.
The receptor profile was B2-
In /
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In the diffuse poorly differentiated and diffusa
mixed group there were tumours with both mature and immature
B receptor patterns and poor correlation with histology.
The Rappaport 'Histiocytic' group included five B cell
tumours and two with receptor silence. Four of the B cell -
tumours had an immature receptor pattern. One patient with
a tumour became leukaamic terminally with the majority
of his peripheral blood cells showing receptor silence.
Comparison of receptor patterns with Lfckss and Collins
Classification (1975)
Table IV shows that 13 of the 15 small lymphocyte
and small cleaved cell tumours consisted of mature B
lymphocytes as judged by receptors. Five of the Six large
non-cleaved tumours (Fig.5) ware either immature or
receptor silent. If the large cell groups
(both cleaved (Fig.4) and non-cleaved (Fig.5)) are taken
together, ei^ht of the ten show immature receptor profiles or
receptor silence. The large cell groups showed the
greatest heterogeneity of receptor expression. In contrast,
the small cell tumours with two exceptions expressed mature
B lymphocyte characteristics.
DISCUSSION
These studies amply confirm that B cell tumours are
the commonest of the Non-Hodgkin lymphomas. However, a
variable number of T cells was noted in more mature tumours
where frequently neither T nor B cells predominated over
the sum of all others present. This mixed pattern was noted
especially in the follicular or 'nodular' lymphomas. It is
not known if this represents contamination of a neoplastic
B /
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B population fey reactive T cells. One may speculate that
the physiological co-operation of T and B cells may be
echoed in neoplasms and if so, the concepts of "neoplastic"
and "reactive"populations may be functionally irrelevant.
Reservation must be expressed over the small number
of T and macrophage derivad tumours observed in this series.
Reliance on E rosetting by itself as a method of identifying
T cells is possibly insufficient and current techniques of
identifying macrophages ignore the precursor cell.
Salmon and Seligraann (1974) proposed a scheme of B
lymphocyte development in lymphoma based upon the class
of secretory or surface expressed immunoglobulin. The classes
of B lymphoma proposed were (B stem cells), (virgin B
lymphocyte) , (immunoblast}, B.} (memory B lymphocyte) ,
(plasmacytoid lymphocyte) and 8^. (plasma cell) . They suggest
that the course of development of lymphoma Involves the
triggering of a clone of responsive cells by antigen, followed
by a second oncogenic stimulus which leads (to irreversible
proliferation of •committed' B cells. In their classification,
the B^ tumours are represented most commonly by CLL and the
'
M
well differentiated lymphocytic lymphoma group. The tumours
are derived by division from cell3, and the Bcomponent
is the cell found in poorly differentiated lymphocytic lymphoma
Burkitt's and some histiocytic lymphomas. The B3 Or 'memory'
cell has no equivalent in the lymphomas but from it is derived
the lymphocytoid plasma cell (B^) which secretes IgM. The
final stage, B^, i3 the plasma cell.
The classification employed by us has some similarities
but all the steps in our proposed maturation sequence are
defined by receptor patterns demonstrated by us and others in
normal,
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nonnal, experimental and neoplastic lymphoid populations.
and tumours are those in which the majority of cells
have non-capping surface Xg. tumour calls have, in
addition, an Fc receptor. and B^ tumour cells cap
their surface Xg and have both Fc and receptors.
tumours differ from by having few Fc and receptor
bearing cells and sometimes showing intra-cytoplasmic Ig
to a slight degree. Xntracytoplasmic Ig is prominent in
Bg tumours.
In our scheme, the primary division is between B
cell tumours that cap their surface Ig and those that do
not. As experimental work previously cited suggests that
this may be an indicator of B cell maturity, it seems
justifiable to use capping as a criterion to divide human
B lymphomas into 'mature and immature' groups. If this
correlated with histology and survival, then receptor
studies might prove clinically useful.
Bp. lymphomas correlate well with a nodular
growth pattern (Rappaport, 1966) and with small cleaved
follicular centre cells (Lukes and Collins, 1975). All have
substantial numbers of ? lymphocytes in the affected node,
giving ri3e to a mixed rather than a B predominant receptor
pattern in half the patients with nodular Ijsmphomas. The
similarity of this pattern to the reactive lymph nodes should
be noted. These findings conflict with Rappaport'a term
'poorly differentiated* lymphocytic as ten of the thirteen
tumours of thi3 cell type had mature receptor profiles.
Table III shows that B cell immaturity as assessed by
surface phenotype correlates reasonably well with histology
showing large cleaved and non-cleaved cells. Thi3 is in
reverse order to the theoretical., basis of the
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cleaved cells are at the start of the transformation
sequence and, therefore, should be less mature functionally
than the large non-cleaved cells which are thought to be
the penultimate stage before B lymphocyte differentiation
into plasma cell, The large non-cleaved tumours are, broadly
speaking, equivalent to what Bappaport calls histiocytic
lymphomas. This group shows the greatest heterogeneity of
receptor expression including two with receptor silence,
five B cell tumours (4 immature, 1 mature), one with receptor
overlap and only one true histiocytic or macrophage tumour.
Brouet et al (1975) reported five histiocytic lymphomas,
four with receptor* silence and one with receptor overlap.
This heterogeneity is reflected in the varied
clinical behaviour shown by these lymphomas in two large
retrospective series (Durant et al.,1975; Schein et al.,1974).
There is no way of separating the small number of histiocytic
lymphomas that do well, even after local treatment, from the
many that are rapidly fatal. Identification of distinct
t - .
sub-groups by receptor studies could therefore be very
t
valuable. It is noteworthy that the receptor overlap is the
only receptor class in which there has been no deaths so far;
one was a diffuse histiocytic lymphoma, the other diffuse
mixed. Both were hard to classify histologically and a search
of retrospective material is being undertaken for cases of
similar histology.
Neoplastic cells which appear receptor silent may
develop surface Immunoglobulin following trypsinisation and
overnight culture. This treatment is often not possible
\
A •
with large cell 'histiocytic' tumours whose calls in culture
show /
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show poor viability. Three of our cases were receptor
silent at the time of initial biopsy and two became so
as their disease progressed; all aro dead within 2 years.
This pattern of receptor silence must be distinguished
from that seen in some patients with diffuse, well
differentiated lymphocytic lymphoma and chronic lymphatic
leukaemia whose small round morphologically mature
lymphocytes in both blood and lymphnodes fail to express
surface Ig, and Fc receptors. These are possibly
•null' cells. We have encountered one such case which
after trypsinisation and overnight culture, expressed
non-capping surface fluorescence (Table III). In two
similar cases seen too recently to be included in this
series the cell3 remained receptor 3ilent after
trypsinisation and overnight culture.
Correlation of receptors with clinical survival
is not possible i^ifch any certainty in this small series
due to the short period of follow-up in some cases.
Nevertheless, ten of fourteen patients with 'mature*
receptors are still alive (one died of a myocardial
infarct) compared with five out of eleven whose receptors
were 'immature'.
TABLEI
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H = Histiocytic or Undifferentiated
WD » Well Differentiated




Comparison of B surface Phenotype and Receptor Silence
with Lukes and Collins Classification
Small Small Large Laj?ge




This group includes one Lymphopla3inacytold tumour
Imraunoblastic sarcomas have been classified with
the large non-cleaved tumours
Receptor Silent
B1 B2 1 12
(follicular)
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Figure I Capping and non-capping surface Ig
bearing cells in 28 control lymph nodes (A. )
and 22 B cell lymphomas (O).
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